{
  "Status Epilepticus": {
    "id": "status-epilepticus",
    "title": "Status Epilepticus",
    "version": "1.4",
    "icd10": [
      "** G40.901 (Epilepsy",
      "unspecified",
      "not intractable",
      "with status epilepticus)",
      "G41.0 (Grand mal status epilepticus)",
      "G41.1 (Petit mal status epilepticus)",
      "G41.2 (Complex partial status epilepticus)",
      "G41.8 (Other status epilepticus)",
      "G41.9 (Status epilepticus",
      "unspecified)"
    ],
    "scope": "** Management of convulsive status epilepticus (CSE) and non-convulsive status epilepticus (NCSE) in adults. Covers staged treatment protocol from emergent benzodiazepines through refractory and super-refractory phases. Includes diagnostic workup to identify underlying etiology and specific protocols for NORSE/FIRES. Excludes pediatric status epilepticus, neonatal seizures, and psychogenic non-epileptic status.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities, renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Ionized 4.5-5.3 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, oxygenation, ventilation status",
            "target": "pH >7.2; correct severe acidosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated in prolonged seizure; marker of severity",
            "target": "Will be elevated; trending useful",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs, withdrawal states",
            "target": "Identify triggers",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol withdrawal common cause",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ASM levels (if on therapy)",
            "rationale": "Subtherapeutic levels as precipitant",
            "target": "Therapeutic range",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pregnancy test (women of childbearing age)",
            "rationale": "Eclampsia; affects ASM choice",
            "target": "Document status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, valproate toxicity, urea cycle disorders",
            "target": "<35 μmol/L",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid storm/myxedema",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac stress from prolonged seizure",
            "target": "May be elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CPK/CK",
            "rationale": "Rhabdomyolysis from prolonged convulsions",
            "target": "Elevated; monitor trend",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cortisol (random)",
            "rationale": "Adrenal insufficiency",
            "target": "Normal stress response",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "CNS infection if suspected",
            "target": "<0.5 ng/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Coagulation panel (PT/INR, PTT)",
            "rationale": "Pre-LP, hemorrhage risk",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Anticipate possible surgical intervention",
            "target": "Available",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as precipitant (especially elderly)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2 in NORSE",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking history, weight loss",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Mitochondrial DNA testing",
            "rationale": "MELAS, other mitochondrial disorders",
            "target": "Normal",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Pyridoxine trial (empiric)",
            "rationale": "Pyridoxine-dependent seizures (rare, usually pediatric)",
            "target": "Response to treatment",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "NORSE, limbic encephalitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Demyelinating disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediately after stabilization",
            "target": "Mass, hemorrhage, stroke, herniation, hydrocephalus",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "As soon as available; mandatory in RSE/SRSE",
            "target": "Seizure burden, treatment response, NCSE detection",
            "contraindications": "None significant",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk, ETT placement confirmation",
            "target": "Aspiration, ETT position",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "When stable; within 24-48h",
            "target": "Encephalitis, stroke, tumor, cortical injury from SE",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT angiography head/neck",
            "timing": "If stroke suspected",
            "target": "Large vessel occlusion, dissection",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "Venous thrombosis, vascular malformation",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "If paraneoplastic suspected",
            "target": "Occult malignancy",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected, endocarditis",
            "target": "Vegetation, thrombus",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT (whole body)",
            "timing": "Occult malignancy workup",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Brain biopsy",
            "timing": "Refractory cases, suspected encephalitis",
            "target": "Histopathologic diagnosis",
            "contraindications": "Coagulopathy, critical location",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Stabilization (Time 0)": [
          {
            "item": "Airway positioning/management",
            "route": "—",
            "indication": "Airway protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Airway positioning/management N/A —"
                }
              ],
              "route": "—",
              "instructions": "Head-tilt chin-lift, oral airway, prepare for intubation",
              "orderSentence": "Airway positioning/management N/A —"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, airway patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Oxygenation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Non-rebreather 15 L/min or bag-valve-mask; target O2 sat >94%",
              "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV access (two large-bore)",
            "route": "—",
            "indication": "Vascular access",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "IV access (two large-bore) N/A —"
                }
              ],
              "route": "—",
              "instructions": "18G or larger x2",
              "orderSentence": "IV access (two large-bore) N/A —"
            },
            "contraindications": "None",
            "monitoring": "IV patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cardiac monitoring",
            "route": "—",
            "indication": "Rhythm monitoring",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Cardiac monitoring N/A —"
                }
              ],
              "route": "—",
              "instructions": "Continuous telemetry",
              "orderSentence": "Cardiac monitoring N/A —"
            },
            "contraindications": "None",
            "monitoring": "Rhythm, HR, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50%",
            "route": "IV",
            "indication": "Hypoglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mL",
                  "orderSentence": "Dextrose 50% 25 mL IV"
                },
                {
                  "text": "50 mL",
                  "orderSentence": "Dextrose 50% 50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "50 mL IV push (25g) if glucose <70 or unknown",
              "orderSentence": "Dextrose 50% 25 mL IV"
            },
            "contraindications": "Document hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine",
            "route": "IV",
            "indication": "Wernicke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Thiamine 100 mg IV"
                },
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV BEFORE or WITH glucose",
              "orderSentence": "Thiamine 100 mg IV"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Isotonic fluids",
            "route": "IV",
            "indication": "Volume resuscitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 1000 mL",
                  "orderSentence": "Isotonic fluids NS 1000 mL IV"
                },
                {
                  "text": "LR 1000 mL",
                  "orderSentence": "Isotonic fluids LR 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "NS or LR wide open initially",
              "orderSentence": "Isotonic fluids NS 1000 mL IV"
            },
            "contraindications": "Pulmonary edema",
            "monitoring": "BP, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Emergent/First-Line - Benzodiazepines (Time 0-5 min)": [
          {
            "item": "Lorazepam IV",
            "route": "IV",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam IV 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam IV 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg/dose); may repeat x1 in 5 min if still seizing; total max 8 mg",
              "orderSentence": "Lorazepam IV 2 mg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP, sedation; airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM",
            "route": "IM",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IM 10 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "10 mg IM (≥40 kg) or 0.2 mg/kg IM; faster than IV if no access",
              "orderSentence": "Midazolam IM 10 mg IM"
            },
            "contraindications": "Respiratory compromise",
            "monitoring": "RR, O2 sat; prepare IV access",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IV",
            "route": "IV",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Midazolam IV 5 mg IV"
                },
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg/kg IV (max 10 mg); may repeat x1",
              "orderSentence": "Midazolam IV 5 mg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal",
            "route": "IN",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam intranasal 10 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "5 mg per nostril (10 mg total) if no IV/IM access",
              "orderSentence": "Midazolam intranasal 10 mg IN"
            },
            "contraindications": "Nasal obstruction",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam buccal",
            "route": "BUCCAL",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam buccal 10 mg BUCCAL"
                }
              ],
              "route": "BUCCAL",
              "instructions": "10 mg buccal (if available)",
              "orderSentence": "Midazolam buccal 10 mg BUCCAL"
            },
            "contraindications": "Oral trauma",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam IV",
            "route": "IV",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Diazepam IV 5 mg IV"
                },
                {
                  "text": "10 mg",
                  "orderSentence": "Diazepam IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV (max 10 mg); may repeat x1 in 5 min; short duration - requires follow-up ASM",
              "orderSentence": "Diazepam IV 5 mg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat; short duration - requires follow-up ASM",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam rectal",
            "route": "PR",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Diazepam rectal 10 mg PR"
                },
                {
                  "text": "20 mg",
                  "orderSentence": "Diazepam rectal 20 mg PR"
                }
              ],
              "route": "PR",
              "instructions": "0.2-0.5 mg/kg PR (max 20 mg); use rectal gel formulation",
              "orderSentence": "Diazepam rectal 10 mg PR"
            },
            "contraindications": "Rectal pathology",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Urgent/Second-Line ASMs (Time 5-20 min)": [
          {
            "item": "Levetiracetam IV (ESETT dosing)",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4000 mg",
                  "orderSentence": "Levetiracetam IV (ESETT dosing) 4000 mg IV"
                },
                {
                  "text": "4500 mg",
                  "orderSentence": "Levetiracetam IV (ESETT dosing) 4500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": "Levetiracetam IV (ESETT dosing) 4000 mg IV"
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam IV (conservative)",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3000 mg",
                  "orderSentence": "Levetiracetam IV (conservative) 3000 mg IV"
                },
                {
                  "text": "4000 mg",
                  "orderSentence": "Levetiracetam IV (conservative) 4000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": "Levetiracetam IV (conservative) 3000 mg IV"
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fosphenytoin IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg PE",
                  "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
                },
                {
                  "text": "1500 mg PE",
                  "orderSentence": "Fosphenytoin IV 1500 mg PE IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg PE/kg IV at 150 mg PE/min; may give additional 5-10 mg PE/kg if needed",
              "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
            },
            "contraindications": "2nd/3rd degree AV block, sinus bradycardia, allergy",
            "monitoring": "Continuous cardiac monitor, BP q5min during infusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2000 mg",
                  "orderSentence": "Valproate IV 2000 mg IV"
                },
                {
                  "text": "2500 mg",
                  "orderSentence": "Valproate IV 2500 mg IV"
                },
                {
                  "text": "3000 mg",
                  "orderSentence": "Valproate IV 3000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV (max 3000 mg) over 10 min",
              "orderSentence": "Valproate IV 2000 mg IV"
            },
            "contraindications": "Pregnancy, hepatic disease, mitochondrial disease, urea cycle disorders, pancreatitis",
            "monitoring": "Ammonia, LFTs; avoid in unknown pregnancy status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Lacosamide IV 200 mg IV"
                },
                {
                  "text": "300 mg",
                  "orderSentence": "Lacosamide IV 300 mg IV"
                },
                {
                  "text": "400 mg",
                  "orderSentence": "Lacosamide IV 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "400 mg IV over 15 min (can give 200 mg over 5 min if urgent)",
              "orderSentence": "Lacosamide IV 200 mg IV"
            },
            "contraindications": "PR >200 ms, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG for PR interval",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Brivaracetam IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Brivaracetam IV 100 mg IV"
                },
                {
                  "text": "200 mg",
                  "orderSentence": "Brivaracetam IV 200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-200 mg IV over 2-5 min; no titration needed",
              "orderSentence": "Brivaracetam IV 100 mg IV"
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Faster onset than levetiracetam; fewer behavioral effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Phenytoin IV 1000 mg IV"
                },
                {
                  "text": "1500 mg",
                  "orderSentence": "Phenytoin IV 1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV at max 50 mg/min (if fosphenytoin unavailable); MUST use large vein",
              "orderSentence": "Phenytoin IV 1000 mg IV"
            },
            "contraindications": "AV block, sinus bradycardia",
            "monitoring": "Cardiac monitor; tissue necrosis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenobarbital IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Phenobarbital IV 1000 mg IV"
                },
                {
                  "text": "1500 mg",
                  "orderSentence": "Phenobarbital IV 1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV at 50-100 mg/min; often requires intubation",
              "orderSentence": "Phenobarbital IV 1000 mg IV"
            },
            "contraindications": "Severe respiratory disease, porphyria",
            "monitoring": "Respiratory depression",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Refractory SE - Anesthetic Infusions (Time 20-60 min)": [
          {
            "item": "Midazolam infusion",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 0.1 mg/kg/hr IV"
                },
                {
                  "text": "0.5 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 0.5 mg/kg/hr IV"
                },
                {
                  "text": "1 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 1 mg/kg/hr IV"
                },
                {
                  "text": "2 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 2 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 0.2 mg/kg bolus; start 0.1 mg/kg/hr, titrate by 0.1 mg/kg/hr q15min to seizure suppression; max 2 mg/kg/hr",
              "orderSentence": "Midazolam infusion 0.1 mg/kg/hr IV"
            },
            "contraindications": "Hemodynamic instability (relative)",
            "monitoring": "cEEG, BP (hypotension common), sedation scale",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Propofol infusion",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mcg/kg/min",
                  "orderSentence": "Propofol infusion 20 mcg/kg/min IV"
                },
                {
                  "text": "50 mcg/kg/min",
                  "orderSentence": "Propofol infusion 50 mcg/kg/min IV"
                },
                {
                  "text": "100 mcg/kg/min",
                  "orderSentence": "Propofol infusion 100 mcg/kg/min IV"
                },
                {
                  "text": "200 mcg/kg/min",
                  "orderSentence": "Propofol infusion 200 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 1-2 mg/kg bolus (may repeat x1); start 20 mcg/kg/min, titrate by 10 mcg/kg/min q5min; max 200 mcg/kg/min",
              "orderSentence": "Propofol infusion 20 mcg/kg/min IV"
            },
            "contraindications": "Propofol infusion syndrome (limit to <48h at high dose), egg/soy allergy, pregnancy",
            "monitoring": "cEEG, triglycerides q24-48h, CPK, metabolic acidosis, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine infusion",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 1 mg/kg/hr IV"
                },
                {
                  "text": "2 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 2 mg/kg/hr IV"
                },
                {
                  "text": "3 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 3 mg/kg/hr IV"
                },
                {
                  "text": "5 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 5 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 1-2 mg/kg bolus; start 1 mg/kg/hr, titrate by 0.5 mg/kg/hr q15-30min; max 5 mg/kg/hr; consider EARLY use",
              "orderSentence": "Ketamine infusion 1 mg/kg/hr IV"
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative - may be neuroprotective)",
            "monitoring": "cEEG, BP (may increase), HR; less hypotension than other anesthetics",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine + Midazolam (combination)",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Dual infusion",
                  "orderSentence": "Ketamine + Midazolam (combination) Dual infusion IV"
                }
              ],
              "route": "IV",
              "instructions": "Ketamine load 1 mg/kg + Midazolam load 0.2 mg/kg; Ketamine 1-5 mg/kg/hr + Midazolam 0.1-2 mg/kg/hr; titrate to burst suppression; 2024 data supports combination",
              "orderSentence": "Ketamine + Midazolam (combination) Dual infusion IV"
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative), hemodynamic instability (relative)",
            "monitoring": "cEEG, combination may reduce SE duration faster than midazolam alone",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pentobarbital infusion",
            "route": "IV",
            "indication": "Super-refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 0.5 mg/kg/hr IV"
                },
                {
                  "text": "1 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 1 mg/kg/hr IV"
                },
                {
                  "text": "3 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 3 mg/kg/hr IV"
                },
                {
                  "text": "5 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 5 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 5-15 mg/kg at 50 mg/min; start 0.5-1 mg/kg/hr, titrate to burst suppression; max 5 mg/kg/hr; longest half-life",
              "orderSentence": "Pentobarbital infusion 0.5 mg/kg/hr IV"
            },
            "contraindications": "Severe cardiac dysfunction",
            "monitoring": "cEEG, BP (significant hypotension - need pressors), cardiac output",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Super-Refractory SE - Additional Agents": [
          {
            "item": "Add second anesthetic",
            "route": "IV",
            "indication": "Super-refractory SE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Add second anesthetic Per agent IV"
                }
              ],
              "route": "IV",
              "instructions": "Combine midazolam + propofol, or add ketamine to either",
              "orderSentence": "Add second anesthetic Per agent IV"
            },
            "contraindications": "Per agent",
            "monitoring": "cEEG, hemodynamics",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Topiramate (enteral)",
            "route": "NGT",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Topiramate (enteral) 200 mg BID NGT"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Topiramate (enteral) 300 mg BID NGT"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Topiramate (enteral) 400 mg BID NGT"
                }
              ],
              "route": "NGT",
              "instructions": "Load 300-400 mg via NGT; then 200-400 mg BID; max 1600 mg/day",
              "orderSentence": "Topiramate (enteral) 200 mg BID NGT"
            },
            "contraindications": "Metabolic acidosis, kidney stones",
            "monitoring": "Bicarbonate, renal function",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Lacosamide (if not tried)",
            "route": "IV",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide (if not tried) 200 mg BID IV"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide (if not tried) 300 mg BID IV"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Lacosamide (if not tried) 400 mg BID IV"
                }
              ],
              "route": "IV",
              "instructions": "400 mg IV load, then 200-400 mg BID",
              "orderSentence": "Lacosamide (if not tried) 200 mg BID IV"
            },
            "contraindications": "PR prolongation",
            "monitoring": "ECG",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Perampanel (enteral)",
            "route": "NGT",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg daily",
                  "orderSentence": "Perampanel (enteral) 4 mg daily NGT"
                },
                {
                  "text": "8 mg daily",
                  "orderSentence": "Perampanel (enteral) 8 mg daily NGT"
                },
                {
                  "text": "12 mg daily",
                  "orderSentence": "Perampanel (enteral) 12 mg daily NGT"
                }
              ],
              "route": "NGT",
              "instructions": "4-8 mg via NGT daily; titrate to 12 mg daily",
              "orderSentence": "Perampanel (enteral) 4 mg daily NGT"
            },
            "contraindications": "None absolute",
            "monitoring": "Aggression, sedation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Magnesium sulfate infusion",
            "route": "IV",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 g load",
                  "orderSentence": "Magnesium sulfate infusion 4 g load IV"
                },
                {
                  "text": "1 g/hr infusion",
                  "orderSentence": "Magnesium sulfate infusion 1 g/hr infusion IV"
                },
                {
                  "text": "2 g/hr infusion",
                  "orderSentence": "Magnesium sulfate infusion 2 g/hr infusion IV"
                }
              ],
              "route": "IV",
              "instructions": "4-6 g IV over 20 min, then 1-2 g/hr infusion; target Mg 3.5-4 mg/dL",
              "orderSentence": "Magnesium sulfate infusion 4 g load IV"
            },
            "contraindications": "Renal failure (relative), myasthenia",
            "monitoring": "Mg levels, reflexes, respiratory status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pyridoxine (empiric trial)",
            "route": "IV",
            "indication": "Pyridoxine-dependent seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Pyridoxine (empiric trial) 100 mg IV"
                },
                {
                  "text": "500 mg",
                  "orderSentence": "Pyridoxine (empiric trial) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV; may try single dose empirically",
              "orderSentence": "Pyridoxine (empiric trial) 100 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Response to treatment",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Ketogenic diet",
            "route": "ENTERAL",
            "indication": "Super-refractory SE metabolic therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Ketogenic diet N/A ENTERAL"
                }
              ],
              "route": "ENTERAL",
              "instructions": "Initiate within 7 days per NORSE consensus; requires nutrition support",
              "orderSentence": "Ketogenic diet N/A ENTERAL"
            },
            "contraindications": "Pyruvate carboxylase deficiency, fatty acid oxidation disorders",
            "monitoring": "Ketones, glucose, lipids",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hypothermia (32-35°C)",
            "route": "—",
            "indication": "Super-refractory SE neuroprotection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Hypothermia (32-35°C) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Targeted temperature management x 24-48h",
              "orderSentence": "Hypothermia (32-35°C) N/A —"
            },
            "contraindications": "Coagulopathy, severe infection",
            "monitoring": "Temperature, coagulation, infection",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Electroconvulsive therapy",
            "route": "—",
            "indication": "Super-refractory SE rescue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Electroconvulsive therapy N/A —"
                }
              ],
              "route": "—",
              "instructions": "If all else fails; requires anesthesia",
              "orderSentence": "Electroconvulsive therapy N/A —"
            },
            "contraindications": "Raised ICP, recent stroke",
            "monitoring": "Per ECT protocol",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Epilepsy surgery (emergent)",
            "route": "—",
            "indication": "Lesional super-refractory SE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Epilepsy surgery (emergent) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Resection if focal lesion identified",
              "orderSentence": "Epilepsy surgery (emergent) N/A —"
            },
            "contraindications": "Eloquent cortex, multifocal",
            "monitoring": "Per surgical team",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "NORSE/FIRES Immunotherapy Protocol": [
          {
            "timing": "**Day 0-3**",
            "dosing": "See below"
          },
          {
            "timing": "**Day 3-7**",
            "dosing": "Add remaining first-line agents"
          },
          {
            "timing": "**Day 7**",
            "dosing": "Initiate with nutrition support"
          },
          {
            "timing": "**Day 7+**",
            "dosing": "If first-line inadequate"
          }
        ],
        "Symptomatic/Supportive ICU Care": [
          {
            "item": "Norepinephrine",
            "route": "IV",
            "indication": "Hypotension from anesthetics",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.1 mcg/kg/min IV"
                },
                {
                  "text": "0.2 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.2 mcg/kg/min IV"
                },
                {
                  "text": "0.5 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.5 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 0.1 mcg/kg/min; titrate to MAP ≥65",
              "orderSentence": "Norepinephrine 0.1 mcg/kg/min IV"
            },
            "contraindications": "Hypovolemia (correct first)",
            "monitoring": "Arterial line, MAP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vasopressin",
            "route": "IV",
            "indication": "Adjunct pressor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.04 units/min",
                  "orderSentence": "Vasopressin 0.04 units/min IV"
                }
              ],
              "route": "IV",
              "instructions": "0.04 units/min fixed dose",
              "orderSentence": "Vasopressin 0.04 units/min IV"
            },
            "contraindications": "Cardiac ischemia",
            "monitoring": "MAP, cardiac status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fentanyl infusion",
            "route": "IV",
            "indication": "Analgesia/sedation adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mcg/hr",
                  "orderSentence": "Fentanyl infusion 25 mcg/hr IV"
                },
                {
                  "text": "50 mcg/hr",
                  "orderSentence": "Fentanyl infusion 50 mcg/hr IV"
                },
                {
                  "text": "100 mcg/hr",
                  "orderSentence": "Fentanyl infusion 100 mcg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "25-100 mcg/hr; titrate to comfort",
              "orderSentence": "Fentanyl infusion 25 mcg/hr IV"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "Pain scale, respiratory status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Propofol (sub-anesthetic)",
            "route": "IV",
            "indication": "Sedation during cEEG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mcg/kg/min",
                  "orderSentence": "Propofol (sub-anesthetic) 10 mcg/kg/min IV"
                },
                {
                  "text": "25 mcg/kg/min",
                  "orderSentence": "Propofol (sub-anesthetic) 25 mcg/kg/min IV"
                },
                {
                  "text": "50 mcg/kg/min",
                  "orderSentence": "Propofol (sub-anesthetic) 50 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "5-50 mcg/kg/min",
              "orderSentence": "Propofol (sub-anesthetic) 10 mcg/kg/min IV"
            },
            "contraindications": "Propofol infusion syndrome risk, egg/soy allergy, pregnancy",
            "monitoring": "Sedation scale",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Dexmedetomidine",
            "route": "IV",
            "indication": "Sedation, possible antiseizure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 0.2 mcg/kg/hr IV"
                },
                {
                  "text": "0.5 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 0.5 mcg/kg/hr IV"
                },
                {
                  "text": "1 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 1 mcg/kg/hr IV"
                },
                {
                  "text": "1.5 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 1.5 mcg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2-1.5 mcg/kg/hr",
              "orderSentence": "Dexmedetomidine 0.2 mcg/kg/hr IV"
            },
            "contraindications": "Bradycardia, heart block",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start when stable)",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, recent LP",
            "monitoring": "Platelets, bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Insulin infusion",
            "route": "IV",
            "indication": "Stress hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin infusion Per protocol IV"
                }
              ],
              "route": "IV",
              "instructions": "Per ICU protocol; target glucose 140-180 mg/dL",
              "orderSentence": "Insulin infusion Per protocol IV"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q1-4h",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bowel regimen",
            "route": "PO",
            "indication": "Constipation prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Docusate 100 mg BID",
                  "orderSentence": "Bowel regimen Docusate 100 mg BID PO"
                },
                {
                  "text": "Senna 8.6 mg daily",
                  "orderSentence": "Bowel regimen Senna 8.6 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Docusate 100 mg BID + senna 8.6 mg daily; escalate to bisacodyl or lactulose PRN",
              "orderSentence": "Bowel regimen Docusate 100 mg BID PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Skin care protocol",
            "route": "—",
            "indication": "Pressure injury prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Skin care protocol N/A —"
                }
              ],
              "route": "—",
              "instructions": "Turn q2h, specialty mattress, moisture barrier, Braden scale assessment",
              "orderSentence": "Skin care protocol N/A —"
            },
            "contraindications": "None",
            "monitoring": "Skin integrity daily",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Eye care",
            "route": "TOPICAL",
            "indication": "Corneal protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Lubricating drops",
                  "orderSentence": "Eye care Lubricating drops TOPICAL"
                }
              ],
              "route": "TOPICAL",
              "instructions": "Lubricating drops q4h, eyelid taping if incomplete closure",
              "orderSentence": "Eye care Lubricating drops TOPICAL"
            },
            "contraindications": "None",
            "monitoring": "Corneal integrity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Epilepsy STAT consult",
            "indication": "All cases of SE",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurocritical care consult",
            "indication": "RSE/SRSE, need for anesthetic infusions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ICU admission",
            "indication": "All SE requiring second-line agents or ongoing seizures",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "EEG technologist/cEEG initiation",
            "indication": "Mandatory for RSE/SRSE; strongly recommended for all SE",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "Suspected CNS infection",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Rheumatology/Neuroimmunology consult",
            "indication": "NORSE/FIRES, suspected autoimmune encephalitis",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pharmacy consult",
            "indication": "Complex ASM dosing, drug interactions",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Nutrition/Dietitian consult",
            "indication": "Enteral feeding, ketogenic diet initiation (by Day 7 in NORSE)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Palliative care consult",
            "indication": "SRSE with poor prognosis, goals of care discussion",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work consult",
            "indication": "Family support, discharge planning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation",
            "indication": "Focal lesion on imaging, refractory to medical therapy",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "EXT"
          },
          {
            "item": "PT/OT/Speech evaluation",
            "indication": "Once stabilized; assess for deficits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy outpatient follow-up",
            "indication": "All SE survivors; ASM optimization, etiology workup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Outpatient video-EEG monitoring",
            "indication": "Characterization of seizure type, presurgical evaluation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Neuropsychology testing",
            "indication": "Cognitive assessment post-SE; baseline before surgery",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Explain SE is a medical emergency requiring ICU care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Discuss prognosis based on etiology and duration of SE",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—"
          },
          {
            "item": "Educate on importance of ASM adherence (if applicable)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Seizure first aid education for family",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Rescue medication training (rectal diazepam, nasal midazolam)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Driving restrictions (minimum 3-6 months seizure-free, varies by state)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Medical alert bracelet recommendation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Seizure action plan development",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Discuss goals of care if SRSE with poor prognosis",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE (ICU)"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Medication adherence counseling",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Avoid abrupt ASM discontinuation (common SE precipitant)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Alcohol cessation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Sleep hygiene (sleep deprivation lowers threshold)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Avoid known seizure triggers",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Drug interaction review (OTC, supplements)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Pregnancy planning counseling (women of childbearing potential)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Psychogenic non-epileptic status",
        "features": "Preserved awareness, asynchronous movements, eye closure, pelvic thrusting, prolonged duration with minimal post-ictal period",
        "tests": "Video EEG, normal cEEG during event"
      },
      {
        "diagnosis": "Convulsive syncope",
        "features": "Brief (< 30 sec), occurs with LOC, myoclonic jerks possible",
        "tests": "History of prodrome, rapid recovery, normal EEG"
      },
      {
        "diagnosis": "Movement disorders (dystonia, chorea)",
        "features": "Non-rhythmic, preserved awareness, stereotyped pattern",
        "tests": "EEG normal during movements"
      },
      {
        "diagnosis": "Rigors (sepsis, transfusion reaction)",
        "features": "Associated with fever/chills, rhythmic shaking, preserves awareness",
        "tests": "Infectious workup, temperature, EEG normal"
      },
      {
        "diagnosis": "Decerebrate/decorticate posturing",
        "features": "Associated with structural brain injury, sustained posturing",
        "tests": "Imaging, cEEG"
      },
      {
        "diagnosis": "Drug-induced dyskinesia",
        "features": "Medication history, stereotyped movements",
        "tests": "Drug levels, history, EEG normal"
      },
      {
        "diagnosis": "Neuroleptic malignant syndrome",
        "features": "Rigidity, hyperthermia, AMS, autonomic instability",
        "tests": "CPK, medication history"
      },
      {
        "diagnosis": "Serotonin syndrome",
        "features": "Hyperreflexia, clonus, agitation, fever",
        "tests": "Medication history, clinical features"
      },
      {
        "diagnosis": "Tetanus",
        "features": "Sustained muscle contraction, trismus, opisthotonos",
        "tests": "History of wound, vaccination status"
      },
      {
        "diagnosis": "Strychnine poisoning",
        "features": "Opisthotonus with preserved consciousness",
        "tests": "Toxicology"
      }
    ],
    "evidence": [
      {
        "recommendation": "Benzodiazepines first-line for SE",
        "evidenceLevel": "Class I, Level A",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/); [AES Guidelines 2016](https://pubmed.ncbi.nlm.nih.gov/26900382/)"
      },
      {
        "recommendation": "Lorazepam preferred IV benzodiazepine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Alldredge et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11547716/)"
      },
      {
        "recommendation": "IM midazolam non-inferior to IV lorazepam",
        "evidenceLevel": "Class I, Level A",
        "source": "[RAMPART Trial, Silbergleit et al. NEJM 2012](https://pubmed.ncbi.nlm.nih.gov/22335736/)"
      },
      {
        "recommendation": "Second-line agents (LEV, VPA, fPHT) equivalent efficacy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial, Kapur et al. NEJM 2019;381:2103-2113](https://pubmed.ncbi.nlm.nih.gov/31774955/)"
      },
      {
        "recommendation": "Levetiracetam 60 mg/kg dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial](https://pubmed.ncbi.nlm.nih.gov/31774955/) - higher than traditional 20-40 mg/kg"
      },
      {
        "recommendation": "Levetiracetam 40 mg/kg may be adequate",
        "evidenceLevel": "Class II, Level B",
        "source": "Meta-analysis, pharmacokinetic modeling 2023-2024"
      },
      {
        "recommendation": "cEEG monitoring in RSE",
        "evidenceLevel": "Class I, Level B",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/)"
      },
      {
        "recommendation": "Burst suppression target for RSE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "Ketamine in RSE/SRSE",
        "evidenceLevel": "Class IIb, Level B",
        "source": "Multiple case series; 2024 systematic reviews"
      },
      {
        "recommendation": "Earlier ketamine = better outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "2024 two-center study; systematic reviews"
      },
      {
        "recommendation": "Ketamine efficacy in RSE/SRSE",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Rosati A et al., CNS Drugs 2018;32(11):997-1009](https://pubmed.ncbi.nlm.nih.gov/30232735/)"
      },
      {
        "recommendation": "Ketamine ± midazolam superiority over midazolam alone",
        "evidenceLevel": "Class II, Level B",
        "source": "[Fletman et al., Clin Neurol Neurosurg 2024](https://pubmed.ncbi.nlm.nih.gov/39418930/); [Yan et al., J Neurol 2024](https://pubmed.ncbi.nlm.nih.gov/38782798/)"
      },
      {
        "recommendation": "NORSE first-line immunotherapy within 72h",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[Wickström et al. Epilepsia 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Ketogenic diet by Day 7 in NORSE",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35951466/); FIRES case series"
      },
      {
        "recommendation": "Second-line immunotherapy by Day 7 if first-line fails",
        "evidenceLevel": "Class IIb, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Brivaracetam for SE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Emerging evidence; case series"
      }
    ],
    "monitoring": [
      {
        "item": "Continuous EEG",
        "frequency": "Continuous",
        "action": "Adjust ASMs/anesthetics",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Cardiac telemetry",
        "frequency": "Continuous",
        "action": "Treat arrhythmia; assess ASM effect",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Pulse oximetry",
        "frequency": "Continuous",
        "action": "Increase O2, assess airway",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q5min during treatment, then q1h",
        "action": "Pressors or antihypertensives",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurologic exam",
        "frequency": "q1-2h when off sedation",
        "action": "Imaging, reassess etiology",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "q1-4h",
        "action": "Insulin or dextrose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Electrolytes (Na, K, Mg, Ca, Phos)",
        "frequency": "q6-12h",
        "action": "Replete deficiencies",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ABG/VBG",
        "frequency": "q4-6h (RSE), PRN",
        "action": "Adjust ventilator, treat acidosis",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Lactate",
        "frequency": "q6-12h",
        "action": "Treat underlying cause",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ASM levels",
        "frequency": "24h after load, then PRN",
        "action": "Adjust dosing",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "URGENT"
      },
      {
        "item": "Ammonia",
        "frequency": "q24h if on valproate",
        "action": "Reduce/stop valproate",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "LFTs",
        "frequency": "q24-48h",
        "action": "Adjust hepatically-metabolized ASMs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Renal function",
        "frequency": "q24h",
        "action": "Adjust renally-cleared ASMs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "CPK",
        "frequency": "q12-24h if prolonged convulsions",
        "action": "Aggressive hydration, monitor renal",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Triglycerides",
        "frequency": "q24-48h if on propofol",
        "action": "Reduce propofol dose",
        "ED": "—",
        "HOSP": "—",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Infection workup; cooling if hyperthermic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ICP (if monitored)",
        "frequency": "Continuous",
        "action": "ICP management protocol",
        "ED": "—",
        "HOSP": "—",
        "OPD": "—",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "ICU admission (REQUIRED)",
        "criteria": "All SE requiring second-line ASMs; all RSE/SRSE; altered mental status; need for airway management; hemodynamic instability"
      },
      {
        "disposition": "Step-down/Telemetry",
        "criteria": "Seizures controlled x 24h, off anesthetics x 24h, stable neuro exam, no airway concerns"
      },
      {
        "disposition": "General floor",
        "criteria": "Seizures controlled, off continuous monitoring, stable on oral ASMs, resolved AMS"
      },
      {
        "disposition": "Discharge home",
        "criteria": "Seizures controlled, stable on oral ASM regimen, etiology identified and addressed, family educated, follow-up arranged"
      },
      {
        "disposition": "Transfer to higher level care",
        "criteria": "Need for services unavailable (cEEG, neurocritical care, epilepsy surgery evaluation)"
      },
      {
        "disposition": "Long-term care/Rehab",
        "criteria": "Persistent deficits after prolonged SE, need for ongoing rehabilitation"
      },
      {
        "disposition": "Palliative/Hospice",
        "criteria": "SRSE with irreversible brain injury, goals of care established"
      }
    ]
  },
  "New Onset Seizure": {
    "id": "new-onset-seizure",
    "title": "New Onset Seizure",
    "version": "1.2",
    "icd10": [
      "** R56.9 (Unspecified convulsions)",
      "G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)"
    ],
    "scope": "** Initial evaluation and management of first-time unprovoked seizure or first presentation of seizure activity in adults. Covers immediate stabilization, diagnostic workup to identify etiology, acute treatment, and framework for anti-seizure medication (ASM) initiation. Excludes status epilepticus (see \"Status Epilepticus\" template), pediatric seizures, febrile seizures, and known epilepsy with breakthrough seizures.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities (Na, Ca, Mg, glucose), renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Normal (ionized 4.5-5.3 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs (cocaine, amphetamines) and withdrawal states",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol intoxication or withdrawal",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI can provoke seizures (especially elderly)",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Prolactin level",
            "rationale": "Elevated if drawn within 10-20 min of event; helps distinguish seizure from non-epileptic event",
            "target": "Elevated 2-3× baseline (if drawn <20 min)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold (especially alcohol withdrawal)",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated post-ictal confirms recent seizure; metabolic acidosis screen",
            "target": "Mild elevation acceptable post-ictal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can affect seizure threshold",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, urea cycle disorders",
            "target": "Normal (<35 μmol/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac ischemia as cause or consequence",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "ECG",
            "rationale": "Arrhythmia, prolonged QTc (some ASMs), Brugada",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, hypoxia",
            "target": "Normal or mild post-ictal acidosis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (urine or serum β-hCG)",
            "rationale": "Eclampsia; affects imaging and ASM choice",
            "target": "Negative (or explains eclampsia if positive)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "B12 level",
            "rationale": "Deficiency associated with seizures",
            "target": "Normal (>300 pg/mL)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Folate level",
            "rationale": "Deficiency can lower threshold; important for women of childbearing potential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum/urine toxicology (expanded panel)",
            "rationale": "Synthetic drugs, medications not on standard screen",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Heavy metals (lead, mercury)",
            "rationale": "Occupational exposure, pica",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2, GABA-B if clinical suspicion",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking, weight loss",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Genetic epilepsy panel",
            "rationale": "Young onset, family history, refractory",
            "target": "Variable",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP, mass effect",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal/TB meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification (14 pathogens)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis (most common treatable cause)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "If clinical suspicion for autoimmune etiology",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "If demyelinating disease suspected",
            "target": "Negative or matched with serum",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediate in ED",
            "target": "Mass, hemorrhage, stroke, calcification, hydrocephalus",
            "contraindications": "Pregnancy (relative - benefit usually outweighs risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "MRI brain with and without contrast (epilepsy protocol)*",
            "timing": "Within 24-48h if inpatient; within 2 weeks if outpatient",
            "target": "Tumor, mesial temporal sclerosis, cortical dysplasia, encephalitis, stroke, vascular malformation",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "EEG (routine)",
            "timing": "Within 24h if possible; ideally within 24-48h of seizure",
            "target": "Epileptiform discharges (spikes, sharp waves), focal slowing",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "If altered mental status persists, suspected non-convulsive status",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Prolonged ambulatory EEG (24-72h)",
            "timing": "Outpatient if routine EEG non-diagnostic",
            "target": "Capture interictal or ictal activity",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Video-EEG monitoring",
            "timing": "If diagnosis uncertain (vs. psychogenic)",
            "target": "Correlate clinical events with EEG",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "AVM, aneurysm, venous thrombosis",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "CT angiography head",
            "timing": "If MRA unavailable and vascular cause suspected",
            "target": "Vascular malformation, aneurysm",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected as cause",
            "target": "Thrombus, PFO, vegetation",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk post-ictal, lung cancer screening if paraneoplastic suspected",
            "target": "Clear lungs or mass",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT brain (interictal FDG)",
            "timing": "Epilepsy surgery workup",
            "target": "Focal hypometabolism",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "SPECT (ictal/interictal)",
            "timing": "Epilepsy surgery workup",
            "target": "Ictal hyperperfusion",
            "contraindications": "Requires seizure capture",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "timing": "Epilepsy surgery workup",
            "target": "Localize epileptogenic focus",
            "contraindications": "Metallic implants",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Neuropsychological testing",
            "timing": "Pre-surgical evaluation, cognitive concerns",
            "target": "Lateralizing deficits",
            "contraindications": "Patient cooperation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Wada test (intracarotid amobarbital)",
            "timing": "Pre-surgical language/memory lateralization",
            "target": "Language and memory dominance",
            "contraindications": "Contrast allergy, vascular anomaly",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam",
            "route": "IV/IM",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat once in 5 min if still seizing; max 8 mg total",
              "orderSentence": "Lorazepam 2 mg IV"
            },
            "contraindications": "Respiratory depression, severe hypotension",
            "monitoring": "RR, O2 sat, BP; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM",
            "route": "IM",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IM 10 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "10 mg IM (if >40 kg) or 0.2 mg/kg IM; single dose; faster than IV if no access",
              "orderSentence": "Midazolam IM 10 mg IM"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal",
            "route": "IN",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam intranasal 10 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "5 mg per nostril (total 10 mg)",
              "orderSentence": "Midazolam intranasal 10 mg IN"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50%",
            "route": "IV",
            "indication": "Hypoglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mL",
                  "orderSentence": "Dextrose 50% 25 mL IV"
                },
                {
                  "text": "50 mL",
                  "orderSentence": "Dextrose 50% 50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mL IV (12.5-25g) if hypoglycemia confirmed or suspected",
              "orderSentence": "Dextrose 50% 25 mL IV"
            },
            "contraindications": "Hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine",
            "route": "IV",
            "indication": "Wernicke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Thiamine 100 mg IV"
                },
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV BEFORE glucose if alcohol use suspected",
              "orderSentence": "Thiamine 100 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxia prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "2-4 L NC or non-rebreather as needed; target O2 sat >94%",
              "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic)",
            "route": "IV",
            "indication": "Volume resuscitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 500 mL",
                  "orderSentence": "IV fluids (isotonic) NS 500 mL IV"
                },
                {
                  "text": "NS 1000 mL",
                  "orderSentence": "IV fluids (isotonic) NS 1000 mL IV"
                },
                {
                  "text": "LR 1000 mL",
                  "orderSentence": "IV fluids (isotonic) LR 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "NS or LR bolus if hypotensive; maintenance if euvolemic",
              "orderSentence": "IV fluids (isotonic) NS 500 mL IV"
            },
            "contraindications": "Fluid overload, severe hyponatremia",
            "monitoring": "I/O, BP, Na",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Flumazenil (rescue only)",
            "route": "IV",
            "indication": "BZD reversal (severe respiratory depression)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mg",
                  "orderSentence": "Flumazenil (rescue only) 0.2 mg IV"
                },
                {
                  "text": "0.4 mg",
                  "orderSentence": "Flumazenil (rescue only) 0.4 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Flumazenil (rescue only) 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg IV over 30 sec; may repeat 0.2 mg q1min to max 1 mg; CAUTION: may precipitate seizures",
              "orderSentence": "Flumazenil (rescue only) 0.2 mg IV"
            },
            "contraindications": "Chronic benzodiazepine use; seizure history; tricyclic overdose",
            "monitoring": "RR, O2 sat; may lower seizure threshold; use only if severe respiratory depression unresponsive to supportive care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Acute Loading": [
          {
            "item": "Levetiracetam IV",
            "route": "IV",
            "indication": "First-line acute loading",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3000 mg",
                  "orderSentence": "Levetiracetam IV 3000 mg IV"
                },
                {
                  "text": "4000 mg",
                  "orderSentence": "Levetiracetam IV 4000 mg IV"
                },
                {
                  "text": "4500 mg",
                  "orderSentence": "Levetiracetam IV 4500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40-60 mg/kg IV (max 4500 mg) over 15 min",
              "orderSentence": "Levetiracetam IV 3000 mg IV"
            },
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam PO",
            "route": "PO",
            "indication": "Acute loading if stable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1500 mg",
                  "orderSentence": "Levetiracetam PO 1500 mg PO"
                },
                {
                  "text": "2000 mg",
                  "orderSentence": "Levetiracetam PO 2000 mg PO"
                },
                {
                  "text": "2500 mg",
                  "orderSentence": "Levetiracetam PO 2500 mg PO"
                },
                {
                  "text": "3000 mg",
                  "orderSentence": "Levetiracetam PO 3000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 1500-3000 mg PO x1, then start maintenance",
              "orderSentence": "Levetiracetam PO 1500 mg PO"
            },
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "—"
          },
          {
            "item": "Fosphenytoin IV",
            "route": "IV",
            "indication": "Alternative first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg PE",
                  "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
                },
                {
                  "text": "1500 mg PE",
                  "orderSentence": "Fosphenytoin IV 1500 mg PE IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg PE/kg IV at 150 mg PE/min (max rate); may give additional 5-10 mg PE/kg if needed",
              "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy (relative)",
            "monitoring": "Continuous cardiac monitoring, BP; purple glove syndrome rare with fosphenytoin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "route": "IV",
            "indication": "If fosphenytoin unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Phenytoin IV 1000 mg IV"
                },
                {
                  "text": "1500 mg",
                  "orderSentence": "Phenytoin IV 1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV at max 50 mg/min",
              "orderSentence": "Phenytoin IV 1000 mg IV"
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy",
            "monitoring": "Cardiac monitor, BP; give via large vein (tissue necrosis risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "route": "IV",
            "indication": "Alternative (broad-spectrum)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2000 mg",
                  "orderSentence": "Valproate IV 2000 mg IV"
                },
                {
                  "text": "2500 mg",
                  "orderSentence": "Valproate IV 2500 mg IV"
                },
                {
                  "text": "3000 mg",
                  "orderSentence": "Valproate IV 3000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV over 10 min (max 3000 mg)",
              "orderSentence": "Valproate IV 2000 mg IV"
            },
            "contraindications": "Pregnancy (teratogenic - neural tube defects), hepatic disease, mitochondrial disease, urea cycle disorders",
            "monitoring": "LFTs, ammonia, platelets; pancreatitis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "route": "IV",
            "indication": "Alternative first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Lacosamide IV 200 mg IV"
                },
                {
                  "text": "300 mg",
                  "orderSentence": "Lacosamide IV 300 mg IV"
                },
                {
                  "text": "400 mg",
                  "orderSentence": "Lacosamide IV 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200-400 mg IV over 15-30 min (can give 200 mg over 5 min if urgent)",
              "orderSentence": "Lacosamide IV 200 mg IV"
            },
            "contraindications": "PR prolongation >200 ms, 2nd/3rd degree AV block",
            "monitoring": "ECG for PR interval; dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Maintenance Therapy": [
          {
            "item": "Levetiracetam",
            "route": "PO",
            "indication": "First-line maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Levetiracetam 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Levetiracetam 750 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; may increase by 500 mg/dose weekly; max 3000 mg/day",
              "orderSentence": "Levetiracetam 500 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl)",
            "monitoring": "Behavioral changes (irritability, depression - \"Keppra rage\"); renal function",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "First-line (especially women of childbearing potential)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Lamotrigine 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Lamotrigine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Lamotrigine 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Lamotrigine 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily × 2 wk, then 50 mg daily × 2 wk, then 100 mg daily; target 200-400 mg/day; SLOW TITRATION REQUIRED",
              "orderSentence": "Lamotrigine 25 mg daily PO"
            },
            "contraindications": "Slow titration required (SJS/TEN risk)",
            "monitoring": "Rash (stop if any rash; SJS/TEN risk higher with fast titration or valproate co-therapy)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Lacosamide",
            "route": "PO",
            "indication": "First-line alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Lacosamide 100 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Lacosamide 150 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Lacosamide 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 100 mg/day weekly; target 200-400 mg BID; max 400 mg BID",
              "orderSentence": "Lacosamide 100 mg BID PO"
            },
            "contraindications": "PR prolongation, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG at baseline and dose changes; dizziness, diplopia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Focal seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Oxcarbazepine 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300-600 mg/day weekly; target 1200-2400 mg/day divided",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia in 2-3%); HLA-B*1502 screening in at-risk populations",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Focal seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Carbamazepine 500 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Carbamazepine 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 200 mg BID; increase by 200 mg/day weekly; target 800-1200 mg/day; max 1600 mg/day",
              "orderSentence": "Carbamazepine 200 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Generalized seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Valproate/Divalproex 750 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Valproate/Divalproex 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-15 mg/kg/day divided; increase by 5-10 mg/kg/week; target 1000-2000 mg/day; max 60 mg/kg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "contraindications": "Pregnancy (teratogenic); hepatic disease; mitochondrial disease; pancreatitis history",
            "monitoring": "LFTs, ammonia, CBC, platelets at baseline, then q3-6mo; weight gain, hair loss, tremor",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Phenytoin",
            "route": "PO",
            "indication": "Focal or generalized",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Phenytoin 100 mg TID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Phenytoin 200 mg BID PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Phenytoin 300 mg daily PO"
                },
                {
                  "text": "400 mg daily",
                  "orderSentence": "Phenytoin 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "300-400 mg daily (extended release) or divided TID; adjust by level; target 10-20 μg/mL",
              "orderSentence": "Phenytoin 100 mg TID PO"
            },
            "contraindications": "Pregnancy (relative - fetal hydantoin syndrome); AV block",
            "monitoring": "Free phenytoin level (target 1-2 μg/mL); total level 10-20 μg/mL; CBC, LFTs; gingival hyperplasia, hirsutism",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Brivaracetam",
            "route": "PO",
            "indication": "Alternative to levetiracetam",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Brivaracetam 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Brivaracetam 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Brivaracetam 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; may increase to 100 mg BID; max 200 mg/day",
              "orderSentence": "Brivaracetam 50 mg BID PO"
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Less behavioral side effects than levetiracetam; somnolence; Schedule C-V",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Zonisamide",
            "route": "PO",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily",
                  "orderSentence": "Zonisamide 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Zonisamide 200 mg daily PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Zonisamide 300 mg daily PO"
                },
                {
                  "text": "400 mg daily",
                  "orderSentence": "Zonisamide 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; increase by 100 mg q2 weeks; target 300-400 mg daily; max 600 mg/day",
              "orderSentence": "Zonisamide 100 mg daily PO"
            },
            "contraindications": "Sulfonamide allergy; kidney stones",
            "monitoring": "Kidney stones (carbonic anhydrase inhibitor); oligohidrosis (pediatric); metabolic acidosis",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg BID",
                  "orderSentence": "Topiramate 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Topiramate 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg BID; increase by 50 mg/day weekly; target 200-400 mg/day divided; max 400 mg/day",
              "orderSentence": "Topiramate 25 mg BID PO"
            },
            "contraindications": "Kidney stones; metabolic acidosis; glaucoma",
            "monitoring": "Cognitive impairment (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Clobazam",
            "route": "PO",
            "indication": "Adjunctive therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Clobazam 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Clobazam 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Clobazam 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Clobazam 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; increase by 5-10 mg weekly; max 40 mg/day divided",
              "orderSentence": "Clobazam 5 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; sleep apnea (untreated)",
            "monitoring": "Sedation; tolerance may develop; CYP2C19 poor metabolizers need lower dose",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Perampanel",
            "route": "PO",
            "indication": "Adjunctive for focal or GTCS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg qHS",
                  "orderSentence": "Perampanel 2 mg qHS PO"
                },
                {
                  "text": "4 mg qHS",
                  "orderSentence": "Perampanel 4 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Perampanel 6 mg qHS PO"
                },
                {
                  "text": "8 mg qHS",
                  "orderSentence": "Perampanel 8 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Perampanel 10 mg qHS PO"
                },
                {
                  "text": "12 mg qHS",
                  "orderSentence": "Perampanel 12 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; increase by 2 mg weekly; target 8-12 mg qHS; max 12 mg/day",
              "orderSentence": "Perampanel 2 mg qHS PO"
            },
            "contraindications": "None absolute",
            "monitoring": "Psychiatric effects (aggression, hostility); dizziness; take at bedtime; Schedule III",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cenobamate",
            "route": "PO",
            "indication": "Adjunctive for focal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Cenobamate 12.5 mg daily PO"
                },
                {
                  "text": "25 mg daily",
                  "orderSentence": "Cenobamate 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Cenobamate 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Cenobamate 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Cenobamate 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily × 2 wk; titrate slowly per package insert; target 200-400 mg daily; SLOW TITRATION REQUIRED",
              "orderSentence": "Cenobamate 12.5 mg daily PO"
            },
            "contraindications": "Familial short QT syndrome",
            "monitoring": "Very slow titration required (DRESS risk); QT shortening; titration pack available",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Phenobarbital",
            "route": "PO",
            "indication": "Refractory or resource-limited",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Phenobarbital 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Phenobarbital 90 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Phenobarbital 120 mg daily PO"
                },
                {
                  "text": "180 mg daily",
                  "orderSentence": "Phenobarbital 180 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Maintenance 1-3 mg/kg/day (60-180 mg/day); target level 15-40 μg/mL",
              "orderSentence": "Phenobarbital 60 mg daily PO"
            },
            "contraindications": "Porphyria; severe respiratory disease",
            "monitoring": "Sedation; cognitive effects; drug interactions (CYP inducer); level monitoring",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Post-ictal headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg",
                  "orderSentence": "Acetaminophen 650 mg PO"
                },
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO/IV q6h PRN; max 3000 mg/day (2000 mg if liver disease)",
              "orderSentence": "Acetaminophen 650 mg PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if chronic use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Post-ictal headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Ibuprofen 400 mg PO"
                },
                {
                  "text": "600 mg",
                  "orderSentence": "Ibuprofen 600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6-8h PRN; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg PO"
            },
            "contraindications": "Renal impairment; GI bleed; post-CABG",
            "monitoring": "Renal function if prolonged use",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Post-ictal nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                },
                {
                  "text": "8 mg",
                  "orderSentence": "Ondansetron 8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4-8 mg IV/PO q8h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Post-ictal agitation (if severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Lorazepam 0.5 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Lorazepam 1 mg IV"
                },
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-2 mg IV/PO PRN; use with caution",
              "orderSentence": "Lorazepam 0.5 mg IV"
            },
            "contraindications": "Respiratory depression; altered mental status",
            "monitoring": "RR, sedation level; avoid if post-ictal confusion resolving",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline 150 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Sertraline 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
              "orderSentence": "Sertraline 50 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Suicidality monitoring weeks 1-4",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Escitalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg daily",
              "orderSentence": "Escitalopram 10 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc if risk factors",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Melatonin 5 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg PO qHS; well tolerated; may help with ASM-related sleep disruption",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None significant",
            "monitoring": "None routine",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mg PO qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Orthostatic hypotension; priapism (rare)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Add second ASM",
            "route": "PO",
            "indication": "Drug-resistant epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Add second ASM Per agent PO"
                }
              ],
              "route": "PO",
              "instructions": "Choose complementary mechanism; see maintenance options",
              "orderSentence": "Add second ASM Per agent PO"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation referral",
            "route": "—",
            "indication": "Drug-resistant epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Epilepsy surgery evaluation referral N/A —"
                }
              ],
              "route": "—",
              "instructions": "Refer if failed 2+ appropriately chosen ASMs",
              "orderSentence": "Epilepsy surgery evaluation referral N/A —"
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Vagus nerve stimulator (VNS)",
            "route": "For drug-resistant epilepsy not surgical candidates",
            "indication": "N/A",
            "dosing": {
              "instructions": "Device checks",
              "orderSentence": "Vagus nerve stimulator (VNS) - For drug-resistant epilepsy not surgical candidates - see dosing"
            },
            "contraindications": "—",
            "monitoring": "—",
            "ED": "EXT",
            "HOSP": "—"
          },
          {
            "item": "Dietary therapy (ketogenic diet, modified Atkins)",
            "route": "For drug-resistant epilepsy",
            "indication": "Fatty acid oxidation disorders; pyruvate carboxylase deficiency",
            "dosing": {
              "instructions": "Metabolic panels; lipids; kidney function",
              "orderSentence": "Dietary therapy (ketogenic diet, modified Atkins) - For drug-resistant epilepsy - see dosing"
            },
            "contraindications": "—",
            "monitoring": "—",
            "ED": "EXT",
            "HOSP": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "indication": "All new onset seizures for evaluation and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Epilepsy specialist referral",
            "indication": "Diagnostic uncertainty, refractory seizures, surgical candidacy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "EEG technologist/neurodiagnostics",
            "indication": "EEG scheduling; continuous EEG if indicated",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Structural lesion requiring intervention (tumor, AVM, SDH)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Medical toxicology consult",
            "indication": "Suspected drug/toxin-induced seizure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "CNS infection confirmed or suspected",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Oncology consult",
            "indication": "Brain tumor identified",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Psychiatry consult",
            "indication": "Depression, anxiety post-diagnosis; psychogenic non-epileptic spells suspected",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work consult",
            "indication": "Driving restrictions impact, employment concerns, insurance navigation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Occupational therapy",
            "indication": "Work safety evaluation, activity modification",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Physical therapy",
            "indication": "If post-ictal weakness, falls, injury from seizure",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Neuropsychology referral",
            "indication": "Cognitive complaints, pre-surgical evaluation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Women's health/OB-GYN",
            "indication": "Contraception counseling (ASM interactions), pregnancy planning",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Epilepsy monitoring unit (EMU) admission",
            "indication": "Characterize seizure type, video-EEG monitoring, pre-surgical evaluation",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Driving evaluation/rehabilitation",
            "indication": "Return to driving assessment when eligible",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "**Return to ED immediately if:** recurrent seizure, prolonged seizure >5 minutes, head injury, persistent confusion, difficulty breathing, or status epilepticus",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Do NOT drive until cleared by neurology (driving restrictions per state guidelines; typically require seizure-free interval)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid operating heavy machinery, working at heights, or swimming alone",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Do not bathe alone; showers preferred over baths; keep bathroom door unlocked",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Inform employer if job involves safety-sensitive duties",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Take ASM exactly as prescribed; do NOT stop abruptly (risk of breakthrough seizures or status epilepticus)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid common seizure triggers: sleep deprivation, alcohol, illicit drugs, missed medications",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Keep a seizure diary: date, time, duration, description, triggers, post-ictal symptoms",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Wear medical identification (bracelet or necklace)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Educate family/coworkers on seizure first aid: stay with person, protect head, do NOT put anything in mouth, time the seizure, call 911 if >5 minutes",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Follow up with neurology within 1-2 weeks of discharge",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Bring list of all medications (including OTC and supplements) to all appointments - many interact with ASMs",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Women: discuss contraception with provider; some ASMs reduce efficacy of hormonal contraception",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Report side effects (mood changes, rash, dizziness, cognitive issues) promptly; do NOT stop medication without calling",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid flashing/strobe lights if photosensitive seizures suspected",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sleep hygiene: aim for 7-9 hours nightly; maintain regular sleep schedule",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid alcohol (lowers seizure threshold; interacts with ASMs)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid illicit drugs (especially stimulants: cocaine, amphetamines)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Stress management techniques",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Regular moderate exercise (not extreme sleep deprivation from overtraining)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Medication adherence: use pill organizers, phone alarms, refill reminders",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Folic acid supplementation 1-4 mg daily for women of childbearing potential (especially if on enzyme-inducing ASMs)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Bone health: vitamin D 1000-2000 IU daily; calcium as needed (enzyme-inducing ASMs affect bone density)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid known personal triggers (flashing lights, certain foods, stress, if identified)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Home safety modifications: pad sharp furniture corners, avoid glass shower doors, use microwave instead of stovetop when alone",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Seizure alert devices or apps for those living alone (optional)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Smoking cessation (increases ASM metabolism; general health)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Syncope (convulsive syncope)",
        "features": "Brief (<15 sec), triggered by standing/Valsalva/micturition, rapid recovery, no post-ictal confusion, possible prodrome (lightheaded, tunnel vision)",
        "tests": "ECG, orthostatic vitals, tilt table test, echocardiogram"
      },
      {
        "diagnosis": "Psychogenic non-epileptic spells (PNES)",
        "features": "Variable/atypical semiology, prolonged duration, preserved awareness with bilateral movements, eye closure, pelvic thrusting, no post-ictal confusion, psychiatric comorbidity",
        "tests": "Video-EEG capturing event; normal prolactin"
      },
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Negative symptoms (weakness, numbness), no LOC, no convulsive activity",
        "tests": "MRI DWI, vascular imaging"
      },
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset, spreading symptoms, headache follows, stereotyped",
        "tests": "Clinical history, normal EEG"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion, rapid glucose corrects symptoms",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Cardiac arrhythmia",
        "features": "Palpitations, sudden LOC without warning, rapid recovery",
        "tests": "ECG, Holter monitor, event recorder, EP study"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia, repetitive questioning, no convulsive activity",
        "tests": "Clinical presentation (self-limited), MRI DWI (hippocampal)"
      },
      {
        "diagnosis": "Sleep disorders (parasomnias, cataplexy)",
        "features": "Occur from sleep, specific features (cataplexy with emotion)",
        "tests": "Sleep study, clinical history"
      },
      {
        "diagnosis": "Movement disorders (dystonia, tics)",
        "features": "Stereotyped, no LOC, suppressible (tics), may have sensory urge",
        "tests": "Clinical history, video"
      },
      {
        "diagnosis": "Drug intoxication/withdrawal",
        "features": "History of substance use, known withdrawal timeline",
        "tests": "Toxicology screen, history"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Gradual onset, diffuse abnormality, asterixis, no discrete seizures",
        "tests": "Labs (ammonia, glucose, Na), EEG (diffuse slowing)"
      }
    ],
    "evidence": [
      {
        "recommendation": "ILAE 2017 seizure classification",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2017"
      },
      {
        "recommendation": "ILAE 2014 practical definition of epilepsy",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2014"
      },
      {
        "recommendation": "EEG within 24-48h increases yield",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter 2007"
      },
      {
        "recommendation": "MRI superior to CT for epilepsy evaluation",
        "evidenceLevel": "Class I, Level A",
        "source": "ILAE Commission Report 2019"
      },
      {
        "recommendation": "Levetiracetam non-inferior to phenytoin for acute seizure cessation",
        "evidenceLevel": "Class I, Level A",
        "source": "ESETT Trial, NEJM 2019"
      },
      {
        "recommendation": "Risk of recurrence after first unprovoked seizure ~40-50%",
        "evidenceLevel": "Class I",
        "source": "Hauser et al., NEJM 1998"
      },
      {
        "recommendation": "Starting ASM after first seizure reduces recurrence but not long-term remission",
        "evidenceLevel": "Class I, Level A",
        "source": "FIRST and MESS trials"
      },
      {
        "recommendation": "Lamotrigine and levetiracetam preferred in women of childbearing potential",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN/AES Guidelines 2009, MONEAD Study"
      },
      {
        "recommendation": "Driving restrictions reduce accident risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple observational studies"
      },
      {
        "recommendation": "Prolactin elevation supports diagnosis of epileptic seizure (if drawn <20 min)",
        "evidenceLevel": "Class II, Level B",
        "source": "Chen et al., Neurology 2005"
      },
      {
        "recommendation": "Continuous EEG detects non-convulsive status in altered patients",
        "evidenceLevel": "Class II, Level B",
        "source": "Claassen et al., Neurology 2004"
      },
      {
        "recommendation": "Folate supplementation reduces teratogenicity risk",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (level of consciousness, focal deficits)",
        "frequency": "Q1-2h in ED; Q4h inpatient; each visit OPD",
        "action": "If prolonged post-ictal state: continuous EEG to rule out non-convulsive status",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "Vital signs",
        "frequency": "Continuous in ED/ICU; Q4h floor",
        "action": "Treat hyperthermia, hypotension, hypoxia",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Respiratory monitoring (post-benzodiazepine)",
        "frequency": "RR q15min × 1h post-administration; SpO2 continuous",
        "action": "Supplemental O2; airway management; consider flumazenil only if severe",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Glucose",
        "frequency": "On arrival; repeat if altered",
        "action": "Dextrose if low",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Electrolytes (Na, Ca, Mg)",
        "frequency": "On arrival; daily if abnormal",
        "action": "Correct deficiencies; identify cause",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "ASM level (phenytoin, valproate, phenobarbital, carbamazepine)",
        "frequency": "Trough level 5-7 days after initiation or dose change; PRN",
        "action": "Adjust dose; check free level for phenytoin",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "LFTs",
        "frequency": "Baseline; q3-6 months on valproate, carbamazepine",
        "action": "Discontinue if hepatotoxicity; hold if transaminases >3× ULN",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "CBC",
        "frequency": "Baseline; q3-6 months on carbamazepine, valproate",
        "action": "Discontinue if significant bone marrow suppression",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "Sodium",
        "frequency": "Baseline; periodically on oxcarbazepine, carbamazepine",
        "action": "Reduce dose or switch if severe hyponatremia",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "EEG",
        "frequency": "Within 24-48h of first seizure; repeat if diagnosis unclear",
        "action": "Adjust treatment if epileptiform activity or non-convulsive seizures",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "MRI brain",
        "frequency": "Within 2 weeks of first seizure; sooner if structural cause suspected",
        "action": "Address structural cause; refer to appropriate specialist",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "—"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Single, self-limited seizure; returned to baseline; no dangerous etiology identified on initial workup; reliable adult supervision for 24h; ASM initiated or deferred with close follow-up; outpatient EEG and MRI arranged; understands return precautions and driving restriction"
      },
      {
        "disposition": "**Admit to floor (observation)**",
        "criteria": "Prolonged post-ictal period; multiple seizures; new structural lesion requiring monitoring; ASM loading requiring observation; social situation preventing safe discharge; need for inpatient EEG; new focal neurologic deficit"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Status epilepticus (current or recent); recurrent seizures despite treatment; need for continuous EEG monitoring; airway compromise; hemodynamic instability; significant aspiration; large structural lesion with mass effect; CNS infection"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "MRI unavailable; EEG unavailable; neurology not available for consultation; need for neurosurgical intervention unavailable at facility"
      }
    ]
  },
  "Multiple Sclerosis - New Diagnosis": {
    "id": "ms-new-diagnosis",
    "title": "Multiple Sclerosis - New Diagnosis",
    "version": "2.5",
    "icd10": [
      "** G35 (Multiple sclerosis)",
      "H46.9 (Optic neuritis",
      "if presenting symptom)",
      "G37.9 (Demyelinating disease of CNS",
      "unspecified)"
    ],
    "scope": "** Initial diagnostic workup and management of suspected or newly confirmed MS. Covers diagnostic criteria evaluation, mimics exclusion, acute symptom treatment, and DMT initiation framework. For established MS with acute relapse, use \"MS - Exacerbation\" template. For ongoing DMT management and monitoring, use \"MS - Maintenance\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP",
            "rationale": "Metabolic screen, renal function",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease mimics MS",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes myelopathy",
            "target": "Normal (>300 pg/mL)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Folate",
            "rationale": "Folate deficiency causes myelopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitis screen",
            "target": "Normal (<20 mm/hr)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as symptom trigger",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Pre-steroid baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D (25-OH)",
            "rationale": "Low levels associated with MS risk/activity",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Lupus/connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Anti-dsDNA",
            "rationale": "If ANA positive, lupus evaluation",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Mayo CDS1 Panel** (AQP4-IgG + MOG-IgG by FACS)",
            "rationale": "Combined NMO/MOGAD screen; cell-based assay is gold standard",
            "target": "Both negative",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated myelopathy/encephalopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis mimics MS",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic areas; neuroborreliosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Neurosarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "SjÃ¶gren syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANCA panel",
            "rationale": "CNS vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Very long chain fatty acids",
            "rationale": "Adrenomyeloneuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Mitochondrial DNA studies",
            "rationale": "Leber hereditary optic neuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (HLA-DRB1)",
            "rationale": "Research/prognostic, not diagnostic",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in infection/carcinomatous",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Oligoclonal bands (CSF AND serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis",
            "target": "â‰¥2 CSF-specific bands (not in serum)"
          },
          {
            "item": "IgG index",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "item": "Myelin basic protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Active demyelination marker",
            "target": "May be elevated acutely"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast (MS protocol)*",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h if acute; within 2 weeks if stable",
            "target": "Periventricular, juxtacortical, infratentorial, or cord lesions; gadolinium enhancement = active",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain MRI",
            "target": "Cord lesions (short segment, peripheral, dorsal)",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI T-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain/C-spine",
            "target": "Cord lesions",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          }
        ],
        "Extended": [
          {
            "item": "Visual evoked potentials (VEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (subclinical optic nerve involvement)",
            "contraindications": "None significant"
          },
          {
            "item": "OCT (Optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline",
            "target": "RNFL thinning (prior optic neuritis)",
            "contraindications": "None significant"
          },
          {
            "item": "MRI orbits with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If optic neuritis suspected",
            "target": "Optic nerve enhancement, swelling",
            "contraindications": "Gadolinium contraindications"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT chest",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS lymphoma or paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "Conventional angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected",
            "target": "Beading, stenosis",
            "contraindications": "Contrast allergy, renal failure"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Atypical cases, tumefactive lesions",
            "target": "Demyelination vs neoplasm vs other",
            "contraindications": "Coagulopathy, inaccessible location"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "Acute MS relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily × 3-5 days",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h (target <180), BP, mood, sleep, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI prophylaxis during steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Omeprazole 20 mg PO"
                },
                {
                  "text": "40 mg",
                  "orderSentence": "Omeprazole 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily during steroids",
              "orderSentence": "Omeprazole 20 mg PO"
            },
            "contraindications": "PPI allergy",
            "monitoring": "None routine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin sliding scale",
            "route": "SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin sliding scale Per protocol SC"
                }
              ],
              "route": "SC",
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale Per protocol SC"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone oral taper (optional)",
            "route": "PO",
            "indication": "Steroid taper post-IV",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone oral taper (optional) 60 mg PO"
                },
                {
                  "text": "40 mg",
                  "orderSentence": "Prednisone oral taper (optional) 40 mg PO"
                },
                {
                  "text": "20 mg",
                  "orderSentence": "Prednisone oral taper (optional) 20 mg PO"
                },
                {
                  "text": "10 mg",
                  "orderSentence": "Prednisone oral taper (optional) 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily × 7 days, then taper over 2 weeks",
              "orderSentence": "Prednisone oral taper (optional) 60 mg PO"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - First-line": [
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3 days; max 80 mg/day divided",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Sedation, weakness; do NOT stop abruptly (withdrawal risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg TID",
                  "orderSentence": "Tizanidine 2 mg TID PO"
                },
                {
                  "text": "4 mg TID",
                  "orderSentence": "Tizanidine 4 mg TID PO"
                },
                {
                  "text": "8 mg TID",
                  "orderSentence": "Tizanidine 8 mg TID PO"
                },
                {
                  "text": "12 mg TID",
                  "orderSentence": "Tizanidine 12 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS or TID; increase by 2-4 mg q3-4 days; max 36 mg/day divided",
              "orderSentence": "Tizanidine 2 mg TID PO"
            },
            "contraindications": "Hepatic impairment; concurrent ciprofloxacin or fluvoxamine",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3 days; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg TID PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Duloxetine 90 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Duloxetine 120 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily × 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs; uncontrolled narrow-angle glaucoma",
            "monitoring": "Nausea (usually transient), BP, discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "Anticholinergic effects; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Carbamazepine 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day q3-7 days; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Oxcarbazepine 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg q3 days; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Oxybutynin IR 5 mg BID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Oxybutynin IR 5 mg TID PO"
                },
                {
                  "text": "5 mg QID",
                  "orderSentence": "Oxybutynin IR 5 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg BID PO"
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (especially elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin ER",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Oxybutynin ER 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Oxybutynin ER 10 mg daily PO"
                },
                {
                  "text": "15 mg daily",
                  "orderSentence": "Oxybutynin ER 15 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Oxybutynin ER 20 mg daily PO"
                },
                {
                  "text": "30 mg daily",
                  "orderSentence": "Oxybutynin ER 30 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; max 30 mg daily",
              "orderSentence": "Oxybutynin ER 5 mg daily PO"
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (fewer than IR)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Solifenacin",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Solifenacin 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Solifenacin 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Solifenacin 5 mg daily PO"
            },
            "contraindications": "Urinary retention; gastric retention; uncontrolled narrow-angle glaucoma; severe hepatic impairment",
            "monitoring": "Dry mouth, constipation; preferred if cognitive concerns",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Mirabegron 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Mirabegron 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg daily PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects (beta-3 agonist)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg daily",
                  "orderSentence": "Tamsulosin 0.4 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 min after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg daily PO"
            },
            "contraindications": "Severe sulfonamide allergy (use caution)",
            "monitoring": "Orthostatic hypotension; retrograde ejaculation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bethanechol",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg TID",
                  "orderSentence": "Bethanechol 10 mg TID PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Bethanechol 25 mg TID PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Bethanechol 50 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "10-50 mg TID-QID",
              "orderSentence": "Bethanechol 10 mg TID PO"
            },
            "contraindications": "Asthma; bradycardia; hypotension; GI/GU obstruction",
            "monitoring": "GI cramping, bronchospasm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desmopressin",
            "route": "PO/IN",
            "indication": "Nocturia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg qHS",
                  "orderSentence": "Desmopressin 0.1 mg qHS PO"
                },
                {
                  "text": "0.2 mg qHS",
                  "orderSentence": "Desmopressin 0.2 mg qHS PO"
                },
                {
                  "text": "0.4 mg qHS",
                  "orderSentence": "Desmopressin 0.4 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.4 mg qHS (oral) or 10-40 mcg intranasal",
              "orderSentence": "Desmopressin 0.1 mg qHS PO"
            },
            "contraindications": "Hyponatremia risk; age >65 (relative); CHF; polydipsia",
            "monitoring": "Sodium at baseline, 1 week, 1 month, then periodically; fluid restrict evening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Amantadine 100 mg qAM PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg every morning; may add 100 mg early afternoon (before 2 PM); max 200 mg/day",
              "orderSentence": "Amantadine 100 mg qAM PO"
            },
            "contraindications": "Renal impairment (adjust dose); uncontrolled seizures",
            "monitoring": "Livedo reticularis; ankle edema; insomnia; hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Modafinil 100 mg qAM PO"
                },
                {
                  "text": "200 mg qAM",
                  "orderSentence": "Modafinil 200 mg qAM PO"
                },
                {
                  "text": "400 mg qAM",
                  "orderSentence": "Modafinil 400 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg every morning; may increase to 200 mg; max 400 mg/day; Schedule IV",
              "orderSentence": "Modafinil 100 mg qAM PO"
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Armodafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg qAM",
                  "orderSentence": "Armodafinil 150 mg qAM PO"
                },
                {
                  "text": "250 mg qAM",
                  "orderSentence": "Armodafinil 250 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg every morning; max 250 mg daily; longer half-life; Schedule IV",
              "orderSentence": "Armodafinil 150 mg qAM PO"
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methylphenidate 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Methylphenidate 10 mg BID PO"
                },
                {
                  "text": "20 mg BID",
                  "orderSentence": "Methylphenidate 20 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID (morning and noon); max 60 mg/day; Schedule II",
              "orderSentence": "Methylphenidate 5 mg BID PO"
            },
            "contraindications": "Marked anxiety; glaucoma; tics/Tourette; concurrent MAOIs",
            "monitoring": "BP, HR, mood",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dalfampridine",
            "route": "PO",
            "indication": "Walking impairment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg q12h",
                  "orderSentence": "Dalfampridine 10 mg q12h PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg q12h (must be exactly 12 hours apart); do NOT exceed 20 mg/day",
              "orderSentence": "Dalfampridine 10 mg q12h PO"
            },
            "contraindications": "Seizure history; CrCl <50 mL/min",
            "monitoring": "Seizure risk (dose-dependent); UTI; insomnia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline 150 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Sertraline 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
              "orderSentence": "Sertraline 50 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide",
            "monitoring": "Suicidality monitoring (especially weeks 1-4); serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Escitalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 20 mg after 1 week; max 20 mg daily",
              "orderSentence": "Escitalopram 10 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide; QT prolongation",
            "monitoring": "QTc if risk factors or dose >10 mg; suicidality monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fluoxetine",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Fluoxetine 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Fluoxetine 40 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Fluoxetine 60 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Fluoxetine 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; may increase after several weeks; max 80 mg daily",
              "orderSentence": "Fluoxetine 20 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide; thioridazine",
            "monitoring": "Long half-life (washout important); suicidality monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion SR/XL",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg daily",
                  "orderSentence": "Bupropion SR/XL 150 mg daily PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Bupropion SR/XL 150 mg BID PO"
                },
                {
                  "text": "300 mg XL daily",
                  "orderSentence": "Bupropion SR/XL 300 mg XL daily PO"
                },
                {
                  "text": "400 mg/day",
                  "orderSentence": "Bupropion SR/XL 400 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg SR daily; increase to 150 mg SR BID after 3 days (or 300 mg XL daily); max 400 mg/day",
              "orderSentence": "Bupropion SR/XL 150 mg daily PO"
            },
            "contraindications": "Seizure disorder; eating disorders; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; no sexual side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression/pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg q4 days; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 75 mg daily PO"
            },
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome (taper slowly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression/insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                },
                {
                  "text": "45 mg qHS",
                  "orderSentence": "Mirtazapine 45 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 15 mg qHS; may increase by 15 mg q1-2 weeks; max 45 mg daily",
              "orderSentence": "Mirtazapine 15 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Weight gain; sedation (lower at higher doses); agranulocytosis (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol 3350 17 g daily PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid once daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g daily PO"
            },
            "contraindications": "Bowel obstruction; ileus",
            "monitoring": "Electrolytes if prolonged use; may take 1-3 days for effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Docusate sodium 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg BID PO"
            },
            "contraindications": "Intestinal obstruction; concurrent mineral oil",
            "monitoring": "Minimal efficacy as monotherapy; best for stool softening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8.6 mg qHS",
                  "orderSentence": "Senna 8.6 mg qHS PO"
                },
                {
                  "text": "17.2 mg qHS",
                  "orderSentence": "Senna 17.2 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 8.6 mg qHS PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; dependency with chronic daily use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bisacodyl",
            "route": "PO/PR",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Bisacodyl 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Bisacodyl 10 mg qHS PO"
                },
                {
                  "text": "10 mg PR",
                  "orderSentence": "Bisacodyl 10 mg PR PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO qHS or 10 mg PR PRN",
              "orderSentence": "Bisacodyl 5 mg qHS PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; electrolyte disturbance with overuse",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lubiprostone",
            "route": "PO",
            "indication": "Constipation (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "24 mcg BID",
                  "orderSentence": "Lubiprostone 24 mcg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "24 mcg BID with food",
              "orderSentence": "Lubiprostone 24 mcg BID PO"
            },
            "contraindications": "Mechanical GI obstruction",
            "monitoring": "Nausea (common); dyspnea; diarrhea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Propranolol 20 mg BID PO"
                },
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "60 mg BID",
                  "orderSentence": "Propranolol 60 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg BID; increase by 20-40 mg q3-7 days; max 320 mg/day divided",
              "orderSentence": "Propranolol 20 mg BID PO"
            },
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated CHF",
            "monitoring": "HR, BP; fatigue; depression; bronchospasm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primidone",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Primidone 25 mg qHS PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Primidone 50 mg TID PO"
                },
                {
                  "text": "125 mg TID",
                  "orderSentence": "Primidone 125 mg TID PO"
                },
                {
                  "text": "250 mg TID",
                  "orderSentence": "Primidone 250 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg weekly; usual 50-250 mg TID",
              "orderSentence": "Primidone 25 mg qHS PO"
            },
            "contraindications": "Porphyria; hypersensitivity to phenobarbital",
            "monitoring": "Severe sedation initially (start very low); ataxia; nausea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Clonazepam 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Clonazepam 2 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg BID; increase by 0.5 mg q3 days; max 6 mg/day",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Severe hepatic impairment; myasthenia gravis; untreated narrow-angle glaucoma",
            "monitoring": "Sedation; dependence; falls risk; do NOT stop abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Topiramate 25 mg daily PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Topiramate 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg weekly; max 400 mg/day divided",
              "orderSentence": "Topiramate 25 mg daily PO"
            },
            "contraindications": "Metabolic acidosis; kidney stones",
            "monitoring": "Cognitive slowing (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan-quinidine",
            "route": "PO",
            "indication": "Pseudobulbar affect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg daily",
                  "orderSentence": "Dextromethorphan-quinidine 20/10 mg daily PO"
                },
                {
                  "text": "20/10 mg q12h",
                  "orderSentence": "Dextromethorphan-quinidine 20/10 mg q12h PO"
                }
              ],
              "route": "PO",
              "instructions": "20/10 mg daily × 7 days, then 20/10 mg q12h",
              "orderSentence": "Dextromethorphan-quinidine 20/10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs; concurrent quinidine/quinine; CYP2D6 substrate drugs",
            "monitoring": "ECG at baseline; QTc monitoring; multiple drug interactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Acute Treatment)": [
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges —"
                }
              ],
              "route": "—",
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges —"
            },
            "contraindications": "Hemodynamic instability, sepsis, line contraindication",
            "monitoring": "BP, electrolytes, coags, fibrinogen, line infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day",
                  "orderSentence": "IVIG 0.4 g/kg/day IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day × 5 days (total 2 g/kg)",
              "orderSentence": "IVIG 0.4 g/kg/day IV"
            },
            "contraindications": "IgA deficiency, renal failure, thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Extended IV steroids",
            "route": "IV",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Extended IV steroids 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Additional 2-5 days methylprednisolone (total 5-10 days)",
              "orderSentence": "Extended IV steroids 1000 mg IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h, BP, mood, sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "ACTH gel (H.P. Acthar)",
            "route": "IM/SC",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 units",
                  "orderSentence": "ACTH gel (H.P. Acthar) 80 units IM/SC"
                }
              ],
              "route": "IM/SC",
              "instructions": "80 units IM/SC daily × 2-3 weeks",
              "orderSentence": "ACTH gel (H.P. Acthar) 80 units IM/SC"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose, BP, electrolytes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (DMT) - OPD ONLY": [
          {
            "item": "**INJECTABLE - MODERATE EFFICACY**"
          },
          {
            "item": "Interferon beta-1a (Avonex)",
            "route": "IM",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "30 mcg IM once weekly",
              "orderSentence": "Interferon beta-1a (Avonex) - IM - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common (pretreat with NSAIDs/acetaminophen)"
          },
          {
            "item": "Interferon beta-1a (Rebif)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "22 or 44 mcg SC three times weekly (titrate over 4 weeks)",
              "orderSentence": "Interferon beta-1a (Rebif) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; injection site reactions"
          },
          {
            "item": "Interferon beta-1b (Betaseron/Extavia)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "250 mcg SC every other day (titrate over 6 weeks)",
              "orderSentence": "Interferon beta-1b (Betaseron/Extavia) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common"
          },
          {
            "item": "Peginterferon beta-1a (Plegridy)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "125 mcg SC every 14 days (titrate over first 4 doses)",
              "orderSentence": "Peginterferon beta-1a (Plegridy) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; less frequent dosing"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 20mg",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg SC daily",
              "orderSentence": "Glatiramer acetate (Copaxone) 20mg - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; post-injection systemic reaction (rare, self-limited)"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 40mg",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "40 mg SC three times weekly (â‰¥48 hours apart)",
              "orderSentence": "Glatiramer acetate (Copaxone) 40mg - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same"
          },
          {
            "item": "Glatiramer acetate (Glatopa)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg SC daily or 40 mg SC three times weekly",
              "orderSentence": "Glatiramer acetate (Glatopa) - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same (generic)"
          },
          {
            "item": "**ORAL - MODERATE EFFICACY**"
          },
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "120 mg BID Ã— 7 days, then 240 mg BID",
              "orderSentence": "Dimethyl fumarate (Tecfidera) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects (take with food); flushing (aspirin 30 min prior)"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "231 mg BID Ã— 7 days, then 462 mg BID",
              "orderSentence": "Diroximel fumarate (Vumerity) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; less GI side effects than Tecfidera; flushing"
          },
          {
            "item": "Monomethyl fumarate (Bafiertam)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "95 mg BID Ã— 7 days, then 190 mg BID",
              "orderSentence": "Monomethyl fumarate (Bafiertam) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects; flushing"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "7 or 14 mg once daily",
              "orderSentence": "Teriflunomide (Aubagio) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, TB test, BP",
            "contraindications": "Pregnancy (Category X - teratogenic); severe hepatic impairment; concurrent leflunomide",
            "monitoring": "LFTs monthly Ã— 6 months, then periodically; BP; hair thinning; requires cholestyramine washout if pregnancy desired"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (S1P MODULATORS)**"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.5 mg once daily",
              "orderSentence": "Fingolimod (Gilenya) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam (macular edema), VZV IgG (vaccinate if negative and wait 4 weeks)",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA (within 6 months)",
            "monitoring": "First-dose observation 6 hours (HR, BP q1h, ECG at 6h); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Siponimod (Mayzent)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Titration pack days 1-5, then 2 mg daily (1 mg if CYP2C9 *1/*3 or *2/*3)",
              "orderSentence": "Siponimod (Mayzent) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG, CYP2C9 genotype",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA; CYP2C9 *3/*3 genotype",
            "monitoring": "First-dose observation 6 hours; macular edema screen; lymphocytes; LFTs; genotype required"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.23 mg daily Ã— 4 days, 0.46 mg daily Ã— 3 days, then 0.92 mg daily",
              "orderSentence": "Ozanimod (Zeposia) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA; concurrent MAOIs",
            "monitoring": "No first-dose observation required (slower titration); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "14-day titration pack, then 20 mg daily",
              "orderSentence": "Ponesimod (Ponvory) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA",
            "monitoring": "No first-dose observation required; macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (OTHER)**"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Year 1: 1.75 mg/kg divided into 2 treatment weeks (week 1 and week 5); Year 2: repeat same dosing; no treatment years 3-4",
              "orderSentence": "Cladribine (Mavenclad) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, HIV, Hepatitis B/C, TB, VZV IgG",
            "contraindications": "Active infection; HIV; active malignancy; pregnancy/breastfeeding; CrCl <30",
            "monitoring": "CBC at months 2 and 6 of each treatment year; lymphopenia expected and desired; screen for malignancy"
          },
          {
            "item": "**INFUSION - HIGH EFFICACY**"
          },
          {
            "item": "Natalizumab (Tysabri)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "300 mg IV every 4 weeks (or extended interval q6 weeks if stable and JCV negative)",
              "orderSentence": "Natalizumab (Tysabri) - IV - see dosing"
            },
            "pretreatment": "JCV antibody, CBC, LFTs",
            "contraindications": "JCV antibody positive with index >1.5 and prior immunosuppression (high PML risk); active infection",
            "monitoring": "JCV antibody q6mo; MRI for PML surveillance q6-12mo; infusion reactions; REMS program required"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 300 mg IV Ã— 2 doses 14 days apart; Maintenance: 600 mg IV every 6 months",
              "orderSentence": "Ocrelizumab (Ocrevus) - IV - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate with methylprednisolone, antihistamine, acetaminophen)"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 20 mg SC at weeks 0, 1, 2; Maintenance: 20 mg SC monthly starting week 4",
              "orderSentence": "Ofatumumab (Kesimpta) - SC - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; self-administered at home"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 150 mg IV day 1, 450 mg IV day 15; Maintenance: 450 mg IV every 24 weeks",
              "orderSentence": "Ublituximab (Briumvi) - IV - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate); 1-hour infusion"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Year 1: 12 mg IV daily Ã— 5 consecutive days; Year 2: 12 mg IV daily Ã— 3 consecutive days (12 months after year 1)",
              "orderSentence": "Alemtuzumab (Lemtrada) - IV - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH, creatinine, urinalysis, Hepatitis B/C, VZV IgG, TB, HPV screening",
            "contraindications": "Active infection; HIV; ongoing autoimmune disease other than MS",
            "monitoring": "CBC monthly Ã— 48 months; TSH q3mo Ã— 48 months; creatinine/urinalysis monthly Ã— 48 months; REMS program; secondary autoimmunity risk (thyroid, ITP, nephropathy)"
          },
          {
            "item": "**MODERATE EFFICACY - SPECIAL POPULATIONS**"
          },
          {
            "item": "Glatiramer acetate (Copaxone)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg daily or 40 mg TIW",
              "orderSentence": "Glatiramer acetate (Copaxone) - SC - see dosing"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Preferred in pregnancy (no evidence of harm)"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neuroimmunology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new MS diagnoses for DMT discussion"
          },
          {
            "item": "Neuro-ophthalmology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Optic neuritis, visual symptoms, OCT baseline"
          },
          {
            "item": "Physical therapy consult for gait and balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Gait dysfunction, lower extremity weakness, falls"
          },
          {
            "item": "Occupational therapy consult for ADL assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Upper extremity dysfunction, ADL impairment, energy conservation"
          },
          {
            "item": "Speech therapy for swallow evaluation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Brainstem involvement, dysphagia, dysarthria"
          },
          {
            "item": "Speech therapy for cognitive rehabilitation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive complaints affecting function"
          },
          {
            "item": "Urology referral for bladder dysfunction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Urgency, frequency, retention, recurrent UTI"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, adjustment to diagnosis"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Insurance navigation, disability questions, support resources"
          },
          {
            "item": "Rehabilitation medicine consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant functional impairment, comprehensive rehab needs"
          },
          {
            "item": "Infusion center coordination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "PLEX scheduling; future DMT infusion planning"
          },
          {
            "item": "Ophthalmology referral (pre-DMT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Baseline macular exam before S1P modulator initiation"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If atypical features, family history concerns"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if rapid vision loss, sudden weakness, difficulty breathing, or urinary retention",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid driving until cleared by neurology",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Keep symptom diary noting new or worsening symptoms",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop steroids abruptly if on oral taper",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop baclofen or tizanidine abruptly - risk of withdrawal/rebound spasticity",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Contact MS specialist before starting any new medications (drug interactions with DMTs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Vaccinations should be completed before DMT initiation (especially live vaccines)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Pregnancy planning requires DMT discussion (some DMTs teratogenic, washout periods vary)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Report any signs of infection (fever, cough, dysuria) promptly",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Post-void residual check if difficulty emptying bladder or recurrent UTIs",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (smoking accelerates MS progression and disability)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Regular aerobic exercise 150 min/week as tolerated (improves fatigue, mood, function)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Resistance training 2-3Ã—/week",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Stress management and adequate sleep (7-8 hours nightly)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid excessive heat exposure (hot tubs, saunas, prolonged direct sun, exercising in heat)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Cooling vest for outdoor activities in warm weather",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Maintain healthy weight (obesity associated with worse outcomes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Limit alcohol intake (can worsen balance, cognition, bladder symptoms)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Ensure vaccinations up to date before DMT initiation (live vaccines contraindicated on many DMTs)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Fall prevention: remove loose rugs, ensure adequate lighting, use assistive devices if needed",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Energy conservation techniques for fatigue management (pacing, prioritization, positioning)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder (NMOSD)",
        "features": "Longitudinally extensive transverse myelitis (â‰¥3 segments), severe optic neuritis (often bilateral), area postrema syndrome (intractable nausea/vomiting), brain lesions in NMOSD-typical locations",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern different"
      },
      {
        "diagnosis": "MOG antibody disease (MOGAD)",
        "features": "Bilateral optic neuritis, ADEM-like presentation, longitudinally extensive myelitis, cortical encephalitis, better steroid response, more favorable prognosis",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Monophasic (usually), encephalopathy, post-infectious, large poorly-defined lesions, pediatric predominance",
        "tests": "Clinical course, MRI pattern, MOG-IgG status"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache, encephalopathy, stroke-like episodes, multifocal infarcts",
        "tests": "Elevated ESR/CRP, angiography, brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (especially VII), hypothalamic involvement, leptomeningeal enhancement, hilar adenopathy",
        "tests": "ACE level, chest CT, biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "CNS lymphoma",
        "features": "Progressive course, deep gray matter/periventricular involvement, homogeneous enhancement, older/immunocompromised",
        "tests": "CSF cytology/flow, FDG-PET, biopsy"
      },
      {
        "diagnosis": "Susac syndrome",
        "features": "Encephalopathy, hearing loss, branch retinal artery occlusions, corpus callosum \"snowball\" lesions",
        "tests": "Audiogram, fluorescein angiography, MRI pattern"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Progressive cognitive decline, tabes dorsalis, Argyll Robertson pupils, positive serology",
        "tests": "RPR/VDRL, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "HIV-associated myelopathy/encephalopathy",
        "features": "Risk factors, vacuolar myelopathy, cognitive impairment",
        "tests": "HIV testing, CD4 count"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Subacute combined degeneration, dorsal column signs, peripheral neuropathy, macrocytic anemia",
        "tests": "B12, MMA, homocysteine"
      },
      {
        "diagnosis": "Migraine with white matter lesions",
        "features": "Headache history, non-specific white matter changes, no enhancement, no cord lesions",
        "tests": "Clinical history, MRI pattern"
      },
      {
        "diagnosis": "Small vessel ischemic disease",
        "features": "Older age, vascular risk factors, periventricular caps/halos, no enhancement, no cord lesions",
        "tests": "Risk factor profile, MRI pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "2017 McDonald Criteria for MS diagnosis",
        "evidenceLevel": "Class I",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "MRI brain/spine with contrast for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wattjes MP et al. Lancet Neurol 2021 (MAGNIMS)](https://pubmed.ncbi.nlm.nih.gov/34139157/)"
      },
      {
        "recommendation": "CSF OCBs can substitute for dissemination in time",
        "evidenceLevel": "Class II, Level B",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "IV methylprednisolone 1g Ã— 3-5 days for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[Filippini et al. Cochrane 2000](https://pubmed.ncbi.nlm.nih.gov/11034713/); Expert consensus"
      },
      {
        "recommendation": "PLEX for steroid-refractory attacks",
        "evidenceLevel": "Class II, Level B",
        "source": "[Faissner et al. J Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27039388/)"
      },
      {
        "recommendation": "Cell-based assay (FACS) for NMO/MOG antibodies",
        "evidenceLevel": "Class I, Level B",
        "source": "[Waters et al. 2014](https://pubmed.ncbi.nlm.nih.gov/27840658/); [Pittock et al.](https://pmc.ncbi.nlm.nih.gov/articles/PMC3286228/)"
      },
      {
        "recommendation": "Vitamin D supplementation",
        "evidenceLevel": "Class II, Level B",
        "source": "[SOLAR trial](https://pubmed.ncbi.nlm.nih.gov/31594857/); [CHOLINE trial](https://pubmed.ncbi.nlm.nih.gov/31454777/)"
      },
      {
        "recommendation": "Smoking cessation reduces progression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedström et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      },
      {
        "recommendation": "Early DMT initiation improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[BENEFIT extension](https://pubmed.ncbi.nlm.nih.gov/26833940/); Multiple RCTs"
      },
      {
        "recommendation": "Dalfampridine for walking impairment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goodman et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19249634/)"
      },
      {
        "recommendation": "Exercise improves fatigue and function",
        "evidenceLevel": "Class I, Level B",
        "source": "[Heine et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26358158/)"
      }
    ],
    "monitoring": [
      {
        "item": "Blood glucose",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Mood and sleep",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose adjustment"
      },
      {
        "item": "Temperature",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift",
        "action": "Infection workup if febrile"
      },
      {
        "item": "Neurologic exam",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓",
        "frequency": "Daily (inpatient); each visit (OPD)",
        "action": "If worsening: re-image, consider PLEX"
      },
      {
        "item": "I/O and weight",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Daily (inpatient)",
        "action": "Diuretics if fluid overload"
      },
      {
        "item": "Respiratory status",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift if cervical myelitis",
        "action": "ICU transfer if NIF >-20 (critical)"
      },
      {
        "item": "Post-void residual",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "If retention suspected",
        "action": "Intermittent catheterization if >200 mL; urology referral"
      },
      {
        "item": "MRI (follow-up) - early",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "3 months after baseline",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "MRI (follow-up) - standard",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "6 months after baseline, then annually",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "Vitamin D level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Annually",
        "action": "Increase supplementation if low"
      },
      {
        "item": "JCV antibody (if on natalizumab)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Every 6 months",
        "action": "If positive/rising: PML risk stratification, consider DMT switch"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms; able to ambulate safely; reliable follow-up within 1-2 weeks; no IV steroids needed OR completing outpatient infusion; stable baseline function; understands return precautions"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe symptoms; needs IV steroids; functional decline requiring therapy; diagnostic uncertainty requiring expedited workup; unable to care for self at home"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Severe myelitis with respiratory compromise (NIF >-30 declining toward -20); brainstem involvement with airway risk or autonomic instability; severe encephalopathy"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; MS specialist not available for complex decision-making; MRI unavailable for urgent imaging"
      }
    ]
  },
  "Peripheral Neuropathy - New Diagnosis/Evaluation": {
    "id": "peripheral-neuropathy",
    "title": "Peripheral Neuropathy - New Diagnosis/Evaluation",
    "version": "2.2",
    "icd10": [
      "** G62.9 (Polyneuropathy",
      "unspecified)",
      "G60.9 (Hereditary and idiopathic neuropathy",
      "unspecified)",
      "G62.0 (Drug-induced polyneuropathy)",
      "G62.1 (Alcoholic polyneuropathy)",
      "G63 (Polyneuropathy in diseases classified elsewhere)",
      "E11.42 (Type 2 diabetes with diabetic polyneuropathy)",
      "E10.42 (Type 1 diabetes with diabetic polyneuropathy)",
      "G60.0 (Hereditary motor and sensory neuropathy - CMT)",
      "E85.1 (Neuropathic heredofamilial amyloidosis - hATTR)"
    ],
    "scope": "** Initial diagnostic workup and symptomatic management of suspected or newly diagnosed peripheral neuropathy. Covers etiologic evaluation, electrodiagnostic testing, pain management, and lifestyle modifications. For acute inflammatory neuropathies (GBS, CIDP), use dedicated templates. For diabetic neuropathy-specific management, this template applies but see also diabetes care protocols for glycemic optimization.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Anemia (B12), infection, malignancy screen",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal dysfunction (uremic neuropathy), hepatic disease, electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes/prediabetes (most common cause)",
            "target": "<5.7%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency neuropathy",
            "target": ">300 pg/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "If B12 borderline (200-400); more sensitive",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Folate deficiency",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitic process",
            "target": "Normal (<20 mm/hr)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Oral glucose tolerance test (2-hour)",
            "rationale": "Detects IGT missed by FBG/HbA1c; high yield in idiopathic neuropathy (34-62% have abnormal OGTT)",
            "target": "<140 mg/dL at 2h",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) with immunofixation",
            "rationale": "Monoclonal gammopathy (MGUS, myeloma)",
            "target": "No M-spike",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine protein electrophoresis (UPEP)",
            "rationale": "Light chain disease",
            "target": "No monoclonal protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free light chains (kappa/lambda)",
            "rationale": "AL amyloidosis, light chain deposition",
            "target": "Normal ratio (0.26-1.65)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B1 (thiamine)",
            "rationale": "Alcoholism, malnutrition, bariatric surgery",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "rationale": "Deficiency OR toxicity (>200 mg/day) causes neuropathy",
            "target": "Normal (5-50 ng/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin E",
            "rationale": "Malabsorption, cholestasis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Copper",
            "rationale": "Copper deficiency (zinc excess, bariatric surgery)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zinc",
            "rationale": "Zinc excess suppresses copper",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated distal sensory polyneuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B surface antigen/antibody",
            "rationale": "Hepatitis B-associated PAN, cryoglobulinemia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "HCV-associated cryoglobulinemia, vasculitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology (endemic areas)",
            "rationale": "Lyme neuroborreliosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Syphilitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatoid factor",
            "rationale": "Rheumatoid vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "SjÃƒÂ¶gren syndrome (small fiber)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-MAG antibody",
            "rationale": "IgM paraproteinemic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "rationale": "If motor-predominant or acute onset (GBS variants)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Subacute sensory neuronopathy, weight loss, smoking",
            "target": "Negative (Anti-Hu, CV2)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cryoglobulins",
            "rationale": "Hepatitis C, autoimmune, vasculitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-CASPR2, Anti-LGI1",
            "rationale": "Neuromyotonia, Morvan syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fat pad or sural nerve biopsy",
            "rationale": "Amyloidosis, vasculitis, CIDP variants",
            "target": "No amyloid or vasculitis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (CMT panel, TTR gene)",
            "rationale": "Hereditary neuropathy, familial amyloidosis",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin punch biopsy for IENFD",
            "rationale": "Small fiber neuropathy confirmation",
            "target": ">8.8 fibers/mm (varies by site/age)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Heavy metal panel (lead, arsenic, thallium, mercury)",
            "rationale": "Occupational/environmental exposure",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Inflammation, infection",
            "target": "WBC <5, RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein",
            "rationale": "Albuminocytologic dissociation in GBS/CIDP",
            "target": "Normal 15-45 mg/dL; elevated in GBS/CIDP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Infection, carcinomatous meningitis",
            "target": "Normal (>60% serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Rule out infection",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cytology",
            "rationale": "Leptomeningeal carcinomatosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme PCR/antibody index",
            "rationale": "Endemic areas",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS) and EMG",
            "timing": "Optimal 3-4 weeks after symptom onset (allows Wallerian degeneration to manifest); can be done earlier if acute weakness suspected",
            "target": "Pattern determines axonal vs demyelinating, distribution, severity",
            "contraindications": "Pacemaker (relative); anticoagulation for needle EMG (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine (cervical/lumbar) with and without contrast",
            "timing": "If radiculopathy, myelopathy, or polyradiculopathy suspected",
            "target": "Nerve root enhancement (radiculopathy), cord signal change",
            "contraindications": "GFR <30, pacemaker, gadolinium allergy",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRI lumbar plexus with contrast",
            "timing": "Lumbosacral plexopathy, asymmetric proximal weakness",
            "target": "Plexus enhancement, mass lesion",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI brachial plexus with contrast",
            "timing": "Brachial plexopathy, Parsonage-Turner syndrome",
            "target": "Plexus enhancement, denervation changes",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing (QSART, tilt table, HRV)",
            "timing": "Autonomic symptoms (orthostasis, anhidrosis, GI dysmotility)",
            "target": "Abnormal sudomotor or cardiovagal function",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quantitative sensory testing (QST)",
            "timing": "Small fiber neuropathy evaluation",
            "target": "Abnormal thermal thresholds",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Chest X-ray",
            "timing": "Lung cancer (paraneoplastic), sarcoidosis",
            "target": "Normal",
            "contraindications": "Pregnancy (relative)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "Occult malignancy if paraneoplastic suspected",
            "target": "No mass",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult malignancy, amyloidosis",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Nerve ultrasound",
            "timing": "CIDP (nerve enlargement), entrapment",
            "target": "Normal nerve caliber",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MR neurography",
            "timing": "Focal nerve pathology, plexopathy",
            "target": "Normal nerve signal/caliber",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sural nerve biopsy",
            "timing": "Vasculitic neuropathy, amyloidosis, CIDP",
            "target": "No vasculitis or amyloid deposits",
            "contraindications": "Coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Thiamine (if alcoholic or malnourished)",
            "route": "IV",
            "indication": "Wernicke prevention, thiamine deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (if alcoholic or malnourished) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3 days, then 250 mg IV daily x 3-5 days, then oral",
              "orderSentence": "Thiamine (if alcoholic or malnourished) 500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "Anaphylaxis (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vitamin B12 (if deficient)",
            "route": "IM",
            "indication": "B12 deficiency neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 (if deficient) 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily x 7 days, then weekly x 4 weeks, then monthly",
              "orderSentence": "Vitamin B12 (if deficient) 1000 mcg IM"
            },
            "contraindications": "Cobalt allergy",
            "monitoring": "Reticulocyte count at 1 week; B12 level at 1-2 months",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose control optimization",
            "route": "IV/PO",
            "indication": "Diabetic neuropathy stabilization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Glucose control optimization Per protocol IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Per diabetes protocol; target HbA1c <7%",
              "orderSentence": "Glucose control optimization Per protocol IV/PO"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Neuropathic Pain": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Renal impairment (CrCl 30-59: max 1400 mg/day; CrCl 15-29: max 600 mg/day; CrCl <15: max 300 mg/day)",
            "monitoring": "Sedation, dizziness, peripheral edema; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl); Class V controlled",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain (first-line, diabetic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Duloxetine 90 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea, BP; discontinuation syndrome (taper 2+ weeks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg q4-7d; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 75 mg daily PO"
            },
            "contraindications": "Uncontrolled HTN; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; fewer anticholinergic effects than amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Desipramine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Desipramine 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Desipramine 75 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Desipramine 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg weekly; max 150 mg daily",
              "orderSentence": "Desipramine 25 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; least anticholinergic of TCAs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day q3-7d; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; MAOIs",
            "monitoring": "CBC, LFTs, sodium; HLA-B*1502 screening in at-risk populations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg q3d; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Carbamazepine hypersensitivity",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin cream 0.075%",
            "route": "TOP",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply thin layer",
                  "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Initial burning (decreases with use); wash hands after",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "TOP",
            "indication": "Localized neuropathic pain (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply by healthcare provider for 30-60 min; may repeat q3 months",
              "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Must be applied in clinic; pretreat with topical lidocaine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "TOP",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1-3 patches to painful area for 12h on, 12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches TOP"
            },
            "contraindications": "Severe hepatic impairment; broken skin",
            "monitoring": "Minimal systemic absorption; local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate neuropathic pain (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tramadol 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; may use ER 100 mg daily; max 400 mg/day",
              "orderSentence": "Tramadol 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule IV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Moderate-severe neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tapentadol ER 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; increase by 50 mg BID q3d; max 250 mg BID",
              "orderSentence": "Tapentadol ER 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule II)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Morphine ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg",
                  "orderSentence": "Morphine ER 15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 15 mg q12h; titrate q1-2d; no max (titrate to effect)",
              "orderSentence": "Morphine ER 15 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxycodone ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Oxycodone ER 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg q12h; titrate q1-2d",
              "orderSentence": "Oxycodone ER 10 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available (Schedule II)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Methadone",
            "route": "PO",
            "indication": "Severe refractory neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Methadone 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; titrate slowly (long half-life); specialist management",
              "orderSentence": "Methadone 2.5 mg PO"
            },
            "contraindications": "QT prolongation; QT-prolonging drugs",
            "monitoring": "ECG at baseline and with dose changes; QTc monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Other Symptoms": [
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "7.5 mg TID",
                  "orderSentence": "Midodrine 7.5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (awakening, midday, mid-afternoon); increase by 2.5 mg q1-2wk; max 10 mg TID; NOT within 4h of bedtime",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Severe heart disease; urinary retention; pheochromocytoma",
            "monitoring": "Supine HTN (avoid lying flat within 4h); urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                },
                {
                  "text": "0.3 mg daily",
                  "orderSentence": "Fludrocortisone 0.3 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; increase by 0.1 mg q1-2wk; max 0.3 mg daily",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; hypertension",
            "monitoring": "Potassium, BP, edema; hypokalemia; supine HTN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (Northera) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; increase by 100 mg TID q24-48h; max 600 mg TID; NOT within 3h of bedtime",
              "orderSentence": "Droxidopa (Northera) 100 mg PO"
            },
            "contraindications": "Concurrent ergot alkaloids",
            "monitoring": "Supine HTN; caution with MAOIs/triptans",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg TID",
              "orderSentence": "Pyridostigmine 30 mg PO"
            },
            "contraindications": "Mechanical GI/GU obstruction; asthma (relative)",
            "monitoring": "Cholinergic effects; less supine HTN than midodrine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "PO",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol 3350 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Electrolytes with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Docusate sodium 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg PO"
            },
            "contraindications": "Intestinal obstruction",
            "monitoring": "Minimal efficacy alone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17.2 mg",
                  "orderSentence": "Senna 17.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 17.2 mg PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg 30 min before meals and qHS; max 40 mg/day; limit 12 weeks (black box: TD)",
              "orderSentence": "Metoclopramide 10 mg PO"
            },
            "contraindications": "Bowel obstruction; Parkinson; TD history",
            "monitoring": "Tardive dyskinesia; QT prolongation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Domperidone",
            "route": "PO",
            "indication": "Gastroparesis (if metoclopramide CI)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Domperidone 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg TID before meals; max 30 mg/day",
              "orderSentence": "Domperidone 10 mg PO"
            },
            "contraindications": "QT prolongation; QT-prolonging drugs",
            "monitoring": "ECG at baseline; not FDA-approved",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin IR 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg PO"
            },
            "contraindications": "Urinary retention; narrow-angle glaucoma",
            "monitoring": "Dry mouth, constipation, cognitive impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 min after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Severe sulfonamide allergy",
            "monitoring": "Orthostatic hypotension (caution if orthostatic)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sildenafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Sildenafil 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg 30-60 min before activity; may adjust 25-100 mg; max 100 mg/day",
              "orderSentence": "Sildenafil 50 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tadalafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Tadalafil 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg before activity (max once daily) OR 2.5-5 mg daily",
              "orderSentence": "Tadalafil 10 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydroxyzine",
            "route": "PO",
            "indication": "Anxiety, pruritus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Hydroxyzine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg TID-QID PRN; max 400 mg/day",
              "orderSentence": "Hydroxyzine 25 mg PO"
            },
            "contraindications": "QT prolongation (high doses)",
            "monitoring": "Sedation; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buspirone",
            "route": "PO",
            "indication": "Generalized anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Buspirone 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg q2-3d; max 60 mg/day",
              "orderSentence": "Buspirone 5 mg PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Takes 2-4 weeks for effect; no dependence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia with chronic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Trazodone 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; increase to 100-150 mg; max 200 mg qHS",
              "orderSentence": "Trazodone 50 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc; priapism (rare); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg qHS 30 min before bed",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Specific Treatments": [
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "CIDP, MMN, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG 2 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg divided over 2-5 days (induction); maintenance 0.4-1 g/kg q2-4wk",
              "orderSentence": "IVIG 2 g/kg IV"
            },
            "pretreatment": "IgA level; renal function; CBC",
            "contraindications": "IgA deficiency (use IgA-depleted); renal failure; thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis, infusion reactions",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "IV",
            "indication": "CIDP, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasma exchange (PLEX) 5-7 exchanges IV"
                }
              ],
              "route": "IV",
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasma exchange (PLEX) 5-7 exchanges IV"
            },
            "pretreatment": "Coags; fibrinogen; line access",
            "contraindications": "Hemodynamic instability; sepsis",
            "monitoring": "BP, electrolytes, coags, fibrinogen",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "CIDP, vasculitic neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 80 mg) x 4-6 weeks; taper over 3-6 months",
              "orderSentence": "Prednisone 60 mg PO"
            },
            "pretreatment": "Glucose; BP; DEXA if prolonged",
            "contraindications": "Active infection; uncontrolled DM; psychosis",
            "monitoring": "Glucose, BP, mood, bone density",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Anti-MAG neuropathy, vasculitic neuropathy, refractory CIDP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses 14 days apart",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "pretreatment": "HBV serology; CBC; immunoglobulins",
            "contraindications": "Active hepatitis B; active infection",
            "monitoring": "HBV serology, infusion reactions, infection monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase to 2-3 mg/kg/day over weeks",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "pretreatment": "TPMT genotype; CBC; LFTs",
            "contraindications": "TPMT deficiency; pregnancy",
            "monitoring": "CBC weekly x 1 month, then q2-4wk; LFTs monthly",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg BID x 2 weeks, then 1000 mg BID",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "pretreatment": "CBC; pregnancy test",
            "contraindications": "Pregnancy (teratogenic); concurrent azathioprine",
            "monitoring": "CBC q2wk x 3 months, then monthly; GI upset",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV/PO",
            "indication": "Vasculitic neuropathy (severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Cyclophosphamide 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 mg/kg/day PO OR 500-1000 mg/m2 IV monthly x 6 months",
              "orderSentence": "Cyclophosphamide 1 mg/kg PO"
            },
            "pretreatment": "CBC; UA; pregnancy test",
            "contraindications": "Pregnancy; bone marrow suppression; active infection",
            "monitoring": "CBC weekly; UA (hemorrhagic cystitis); cumulative dose limit",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tafamidis (Vyndamax)",
            "route": "PO",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "61 mg",
                  "orderSentence": "Tafamidis (Vyndamax) 61 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "61 mg (Vyndamax) or 80 mg (Vyndaqel) daily",
              "orderSentence": "Tafamidis (Vyndamax) 61 mg PO"
            },
            "pretreatment": "LFTs; cardiac eval",
            "contraindications": "None absolute",
            "monitoring": "LFTs; clinical response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Patisiran (Onpattro)",
            "route": "IV",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.3 mg/kg IV every 3 weeks",
              "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
            },
            "pretreatment": "LFTs; vitamin A level",
            "contraindications": "None absolute",
            "monitoring": "Vitamin A supplementation required (RDA); infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Inotersen (Tegsedi)",
            "route": "SC",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "284 mg",
                  "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "284 mg SC once weekly",
              "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
            },
            "pretreatment": "Platelets; renal function; REMS enrollment",
            "contraindications": "Platelet <100K; prior glomerulonephritis from inotersen",
            "monitoring": "Platelets weekly (more frequent if <75K); renal q2wk; continue 8wk post-discontinuation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular neurology referral",
            "indication": "All new neuropathy diagnoses for etiology workup and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Electrodiagnostic medicine/EMG referral",
            "indication": "NCS/EMG for characterization (axonal vs demyelinating, pattern)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy consult for balance and gait",
            "indication": "Gait instability, weakness, falls prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy consult for hand function",
            "indication": "Fine motor impairment, ADL difficulty",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Podiatry referral",
            "indication": "Diabetic neuropathy, foot care education, orthotics, wound prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology referral",
            "indication": "Diabetes management optimization if HbA1c not at goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management/Anesthesia referral",
            "indication": "Refractory neuropathic pain, spinal cord stimulator evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology referral",
            "indication": "Suspected vasculitic neuropathy, connective tissue disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hematology/Oncology referral",
            "indication": "Paraproteinemic neuropathy, suspected malignancy, amyloidosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling referral",
            "indication": "Suspected hereditary neuropathy (CMT, hATTR), family history",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "indication": "Chronic pain management, depression, anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work consult",
            "indication": "Disability resources, insurance navigation, DME assistance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care referral",
            "indication": "Diabetic foot ulcers, non-healing wounds",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Orthotics/Prosthetics",
            "indication": "AFOs for foot drop, custom orthotics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/Dietitian referral",
            "indication": "Alcoholic neuropathy, nutritional deficiencies, bariatric surgery patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Addiction medicine/Psychiatry",
            "indication": "Alcohol use disorder, opioid risk mitigation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if sudden severe weakness, difficulty breathing, or rapid symptom progression",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Inspect feet daily for cuts, blisters, or wounds (use mirror for soles)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear well-fitting, protective footwear at all times (never barefoot)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Test bath water temperature with elbow or thermometer before entering (avoid burns)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid prolonged hot or cold exposure to affected extremities (impaired sensation increases injury risk)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Use night lights and handrails to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Report new numbness, weakness, or autonomic symptoms (dizziness, bladder changes)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Keep pain medication diary to track effectiveness and side effects",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Neuropathic pain medications take 2-4 weeks to reach full effect",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid alcohol (worsens neuropathy, interacts with pain medications)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Rise slowly from sitting/lying position if orthostatic hypotension present",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Increase salt and fluid intake if orthostatic (unless contraindicated by cardiac/renal disease)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear compression stockings for orthostatic hypotension",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not drive until cleared if significant sensory loss or weakness affects pedal control",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "B12 injections: if self-administering, use proper technique and rotate injection sites",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict glycemic control (HbA1c <7% or individualized target) - most important modifiable factor",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Complete alcohol cessation (alcoholic neuropathy is reversible if early)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Smoking cessation (microvascular disease worsens neuropathy)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular exercise as tolerated (improves circulation, glycemic control, reduces pain)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Balance exercises and strength training (PT-guided) to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Pool therapy/aquatic exercise (reduces fall risk while exercising)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Vitamin B12 supplementation if vegan/vegetarian or on metformin",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Review medications for neurotoxic agents (metronidazole, nitrofurantoin, chemotherapy, amiodarone, statins)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid excessive vitamin B6 supplementation (>100 mg/day can cause neuropathy)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Blood pressure control (target <130/80 for diabetic patients)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Weight loss if obese (reduces pressure on nerves, improves metabolic syndrome)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Fall prevention: remove throw rugs, ensure adequate lighting, use assistive devices",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Annual foot exams by podiatry or primary care for diabetic patients",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular ophthalmology exams if diabetic (concurrent retinopathy common)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diabetic polyneuropathy",
        "features": "Symmetric, length-dependent, sensory-predominant, feet before hands, burning/tingling",
        "tests": "HbA1c >6.5% (or 2-hour OGTT >200); NCS shows axonal sensorimotor polyneuropathy"
      },
      {
        "diagnosis": "Alcoholic neuropathy",
        "features": "History of chronic alcohol use, nutritional deficiency, burning feet",
        "tests": "History, thiamine level, liver function tests"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Subacute combined degeneration, myelopathy features (ataxia, Romberg), macrocytic anemia",
        "tests": "B12 <200 pg/mL or MMA elevated; may have cord signal changes on MRI"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Progressive or relapsing weakness >8 weeks, proximal and distal, areflexia",
        "tests": "NCS shows demyelination; CSF protein elevated; nerve enlargement on ultrasound"
      },
      {
        "diagnosis": "Guillain-BarrÃƒÂ© syndrome (GBS)",
        "features": "Acute ascending weakness <4 weeks, areflexia, post-infectious",
        "tests": "NCS early may be normal then demyelinating; CSF albuminocytologic dissociation"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history, pes cavus, hammertoes, childhood onset, slowly progressive",
        "tests": "Genetic testing; NCS shows uniform slowing in CMT1"
      },
      {
        "diagnosis": "Hereditary transthyretin amyloidosis (hATTR)",
        "features": "Autonomic dysfunction, carpal tunnel, cardiac involvement, family history",
        "tests": "TTR gene mutation; tissue biopsy with amyloid"
      },
      {
        "diagnosis": "Monoclonal gammopathy-associated neuropathy",
        "features": "Distal sensory-predominant, ataxia (IgM anti-MAG), older patient",
        "tests": "SPEP/UPEP; anti-MAG antibody; may need bone marrow biopsy"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Mononeuritis multiplex pattern (asymmetric, stepwise), pain, systemic symptoms",
        "tests": "Elevated ESR/CRP; ANCA; nerve/muscle biopsy shows necrotizing vasculitis"
      },
      {
        "diagnosis": "Paraneoplastic sensory neuronopathy",
        "features": "Subacute onset, asymmetric, dorsal root ganglia involvement, weight loss",
        "tests": "Anti-Hu antibody; CT chest for small cell lung cancer"
      },
      {
        "diagnosis": "Radiculopathy",
        "features": "Dermatomal distribution, unilateral, neck/back pain, preserved reflexes outside affected root",
        "tests": "MRI spine; NCS/EMG shows radicular pattern"
      },
      {
        "diagnosis": "Lumbosacral plexopathy (diabetic amyotrophy)",
        "features": "Acute/subacute proximal weakness, thigh pain, unilateral then contralateral",
        "tests": "NCS/EMG; MRI lumbosacral plexus; diagnosis of exclusion"
      },
      {
        "diagnosis": "Small fiber neuropathy",
        "features": "Pain/autonomic symptoms with normal NCS, preserved reflexes",
        "tests": "Skin biopsy for IENFD; autonomic testing"
      },
      {
        "diagnosis": "Charcot-Marie-Tooth disease",
        "features": "Childhood/adolescent onset, pes cavus, distal atrophy, family history",
        "tests": "Genetic testing (PMP22 duplication most common)"
      },
      {
        "diagnosis": "Chemotherapy-induced peripheral neuropathy (CIPN)",
        "features": "Temporal relationship to neurotoxic chemotherapy (platinum, taxanes, vincristine)",
        "tests": "History; dose-dependent; may improve after discontinuation"
      },
      {
        "diagnosis": "HIV-associated distal sensory polyneuropathy",
        "features": "HIV+ patient, distal symmetric painful neuropathy",
        "tests": "HIV testing; CD4 count"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, prior tick bite, radiculopathy, cranial neuropathy, polyradiculopathy",
        "tests": "Lyme serology; may need CSF analysis"
      },
      {
        "diagnosis": "Sarcoidosis",
        "features": "Multifocal neuropathy, cranial neuropathy (especially VII), pulmonary symptoms",
        "tests": "ACE level; chest imaging; biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "Leprosy",
        "features": "Endemic areas, skin lesions, enlarged palpable nerves, anesthetic patches",
        "tests": "Skin smear/biopsy for AFB; nerve biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Diabetes is most common cause of polyneuropathy in developed countries",
        "evidenceLevel": "Class I",
        "source": "[Dyck PJ et al. Neurology 1993](https://pubmed.ncbi.nlm.nih.gov/8469345/)"
      },
      {
        "recommendation": "HbA1c <7% reduces neuropathy incidence in Type 1 DM",
        "evidenceLevel": "Class I, Level A",
        "source": "[DCCT/EDIC, Martin et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24356595/)"
      },
      {
        "recommendation": "Gabapentin, pregabalin, duloxetine first-line for painful diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN/AANEM Practice Guideline 2022](https://pubmed.ncbi.nlm.nih.gov/34965987/)"
      },
      {
        "recommendation": "Tricyclic antidepressants effective for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
      },
      {
        "recommendation": "NCS/EMG for characterization of peripheral neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "SPEP indicated in idiopathic neuropathy workup",
        "evidenceLevel": "Class II, Level B",
        "source": "[England JD et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "OGTT detects IGT in 34-62% of idiopathic neuropathy patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Singleton et al. Diabetes Care 2001](https://pubmed.ncbi.nlm.nih.gov/11473085/); [Hoffman-Snyder et al. Arch Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16769858/)"
      },
      {
        "recommendation": "Skin biopsy (IENFD) for small fiber neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lauria G et al. Eur J Neurol 2010](https://pubmed.ncbi.nlm.nih.gov/20642627/)"
      },
      {
        "recommendation": "IVIG first-line for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[EAN/PNS Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/33506534/)"
      },
      {
        "recommendation": "Thiamine supplementation in alcoholic neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "Foot care reduces amputations in diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ADA Standards of Care 2023: Foot Care](https://pubmed.ncbi.nlm.nih.gov/36507636/)"
      },
      {
        "recommendation": "Capsaicin 8% patch effective for localized neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Qutenza Prescribing Information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022395s012lbl.pdf)"
      },
      {
        "recommendation": "Tafamidis for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Coelho T et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22843282/)"
      },
      {
        "recommendation": "Patisiran/inotersen for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Adams D et al. NEJM 2018 (APOLLO)](https://pubmed.ncbi.nlm.nih.gov/29972753/); [Benson MD et al. NEJM 2018 (NEURO-TTR)](https://pubmed.ncbi.nlm.nih.gov/29972757/)"
      },
      {
        "recommendation": "Combination therapy for neuropathic pain improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gilron I et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19796802/)"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "frequency": "Every 3 months until stable, then every 6 months",
        "action": "Intensify glycemic therapy; endocrinology referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin B12",
        "frequency": "1-2 months after starting supplementation, then annually",
        "action": "Continue supplementation; rule out malabsorption",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Pain scores (0-10 NRS)",
        "frequency": "Each visit",
        "action": "Titrate medications; consider adjuncts or referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Foot exam",
        "frequency": "Every visit; comprehensive annually",
        "action": "Podiatry referral; wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (supine and standing)",
        "frequency": "Each visit if orthostatic symptoms",
        "action": "Adjust orthostatic hypotension medications; consider compression",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Gait and fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; assistive devices; home safety evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine clearance",
        "frequency": "Baseline; with renal disease, elderly, or gabapentinoid use; with dose changes",
        "action": "Adjust gabapentin: CrCl 30-59 max 900-1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "LFTs (if on high-dose gabapentinoid)",
        "frequency": "Baseline, then annually",
        "action": "Dose adjustment if hepatic impairment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function",
        "frequency": "Every 6-12 months",
        "action": "Adjust renally cleared medications (gabapentin, pregabalin)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CBC (if on immunotherapy)",
        "frequency": "Per medication protocol",
        "action": "Adjust immunosuppression dose; infection evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "NCS/EMG follow-up",
        "frequency": "6-12 months if treatment initiated; PRN for symptom change",
        "action": "If progressive despite treatment, reconsider diagnosis or escalate therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on TCAs)",
        "frequency": "Baseline; with dose increases >100 mg",
        "action": "Reduce dose or switch medication",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "Weight (if on gabapentinoid)",
        "frequency": "Each visit",
        "action": "Diet/exercise counseling; consider switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression/anxiety screening (PHQ-9, GAD-7)",
        "frequency": "Annually or with symptom concern",
        "action": "Psychiatry referral; pharmacotherapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Respiratory function (if GBS/CIDP suspected)",
        "frequency": "Q4h if concern; FVC and NIF",
        "action": "ICU transfer if FVC <20 or NIF >-30; intubation if declining",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable symptoms; chronic/slowly progressive course; ambulatory; reliable follow-up with neurology within 2-4 weeks; pain controlled; able to perform ADLs; no fall risk requiring inpatient therapy"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Acute/subacute progression concerning for GBS or CIDP; significant functional decline; falls requiring therapy evaluation; severe uncontrolled pain; new autonomic instability; workup requiring inpatient procedures (nerve biopsy, LP)"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "GBS with respiratory compromise (FVC <20 mL/kg, NIF >-30, or declining trajectory); autonomic instability with cardiac arrhythmia or BP lability; aspiration risk"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "EMG/NCS not available urgently; neuromuscular specialist not available; PLEX/IVIG needed but not available; rehabilitation services not available"
      }
    ]
  },
  "Acute Ischemic Stroke": {
    "id": "acute-ischemic-stroke",
    "title": "Acute Ischemic Stroke",
    "version": "1.2",
    "icd10": [
      "** I63.9 (Cerebral infarction",
      "unspecified)",
      "I63.50 (Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery)",
      "I63.30 (Cerebral infarction due to thrombosis of unspecified cerebral artery)",
      "I63.40 (Cerebral infarction due to embolism of unspecified cerebral artery)",
      "G45.9 (Transient cerebral ischemic attack",
      "unspecified)"
    ],
    "scope": "** Emergency evaluation and treatment of acute ischemic stroke, including thrombolysis decision-making, mechanical thrombectomy candidacy, acute stroke unit care, secondary prevention, and etiologic workup. For hemorrhagic stroke, TIA, or venous sinus thrombosis, use dedicated templates.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia can mimic stroke; required before tPA",
            "target": "60-180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Baseline; thrombocytopenia contraindication to tPA",
            "target": "Platelets >100K",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR",
            "rationale": "Anticoagulation status; INR >1.7 contraindication to tPA",
            "target": "INR <1.7",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "PTT",
            "rationale": "Baseline; heparin effect assessment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Basic metabolic panel",
            "rationale": "Electrolytes, renal function",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Concurrent MI; cardioembolic source",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BNP or NT-proBNP",
            "rationale": "Heart failure; atrial cardiopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lipid panel (fasting preferred)",
            "rationale": "Cardiovascular risk; statin candidacy",
            "target": "LDL target <70",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes as risk factor",
            "target": "<7% goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid disease and atrial fibrillation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Baseline for statin therapy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Cocaine, amphetamine-induced stroke",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (females of childbearing age)",
            "rationale": "tPA risk assessment",
            "target": "Negative (or counsel risks)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Glycemic control assessment",
            "target": "<7% goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR",
            "rationale": "Vasculitis screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CRP",
            "rationale": "Inflammation; vasculitis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Hypercoagulable workup in young stroke",
            "target": "Normal (<15 umol/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Hyperhomocysteinemia cause",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Hyperhomocysteinemia cause",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-beta2 glycoprotein)",
            "rationale": "Hypercoagulable workup; repeat in 12 weeks if positive",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein C, Protein S, Antithrombin III",
            "rationale": "Inherited thrombophilia (defer acute phase; check 2-4 weeks post-stroke)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Factor V Leiden, Prothrombin gene mutation",
            "rationale": "Inherited thrombophilia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Vasculitis, SLE",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANCA (c-ANCA, p-ANCA)",
            "rationale": "Primary CNS vasculitis; systemic vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Syphilis serology (RPR)",
            "rationale": "Infectious vasculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated vasculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B and C serology",
            "rationale": "Associated with vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Elevated in cryptogenic stroke",
            "target": "Normal (<50 nmol/L or <30 mg/dL)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sickle cell screen",
            "rationale": "If clinical suspicion",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (alpha-galactosidase A, GLA gene)",
            "rationale": "Young cryptogenic stroke, especially with other Fabry features",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Vasculitis, infection",
            "target": "WBC <5, RBC 0"
          },
          {
            "item": "Protein",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Inflammation",
            "target": "Normal 15-45 mg/dL"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Infection",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Malignancy",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Non-contrast CT head (NCCT)",
            "timing": "STAT - door to CT <25 min target",
            "target": "No hemorrhage; early ischemic changes (ASPECTS score)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "CT angiography head and neck (CTA)",
            "timing": "STAT with NCCT",
            "target": "Large vessel occlusion (LVO); carotid/vertebral stenosis",
            "contraindications": "Contrast allergy (premedicate), CKD (benefit usually outweighs risk in acute stroke)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "CT perfusion (CTP)",
            "timing": "If within extended window (6-24 hours) or wake-up stroke",
            "target": "Mismatch (ischemic penumbra salvageable)",
            "contraindications": "Contrast allergy (premedicate), CKD (benefit usually outweighs risk in acute stroke)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "STAT",
            "target": "Atrial fibrillation, STEMI, LVH",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with DWI",
            "timing": "Within 24 hours; better for small/posterior strokes",
            "target": "Acute infarct confirmation; lesion pattern",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRA head and neck",
            "timing": "With MRI if CTA not done",
            "target": "Stenosis, dissection, aneurysm",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Transthoracic echocardiogram (TTE) with bubble study",
            "timing": "Within 24-48 hours",
            "target": "LV thrombus, PFO, valvular disease, wall motion abnormalities",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram (TEE)",
            "timing": "If TTE non-diagnostic and high suspicion for cardiac source; or PFO evaluation",
            "target": "LAA thrombus, aortic atheroma, PFO with atrial septal aneurysm",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "If CTA/MRA not done or for follow-up",
            "target": "Stenosis >50%",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transcranial Doppler (TCD) with bubble study",
            "timing": "PFO evaluation; vasospasm monitoring",
            "target": "Right-to-left shunt; microembolic signals",
            "contraindications": "Inadequate acoustic windows",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Continuous cardiac telemetry (minimum 24-72 hours)",
            "timing": "Paroxysmal AF detection",
            "target": "Atrial fibrillation",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Extended cardiac monitoring (Holter 7-30 days or implantable loop recorder)",
            "timing": "Cryptogenic stroke; AF not detected on telemetry",
            "target": "Paroxysmal AF",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Conventional cerebral angiography (DSA)",
            "timing": "If vasculitis suspected; CNS vasculitis workup",
            "target": "Beading, stenosis, aneurysm",
            "contraindications": "Contrast allergy, CKD, coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "High-resolution vessel wall MRI",
            "timing": "Vasculitis, intracranial atherosclerosis characterization",
            "target": "Wall enhancement pattern",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lumbar puncture",
            "timing": "If vasculitis, infectious, or inflammatory etiology suspected",
            "target": "See LP section",
            "contraindications": "See LP section",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET-CT or PET-MRI",
            "timing": "Occult malignancy workup; giant cell arteritis",
            "target": "No malignancy/inflammation",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Implantable loop recorder (ILR)",
            "timing": "Cryptogenic stroke after negative workup",
            "target": "Paroxysmal AF detection",
            "contraindications": "Active infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Hyperacute Phase)": [
          {
            "item": "Alteplase (tPA) IV",
            "route": "IV",
            "indication": "Acute ischemic stroke within 4.5h",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.9 mg/kg (max 90 mg)",
                  "orderSentence": "Alteplase (tPA) IV 0.9 mg/kg (max 90 mg) IV"
                }
              ],
              "route": "IV",
              "instructions": "0.9 mg/kg IV (max 90 mg); 10% as bolus over 1 min, remainder over 60 min; within 4.5 hours",
              "orderSentence": "Alteplase (tPA) IV 0.9 mg/kg (max 90 mg) IV"
            },
            "contraindications": "See Appendix A; major: ICH, recent surgery, BP >185/110, INR >1.7, platelets <100K",
            "monitoring": "Neuro checks q15min x 2h, then q30min x 6h, then q1h x 16h; BP q15min x 2h; hold anticoagulants 24h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Tenecteplase IV",
            "route": "IV",
            "indication": "Acute ischemic stroke within 4.5h",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg/kg (max 25 mg)",
                  "orderSentence": "Tenecteplase IV 0.25 mg/kg (max 25 mg) IV"
                }
              ],
              "route": "IV",
              "instructions": "0.25 mg/kg IV bolus (max 25 mg); single bolus (no infusion); within 4.5 hours",
              "orderSentence": "Tenecteplase IV 0.25 mg/kg (max 25 mg) IV"
            },
            "contraindications": "See Appendix A; major: ICH, recent surgery, BP >185/110, INR >1.7, platelets <100K",
            "monitoring": "Neuro checks q15min x 2h, then q30min x 6h; BP q15min x 2h; hold anticoagulants 24h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Labetalol (pre-thrombolysis)",
            "route": "IV",
            "indication": "BP control for tPA eligibility",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Labetalol (pre-thrombolysis) 10 mg IV"
                },
                {
                  "text": "20 mg",
                  "orderSentence": "Labetalol (pre-thrombolysis) 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 1-2 min; may repeat or double q10min; max 300 mg; target BP <185/110",
              "orderSentence": "Labetalol (pre-thrombolysis) 10 mg IV"
            },
            "contraindications": "Asthma, severe bradycardia, decompensated HF, 2nd/3rd degree heart block",
            "monitoring": "Continuous BP; target BP <185/110 for tPA eligibility",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Nicardipine (pre-thrombolysis)",
            "route": "IV",
            "indication": "BP control for tPA eligibility",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/hr",
                  "orderSentence": "Nicardipine (pre-thrombolysis) 5 mg/hr IV"
                },
                {
                  "text": "10 mg/hr",
                  "orderSentence": "Nicardipine (pre-thrombolysis) 10 mg/hr IV"
                },
                {
                  "text": "15 mg/hr",
                  "orderSentence": "Nicardipine (pre-thrombolysis) 15 mg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 5 mg/hr IV; increase by 2.5 mg/hr q5-15min; max 15 mg/hr; target BP <185/110",
              "orderSentence": "Nicardipine (pre-thrombolysis) 5 mg/hr IV"
            },
            "contraindications": "None significant",
            "monitoring": "Continuous BP; target <185/110",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Clevidipine (pre-thrombolysis)",
            "route": "IV",
            "indication": "BP control for tPA eligibility",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 1 mg/hr IV"
                },
                {
                  "text": "2 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 2 mg/hr IV"
                },
                {
                  "text": "4 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 4 mg/hr IV"
                },
                {
                  "text": "8 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 8 mg/hr IV"
                },
                {
                  "text": "16 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 16 mg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 1-2 mg/hr IV; titrate by doubling q90sec initially; max 32 mg/hr",
              "orderSentence": "Clevidipine (pre-thrombolysis) 1 mg/hr IV"
            },
            "contraindications": "Soy/egg allergy, severe aortic stenosis, lipid disorders",
            "monitoring": "Continuous BP; rapid onset; short half-life",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "BP management (post-tPA)",
            "route": "IV",
            "indication": "Post-tPA BP control",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Labetalol 10-20 mg IV",
                  "orderSentence": "BP management (post-tPA) Labetalol 10-20 mg IV IV"
                },
                {
                  "text": "Nicardipine 5-15 mg/hr IV",
                  "orderSentence": "BP management (post-tPA) Nicardipine 5-15 mg/hr IV IV"
                },
                {
                  "text": "Clevidipine 1-32 mg/hr IV",
                  "orderSentence": "BP management (post-tPA) Clevidipine 1-32 mg/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "Labetalol 10-20 mg IV q10min, nicardipine 5-15 mg/hr, or clevidipine 1-32 mg/hr; target BP <180/105 x 24h",
              "orderSentence": "BP management (post-tPA) Labetalol 10-20 mg IV IV"
            },
            "contraindications": "Asthma (labetalol); soy/egg allergy (clevidipine)",
            "monitoring": "Continuous BP; target BP <180/105 for 24 hours post-tPA",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical thrombectomy",
            "route": "—",
            "indication": "Large vessel occlusion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical thrombectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Endovascular clot retrieval; within 6 hours for anterior LVO; up to 24 hours with favorable perfusion imaging",
              "orderSentence": "Mechanical thrombectomy N/A —"
            },
            "contraindications": "Large completed infarct (ASPECTS <6), poor baseline function (mRS >2), no LVO",
            "monitoring": "Post-procedure: BP per protocol, groin site checks, neuro checks q1h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Acute Supportive Care": [
          {
            "item": "NPO status",
            "route": "—",
            "indication": "All acute stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NPO",
                  "orderSentence": "NPO status NPO —"
                }
              ],
              "route": "—",
              "instructions": "NPO until formal swallow screen passed",
              "orderSentence": "NPO status NPO —"
            },
            "contraindications": "None",
            "monitoring": "Aspiration risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids - Normal saline",
            "route": "IV",
            "indication": "Volume resuscitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 500 mL",
                  "orderSentence": "IV fluids - Normal saline NS 500 mL IV"
                },
                {
                  "text": "NS 1000 mL",
                  "orderSentence": "IV fluids - Normal saline NS 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "0.9% NaCl; avoid dextrose-containing fluids (hyperglycemia worsens outcomes)",
              "orderSentence": "IV fluids - Normal saline NS 500 mL IV"
            },
            "contraindications": "Volume overload",
            "monitoring": "I/O, daily weights",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin - Glucose management",
            "route": "IV/SC",
            "indication": "Hyperglycemia in acute stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin - Glucose management Per protocol IV/SC"
                }
              ],
              "route": "IV/SC",
              "instructions": "Sliding scale or infusion; target glucose 140-180 mg/dL; avoid hypoglycemia",
              "orderSentence": "Insulin - Glucose management Per protocol IV/SC"
            },
            "contraindications": "Hypoglycemia (<60)",
            "monitoring": "Glucose q1-6h depending on regimen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intermittent pneumatic compression",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply bilateral",
                  "orderSentence": "Intermittent pneumatic compression Apply bilateral —"
                }
              ],
              "route": "—",
              "instructions": "Apply to both legs",
              "orderSentence": "Intermittent pneumatic compression Apply bilateral —"
            },
            "contraindications": "Active DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Enoxaparin 30 mg SC"
                },
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; reduce to 30 mg if CrCl <30; start 24-48h post-stroke if no hemorrhage",
              "orderSentence": "Enoxaparin 30 mg SC"
            },
            "contraindications": "Active bleeding, HIT, hemorrhagic transformation",
            "monitoring": "Platelets; signs of bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Heparin (unfractionated)",
            "route": "SC",
            "indication": "DVT prophylaxis (CrCl <30)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units",
                  "orderSentence": "Heparin (unfractionated) 5000 units SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h; alternative to enoxaparin if CrCl <30",
              "orderSentence": "Heparin (unfractionated) 5000 units SC"
            },
            "contraindications": "Active bleeding, HIT, hemorrhagic transformation",
            "monitoring": "Platelets; signs of bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/PR",
            "indication": "Fever management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg",
                  "orderSentence": "Acetaminophen 650 mg PO"
                },
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO/PR q4-6h PRN temp >38C; max 4g/day; target normothermia",
              "orderSentence": "Acetaminophen 650 mg PO"
            },
            "contraindications": "Hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Head of bed positioning",
            "route": "—",
            "indication": "Perfusion optimization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "HOB flat to 15°",
                  "orderSentence": "Head of bed positioning HOB flat to 15° —"
                },
                {
                  "text": "HOB 30°",
                  "orderSentence": "Head of bed positioning HOB 30° —"
                }
              ],
              "route": "—",
              "instructions": "Flat to 15° initially if no LVO treated; elevate to 30° if large infarct or aspiration risk",
              "orderSentence": "Head of bed positioning HOB flat to 15° —"
            },
            "contraindications": "None",
            "monitoring": "Neuro exam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
                },
                {
                  "text": "NRB PRN",
                  "orderSentence": "Supplemental oxygen NRB PRN INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to SpO2 >94%; avoid routine oxygen in non-hypoxic patients",
              "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "Continuous SpO2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Secondary Prevention (Initiate During Hospitalization)": [
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "Non-cardioembolic stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin 81 mg daily PO"
                },
                {
                  "text": "325 mg daily",
                  "orderSentence": "Aspirin 325 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 325 mg (after tPA, wait 24h, confirm no ICH); Maintenance 81-325 mg daily",
              "orderSentence": "Aspirin 81 mg daily PO"
            },
            "contraindications": "Active bleeding, aspirin allergy, concurrent anticoagulation",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel",
            "route": "PO",
            "indication": "Aspirin intolerance; or DAPT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Clopidogrel 75 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 300-600 mg; Maintenance 75 mg daily",
              "orderSentence": "Clopidogrel 75 mg daily PO"
            },
            "contraindications": "Active bleeding, severe hepatic impairment",
            "monitoring": "Bleeding, bruising",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DAPT - Aspirin + Clopidogrel",
            "route": "PO",
            "indication": "Minor stroke (NIHSS ≤3) or high-risk TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "ASA 81 mg + Clopidogrel 75 mg",
                  "orderSentence": "DAPT - Aspirin + Clopidogrel ASA 81 mg + Clopidogrel 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg + Clopidogrel 75 mg daily x 21 days; preceded by loading doses; then single agent",
              "orderSentence": "DAPT - Aspirin + Clopidogrel ASA 81 mg + Clopidogrel 75 mg PO"
            },
            "contraindications": "Major stroke, high bleeding risk, planned surgery",
            "monitoring": "Bleeding; discontinue one agent at day 21",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DAPT - Aspirin + Ticagrelor",
            "route": "PO",
            "indication": "Minor stroke (THALES trial)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "ASA 81 mg + Ticagrelor 90 mg BID",
                  "orderSentence": "DAPT - Aspirin + Ticagrelor ASA 81 mg + Ticagrelor 90 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg + Ticagrelor 90 mg BID x 30 days; then single agent",
              "orderSentence": "DAPT - Aspirin + Ticagrelor ASA 81 mg + Ticagrelor 90 mg BID PO"
            },
            "contraindications": "Major stroke, high bleeding risk, planned surgery; CYP3A4 inhibitors",
            "monitoring": "Bleeding; dyspnea (common)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "All ischemic stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Atorvastatin 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Atorvastatin 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "40-80 mg daily; start in hospital; high-intensity statin",
              "orderSentence": "Atorvastatin 40 mg daily PO"
            },
            "contraindications": "Active liver disease, pregnancy",
            "monitoring": "LFTs at baseline; CK if myalgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "All ischemic stroke (alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rosuvastatin 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Rosuvastatin 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily; dose adjust for Asian patients, CKD",
              "orderSentence": "Rosuvastatin 20 mg daily PO"
            },
            "contraindications": "Active liver disease, pregnancy",
            "monitoring": "LFTs at baseline; CK if myalgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Apixaban 5 mg BID PO"
                },
                {
                  "text": "2.5 mg BID",
                  "orderSentence": "Apixaban 2.5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID; reduce to 2.5 mg BID if 2 of: age ≥80, weight ≤60 kg, Cr ≥1.5; delay 4-14 days post-stroke",
              "orderSentence": "Apixaban 5 mg BID PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg daily",
                  "orderSentence": "Rivaroxaban 15 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rivaroxaban 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with dinner; 15 mg if CrCl 15-50; delay 4-14 days post-stroke",
              "orderSentence": "Rivaroxaban 15 mg daily PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dabigatran",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Dabigatran 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Dabigatran 150 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg BID; 75 mg BID if CrCl 15-30; delay 4-14 days post-stroke",
              "orderSentence": "Dabigatran 75 mg BID PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment; GI upset common",
            "monitoring": "Renal function; bleeding; reversal agent availability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edoxaban",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Edoxaban 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Edoxaban 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily; 30 mg if CrCl 15-50, weight ≤60 kg, or P-gp inhibitor; delay 4-14 days",
              "orderSentence": "Edoxaban 30 mg daily PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve, antiphospholipid syndrome",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per INR",
                  "orderSentence": "Warfarin Per INR PO"
                }
              ],
              "route": "PO",
              "instructions": "Start with heparin bridge; target INR 2-3 (2.5-3.5 for mechanical mitral); delay 4-14 days",
              "orderSentence": "Warfarin Per INR PO"
            },
            "contraindications": "Active bleeding, severe hepatic impairment",
            "monitoring": "INR weekly then monthly; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Hypertension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg daily",
                  "orderSentence": "Lisinopril 2.5 mg daily PO"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Lisinopril 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Lisinopril 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg daily; titrate to 20-40 mg daily; target BP <130/80",
              "orderSentence": "Lisinopril 2.5 mg daily PO"
            },
            "contraindications": "Bilateral renal artery stenosis, angioedema history, pregnancy",
            "monitoring": "BP, K+, Cr",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "Hypertension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Amlodipine 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Amlodipine 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; max 10 mg daily",
              "orderSentence": "Amlodipine 5 mg daily PO"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "BP, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "Hypertension (volume-dependent)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Chlorthalidone 12.5 mg daily PO"
                },
                {
                  "text": "25 mg daily",
                  "orderSentence": "Chlorthalidone 25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "12.5-25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg daily PO"
            },
            "contraindications": "Sulfa allergy (relative), hypokalemia, gout",
            "monitoring": "K+, Na+, uric acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Complications Management": [
          {
            "item": "Mannitol",
            "route": "IV",
            "indication": "Cerebral edema; increased ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 g/kg",
                  "orderSentence": "Mannitol 0.5 g/kg IV"
                },
                {
                  "text": "1 g/kg",
                  "orderSentence": "Mannitol 1 g/kg IV"
                },
                {
                  "text": "1.5 g/kg",
                  "orderSentence": "Mannitol 1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1.5 g/kg IV over 20-30 min; may repeat q6h; serum osm goal <320",
              "orderSentence": "Mannitol 0.5 g/kg IV"
            },
            "contraindications": "Hypovolemia, anuria",
            "monitoring": "Serum osm, Na+, renal function; Foley required",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "Severe cerebral edema; herniation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV push via central line over 10-20 min",
              "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "Severe hypernatremia (Na >160)",
            "monitoring": "Na q4-6h; target Na 145-155 for edema",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 3%",
            "route": "IV",
            "indication": "Cerebral edema (less severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mL",
                  "orderSentence": "Hypertonic saline 3% 150 mL IV"
                },
                {
                  "text": "250 mL",
                  "orderSentence": "Hypertonic saline 3% 250 mL IV"
                },
                {
                  "text": "500 mL",
                  "orderSentence": "Hypertonic saline 3% 500 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "150-500 mL IV bolus or continuous infusion at 30-50 mL/hr",
              "orderSentence": "Hypertonic saline 3% 150 mL IV"
            },
            "contraindications": "Severe hypernatremia (Na >160)",
            "monitoring": "Na q4-6h; target Na 145-155 for edema",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "—",
            "indication": "Malignant MCA infarction with edema",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Decompressive craniectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical; within 48 hours of stroke onset; age <60",
              "orderSentence": "Decompressive craniectomy N/A —"
            },
            "contraindications": "Poor pre-stroke function, extensive infarct, patient/family preference",
            "monitoring": "Post-op neuro checks, ICP if monitored",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Levetiracetam",
            "route": "IV/PO",
            "indication": "Seizure (not routine prophylaxis)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Levetiracetam 500 mg BID IV/PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500-1000 mg IV/PO BID; max 3000 mg/day; use only if seizure occurs",
              "orderSentence": "Levetiracetam 500 mg BID IV/PO"
            },
            "contraindications": "None significant",
            "monitoring": "Mood, behavior",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ceftriaxone + Metronidazole",
            "route": "IV",
            "indication": "Aspiration pneumonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ceftriaxone 1 g daily + Metronidazole 500 mg q8h",
                  "orderSentence": "Ceftriaxone + Metronidazole Ceftriaxone 1 g daily + Metronidazole 500 mg q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "Ceftriaxone 1-2 g IV daily + Metronidazole 500 mg IV/PO q8h",
              "orderSentence": "Ceftriaxone + Metronidazole Ceftriaxone 1 g daily + Metronidazole 500 mg q8h IV"
            },
            "contraindications": "Cephalosporin allergy, alcohol with metronidazole",
            "monitoring": "WBC, fever, respiratory status",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Special Situations": [
          {
            "item": "Heparin infusion",
            "route": "IV",
            "indication": "Cervical artery dissection; warfarin bridge",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 units/kg bolus",
                  "orderSentence": "Heparin infusion 80 units/kg bolus IV"
                },
                {
                  "text": "18 units/kg/hr",
                  "orderSentence": "Heparin infusion 18 units/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "80 units/kg bolus, then 18 units/kg/hr; titrate to PTT 60-80",
              "orderSentence": "Heparin infusion 80 units/kg bolus IV"
            },
            "contraindications": "Active bleeding, large infarct, hemorrhagic transformation",
            "monitoring": "PTT q6h until therapeutic, then q12-24h",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "PFO closure (device)",
            "route": "—",
            "indication": "Cryptogenic stroke with high-risk PFO",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "PFO closure (device) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Interventional procedure; typically after stroke recovery; age <60",
              "orderSentence": "PFO closure (device) N/A —"
            },
            "contraindications": "Active infection, other stroke etiology identified",
            "monitoring": "Post-procedure: antiplatelet therapy, bubble study follow-up",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid endarterectomy (CEA)",
            "route": "—",
            "indication": "Symptomatic carotid stenosis 70-99%",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Carotid endarterectomy (CEA) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical; timing 2-14 days post-stroke optimal",
              "orderSentence": "Carotid endarterectomy (CEA) N/A —"
            },
            "contraindications": "Unstable medical condition, near-complete occlusion",
            "monitoring": "Post-op: BP control, neuro checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid artery stenting (CAS)",
            "route": "—",
            "indication": "Carotid stenosis (high surgical risk)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Carotid artery stenting (CAS) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Interventional procedure; alternative to CEA",
              "orderSentence": "Carotid artery stenting (CAS) N/A —"
            },
            "contraindications": "Unstable medical condition, near-complete occlusion; unfavorable anatomy",
            "monitoring": "Post-procedure: DAPT x 30 days minimum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Stroke neurology consult",
            "indication": "All acute ischemic stroke",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Interventional neuroradiology/neuroendovascular",
            "indication": "LVO identified; thrombectomy candidate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Malignant edema; decompressive craniectomy candidate",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cardiology consult",
            "indication": "AF management, PFO evaluation, cardiac source workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Vascular surgery consult",
            "indication": "Symptomatic carotid stenosis; CEA candidate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology",
            "indication": "Swallow evaluation; aphasia therapy",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Physical therapy",
            "indication": "Mobility, gait, balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy",
            "indication": "ADLs, upper extremity function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Rehabilitation medicine (PM&R)",
            "indication": "Inpatient rehabilitation placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work",
            "indication": "Discharge planning, community resources",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Case management",
            "indication": "Insurance authorization, rehab placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care",
            "indication": "Large stroke with poor prognosis; goals of care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Smoking cessation counseling",
            "indication": "All smokers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/Dietitian",
            "indication": "Dysphagia diet, heart-healthy diet education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if new or worsening weakness, numbness, vision changes, speech difficulty, or severe headache",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Know stroke warning signs: F.A.S.T. (Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Take all prescribed medications as directed; do not stop antiplatelet or anticoagulant without physician guidance",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Attend all follow-up appointments (neurology, cardiology, primary care)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "No driving until cleared by physician (typically minimum 2-4 weeks; varies by state law and deficit severity)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Report any bleeding (blood in stool, urine, gums, excessive bruising) while on blood thinners",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Check blood pressure at home daily if hypertensive; keep log for follow-up visits",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Monitor blood glucose if diabetic; maintain good glycemic control",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Follow swallow precautions if dysphagia present (diet modification, positioning, supervision)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Use fall precautions: clear pathways, use assistive devices as prescribed, adequate lighting",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (most important modifiable risk factor)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Blood pressure control: target <130/80 mmHg",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "LDL cholesterol target <70 mg/dL (or 50% reduction) with high-intensity statin",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Diabetes management: HbA1c target <7%",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Limit alcohol: ≤1 drink/day women, ≤2 drinks/day men; abstinence if alcohol-related stroke",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Heart-healthy diet: Mediterranean or DASH diet",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Regular aerobic exercise: 40 min moderate-intensity 3-4 days/week when able",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Weight management: BMI target 18.5-24.9",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Sleep apnea screening and treatment if indicated",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid illicit drugs (cocaine, amphetamines)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Hormone replacement therapy: avoid or use caution",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Stress management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "✓"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hypoglycemia",
        "features": "Rapid response to glucose; often diabetic on insulin/sulfonylureas",
        "tests": "Point-of-care glucose; resolves with correction"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "History of seizure; gradual resolution over hours; post-ictal confusion",
        "tests": "EEG; witnessed seizure; gradual resolution"
      },
      {
        "diagnosis": "Complex migraine with aura",
        "features": "Headache (usually); positive symptoms (scintillating scotoma); history of similar; <60 min",
        "tests": "Clinical history; normal imaging; resolves"
      },
      {
        "diagnosis": "Intracranial hemorrhage",
        "features": "Sudden severe headache; rapid progression; may have anticoagulation history",
        "tests": "CT head shows hemorrhage"
      },
      {
        "diagnosis": "Brain tumor",
        "features": "Gradual onset; headache; seizures; may have mass effect",
        "tests": "MRI brain shows mass lesion"
      },
      {
        "diagnosis": "Subdural hematoma",
        "features": "History of trauma (may be minor); elderly; anticoagulation",
        "tests": "CT shows crescent-shaped collection"
      },
      {
        "diagnosis": "Encephalitis",
        "features": "Fever; altered mental status; seizures; behavioral changes",
        "tests": "MRI (temporal lobe); LP; CSF PCR"
      },
      {
        "diagnosis": "Multiple sclerosis (acute relapse)",
        "features": "Younger patient; prior episodes; MRI pattern (periventricular, Dawson fingers)",
        "tests": "MRI brain/spine; LP (oligoclonal bands)"
      },
      {
        "diagnosis": "Conversion disorder/functional neurological disorder",
        "features": "Inconsistent exam; positive functional signs (Hoover, give-way weakness)",
        "tests": "Clinical; normal imaging; psychiatric history"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Ataxia, ophthalmoplegia, confusion; alcohol/malnutrition history",
        "tests": "Clinical; MRI (mammillary bodies); thiamine response"
      },
      {
        "diagnosis": "Hypertensive encephalopathy",
        "features": "Severely elevated BP; headache; confusion; PRES pattern on MRI",
        "tests": "MRI (PRES); BP reduction reverses symptoms"
      },
      {
        "diagnosis": "Cerebral venous sinus thrombosis",
        "features": "Headache; may have hypercoagulable state or OCP use; hemorrhagic infarcts",
        "tests": "CT/MR venography; D-dimer"
      },
      {
        "diagnosis": "Hyponatremia",
        "features": "Confusion, seizures; recent medication change; SIADH",
        "tests": "BMP shows low sodium"
      },
      {
        "diagnosis": "Hepatic encephalopathy",
        "features": "Liver disease; asterixis; confusion",
        "tests": "Ammonia; LFTs; history"
      },
      {
        "diagnosis": "Drug intoxication",
        "features": "History of substance use; pupils; toxidrome",
        "tests": "Urine drug screen"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV alteplase within 4.5 hours improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[NINDS, ECASS III](https://pubmed.ncbi.nlm.nih.gov/7477192/)"
      },
      {
        "recommendation": "Tenecteplase non-inferior to alteplase",
        "evidenceLevel": "Class I, Level B",
        "source": "[AcT Trial, Menon et al. Lancet 2022](https://pubmed.ncbi.nlm.nih.gov/35779553/)"
      },
      {
        "recommendation": "Mechanical thrombectomy for LVO within 6 hours",
        "evidenceLevel": "Class I, Level A",
        "source": "[MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT](https://pubmed.ncbi.nlm.nih.gov/25517348/)"
      },
      {
        "recommendation": "Thrombectomy up to 24 hours with favorable imaging",
        "evidenceLevel": "Class I, Level A",
        "source": "[DAWN](https://pubmed.ncbi.nlm.nih.gov/29129157/); [DEFUSE 3](https://pubmed.ncbi.nlm.nih.gov/29364767/)"
      },
      {
        "recommendation": "DAPT (aspirin + clopidogrel) for minor stroke/high-risk TIA x 21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "[CHANCE](https://pubmed.ncbi.nlm.nih.gov/23803136/); [POINT](https://pubmed.ncbi.nlm.nih.gov/29766750/)"
      },
      {
        "recommendation": "High-intensity statin therapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPARCL](https://pubmed.ncbi.nlm.nih.gov/16899775/); AHA/ASA Guidelines"
      },
      {
        "recommendation": "Anticoagulation for AF-related stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Blood pressure management post-stroke",
        "evidenceLevel": "Class I, Level B",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Early mobilization",
        "evidenceLevel": "Class III (Harm), Level A",
        "source": "[AVERT Trial](https://pubmed.ncbi.nlm.nih.gov/25892679/) - very early mobilization harmful"
      },
      {
        "recommendation": "Decompressive craniectomy for malignant MCA stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[DECIMAL, DESTINY, HAMLET pooled analysis](https://pubmed.ncbi.nlm.nih.gov/17303527/)"
      },
      {
        "recommendation": "PFO closure for cryptogenic stroke",
        "evidenceLevel": "Class I, Level B",
        "source": "[CLOSE](https://pubmed.ncbi.nlm.nih.gov/28902580/); [RESPECT](https://pubmed.ncbi.nlm.nih.gov/28885996/); [DEFENSE-PFO](https://pubmed.ncbi.nlm.nih.gov/29544871/)"
      },
      {
        "recommendation": "Carotid endarterectomy for symptomatic stenosis ≥70%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET](https://pubmed.ncbi.nlm.nih.gov/1852179/); [ECST](https://pubmed.ncbi.nlm.nih.gov/1674060/)"
      },
      {
        "recommendation": "Intensive glucose control (avoid hypoglycemia)",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Fever treatment",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      }
    ],
    "monitoring": [
      {
        "item": "NIHSS (National Institutes of Health Stroke Scale)",
        "frequency": "Q1h x 24h, then q4h x 48h, then q shift",
        "action": "If worsening ≥4 points: emergent CT, consider hemorrhage or extension",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q15min x 2h post-tPA, then q30min x 6h, then q1h x 16h; q4h after",
        "action": "Treat per protocol; labetalol, nicardipine",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "Q6h; q1h if on insulin infusion",
        "action": "Insulin adjustment",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "Q4h",
        "action": "Acetaminophen; cooling; infection workup if fever",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous if on supplemental O2",
        "action": "Oxygen titration; evaluate for aspiration, PE",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Neurological examination",
        "frequency": "Q1h x 24h, then per protocol",
        "action": "If worsening: emergent imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "INR (if on warfarin)",
        "frequency": "Daily until therapeutic",
        "action": "Warfarin dose adjustment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "frequency": "Daily during hospitalization; baseline for DOACs",
        "action": "DOAC dose adjustment; avoid nephrotoxins",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Lipid panel",
        "frequency": "Fasting, within 24-48h",
        "action": "Statin intensification",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Once during hospitalization",
        "action": "Diabetes medication optimization",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallow evaluation",
        "frequency": "Before any oral intake",
        "action": "NPO; modified diet; SLP consult",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Continuous cardiac telemetry",
        "frequency": "Minimum 24-72 hours",
        "action": "Anticoagulation if AF detected",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Repeat CT head",
        "frequency": "24 hours post-tPA; or if neurological decline",
        "action": "If hemorrhage: reverse anticoagulation, neurosurgery consult",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Minor stroke or TIA; able to ambulate safely or with minimal assistance; swallow intact; stable on oral medications; adequate home support; follow-up arranged within 1-2 weeks; compliant with secondary prevention"
      },
      {
        "disposition": "**Admit to stroke unit/floor**",
        "criteria": "Most acute ischemic strokes; requires monitoring, workup, rehabilitation assessment; stable vital signs; no respiratory compromise"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Received tPA or thrombectomy (24h monitoring); large vessel occlusion; declining neurological exam; respiratory compromise; malignant edema risk; BP requiring IV infusion; arrhythmia requiring intervention"
      },
      {
        "disposition": "**Inpatient rehabilitation**",
        "criteria": "Significant functional deficits; able to participate in 3 hours therapy/day; medically stable; expected to benefit"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Functional deficits; unable to tolerate intensive rehabilitation; needs skilled nursing care"
      },
      {
        "disposition": "**Long-term acute care (LTAC)**",
        "criteria": "Prolonged ventilator dependence; complex medical needs"
      },
      {
        "disposition": "**Transfer to comprehensive stroke center**",
        "criteria": "LVO needing thrombectomy not available locally; neurosurgical intervention needed; complex case"
      }
    ]
  },
  "Guillain-Barré Syndrome": {
    "id": "guillain-barre-syndrome",
    "title": "Guillain-Barré Syndrome",
    "version": "1.1",
    "icd10": [
      "** G61.0 (Guillain-Barré syndrome)"
    ],
    "scope": "** Evaluation and management of acute Guillain-Barré Syndrome in adults, including all major variants (AIDP, AMAN, AMSAN, Miller Fisher). Covers respiratory monitoring protocols, immunotherapy (IVIg and plasmapheresis), autonomic dysfunction management, and ICU care. Excludes CIDP (chronic inflammatory demyelinating polyneuropathy) and pediatric GBS.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline, infection screen",
            "target": "Normal or mild leukocytosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal function for IVIg",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia worsens weakness",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia causes weakness",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "May be mildly elevated",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as trigger",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Hyperglycemia worsens outcomes",
            "target": "<180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid myopathy in differential",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CPK",
            "rationale": "Myopathy in differential",
            "target": "Normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP, pre-PLEX",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "rationale": "Variant classification, prognosis",
            "target": "Document positivity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Campylobacter jejuni serology",
            "rationale": "Most common trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CMV IgM/IgG",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "EBV panel",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Mycoplasma pneumoniae IgM",
            "rationale": "Bacterial trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated GBS",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "Pre-PLEX screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "COVID-19 PCR/antigen",
            "rationale": "COVID-associated GBS",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "IgA deficiency (IVIg contraindication)",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Zika virus serology",
            "rationale": "Travel to endemic area",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "West Nile virus serology",
            "rationale": "Endemic area, summer months",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area, tick exposure",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Porphyrins (urine)",
            "rationale": "Motor neuropathy with abdominal pain",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Heavy metals (lead, arsenic, thallium)",
            "rationale": "Toxic neuropathy differential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Serum protein electrophoresis",
            "rationale": "Paraproteinemic neuropathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Anti-acetylcholine receptor antibodies",
            "rationale": "MG in differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Exclude elevated ICP",
            "target": "Normal (10-20 cmH2O)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Albuminocytologic dissociation",
            "target": "WBC <10 (usually <5)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in GBS",
            "target": "Elevated (>45 mg/dL; often >100)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Exclude infection",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Exclude bacterial meningitis",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "If malignancy suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Atypical cases",
            "target": "Usually negative (positive in <10%)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Aspiration, atelectasis",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ECG",
            "timing": "On admission",
            "target": "Autonomic dysfunction (arrhythmia)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Forced vital capacity (FVC)",
            "timing": "Serial q4-6h",
            "target": "FVC >20 mL/kg (stable)",
            "contraindications": "Facial weakness limiting seal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Negative inspiratory force (NIF)",
            "timing": "Serial q4-6h",
            "target": "NIF more negative than -30 cmH2O",
            "contraindications": "Facial weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Nerve conduction studies/EMG",
            "timing": "Within 48-72 hours",
            "target": "Demyelination, conduction block",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine with contrast",
            "timing": "If diagnostic uncertainty",
            "target": "Nerve root enhancement (spinal roots)",
            "contraindications": "Pacemaker, hemodynamic instability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "MRI brain with contrast",
            "timing": "Miller Fisher variant",
            "target": "Cranial nerve enhancement",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Swallow evaluation",
            "timing": "If bulbar weakness",
            "target": "Aspiration risk",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If autonomic instability",
            "target": "Takotsubo, cardiac dysfunction",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Repetitive nerve stimulation",
            "timing": "If MG suspected",
            "target": "Normal (vs decrement in MG)",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Persistent dysautonomia",
            "target": "Abnormal heart rate variability",
            "contraindications": "Unstable patient",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent - Respiratory Support": [
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-6 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to O2 sat >94%; escalate to high-flow if needed",
              "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, RR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Endotracheal intubation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Endotracheal intubation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Intubate if FVC <20 mL/kg, NIF >-30 cmH2O, or clinical deterioration; avoid succinylcholine (hyperkalemia risk)",
              "orderSentence": "Endotracheal intubation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ETT position, ventilator settings",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical ventilation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Lung-protective ventilation; TV 6-8 mL/kg IBW; PEEP 5-8 cmH2O",
              "orderSentence": "Mechanical ventilation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ABG, ventilator parameters",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Immunotherapy - First-line": [
          {
            "item": "IVIg (immune globulin IV) - 5-day protocol",
            "route": "IV",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (total 2 g/kg); infuse slowly day 1 (start 0.5-1 mL/kg/hr, advance to max 4 mL/kg/hr)",
              "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; pre-medicate with acetaminophen/diphenhydramine",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IVIg (immune globulin IV) - 2-day protocol",
            "route": "IV",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g/kg/day x 2 days",
                  "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g/kg/day IV for 2 days (total 2 g/kg); alternative accelerated protocol; same total dose",
              "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
            },
            "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; higher daily dose may increase infusion reactions",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 1-2 weeks",
                  "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
                }
              ],
              "route": "—",
              "instructions": "5 exchanges (200-250 mL/kg per exchange) over 7-14 days; typically QOD",
              "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
            },
            "contraindications": "Hemodynamic instability; severe sepsis; IV access issues",
            "monitoring": "BP, electrolytes (Ca, Mg, K), coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Autonomic Dysfunction Management": [
          {
            "item": "Normal saline",
            "route": "IV",
            "indication": "Hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL",
                  "orderSentence": "Normal saline 250 mL IV"
                },
                {
                  "text": "500 mL",
                  "orderSentence": "Normal saline 500 mL IV"
                },
                {
                  "text": "1000 mL",
                  "orderSentence": "Normal saline 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "250-500 mL bolus for SBP <90; avoid overhydration",
              "orderSentence": "Normal saline 250 mL IV"
            },
            "contraindications": "Heart failure",
            "monitoring": "BP, I/O, JVD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenylephrine",
            "route": "IV",
            "indication": "Refractory hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mcg bolus",
                  "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
                },
                {
                  "text": "0.5-2 mcg/kg/min",
                  "orderSentence": "Phenylephrine 0.5-2 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 0.5 mcg/kg/min; titrate to MAP >65",
              "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
            },
            "contraindications": "Severe bradycardia",
            "monitoring": "Continuous BP, HR",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Esmolol",
            "route": "IV",
            "indication": "Hypertensive crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mcg/kg load",
                  "orderSentence": "Esmolol 500 mcg/kg load IV"
                },
                {
                  "text": "50-200 mcg/kg/min",
                  "orderSentence": "Esmolol 50-200 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 500 mcg/kg over 1 min, then 50-200 mcg/kg/min; short-acting preferred in GBS",
              "orderSentence": "Esmolol 500 mcg/kg load IV"
            },
            "contraindications": "Bradycardia, heart block, decompensated HF",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Atropine",
            "route": "IV",
            "indication": "Symptomatic bradycardia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Atropine 0.5 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Atropine 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV push for HR <50 with symptoms; may repeat q3-5min; max 3 mg",
              "orderSentence": "Atropine 0.5 mg IV"
            },
            "contraindications": "Tachycardia",
            "monitoring": "HR, rhythm",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Temporary pacing",
            "route": "—",
            "indication": "Complete heart block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Temporary pacing N/A —"
                }
              ],
              "route": "—",
              "instructions": "Transcutaneous or transvenous pacing for refractory bradycardia/asystole",
              "orderSentence": "Temporary pacing N/A —"
            },
            "contraindications": "—",
            "monitoring": "Continuous telemetry",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg PO daily for persistent orthostatic hypotension",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "Hypertension, heart failure",
            "monitoring": "BP (supine and standing), edema, K+",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; max 10 mg TID; avoid evening dose",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension, urinary retention",
            "monitoring": "BP (supine and standing)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic/Supportive Care": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q1-3d; max 3600 mg/day in 3 divided doses",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness; reduce dose if CrCl <60",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; may increase to 150 mg BID after 1 week; max 600 mg/day",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, edema, weight gain",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Morphine",
            "route": "IV",
            "indication": "Severe pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg q4h PRN",
                  "orderSentence": "Morphine 2 mg q4h PRN IV"
                },
                {
                  "text": "4 mg q4h PRN",
                  "orderSentence": "Morphine 4 mg q4h PRN IV"
                }
              ],
              "route": "IV",
              "instructions": "2-4 mg IV q4h PRN for severe pain; use cautiously with respiratory compromise",
              "orderSentence": "Morphine 2 mg q4h PRN IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, sedation, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                },
                {
                  "text": "30 mg BID",
                  "orderSentence": "Enoxaparin 30 mg BID SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (BMI <40) or 30 mg BID (BMI >40); hold if CrCl <30; **HOLD if LP planned within 12 hours**",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, CrCl <30 (use UFH), pending LP",
            "monitoring": "Platelet count, signs of bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Heparin (UFH)",
            "route": "SC",
            "indication": "DVT prophylaxis (renal impairment)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units q8h",
                  "orderSentence": "Heparin (UFH) 5000 units q8h SC"
                },
                {
                  "text": "5000 units q12h",
                  "orderSentence": "Heparin (UFH) 5000 units q12h SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
              "orderSentence": "Heparin (UFH) 5000 units q8h SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count, signs of bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "SCDs (sequential compression devices)",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "SCDs (sequential compression devices) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Bilateral lower extremity SCDs; use in addition to pharmacologic prophylaxis",
              "orderSentence": "SCDs (sequential compression devices) N/A —"
            },
            "contraindications": "Acute DVT in that extremity",
            "monitoring": "Skin integrity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bisacodyl",
            "route": "PO/PR",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Bisacodyl 10 mg daily PO/PR"
                },
                {
                  "text": "10 mg suppository",
                  "orderSentence": "Bisacodyl 10 mg suppository PO/PR"
                }
              ],
              "route": "PO/PR",
              "instructions": "10 mg PO or PR daily as needed",
              "orderSentence": "Bisacodyl 10 mg daily PO/PR"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Polyethylene glycol",
            "route": "PO",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) PO daily-BID; titrate to 1-2 BMs daily",
              "orderSentence": "Polyethylene glycol 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Metoclopramide",
            "route": "IV/PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg q6h AC",
                  "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "10 mg IV/PO before meals and at bedtime; max 40 mg/day; limit to 5 days",
              "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
            },
            "contraindications": "Parkinson disease, GI obstruction",
            "monitoring": "EPS, tardive dyskinesia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg q6h PRN",
                  "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
                },
                {
                  "text": "8 mg q8h PRN",
                  "orderSentence": "Ondansetron 8 mg q8h PRN IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV/PO q6-8h PRN",
              "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Fever, mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4 g/day (3 g if hepatic impairment)",
              "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged use",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Treatment of GBS Variants": [
          {
            "item": "IVIg (Miller Fisher)",
            "route": "IV",
            "indication": "Miller Fisher syndrome",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Same as standard GBS; benefit less clear for pure MFS without weakness",
              "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function, infusion reactions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Observation only (MFS)",
            "route": "—",
            "indication": "Pure MFS (mild)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Observation only (MFS) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Consider observation without immunotherapy for pure MFS with mild symptoms and no limb weakness",
              "orderSentence": "Observation only (MFS) N/A —"
            },
            "contraindications": "If weakness present, treat",
            "monitoring": "Serial neuro exam, FVC",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Refractory/Treatment Failure": [
          {
            "item": "Second course IVIg",
            "route": "IV",
            "indication": "Treatment-related fluctuation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Consider if deterioration during/after IVIg or PLEX; typically 2-3 weeks after first course",
              "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PLEX after IVIg failure",
            "route": "—",
            "indication": "IVIg non-response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 1-2 weeks",
                  "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
                }
              ],
              "route": "—",
              "instructions": "Consider if no improvement 2-4 weeks post-IVIg; wait at least 2 weeks after IVIg completion",
              "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "BP, coagulation",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, immunotherapy initiation, and prognosis discussion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology consult for respiratory function monitoring and ventilator management if FVC declining",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given FVC <30 mL/kg or rapidly declining respiratory function",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment, fall prevention, and early mobilization when stable",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Occupational therapy for ADL assessment and adaptive equipment to maintain independence",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Speech therapy for swallow evaluation given bulbar weakness and aspiration risk",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Respiratory therapy for airway clearance techniques and ventilator management if intubated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pain management consult for refractory neuropathic pain not responding to gabapentin/pregabalin",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Physiatry/PM&R for rehabilitation planning and discharge disposition to optimize functional recovery",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work for discharge planning, caregiver support, and GBS Foundation resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness or breathing difficulty develops (may indicate disease progression requiring intubation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Use fall precautions including walker and assistance due to proximal weakness and areflexia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Do not drive until cleared by neurology due to unpredictable weakness and impaired reflexes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Perform physical therapy exercises as prescribed to maintain range of motion and prevent contractures",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Expect gradual recovery over weeks to months; most patients recover but pace varies by severity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fevers, severe headache, or new symptoms immediately as these may indicate infection or relapse",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Contact GBS-CIDP Foundation (www.gbs-cidp.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning given bulbar weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Early mobilization when medically stable to prevent DVT and deconditioning (with PT guidance)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Frequent repositioning every 2 hours to prevent pressure ulcers during immobility",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Monitor for urinary retention and catheterize if needed due to autonomic dysfunction",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Use energy conservation techniques including scheduled rest periods to manage post-GBS fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Gradual return to activities as strength permits; avoid overexertion which may worsen fatigue",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Discuss future vaccination timing with neurologist; avoid live vaccines if on immunotherapy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Myasthenia gravis",
        "features": "Fatigable weakness, ptosis, diplopia; reflexes preserved",
        "tests": "AChR/MuSK antibodies, repetitive nerve stimulation, edrophonium test"
      },
      {
        "diagnosis": "Transverse myelitis",
        "features": "Sensory level, bowel/bladder dysfunction early, UMN signs",
        "tests": "MRI spine with contrast, CSF"
      },
      {
        "diagnosis": "Spinal cord compression",
        "features": "Sensory level, UMN signs below lesion, back pain",
        "tests": "MRI spine emergent"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis, pupil involvement, GI symptoms",
        "tests": "Stool/serum toxin assay, EMG (incremental response)"
      },
      {
        "diagnosis": "Poliomyelitis/West Nile",
        "features": "Asymmetric weakness, fever, CSF pleocytosis",
        "tests": "CSF PCR, serology"
      },
      {
        "diagnosis": "Tick paralysis",
        "features": "Recent tick exposure, ascending paralysis",
        "tests": "Physical exam (find tick), rapid improvement with tick removal"
      },
      {
        "diagnosis": "Critical illness polyneuropathy",
        "features": "ICU setting, sepsis, prolonged weakness",
        "tests": "EMG/NCS, clinical context"
      },
      {
        "diagnosis": "Hypokalemic periodic paralysis",
        "features": "Episodic weakness, low K+ during attacks",
        "tests": "Serum K+ during attack, genetic testing"
      },
      {
        "diagnosis": "Acute porphyria",
        "features": "Abdominal pain, psychiatric symptoms, motor neuropathy",
        "tests": "Urine porphyrins, ALA, PBG"
      },
      {
        "diagnosis": "Heavy metal poisoning",
        "features": "Exposure history, other systemic symptoms",
        "tests": "Heavy metal levels"
      },
      {
        "diagnosis": "Diphtheria",
        "features": "Pharyngitis, palatal weakness, cardiac involvement",
        "tests": "Throat culture, toxin assay"
      },
      {
        "diagnosis": "HIV-associated neuropathy",
        "features": "Risk factors, may have CSF pleocytosis",
        "tests": "HIV testing"
      },
      {
        "diagnosis": "CIDP",
        "features": "Chronic course (>8 weeks), relapsing",
        "tests": "Clinical course, EMG/NCS, CSF"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg or PLEX equally effective for GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "IVIg 0.4 g/kg x 5 days standard dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[van der Meché et al. NEJM 1992](https://pubmed.ncbi.nlm.nih.gov/1557426/)"
      },
      {
        "recommendation": "PLEX effective within 4 weeks of onset",
        "evidenceLevel": "Class I, Level A",
        "source": "[Raphaël et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22786476/)"
      },
      {
        "recommendation": "Combined IVIg + PLEX not superior",
        "evidenceLevel": "Class I, Level A",
        "source": "[Plasma Exchange/Sandoglobulin GBS Trial Group 1997](https://pubmed.ncbi.nlm.nih.gov/9008066/)"
      },
      {
        "recommendation": "Corticosteroids ineffective in GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27775812/)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      },
      {
        "recommendation": "Anti-GQ1b associated with Miller Fisher",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chiba et al. Ann Neurol 1992](https://pubmed.ncbi.nlm.nih.gov/1514781/)"
      },
      {
        "recommendation": "Campylobacter most common antecedent",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jacobs et al. Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9781538/)"
      },
      {
        "recommendation": "Early IVIg (within 2 weeks) improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "20/30/40 rule for intubation",
        "evidenceLevel": "Class III, Level C",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "q4-6h initially; q2h if declining",
        "action": "Intubate if <20 mL/kg or >30% decline",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "q4-6h initially; q2h if declining",
        "action": "Intubate if weaker than -30 cmH2O",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement oxygen, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate",
        "frequency": "Continuous",
        "action": "Treat bradycardia <50 or tachy >120",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1-4h",
        "action": "Treat hypo/hypertension",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurological exam (strength)",
        "frequency": "q4-8h",
        "action": "Escalate care if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Daily if bulbar symptoms",
        "action": "NPO, NG tube if unsafe",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Urine output",
        "frequency": "q4-8h",
        "action": "Bladder scan, catheterize if needed",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily during IVIg",
        "action": "Hold IVIg, hydrate if rising",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Skin integrity",
        "frequency": "q shift",
        "action": "Reposition, pressure relief",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "action": "Bowel regimen if constipated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "FVC <30 mL/kg; NIF weaker than -40 cmH2O; rapid progression; autonomic instability; bulbar dysfunction; need for intubation"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable FVC >30 mL/kg; improving or stable exam; no autonomic instability; on telemetry monitoring"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Mild weakness (ambulatory); stable FVC >40 mL/kg; no bulbar symptoms; no autonomic dysfunction"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Medically stable; significant residual weakness requiring intensive therapy; FVC stable >25 mL/kg"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Ambulatory or near-ambulatory; stable >48-72 hours; adequate home support; outpatient PT arranged; no respiratory compromise"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Unable to participate in intensive rehab; requires ongoing nursing care; medically stable"
      }
    ]
  },
  "Myasthenia Gravis - Exacerbation/Crisis": {
    "id": "myasthenia-gravis-crisis",
    "title": "Myasthenia Gravis - Exacerbation/Crisis",
    "version": "1.1",
    "icd10": [
      "** G70.00 (Myasthenia gravis without exacerbation)",
      "G70.01 (Myasthenia gravis with exacerbation)",
      "G70.1 (Toxic myoneural disorders)"
    ],
    "scope": "** Evaluation and management of acute myasthenic exacerbation and myasthenic crisis in adults. Covers respiratory monitoring, immunotherapy (IVIg and plasmapheresis), medications to avoid, and ICU management. Excludes new diagnosis workup, chronic maintenance therapy, Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection as trigger, baseline",
            "target": "Normal or elevated WBC if infected",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal/hepatic function",
            "target": "Normal; hypokalemia worsens weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia worsens NMJ transmission",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia causes weakness",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease common comorbidity",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Hyperglycemia worsens outcomes",
            "target": "<180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as trigger",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood cultures",
            "rationale": "If febrile or sepsis suspected",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "Differentiate infection vs non-infectious flare",
            "target": "<0.5 ng/mL if non-infectious",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "ABG or VBG",
            "rationale": "Respiratory status, CO2 retention",
            "target": "PaCO2 <45 mmHg, pH >7.35",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "AChR (acetylcholine receptor) antibody",
            "rationale": "Confirm diagnosis if unknown",
            "target": "Document if positive (~85% of generalized MG)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "MuSK antibody",
            "rationale": "If AChR negative",
            "target": "Document if positive (~40% of AChR-negative)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "LRP4 antibody",
            "rationale": "If AChR and MuSK negative",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Anti-striated muscle antibody",
            "rationale": "Thymoma association",
            "target": "If positive, CT chest",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "IgA deficiency (IVIg contraindication)",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-PLEX",
            "target": "Normal",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fibrinogen",
            "rationale": "Pre-PLEX baseline",
            "target": "Normal",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac involvement, stress",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BNP/NT-proBNP",
            "rationale": "Heart failure assessment",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Cortisol (random or AM)",
            "rationale": "Adrenal insufficiency if on chronic steroids",
            "target": "Normal stress response",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Acetylcholinesterase inhibitor level",
            "rationale": "Cholinergic crisis concern (if available)",
            "target": "Therapeutic range",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Occult malignancy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Respiratory viral panel",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Aspiration, atelectasis, pneumonia",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ECG",
            "timing": "On admission",
            "target": "Arrhythmia, QT prolongation",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Forced vital capacity (FVC)",
            "timing": "Serial q4-6h (q2h if declining)",
            "target": "FVC >15-20 mL/kg",
            "contraindications": "Facial weakness limiting seal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Negative inspiratory force (NIF)",
            "timing": "Serial q4-6h (q2h if declining)",
            "target": "NIF more negative than -20 cmH2O",
            "contraindications": "Facial weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "CT chest with contrast",
            "timing": "If thymoma not previously evaluated",
            "target": "Thymoma or thymic hyperplasia",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CT chest without contrast",
            "timing": "Thymoma evaluation (if contrast contraindicated)",
            "target": "Thymic abnormality",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Swallow evaluation",
            "timing": "Bulbar symptoms",
            "target": "Aspiration risk",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Repetitive nerve stimulation",
            "timing": "If diagnosis uncertain",
            "target": "Decremental response >10%",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Single-fiber EMG",
            "timing": "If RNS negative but MG suspected",
            "target": "Increased jitter, blocking",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult thymoma or malignancy",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Ice pack test",
            "timing": "Bedside diagnostic (ptosis)",
            "target": "Improvement with cooling",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent - Airway and Respiratory Support": [
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-6 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to O2 sat >94%; escalate as needed",
              "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, RR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Endotracheal intubation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Endotracheal intubation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Intubate if FVC <15 mL/kg, NIF >-20 cmH2O, or clinical deterioration; AVOID succinylcholine (may have prolonged block); use rocuronium (may need higher dose)",
              "orderSentence": "Endotracheal intubation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ETT position, ventilator settings",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Non-invasive ventilation (BiPAP)",
            "route": "—",
            "indication": "Bridge to intubation or mild hypoventilation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "IPAP 10-15",
                  "orderSentence": "Non-invasive ventilation (BiPAP) IPAP 10-15 —"
                },
                {
                  "text": "EPAP 5",
                  "orderSentence": "Non-invasive ventilation (BiPAP) EPAP 5 —"
                }
              ],
              "route": "—",
              "instructions": "BiPAP may temporize; NOT a substitute for intubation in true crisis",
              "orderSentence": "Non-invasive ventilation (BiPAP) IPAP 10-15 —"
            },
            "contraindications": "Severe respiratory failure, inability to protect airway",
            "monitoring": "RR, TV, O2 sat, CO2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical ventilation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Lung-protective ventilation; expect prolonged wean; daily SBT when improved",
              "orderSentence": "Mechanical ventilation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ABG, ventilator parameters",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Immunotherapy - First-line for Crisis/Severe Exacerbation": [
          {
            "item": "IVIg (immune globulin IV)",
            "route": "IV",
            "indication": "Myasthenic crisis or severe exacerbation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
                },
                {
                  "text": "1 g/kg/day x 2 days",
                  "orderSentence": "IVIg (immune globulin IV) 1 g/kg/day x 2 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (preferred) OR 1 g/kg/day x 2 days; infuse slowly day 1",
              "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency with anti-IgA antibodies; severe renal impairment; recent MI/stroke (thrombosis risk)",
            "monitoring": "Renal function daily, headache, infusion reactions; pre-medicate",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Myasthenic crisis or severe exacerbation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 7-14 days",
                  "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 7-14 days —"
                }
              ],
              "route": "—",
              "instructions": "5 exchanges (1-1.5 plasma volumes per exchange) over 7-14 days; typically QOD",
              "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 7-14 days —"
            },
            "contraindications": "Hemodynamic instability, severe sepsis, poor IV access",
            "monitoring": "BP, electrolytes, coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Cholinesterase Inhibitors": [
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Symptomatic treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Pyridostigmine 30 mg TID PO"
                },
                {
                  "text": "60 mg TID",
                  "orderSentence": "Pyridostigmine 60 mg TID PO"
                },
                {
                  "text": "60 mg QID",
                  "orderSentence": "Pyridostigmine 60 mg QID PO"
                },
                {
                  "text": "90 mg QID",
                  "orderSentence": "Pyridostigmine 90 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30-60 mg TID; titrate by 30 mg/dose q2-3d; max ~120 mg q4h; usual maintenance 60-90 mg q4-6h",
              "orderSentence": "Pyridostigmine 30 mg TID PO"
            },
            "contraindications": "Mechanical bowel/bladder obstruction",
            "monitoring": "Cholinergic symptoms (SLUDGE), HR",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pyridostigmine (in crisis)",
            "route": "—",
            "indication": "During crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "HOLD or reduce",
                  "orderSentence": "Pyridostigmine (in crisis) HOLD or reduce —"
                }
              ],
              "route": "—",
              "instructions": "HOLD pyridostigmine in intubated patients or suspected cholinergic crisis; restart at low dose when improving",
              "orderSentence": "Pyridostigmine (in crisis) HOLD or reduce —"
            },
            "contraindications": "Cholinergic crisis",
            "monitoring": "Secretions, HR",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neostigmine",
            "route": "IV/IM",
            "indication": "If NPO and needs AChEI",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV q3h",
                  "orderSentence": "Neostigmine 0.5 mg IV q3h IV/IM"
                },
                {
                  "text": "1.5 mg IM q3h",
                  "orderSentence": "Neostigmine 1.5 mg IM q3h IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "0.5 mg IV or 1.5 mg IM roughly equivalent to 60 mg PO pyridostigmine; use ONLY if cannot take PO and essential",
              "orderSentence": "Neostigmine 0.5 mg IV q3h IV/IM"
            },
            "contraindications": "Cholinergic toxicity",
            "monitoring": "HR, secretions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO/IV",
            "indication": "Cholinergic side effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg PO TID",
                  "orderSentence": "Glycopyrrolate 1 mg PO TID PO/IV"
                },
                {
                  "text": "0.2 mg IV PRN",
                  "orderSentence": "Glycopyrrolate 0.2 mg IV PRN PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "1-2 mg PO TID for secretions/GI effects; 0.2 mg IV PRN; does not cross BBB",
              "orderSentence": "Glycopyrrolate 1 mg PO TID PO/IV"
            },
            "contraindications": "Glaucoma, severe cardiac disease",
            "monitoring": "HR, urinary retention",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Corticosteroids (Use with CAUTION)": [
          {
            "item": "Prednisone (high-dose, post-crisis)",
            "route": "PO",
            "indication": "Crisis treated with IVIg/PLEX, improving",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone (high-dose, post-crisis) 60 mg daily PO"
                },
                {
                  "text": "1 mg/kg daily",
                  "orderSentence": "Prednisone (high-dose, post-crisis) 1 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60 mg (or 1 mg/kg) daily AFTER day 3 of IVIg/PLEX if improving; for patients whose crisis is being treated; taper once stable",
              "orderSentence": "Prednisone (high-dose, post-crisis) 60 mg daily PO"
            },
            "contraindications": "Active infection (relative)",
            "monitoring": "Glucose, BP, K+; already covered by IVIg/PLEX",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone (low-dose start)",
            "route": "PO",
            "indication": "Stable patient, outpatient, new start",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start LOW (10-20 mg daily) and increase slowly by 10 mg q5-7d to target 1 mg/kg/day; for OUTPATIENT or STABLE inpatients not in crisis; HIGH-DOSE INITIATION CAN WORSEN MG",
              "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
            },
            "contraindications": "Active infection (relative), brittle MG without IVIg/PLEX cover",
            "monitoring": "Glucose, BP, K+; WATCH FOR TRANSIENT WORSENING days 5-10",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Severe exacerbation (with IVIg/PLEX cover)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg daily x 3-5 days",
                  "orderSentence": "Methylprednisolone 500 mg daily x 3-5 days IV"
                },
                {
                  "text": "1000 mg daily x 3-5 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 3-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV daily x 3-5 days; ONLY with IVIg/PLEX coverage due to risk of transient worsening",
              "orderSentence": "Methylprednisolone 500 mg daily x 3-5 days IV"
            },
            "contraindications": "Active untreated infection",
            "monitoring": "Glucose, BP, K+, psychiatric effects",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Supportive Care": [
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                },
                {
                  "text": "30 mg BID",
                  "orderSentence": "Enoxaparin 30 mg BID SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; 30 mg BID if BMI >40; hold if CrCl <30; **HOLD if LP planned within 12 hours**",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count, bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Heparin (UFH)",
            "route": "SC",
            "indication": "DVT prophylaxis (renal impairment)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units q8h",
                  "orderSentence": "Heparin (UFH) 5000 units q8h SC"
                },
                {
                  "text": "5000 units q12h",
                  "orderSentence": "Heparin (UFH) 5000 units q12h SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
              "orderSentence": "Heparin (UFH) 5000 units q8h SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Famotidine",
            "route": "IV/PO",
            "indication": "Stress ulcer prophylaxis (if on steroids)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV/PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Famotidine 40 mg daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "20 mg IV/PO BID or 40 mg daily",
              "orderSentence": "Famotidine 20 mg BID IV/PO"
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin (regular)",
            "route": "IV/SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Sliding scale",
                  "orderSentence": "Insulin (regular) Sliding scale IV/SC"
                },
                {
                  "text": "basal-bolus",
                  "orderSentence": "Insulin (regular) basal-bolus IV/SC"
                }
              ],
              "route": "IV/SC",
              "instructions": "Sliding scale or basal-bolus; target glucose <180 mg/dL",
              "orderSentence": "Insulin (regular) Sliding scale IV/SC"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q4-6h",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Fever, mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "650-1000 mg q6h; max 4 g/day",
              "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "SCDs (sequential compression devices)",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "SCDs (sequential compression devices) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Bilateral lower extremity SCDs",
              "orderSentence": "SCDs (sequential compression devices) N/A —"
            },
            "contraindications": "DVT in that extremity",
            "monitoring": "Skin integrity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Long-term Immunosuppression (Initiate/Continue as Indicated)": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing agent",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg q2-4wk to 2-3 mg/kg/day; check TPMT before starting",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "contraindications": "TPMT deficiency, pregnancy",
            "monitoring": "CBC weekly x 4, then monthly; LFTs monthly",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing agent",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "contraindications": "Pregnancy, hypersensitivity",
            "monitoring": "CBC q2wk x 2mo, then monthly; LFTs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Refractory MG, MuSK-positive MG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² weekly x 4 OR 1000 mg x 2 doses (2 weeks apart); pre-medicate with methylpred, acetaminophen, diphenhydramine",
              "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
            },
            "contraindications": "Active infection, HBV (screen first)",
            "monitoring": "Infusion reactions, CD19/CD20, immunoglobulins",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for crisis management, immunotherapy guidance, and medication safety review",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology consult for respiratory function monitoring and ventilator wean planning if intubated",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given FVC <20 mL/kg or impending respiratory failure",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thoracic surgery consult for thymectomy planning if thymoma identified or considering elective thymectomy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Speech therapy for swallow evaluation and aspiration risk assessment given bulbar symptoms",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for mobility assessment and safe transfer training given fluctuating weakness",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Occupational therapy for ADL assessment and energy conservation strategies to manage fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Respiratory therapy for airway clearance and pulmonary toilet given weak cough and secretion management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pharmacy consult to review all medications for MG-exacerbating drugs (see medications to avoid list)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Social work for discharge planning and Myasthenia Gravis Foundation support resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness or breathing difficulty develops (may indicate crisis requiring intubation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Do not skip or suddenly stop immunosuppressive medications as this may trigger severe exacerbation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Carry MG medical alert card listing medications to avoid (aminoglycosides, fluoroquinolones, beta-blockers, etc.)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Take pyridostigmine 30-60 minutes before meals to improve swallowing and reduce aspiration risk",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever or signs of infection promptly as infection is a common exacerbation trigger",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Avoid extreme heat as high temperatures worsen neuromuscular transmission and increase weakness",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Get adequate rest and avoid overexertion; fatigue worsens throughout the day in MG",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if diplopia or ptosis impairs vision; symptoms may fluctuate unpredictably",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Contact Myasthenia Gravis Foundation (www.myasthenia.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning given bulbar weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Fall precautions including walker and bed rails due to fluctuating proximal weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Medication reconciliation before any new prescription to avoid MG-exacerbating drugs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Avoid live vaccines while on immunosuppression; flu and pneumococcal vaccines recommended to prevent infections",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques as psychological stress can trigger MG exacerbations",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain good sleep hygiene as fatigue and sleep deprivation worsen MG symptoms",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use energy conservation techniques including pacing activities and scheduling rest periods",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Guillain-Barré syndrome",
        "features": "Ascending weakness, areflexia, no fluctuation",
        "tests": "CSF (albuminocytologic dissociation), EMG/NCS"
      },
      {
        "diagnosis": "Lambert-Eaton syndrome",
        "features": "Proximal weakness, autonomic symptoms, reflexes improve with exercise",
        "tests": "VGCC antibodies, EMG (incremental response)"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending weakness, pupil involvement, GI symptoms",
        "tests": "Stool/serum toxin, EMG"
      },
      {
        "diagnosis": "Brainstem stroke",
        "features": "Acute onset, crossed findings, other cranial nerve signs",
        "tests": "MRI brain"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "CNS symptoms, sensory involvement, different time course",
        "tests": "MRI brain/spine, CSF"
      },
      {
        "diagnosis": "Thyroid eye disease",
        "features": "Thyroid dysfunction, proptosis, restrictive ophthalmopathy",
        "tests": "TFTs, orbital imaging"
      },
      {
        "diagnosis": "Oculopharyngeal muscular dystrophy",
        "features": "Older onset, slowly progressive, no fluctuation",
        "tests": "Genetic testing, muscle biopsy"
      },
      {
        "diagnosis": "Mitochondrial myopathy",
        "features": "Progressive, elevated lactate, other organ involvement",
        "tests": "Lactate, muscle biopsy, genetic testing"
      },
      {
        "diagnosis": "Drug-induced MG",
        "features": "Recent D-penicillamine, checkpoint inhibitors",
        "tests": "Medication history, antibodies"
      },
      {
        "diagnosis": "Cholinergic crisis",
        "features": "SLUDGE symptoms, miosis, bradycardia",
        "tests": "Clinical, response to stopping AChEI"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg and PLEX equally effective for MG exacerbation",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gajdos et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "IVIg 2 g/kg total dose standard",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zinman et al. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17706563/)"
      },
      {
        "recommendation": "PLEX effective for MG crisis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gajdos et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Rabinstein & Wijdicks. Neurology 2003](https://pubmed.ncbi.nlm.nih.gov/12654988/)"
      },
      {
        "recommendation": "Pyridostigmine for symptomatic treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25304970/)"
      },
      {
        "recommendation": "Corticosteroids can cause initial worsening",
        "evidenceLevel": "Class II, Level B",
        "source": "[Palace et al. Lancet Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22305458/)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class I, Level B",
        "source": "[Palace et al. NEJM 1998](https://pubmed.ncbi.nlm.nih.gov/9771070/)"
      },
      {
        "recommendation": "Rituximab effective in refractory/MuSK+ MG",
        "evidenceLevel": "Class II, Level C",
        "source": "[Nowak et al. Neurology 2022](https://pubmed.ncbi.nlm.nih.gov/34986310/)"
      },
      {
        "recommendation": "Medications to avoid in MG",
        "evidenceLevel": "Class III, Level C",
        "source": "[Juel. Semin Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15257515/)"
      },
      {
        "recommendation": "Thymectomy beneficial in generalized MG",
        "evidenceLevel": "Class I, Level B",
        "source": "[Wolfe et al. NEJM 2016 (MGTX Trial)](https://pubmed.ncbi.nlm.nih.gov/27509100/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "q4-6h; q2h if declining",
        "action": "Intubate if <15 mL/kg",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "q4-6h; q2h if declining",
        "action": "Intubate if weaker than -20 cmH2O",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement O2, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurological exam (strength)",
        "frequency": "q4-8h",
        "action": "Escalate therapy if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Daily if bulbar symptoms",
        "action": "NPO, NG tube if unsafe",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h if on steroids",
        "action": "Insulin adjustment",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily during IVIg",
        "action": "Hold IVIg, hydrate if rising",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Electrolytes (K+, Mg)",
        "frequency": "Daily",
        "action": "Replete aggressively",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate/rhythm",
        "frequency": "Continuous",
        "action": "Evaluate for autonomic dysfunction",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q4h",
        "action": "Evaluate for autonomic dysfunction",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Cholinergic symptoms",
        "frequency": "Each dose of pyridostigmine",
        "action": "Reduce dose, consider cholinergic crisis",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "FVC <20 mL/kg or declining; NIF weaker than -30 cmH2O; rapid progression; bulbar dysfunction with aspiration risk; need for intubation/BiPAP"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable FVC >20 mL/kg; improving or stable exam; receiving IVIg/PLEX; no bulbar symptoms"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Mild exacerbation; FVC >30 mL/kg and stable; no bulbar symptoms; stable on oral medications"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable or improved x 24-48 hours; FVC stable >30 mL/kg; adequate oral intake; medications optimized; outpatient follow-up arranged"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Significant residual weakness after crisis; requires intensive therapy; medically stable"
      }
    ]
  },
  "Bacterial Meningitis": {
    "id": "bacterial-meningitis",
    "title": "Bacterial Meningitis",
    "version": "1.1",
    "icd10": [
      "** G00.9 (Bacterial meningitis",
      "unspecified)",
      "G00.0 (Hemophilus meningitis)",
      "G00.1 (Pneumococcal meningitis)",
      "G00.2 (Streptococcal meningitis)",
      "G00.3 (Staphylococcal meningitis)",
      "G00.8 (Other bacterial meningitis)",
      "G01 (Meningitis in bacterial diseases classified elsewhere)",
      "G03.9 (Meningitis",
      "unspecified)"
    ],
    "scope": "** Evaluation and empiric treatment of acute community-acquired bacterial meningitis in adults. Covers empiric antibiotic selection by age/risk, dexamethasone adjunctive therapy, lumbar puncture interpretation, and ICU management. Excludes neonatal meningitis, healthcare-associated/post-neurosurgical meningitis, tuberculous meningitis, and fungal meningitis.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Blood cultures (2 sets)",
            "rationale": "Identify organism (positive in 50-80%)",
            "target": "Organism identification",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Leukocytosis, left shift; baseline",
            "target": "Elevated WBC; bandemia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal/hepatic function for antibiotic dosing",
            "target": "Normal or evidence of sepsis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Sepsis severity marker",
            "target": "<2 mmol/L (elevated indicates sepsis)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "Bacterial vs viral differentiation",
            "target": "Elevated (>0.5 ng/mL suggests bacterial)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP coagulation status",
            "target": "INR <1.5, PTT normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Platelet count",
            "rationale": "Pre-LP, DIC screening",
            "target": ">50,000/μL for safe LP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Compare with CSF glucose",
            "target": "Document for CSF ratio",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "Infection source if UTI",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "CRP",
            "rationale": "Inflammatory marker, follow response",
            "target": "Elevated; trend with treatment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "D-dimer, fibrinogen",
            "rationale": "DIC screening (meningococcal)",
            "target": "Normal (elevated = DIC)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Anticipate transfusion if DIC",
            "target": "Available",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cortisol (random)",
            "rationale": "Adrenal insufficiency (Waterhouse-Friderichsen)",
            "target": "Normal stress response",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HIV antibody/antigen",
            "rationale": "Immunocompromise screen",
            "target": "Document status",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "BNP/troponin",
            "rationale": "Cardiac involvement, septic cardiomyopathy",
            "target": "Normal or elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ABG or VBG",
            "rationale": "Respiratory status, acid-base",
            "target": "Normal or compensated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum cryptococcal antigen",
            "rationale": "If immunocompromised",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Histoplasma/Blastomyces antigen",
            "rationale": "Endemic area, immunocompromised",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Quantiferon/T-SPOT",
            "rationale": "TB risk factors",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Complement levels (C3, C4, CH50)",
            "rationale": "Recurrent Neisseria infection",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Immunoglobulin levels",
            "rationale": "Recurrent infections",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated in bacterial meningitis",
            "target": "10-20 cmH2O normal; often >30 in bacterial",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "rationale": "Pleocytosis pattern",
            "target": "WBC >1000/μL typical; PMN predominant (>80%)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in bacterial infection",
            "target": ">100 mg/dL (often >200-500)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial meningitis",
            "target": "<40 mg/dL or CSF:serum ratio <0.4",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain",
            "rationale": "Rapid organism identification",
            "target": "Positive in 60-90% untreated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bacterial culture",
            "rationale": "Definitive organism identification",
            "target": "Positive in 70-85% untreated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray Meningitis/Encephalitis Panel",
            "rationale": "Rapid multiplex PCR (14 pathogens)",
            "target": "Organism identification within 1 hour",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Latex agglutination (if available)",
            "rationale": "Rapid antigen detection",
            "target": "Organism-specific antigens",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HSV PCR",
            "rationale": "Exclude HSV encephalitis",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Procalcitonin (CSF)",
            "rationale": "Bacterial vs aseptic",
            "target": "Elevated in bacterial",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "BEFORE LP if criteria met (see below)",
            "target": "Exclude mass, herniation, hydrocephalus",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Pneumonia (source), aspiration",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with contrast",
            "timing": "If complications suspected",
            "target": "Abscess, ventriculitis, infarct, subdural empyema",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT venogram",
            "timing": "If venous sinus thrombosis suspected",
            "target": "Sinus thrombosis",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "EEG",
            "timing": "If seizures or altered mental status",
            "target": "Seizure activity, encephalopathy",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If endocarditis suspected",
            "target": "Vegetation",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT/MRI spine",
            "timing": "If spinal epidural abscess suspected",
            "target": "Epidural collection",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Treatment": {
        "Empiric Antibiotic Therapy": [
          {
            "item": "Ceftriaxone",
            "route": "IV",
            "indication": "Empiric coverage (all ages)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q12h",
                  "orderSentence": "Ceftriaxone 2 g q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h; meningeal dosing required",
              "orderSentence": "Ceftriaxone 2 g q12h IV"
            },
            "contraindications": "Severe cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vancomycin",
            "route": "IV",
            "indication": "DRSP coverage (all patients)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg q8-12h",
                  "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
                },
                {
                  "text": "25-30 mg/kg load",
                  "orderSentence": "Vancomycin 25-30 mg/kg load IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 25-30 mg/kg IV, then 15-20 mg/kg q8-12h (target trough 15-20 mcg/mL); adjust for renal function",
              "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
            },
            "contraindications": "Renal impairment (adjust dose)",
            "monitoring": "Trough levels, renal function, ototoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ampicillin",
            "route": "IV",
            "indication": "Listeria coverage (age ≥50-60, immunocompromised, alcoholism)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q4h",
                  "orderSentence": "Ampicillin 2 g q4h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q4h; required for Listeria coverage in at-risk patients; **NOTE: guidelines vary (≥50 vs >60) - use lower threshold if any additional risk factors**",
              "orderSentence": "Ampicillin 2 g q4h IV"
            },
            "contraindications": "Penicillin allergy (use TMP-SMX)",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "Adjunctive therapy (BEFORE/WITH antibiotics)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg q6h x 4 days",
                  "orderSentence": "Dexamethasone 0.15 mg/kg q6h x 4 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV (typically 10 mg) q6h x 4 days; give 15-20 min BEFORE or WITH first antibiotic dose; see immunocompromised guidance below",
              "orderSentence": "Dexamethasone 0.15 mg/kg q6h x 4 days IV"
            },
            "contraindications": "GI bleed (relative), see immunocompromised guidance",
            "monitoring": "Glucose, GI bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Organism-Directed Therapy (After Culture/Sensitivity)": [
          {
            "item": "Penicillin G",
            "route": "IV",
            "indication": "Penicillin-sensitive pneumococcus, meningococcus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 million units q4h",
                  "orderSentence": "Penicillin G 4 million units q4h IV"
                }
              ],
              "route": "IV",
              "instructions": "4 million units IV q4h; can de-escalate if susceptible",
              "orderSentence": "Penicillin G 4 million units q4h IV"
            },
            "contraindications": "Penicillin allergy",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ceftriaxone (continued)",
            "route": "IV",
            "indication": "Pneumococcus (intermediate), meningococcus, H. flu",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q12h",
                  "orderSentence": "Ceftriaxone (continued) 2 g q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "Continue 2 g IV q12h if organism susceptible",
              "orderSentence": "Ceftriaxone (continued) 2 g q12h IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ampicillin (continued)",
            "route": "IV",
            "indication": "Listeria monocytogenes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q4h",
                  "orderSentence": "Ampicillin (continued) 2 g q4h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q4h x 21 days for Listeria",
              "orderSentence": "Ampicillin (continued) 2 g q4h IV"
            },
            "contraindications": "Penicillin allergy",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TMP-SMX",
            "route": "IV",
            "indication": "Listeria (penicillin-allergic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/kg TMP q6h",
                  "orderSentence": "TMP-SMX 5 mg/kg TMP q6h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/kg (TMP component) IV q6h; alternative for Listeria",
              "orderSentence": "TMP-SMX 5 mg/kg TMP q6h IV"
            },
            "contraindications": "Sulfa allergy, severe renal impairment",
            "monitoring": "Renal function, K+, rash",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Meropenem",
            "route": "IV",
            "indication": "Resistant GNR, penicillin allergy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q8h",
                  "orderSentence": "Meropenem 2 g q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q8h; meningeal dosing",
              "orderSentence": "Meropenem 2 g q8h IV"
            },
            "contraindications": "Carbapenem allergy",
            "monitoring": "Renal function, seizures",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Dexamethasone Guidance": [
          {
            "item": "Dexamethasone (continue)",
            "route": "IV",
            "indication": "Proven pneumococcal meningitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg q6h x 4 days",
                  "orderSentence": "Dexamethasone (continue) 0.15 mg/kg q6h x 4 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Continue full 4-day course if S. pneumoniae confirmed",
              "orderSentence": "Dexamethasone (continue) 0.15 mg/kg q6h x 4 days IV"
            },
            "contraindications": "See below",
            "monitoring": "Glucose, GI bleed",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone (discontinue)",
            "route": "—",
            "indication": "Non-pneumococcal meningitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Dexamethasone (discontinue) N/A —"
                }
              ],
              "route": "—",
              "instructions": "DISCONTINUE dexamethasone if organism other than S. pneumoniae (benefit unproven)",
              "orderSentence": "Dexamethasone (discontinue) N/A —"
            },
            "contraindications": "—",
            "monitoring": "—",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Supportive Care": [
          {
            "item": "Normal saline",
            "route": "IV",
            "indication": "Fluid resuscitation, maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL/kg bolus",
                  "orderSentence": "Normal saline 30 mL/kg bolus IV"
                },
                {
                  "text": "125 mL/hr maintenance",
                  "orderSentence": "Normal saline 125 mL/hr maintenance IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL/kg bolus for sepsis; avoid over-hydration (cerebral edema risk)",
              "orderSentence": "Normal saline 30 mL/kg bolus IV"
            },
            "contraindications": "Cerebral edema (restrict fluids)",
            "monitoring": "I/O, Na+, mental status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Norepinephrine",
            "route": "IV",
            "indication": "Septic shock",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.5 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.1-0.5 mcg/kg/min IV"
                },
                {
                  "text": "2-30 mcg/min",
                  "orderSentence": "Norepinephrine 2-30 mcg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 2-5 mcg/min; titrate to MAP ≥65",
              "orderSentence": "Norepinephrine 0.1-0.5 mcg/kg/min IV"
            },
            "contraindications": "—",
            "monitoring": "Continuous BP, lactate",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin",
            "route": "IV",
            "indication": "Seizure prophylaxis (if seizures occur)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg load",
                  "orderSentence": "Phenytoin 20 mg/kg load IV"
                },
                {
                  "text": "100 mg q8h",
                  "orderSentence": "Phenytoin 100 mg q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV load (max rate 50 mg/min), then 100 mg IV q8h; NOT recommended routinely for prophylaxis",
              "orderSentence": "Phenytoin 20 mg/kg load IV"
            },
            "contraindications": "Bradycardia, heart block",
            "monitoring": "Cardiac monitoring during load, levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizure treatment/prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV BID; preferred for seizure prophylaxis if indicated",
              "orderSentence": "Levetiracetam 1000 mg BID IV"
            },
            "contraindications": "Severe renal impairment (adjust)",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV/PO",
            "indication": "Fever, headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "650-1000 mg q6h; max 4 g/day",
              "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mannitol",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 g/kg bolus",
                  "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 g/kg IV bolus over 15-20 min; may repeat q6h PRN; target serum osm <320",
              "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
            },
            "contraindications": "Renal failure, hypotension",
            "monitoring": "Serum osm, Na+, renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline (3%)",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL bolus",
                  "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "250 mL (or 30 mL of 23.4%) bolus for acute herniation; target Na 145-155",
              "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
            },
            "contraindications": "—",
            "monitoring": "Na+, serum osm",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (after stabilization)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; start after 48-72h if no hemorrhagic complications",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, recent LP, coagulopathy",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Famotidine",
            "route": "IV",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg IV BID if on steroids or intubated",
              "orderSentence": "Famotidine 20 mg BID IV"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Chemoprophylaxis for Close Contacts": [
          {
            "item": "Rifampin",
            "route": "PO",
            "indication": "Meningococcal prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg BID x 2 days",
                  "orderSentence": "Rifampin 600 mg BID x 2 days PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg PO q12h x 4 doses (2 days); for household/close contacts",
              "orderSentence": "Rifampin 600 mg BID x 2 days PO"
            },
            "contraindications": "Pregnancy, liver disease",
            "monitoring": "Orange secretions warning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Ciprofloxacin",
            "route": "PO",
            "indication": "Meningococcal prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg single dose",
                  "orderSentence": "Ciprofloxacin 500 mg single dose PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg PO x 1 dose; alternative to rifampin",
              "orderSentence": "Ciprofloxacin 500 mg single dose PO"
            },
            "contraindications": "Pregnancy, children (relative)",
            "monitoring": "Tendon warning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Ceftriaxone",
            "route": "IM",
            "indication": "Meningococcal prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg single dose",
                  "orderSentence": "Ceftriaxone 250 mg single dose IM"
                }
              ],
              "route": "IM",
              "instructions": "250 mg IM x 1 dose; safe in pregnancy",
              "orderSentence": "Ceftriaxone 250 mg single dose IM"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Rifampin (H. flu)",
            "route": "PO",
            "indication": "H. influenzae prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg daily x 4 days",
                  "orderSentence": "Rifampin (H. flu) 20 mg/kg daily x 4 days PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg/kg (max 600 mg) PO daily x 4 days; for household contacts if unvaccinated child <4 yo present",
              "orderSentence": "Rifampin (H. flu) 20 mg/kg daily x 4 days PO"
            },
            "contraindications": "Pregnancy, liver disease",
            "monitoring": "Orange secretions warning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Infectious disease consult for antibiotic optimization, duration guidance, and organism-specific management",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurology consult for seizure management, focal deficits evaluation, and neurological complication monitoring",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given septic shock, hemodynamic instability, or respiratory failure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult for hydrocephalus management, abscess drainage, or elevated ICP requiring intervention",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ENT consult for hearing evaluation as sensorineural hearing loss is a common complication of bacterial meningitis",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Audiology for formal hearing test before discharge to document baseline and detect early hearing loss",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Infection control for droplet isolation implementation and contact tracing if meningococcal disease confirmed",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Public health notification required for meningococcal disease (reportable condition) to enable contact prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening headache, fever, confusion, or seizures develop (may indicate treatment failure or complication)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Complete full antibiotic course even if feeling better to prevent relapse and resistance",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Obtain hearing test after recovery as sensorineural hearing loss is a common complication of bacterial meningitis",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ensure close contacts receive prophylaxis if meningococcal disease confirmed (rifampin, ciprofloxacin, or ceftriaxone)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Report persistent headaches, hearing changes, or cognitive difficulties as these may indicate late complications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Maintain droplet isolation (meningococcal) until 24h of effective antibiotics to prevent transmission",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Meningococcal vaccination for close contacts and patient after recovery to prevent future infection",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pneumococcal vaccination if not up to date as pneumococcus is the most common cause of bacterial meningitis",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Practice hand hygiene and respiratory etiquette to prevent transmission of respiratory pathogens",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sharing utensils, drinks, or close contact with respiratory secretions during active infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Viral meningitis",
        "features": "Milder course, lymphocytic CSF, normal glucose",
        "tests": "CSF profile, viral PCR"
      },
      {
        "diagnosis": "HSV encephalitis",
        "features": "Altered mental status, temporal lobe findings, seizures",
        "tests": "MRI brain, CSF HSV PCR"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute course, basilar enhancement, low glucose",
        "tests": "CSF AFB, adenosine deaminase, PCR"
      },
      {
        "diagnosis": "Fungal meningitis",
        "features": "Immunocompromised, indolent course",
        "tests": "CSF fungal culture, cryptococcal antigen"
      },
      {
        "diagnosis": "Subarachnoid hemorrhage",
        "features": "Thunderclap headache, xanthochromia",
        "tests": "CT head, LP (xanthochromia, RBCs)"
      },
      {
        "diagnosis": "Brain abscess",
        "features": "Focal deficits, ring-enhancing lesion",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Subdural empyema",
        "features": "Post-sinusitis/otitis, focal deficits",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute, psychiatric symptoms, movement disorder",
        "tests": "Autoimmune panel (serum/CSF)"
      },
      {
        "diagnosis": "Carcinomatous meningitis",
        "features": "Cancer history, cranial neuropathies",
        "tests": "CSF cytology, MRI"
      },
      {
        "diagnosis": "Drug-induced meningitis",
        "features": "NSAIDs, IVIG, TMP-SMX exposure",
        "tests": "Temporal relationship, improvement off drug"
      },
      {
        "diagnosis": "Endocarditis with CNS embolization",
        "features": "Heart murmur, embolic phenomena",
        "tests": "Echocardiogram, blood cultures"
      },
      {
        "diagnosis": "Septic dural sinus thrombosis",
        "features": "Headache, papilledema, focal signs",
        "tests": "CT/MR venography"
      }
    ],
    "evidence": [
      {
        "recommendation": "Dexamethasone before antibiotics improves outcomes in pneumococcal meningitis",
        "evidenceLevel": "Class I, Level A",
        "source": "[de Gans et al. NEJM 2002](https://pubmed.ncbi.nlm.nih.gov/12432041/)"
      },
      {
        "recommendation": "Antibiotics within 1 hour reduce mortality",
        "evidenceLevel": "Class II, Level B",
        "source": "[Proulx et al. QJM 2005](https://pubmed.ncbi.nlm.nih.gov/15728404/)"
      },
      {
        "recommendation": "CT before LP only if criteria met",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hasbun et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11742046/)"
      },
      {
        "recommendation": "Vancomycin + ceftriaxone empiric for DRSP",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tunkel et al. IDSA Guidelines Clin Infect Dis 2004](https://pubmed.ncbi.nlm.nih.gov/15494903/)"
      },
      {
        "recommendation": "Ampicillin for Listeria coverage in at-risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[IDSA Guidelines 2004](https://pubmed.ncbi.nlm.nih.gov/15494903/)"
      },
      {
        "recommendation": "BioFire Panel for rapid diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Leber et al. J Clin Microbiol 2016](https://pubmed.ncbi.nlm.nih.gov/27335149/)"
      },
      {
        "recommendation": "Rifampin or ciprofloxacin prophylaxis for meningococcal contacts",
        "evidenceLevel": "Class I, Level A",
        "source": "[CDC MMWR Recommendations](https://pubmed.ncbi.nlm.nih.gov/23486021/)"
      },
      {
        "recommendation": "Antibiotic duration by organism",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tunkel et al. IDSA Guidelines](https://pubmed.ncbi.nlm.nih.gov/15494903/)"
      },
      {
        "recommendation": "Delay in antibiotics increases mortality",
        "evidenceLevel": "Class II, Level B",
        "source": "[Auburtin et al. Crit Care Med 2006](https://pubmed.ncbi.nlm.nih.gov/16940475/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam (GCS)",
        "frequency": "q1-2h initially, then q4h",
        "action": "Head CT, consider ICP monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Reassess antibiotic coverage",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1-4h",
        "action": "Vasopressors if septic shock",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate",
        "frequency": "Continuous",
        "action": "Evaluate for sepsis, arrhythmia",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement O2, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Urine output",
        "frequency": "q4h",
        "action": "Fluid resuscitation",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Serum sodium",
        "frequency": "q6-12h",
        "action": "Evaluate for SIADH, cerebral salt wasting",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Lactate",
        "frequency": "q6-12h until normal",
        "action": "Optimize resuscitation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Vancomycin trough",
        "frequency": "Before 4th dose",
        "action": "Dose adjustment",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily",
        "action": "Adjust antibiotic doses",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "q6h if on steroids",
        "action": "Insulin",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Hearing assessment",
        "frequency": "Before discharge",
        "action": "Audiology referral",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "GCS <12; hemodynamic instability (septic shock); respiratory failure; seizures; signs of elevated ICP; DIC; rapidly worsening"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable but requiring close monitoring; improving mental status; weaning vasopressors"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Stable; GCS 15; hemodynamically stable; no seizures; improving on antibiotics"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "NOT recommended for acute bacterial meningitis; requires IV antibiotics"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "Need for neurosurgical intervention; refractory elevated ICP; ECMO candidacy"
      }
    ]
  },
  "HSV Encephalitis": {
    "id": "hsv-encephalitis",
    "title": "HSV Encephalitis",
    "version": "1.1",
    "icd10": [
      "** B00.4 (Herpesviral encephalitis)",
      "G05.1 (Encephalitis",
      "myelitis and encephalomyelitis in viral diseases classified elsewhere)"
    ],
    "scope": "** Evaluation and management of herpes simplex virus encephalitis (HSVE) in adults. Covers empiric acyclovir, diagnostic workup including CSF PCR and neuroimaging, seizure management, and ICU care. Primarily addresses HSV-1 encephalitis (most common in adults). Excludes neonatal HSV, HSV-2 meningitis (Mollaret's), and other viral encephalitides.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection workup, baseline",
            "target": "May show leukocytosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal function (acyclovir dosing), hepatic function",
            "target": "Normal or mildly elevated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BUN/Creatinine",
            "rationale": "Baseline for acyclovir dosing",
            "target": "Normal (adjust acyclovir if elevated)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Compare with CSF glucose",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP coagulation status",
            "target": "INR <1.5",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood cultures (2 sets)",
            "rationale": "Exclude bacterial infection",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Serum sodium",
            "rationale": "SIADH common in encephalitis",
            "target": "135-145 mEq/L",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "May be mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV antibody/antigen",
            "rationale": "Immunocompromised host evaluation",
            "target": "Document status",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HSV-1/HSV-2 serology (IgG, IgM)",
            "rationale": "Not useful for acute diagnosis; documents prior exposure",
            "target": "Document (NOT diagnostic of encephalitis)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Procalcitonin",
            "rationale": "Bacterial vs viral differentiation",
            "target": "Low (<0.5) in viral",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Altered mental status workup",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ammonia",
            "rationale": "Altered mental status workup",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "B12",
            "rationale": "Encephalopathy workup",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Altered mental status differential",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Stress cardiomyopathy",
            "target": "Normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum autoimmune encephalitis panel",
            "rationale": "Post-HSV autoimmune encephalitis",
            "target": "Negative initially (may become positive later)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "VZV serology",
            "rationale": "VZV encephalitis differential",
            "target": "Document",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "EBV serology",
            "rationale": "EBV encephalitis differential",
            "target": "Document",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CMV PCR",
            "rationale": "Immunocompromised patients",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Serum West Nile IgM",
            "rationale": "Endemic area, summer months",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "May be elevated in encephalitis",
            "target": "10-20 cmH2O normal; often elevated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "rationale": "Lymphocytic pleocytosis",
            "target": "10-500 WBC/μL; lymphocyte predominant; RBCs may be present",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in encephalitis",
            "target": "60-100 mg/dL (mildly elevated)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Usually normal in viral encephalitis",
            "target": "Normal (>40 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "**HSV PCR (CSF)**",
            "rationale": "**Definitive diagnosis**",
            "target": "**Positive (sensitivity 96%, specificity >99%)**",
            "ED": "**STAT**",
            "HOSP": "**STAT**",
            "OPD": "—",
            "ICU": "**STAT**"
          },
          {
            "item": "HSV-1 and HSV-2 specific PCR",
            "rationale": "Distinguish HSV-1 vs HSV-2",
            "target": "Document which type",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "VZV PCR",
            "rationale": "VZV encephalitis differential",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enterovirus PCR",
            "rationale": "Viral encephalitis differential",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid multiplex PCR",
            "target": "HSV and other pathogens",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and bacterial culture",
            "rationale": "Exclude bacterial meningitis",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "If malignancy suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "Post-HSV autoimmune encephalitis",
            "target": "Negative initially",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "STAT (within 24h)",
            "target": "Temporal lobe T2/FLAIR hyperintensity, hemorrhage, edema",
            "contraindications": "Hemodynamic instability (get CT first)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CT head without contrast",
            "timing": "If MRI delayed or unavailable",
            "target": "Temporal lobe hypodensity, hemorrhage, edema (less sensitive than MRI)",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "EEG",
            "timing": "If seizures or altered mental status",
            "target": "Periodic lateralized epileptiform discharges (PLEDs), temporal slowing",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain (repeat)",
            "timing": "Day 3-7 if initial negative",
            "target": "Evolution of findings",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "timing": "If seizures, persistent AMS",
            "target": "Nonconvulsive seizures, PLEDs",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CT angiogram",
            "timing": "If vasculitis suspected",
            "target": "Normal (or vasculitic changes)",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "timing": "Refractory to treatment, diagnostic uncertainty",
            "target": "HSV inclusions (Cowdry type A)",
            "contraindications": "Coagulopathy",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "PET scan",
            "timing": "If autoimmune encephalitis suspected post-HSV",
            "target": "Temporal hypermetabolism",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Antiviral Therapy": [
          {
            "item": "Acyclovir",
            "route": "IV",
            "indication": "Empiric and definitive treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg q8h",
                  "orderSentence": "Acyclovir 10 mg/kg q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h (infuse over 1 hour); adjust for renal function; minimum 14 days, extend to 21 days if severe or immunocompromised",
              "orderSentence": "Acyclovir 10 mg/kg q8h IV"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Renal function daily, hydration status, neurotoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir (renal adjustment)",
            "route": "IV",
            "indication": "CrCl 25-50 mL/min",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg q12h",
                  "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q12h if CrCl 25-50 mL/min",
              "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q12h IV"
            },
            "contraindications": "—",
            "monitoring": "Cr daily",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir (renal adjustment)",
            "route": "IV",
            "indication": "CrCl 10-25 mL/min",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg q24h",
                  "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q24h IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q24h if CrCl 10-25 mL/min",
              "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q24h IV"
            },
            "contraindications": "—",
            "monitoring": "Cr daily",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir (HD)",
            "route": "IV",
            "indication": "Hemodialysis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg post-HD",
                  "orderSentence": "Acyclovir (HD) 10 mg/kg post-HD IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV after each hemodialysis session",
              "orderSentence": "Acyclovir (HD) 10 mg/kg post-HD IV"
            },
            "contraindications": "—",
            "monitoring": "Post-HD levels",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Empiric Bacterial Coverage (Until Bacterial Ruled Out)": [
          {
            "item": "Ceftriaxone",
            "route": "IV",
            "indication": "Empiric bacterial coverage",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q12h",
                  "orderSentence": "Ceftriaxone 2 g q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h until bacterial meningitis ruled out",
              "orderSentence": "Ceftriaxone 2 g q12h IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vancomycin",
            "route": "IV",
            "indication": "Empiric DRSP coverage",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg q8-12h",
                  "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV q8-12h until bacterial ruled out",
              "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Trough 15-20, renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "If bacterial meningitis possible",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg q6h",
                  "orderSentence": "Dexamethasone 0.15 mg/kg q6h IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV q6h ONLY if bacterial meningitis not ruled out; discontinue if HSV confirmed",
              "orderSentence": "Dexamethasone 0.15 mg/kg q6h IV"
            },
            "contraindications": "—",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Seizure Management": [
          {
            "item": "Levetiracetam",
            "route": "IV/PO",
            "indication": "Seizure treatment/prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV/PO"
                },
                {
                  "text": "2000 mg BID",
                  "orderSentence": "Levetiracetam 2000 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 1000-2000 mg IV, then 1000-1500 mg BID; preferred first-line",
              "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
            },
            "contraindications": "Severe renal impairment (adjust)",
            "monitoring": "Seizure frequency, behavior",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin",
            "route": "IV",
            "indication": "Alternative for seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg load",
                  "orderSentence": "Phenytoin 20 mg/kg load IV"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Phenytoin 100 mg TID IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV load (max 50 mg/min), then 100 mg q8h or 300 mg daily; target level 10-20",
              "orderSentence": "Phenytoin 20 mg/kg load IV"
            },
            "contraindications": "Bradycardia, AV block",
            "monitoring": "Cardiac monitor during load, levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide",
            "route": "IV/PO",
            "indication": "Alternative/adjunctive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID IV/PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide 300 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 200-400 mg IV, then 200-300 mg BID",
              "orderSentence": "Lacosamide 200 mg BID IV/PO"
            },
            "contraindications": "PR prolongation, severe cardiac disease",
            "monitoring": "ECG, PR interval",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Acute seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat x1 in 5 min",
              "orderSentence": "Lorazepam 2 mg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Cerebral Edema / Elevated ICP Management": [
          {
            "item": "Mannitol",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 g/kg bolus",
                  "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 g/kg IV bolus over 15-20 min; may repeat q6h PRN; target serum osm <320",
              "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
            },
            "contraindications": "Renal failure, hypotension",
            "monitoring": "Serum osm, Na+, renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline (3%)",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL bolus",
                  "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "250 mL IV bolus for acute herniation; target Na 145-155",
              "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
            },
            "contraindications": "—",
            "monitoring": "Na+, serum osm",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Head of bed elevation",
            "route": "—",
            "indication": "ICP management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Head of bed elevation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Elevate HOB 30-45 degrees",
              "orderSentence": "Head of bed elevation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ICP (if monitored)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "—",
            "indication": "Refractory elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Decompressive craniectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Consider for malignant cerebral edema with impending herniation",
              "orderSentence": "Decompressive craniectomy N/A —"
            },
            "contraindications": "Multifocal disease, poor prognosis",
            "monitoring": "Neurosurgery consult",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Supportive Care": [
          {
            "item": "IV fluids (isotonic)",
            "route": "IV",
            "indication": "Hydration (prevent acyclovir nephrotoxicity)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 100-150 mL/hr",
                  "orderSentence": "IV fluids (isotonic) NS 100-150 mL/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Maintain euvolemia; avoid dehydration (acyclovir crystallizes in renal tubules)",
              "orderSentence": "IV fluids (isotonic) NS 100-150 mL/hr IV"
            },
            "contraindications": "Cerebral edema (may need to restrict)",
            "monitoring": "I/O, renal function, Na+",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV/PO",
            "indication": "Fever, headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "650-1000 mg q6h; max 4 g/day",
              "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg q6h PRN",
                  "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
                },
                {
                  "text": "8 mg q8h PRN",
                  "orderSentence": "Ondansetron 8 mg q8h PRN IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV/PO q6-8h PRN",
              "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (after stabilization)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; start after 48-72h if no hemorrhage",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, recent hemorrhagic transformation",
            "monitoring": "Platelet count, bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Famotidine",
            "route": "IV/PO",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "20 mg IV/PO BID",
              "orderSentence": "Famotidine 20 mg BID IV/PO"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Post-HSV Autoimmune Encephalitis": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Post-HSV autoimmune encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 5 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 5 days; for secondary deterioration 2-6 weeks post-HSVE",
              "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
            },
            "contraindications": "Active untreated infection",
            "monitoring": "Glucose, BP, psychiatric symptoms",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "IVIg",
            "route": "IV",
            "indication": "Post-HSV autoimmune encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV x 5 days",
              "orderSentence": "IVIg 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function, infusion reactions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, antiviral guidance, and seizure management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consult for atypical course, treatment failure, or diagnostic uncertainty",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Critical care consult for ICU admission given altered mental status, respiratory failure, or elevated ICP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult for elevated ICP management, decompressive surgery, or brain biopsy consideration",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Epilepsy consult for refractory seizures and continuous EEG monitoring interpretation",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment and fall prevention given weakness and cognitive impairment",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy for ADL assessment and early cognitive rehabilitation planning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Speech therapy for swallow evaluation given aspiration risk and aphasia therapy for temporal lobe involvement",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Neuropsychology for formal cognitive assessment after acute illness to guide rehabilitation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work for discharge planning and caregiver support given potential for significant disability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening headache, confusion, or seizures develop (may indicate relapse or post-HSV autoimmune encephalitis)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Complete full 14-21 day acyclovir course to ensure viral eradication and prevent relapse",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Follow seizure precautions including no driving, heights, or operating machinery due to high seizure risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Report any new neurological symptoms weeks after discharge as post-HSV autoimmune encephalitis can occur 2-6 weeks later",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Attend neurology follow-up in 2-4 weeks to assess recovery and screen for delayed complications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect that cognitive rehabilitation may be needed as memory and behavioral deficits are common after HSVE",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact Encephalitis Society (www.encephalitis.info) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Use fall precautions including walker and supervision due to weakness and cognitive impairment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning if bulbar involvement present",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Maintain adequate hydration (2-3 L/day) to prevent acyclovir-induced nephrotoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Follow seizure safety including no swimming alone and showers instead of baths due to ongoing seizure risk",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use cognitive pacing with scheduled rest periods to manage post-encephalitis fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by neurology due to seizure risk and potential cognitive impairment",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute, psychiatric symptoms, movement disorder, may have tumor",
        "tests": "CSF autoimmune panel, serum panel, CT body"
      },
      {
        "diagnosis": "Bacterial meningitis/abscess",
        "features": "More toxic, CSF with PMNs, low glucose",
        "tests": "CSF Gram stain/culture, MRI"
      },
      {
        "diagnosis": "Other viral encephalitis",
        "features": "Geographic/seasonal clues, different MRI pattern",
        "tests": "CSF viral PCR panel, serology"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute, basilar meningitis, low glucose",
        "tests": "CSF AFB, TB PCR, adenosine deaminase"
      },
      {
        "diagnosis": "Fungal meningitis",
        "features": "Immunocompromised, indolent course",
        "tests": "CSF fungal culture, cryptococcal antigen"
      },
      {
        "diagnosis": "Primary CNS lymphoma",
        "features": "Immunocompromised, periventricular lesions",
        "tests": "MRI pattern, CSF cytology"
      },
      {
        "diagnosis": "Glioblastoma",
        "features": "Focal deficits, ring-enhancing mass",
        "tests": "MRI with contrast, biopsy"
      },
      {
        "diagnosis": "Cerebral vasculitis",
        "features": "Multifocal strokes, systemic symptoms",
        "tests": "Angiography, vessel wall MRI, biopsy"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Post-infectious, multifocal white matter",
        "tests": "MRI pattern (multifocal), CSF"
      },
      {
        "diagnosis": "Posterior reversible encephalopathy (PRES)",
        "features": "Hypertension, posterior predominance",
        "tests": "MRI pattern, BP history"
      },
      {
        "diagnosis": "Status epilepticus",
        "features": "Seizure history, EEG pattern",
        "tests": "EEG, response to antiseizure meds"
      },
      {
        "diagnosis": "Toxic/metabolic encephalopathy",
        "features": "Drug exposure, organ failure",
        "tests": "Toxicology, metabolic panel"
      },
      {
        "diagnosis": "Paraneoplastic encephalitis",
        "features": "Cancer history, antibody-positive",
        "tests": "Paraneoplastic panel, CT body"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid dementia, myoclonus, DWI restriction",
        "tests": "MRI pattern, 14-3-3, RT-QuIC"
      }
    ],
    "evidence": [
      {
        "recommendation": "Acyclovir 10 mg/kg q8h for HSVE",
        "evidenceLevel": "Class I, Level A",
        "source": "[Whitley et al. NEJM 1986](https://pubmed.ncbi.nlm.nih.gov/3001520/)"
      },
      {
        "recommendation": "CSF HSV PCR for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Lakeman & Whitley. J Infect Dis 1995](https://pubmed.ncbi.nlm.nih.gov/7706801/)"
      },
      {
        "recommendation": "Early acyclovir improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Raschilas et al. Clin Infect Dis 2002](https://pubmed.ncbi.nlm.nih.gov/12115091/)"
      },
      {
        "recommendation": "MRI superior to CT for HSVE",
        "evidenceLevel": "Class II, Level B",
        "source": "[Domingues et al. J Neurol Sci 1997](https://pubmed.ncbi.nlm.nih.gov/9285472/)"
      },
      {
        "recommendation": "14-21 day treatment duration",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gnann & Whitley. Clin Infect Dis 2002](https://pubmed.ncbi.nlm.nih.gov/12353702/)"
      },
      {
        "recommendation": "Repeat CSF PCR if clinical concern",
        "evidenceLevel": "Class III, Level C",
        "source": "[Tyler. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15295046/)"
      },
      {
        "recommendation": "Post-HSV autoimmune encephalitis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Armangue et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30049614/)"
      },
      {
        "recommendation": "Seizure prophylaxis consideration",
        "evidenceLevel": "Class III, Level C",
        "source": "[Misra et al. Seizure 2008](https://pubmed.ncbi.nlm.nih.gov/17851101/)"
      },
      {
        "recommendation": "Prognosis with early treatment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Skoldenberg et al. Lancet 1984](https://pubmed.ncbi.nlm.nih.gov/6147584/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam (GCS, pupils)",
        "frequency": "q1-2h initially, then q4h",
        "action": "Head CT, consider ICP monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Seizure activity",
        "frequency": "Continuous if cEEG, otherwise q4h assessment",
        "action": "Escalate antiepileptic therapy",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Antipyretics, infection workup",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "frequency": "Daily",
        "action": "Adjust acyclovir dose, increase hydration",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Serum sodium",
        "frequency": "q6-12h initially",
        "action": "Evaluate for SIADH, cerebral salt wasting",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Fluid balance (I/O)",
        "frequency": "q8h",
        "action": "Adjust fluids",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Mental status",
        "frequency": "q4-8h",
        "action": "Re-evaluate, repeat imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Signs of herniation",
        "frequency": "q1-2h if concern",
        "action": "Emergent intervention, neurosurgery",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "CSF HSV PCR (repeat)",
        "frequency": "Day 14-21",
        "action": "Extend acyclovir if still positive",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "GCS <12; seizures; signs of elevated ICP; need for intubation; hemodynamic instability; rapidly worsening"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "GCS 12-14; stable on antiepileptics; no ICP concerns; improving"
      },
      {
        "disposition": "**General floor**",
        "criteria": "GCS 15; stable neurologically; no seizures; tolerating PO; can complete IV acyclovir"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Completed 14-21 days IV acyclovir; neurologically stable; safe swallow; adequate support; outpatient follow-up arranged"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Significant residual cognitive or motor deficits; requires intensive therapy"
      },
      {
        "disposition": "**Long-term care**",
        "criteria": "Severe persistent deficits; unable to live independently"
      }
    ]
  },
  "Autoimmune Encephalitis": {
    "id": "autoimmune-encephalitis",
    "title": "Autoimmune Encephalitis",
    "version": "1.0",
    "icd10": [
      "** G04.81 (Other encephalitis and encephalomyelitis",
      "autoimmune)",
      "G04.90 (Encephalitis and encephalomyelitis",
      "unspecified)",
      "G13.1 (Other systemic atrophy primarily affecting CNS in neoplastic disease)"
    ],
    "scope": "** Evaluation and management of autoimmune encephalitis in adults, including antibody-mediated (anti-NMDAR, LGI1, CASPR2, GABA-B, AMPA, etc.) and paraneoplastic encephalitis. Covers diagnostic workup, tumor screening, first-line and second-line immunotherapy, and long-term management. Excludes infectious encephalitis, Hashimoto's encephalopathy (SREAT), and pediatric-specific presentations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes (hyponatremia in LGI1), renal/hepatic function",
            "target": "Na+ <135 suggests LGI1; otherwise normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Hashimoto's encephalopathy differential",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Metabolic encephalopathy screen",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "Usually normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP",
            "target": "INR <1.5",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "HIV antibody/antigen",
            "rationale": "Immunocompromise screen",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Urinalysis, urine drug screen",
            "rationale": "Alternative diagnoses",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ammonia",
            "rationale": "Metabolic encephalopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "B12, folate",
            "rationale": "Metabolic causes of encephalopathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Extended Workup": [
          {
            "item": "**Autoimmune encephalitis panel (serum)**",
            "rationale": "Antibody identification",
            "target": "Identify specific antibody (NMDAR, LGI1, CASPR2, GABA-B, AMPA, GAD65, others)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "**Paraneoplastic panel (serum)**",
            "rationale": "Tumor-associated antibodies",
            "target": "Identify Hu, Yo, Ri, Ma2/Ta, CV2, amphiphysin",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TPO antibodies",
            "rationale": "Hashimoto's encephalopathy",
            "target": "Document if elevated",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Anti-thyroglobulin antibodies",
            "rationale": "Hashimoto's encephalopathy",
            "target": "Document if elevated",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "ANA, dsDNA",
            "rationale": "Autoimmune disease screen",
            "target": "Usually negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "ANCA",
            "rationale": "Vasculitis screen",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tumor markers (CEA, AFP, CA-125, CA 19-9, beta-hCG, PSA)",
            "rationale": "Occult malignancy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Serum protein electrophoresis",
            "rationale": "Paraproteinemia",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "Pre-IVIg, immunodeficiency",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-rituximab screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Cell-based assay for neuronal antibodies",
            "rationale": "More sensitive than commercial panels",
            "target": "Antibody confirmation",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "VGCC antibodies (P/Q and N-type)",
            "rationale": "LEMS, cerebellar degeneration",
            "target": "Negative unless paraneoplastic",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "SOX1 antibody",
            "rationale": "SCLC-associated",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "DPPX antibody",
            "rationale": "GI symptoms + encephalopathy",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Neurexin-3 antibody",
            "rationale": "Encephalitis, seizures",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "IgLON5 antibody",
            "rationale": "Sleep disorder, brainstem dysfunction",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Mitochondrial DNA testing",
            "rationale": "Mitochondrial encephalopathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Usually normal",
            "target": "10-20 cmH2O",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count with differential",
            "rationale": "Lymphocytic pleocytosis",
            "target": "WBC 10-100 (lymphocyte predominant); may be normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Often mildly elevated",
            "target": "45-100 mg/dL; may be normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Usually normal",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "**Autoimmune encephalitis panel (CSF)**",
            "rationale": "**Critical for diagnosis**",
            "target": "**Identify neuronal antibodies; CSF more sensitive than serum for some (NMDAR)**",
            "ED": "**STAT**",
            "HOSP": "**STAT**",
            "OPD": "—",
            "ICU": "**STAT**"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Intrathecal synthesis",
            "target": "May be positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "IgG index",
            "rationale": "Intrathecal synthesis",
            "target": "May be elevated",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HSV PCR",
            "rationale": "Exclude HSV encephalitis",
            "target": "Negative (but post-HSV autoimmune is possible)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "VZV PCR",
            "rationale": "Exclude VZV encephalitis",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bacterial culture, Gram stain",
            "rationale": "Exclude bacterial infection",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "BioFire ME Panel",
            "rationale": "Exclude infectious causes",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "STAT",
            "target": "Medial temporal T2/FLAIR hyperintensity (limbic); may be normal in 50%",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "EEG (routine or continuous)",
            "timing": "STAT if seizures or AMS",
            "target": "Extreme delta brush (NMDAR), temporal slowing, seizures",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "timing": "Tumor search",
            "target": "Occult malignancy (lung, ovary, testes, thymus)",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Pelvic ultrasound (women)",
            "timing": "If anti-NMDAR positive",
            "target": "Ovarian teratoma",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "MRI pelvis with contrast",
            "timing": "If US equivocal",
            "target": "Ovarian teratoma",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Testicular ultrasound (men <50)",
            "timing": "If anti-Ma2 or clinical concern",
            "target": "Testicular tumor",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT or PET-CT chest",
            "timing": "Thymoma, lung cancer",
            "target": "Tumor identification",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Whole body PET-CT",
            "timing": "Occult malignancy search",
            "target": "Any FDG-avid tumor",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Mammogram",
            "timing": "Breast cancer screening",
            "target": "Normal",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "timing": "Refractory cases, coma",
            "target": "Nonconvulsive seizures",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "timing": "Diagnostic uncertainty, refractory",
            "target": "Inflammatory infiltrate",
            "contraindications": "Coagulopathy",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "FDG-PET brain",
            "timing": "Clarify extent of involvement",
            "target": "Temporal hypermetabolism",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Repeat whole body imaging",
            "timing": "If initial negative, strong suspicion",
            "target": "Occult tumor",
            "contraindications": "—",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "First-Line Immunotherapy": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "First-line immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 5 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 3-5 days; infuse over 1 hour",
              "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes (relative)",
            "monitoring": "Glucose, BP, psychiatric symptoms, GI bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IVIg (immune globulin IV)",
            "route": "IV",
            "indication": "First-line immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (total 2 g/kg); start slow day 1",
              "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "First-line immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges over 10-14 days",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges over 10-14 days —"
                }
              ],
              "route": "—",
              "instructions": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges over 10-14 days —"
            },
            "contraindications": "Hemodynamic instability, severe sepsis",
            "monitoring": "BP, electrolytes, coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Second-Line Immunotherapy (If First-Line Fails)": [
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "First-line failure, anti-NMDAR",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg x 2 doses",
                  "orderSentence": "Rituximab 1000 mg x 2 doses IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² IV weekly x 4 OR 1000 mg IV x 2 doses (2 weeks apart); pre-medicate",
              "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
            },
            "contraindications": "Active infection, HBV (screen), live vaccines",
            "monitoring": "Infusion reactions, B-cell counts, immunoglobulins",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "First-line failure, paraneoplastic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg/m² monthly x 6",
                  "orderSentence": "Cyclophosphamide 750 mg/m² monthly x 6 IV"
                }
              ],
              "route": "IV",
              "instructions": "750 mg/m² IV monthly x 6 cycles; with mesna for bladder protection",
              "orderSentence": "Cyclophosphamide 750 mg/m² monthly x 6 IV"
            },
            "contraindications": "Cytopenias, active infection, pregnancy",
            "monitoring": "CBC weekly, renal function, hemorrhagic cystitis",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Tumor Treatment": [
          {
            "item": "Tumor resection (ovarian teratoma)",
            "route": "Surgical",
            "indication": "Anti-NMDAR with teratoma",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Tumor resection (ovarian teratoma) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical removal of ovarian teratoma is CRITICAL for recovery; early surgery improves outcomes",
              "orderSentence": "Tumor resection (ovarian teratoma) N/A —"
            },
            "contraindications": "Unstable patient",
            "monitoring": "Post-op neuro status",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Thymectomy",
            "route": "Surgical",
            "indication": "Thymoma-associated encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Thymectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical resection of thymoma",
              "orderSentence": "Thymectomy N/A —"
            },
            "contraindications": "Unstable patient",
            "monitoring": "Post-op neuro status",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oncology treatment",
            "route": "Various",
            "indication": "Tumor-associated encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per oncology",
                  "orderSentence": "Oncology treatment Per oncology —"
                }
              ],
              "route": "—",
              "instructions": "Treat underlying malignancy per oncology recommendations",
              "orderSentence": "Oncology treatment Per oncology —"
            },
            "contraindications": "—",
            "monitoring": "Per oncology",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Seizure Management": [
          {
            "item": "Levetiracetam",
            "route": "IV/PO",
            "indication": "Seizures, seizure prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV/PO"
                },
                {
                  "text": "2000 mg BID",
                  "orderSentence": "Levetiracetam 2000 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 1000-2000 mg IV, then 1000-1500 mg BID; may need higher doses",
              "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
            },
            "contraindications": "Severe renal impairment (adjust)",
            "monitoring": "Seizure frequency, behavior",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide",
            "route": "IV/PO",
            "indication": "Adjunctive seizure control",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID IV/PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide 300 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 200-400 mg IV, then 200-300 mg BID",
              "orderSentence": "Lacosamide 200 mg BID IV/PO"
            },
            "contraindications": "PR prolongation, severe cardiac disease",
            "monitoring": "ECG, PR interval",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate",
            "route": "IV/PO",
            "indication": "Seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg load",
                  "orderSentence": "Valproate 20 mg/kg load IV/PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate 500 mg BID IV/PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Valproate 750 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 20-30 mg/kg IV, then 500-750 mg BID; target level 50-100",
              "orderSentence": "Valproate 20 mg/kg load IV/PO"
            },
            "contraindications": "Liver disease, mitochondrial disease, pregnancy",
            "monitoring": "LFTs, ammonia, levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Acute seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat x1",
              "orderSentence": "Lorazepam 2 mg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam infusion",
            "route": "IV",
            "indication": "Refractory status epilepticus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.4 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 0.1-0.4 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg/kg bolus, then 0.1-0.4 mg/kg/hr infusion; for refractory seizures",
              "orderSentence": "Midazolam infusion 0.1-0.4 mg/kg/hr IV"
            },
            "contraindications": "—",
            "monitoring": "EEG, sedation, respiratory",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Symptomatic/Supportive Care": [
          {
            "item": "Haloperidol",
            "route": "IV/IM",
            "indication": "Agitation, psychosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-5 mg q4-6h PRN",
                  "orderSentence": "Haloperidol 2-5 mg q4-6h PRN IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "2-5 mg IV/IM q4-6h PRN for severe agitation; avoid in movement disorders",
              "orderSentence": "Haloperidol 2-5 mg q4-6h PRN IV/IM"
            },
            "contraindications": "QT prolongation, movement disorders, Parkinson",
            "monitoring": "QTc, EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Agitation, psychosis (milder)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Quetiapine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg BID; titrate as needed; lower EPS risk",
              "orderSentence": "Quetiapine 25 mg BID PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc, sedation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Catatonia, agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg q6h",
                  "orderSentence": "Lorazepam 1 mg q6h IV/PO"
                },
                {
                  "text": "2 mg q6h",
                  "orderSentence": "Lorazepam 2 mg q6h IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "1-2 mg IV/PO q6h; often effective for catatonia",
              "orderSentence": "Lorazepam 1 mg q6h IV/PO"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "Autonomic instability (tachycardia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg TID",
                  "orderSentence": "Propranolol 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Propranolol 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg PO TID for tachycardia",
              "orderSentence": "Propranolol 10 mg TID PO"
            },
            "contraindications": "Bradycardia, hypotension, asthma",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Clonidine",
            "route": "PO/transdermal",
            "indication": "Autonomic instability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg BID",
                  "orderSentence": "Clonidine 0.1 mg BID PO/TD"
                },
                {
                  "text": "0.1 mg patch weekly",
                  "orderSentence": "Clonidine 0.1 mg patch weekly PO/TD"
                }
              ],
              "route": "PO/TD",
              "instructions": "0.1 mg PO BID or 0.1 mg/24h patch; for hypertension/tachycardia",
              "orderSentence": "Clonidine 0.1 mg BID PO/TD"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP, HR",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, coagulopathy",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Famotidine",
            "route": "IV/PO",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "20 mg BID if on steroids or intubated",
              "orderSentence": "Famotidine 20 mg BID IV/PO"
            },
            "contraindications": "None",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin",
            "route": "IV/SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per sliding scale",
                  "orderSentence": "Insulin Per sliding scale IV/SC"
                }
              ],
              "route": "IV/SC",
              "instructions": "Target glucose <180 mg/dL",
              "orderSentence": "Insulin Per sliding scale IV/SC"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q4-6h",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Long-Term/Maintenance Immunotherapy": [
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Maintenance immunosuppression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "contraindications": "Pregnancy, cytopenias",
            "monitoring": "CBC q2wk x 2 mo, then monthly",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Maintenance immunosuppression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg q2-4wk to 2-3 mg/kg/day; check TPMT first",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "contraindications": "TPMT deficiency, pregnancy",
            "monitoring": "CBC weekly x 4, then monthly; LFTs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Prednisone (oral taper)",
            "route": "PO",
            "indication": "Steroid taper",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone (oral taper) 60 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Prednisone (oral taper) 40 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone (oral taper) 20 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Prednisone (oral taper) 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Taper over weeks to months; individualize based on response",
              "orderSentence": "Prednisone (oral taper) 60 mg daily PO"
            },
            "contraindications": "—",
            "monitoring": "Glucose, BP, bone density",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab (maintenance)",
            "route": "IV",
            "indication": "Relapse prevention (NMDAR)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg q6mo",
                  "orderSentence": "Rituximab (maintenance) 500-1000 mg q6mo IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV q6 months for 2 years or longer; recheck antibodies",
              "orderSentence": "Rituximab (maintenance) 500-1000 mg q6mo IV"
            },
            "contraindications": "Active infection",
            "monitoring": "B-cell counts, immunoglobulins",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, immunotherapy guidance, and antibody interpretation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neuro-immunology consult for complex cases, second-line therapy decisions, and long-term management",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Oncology consult for tumor workup and treatment if paraneoplastic syndrome identified",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Gynecologic oncology for ovarian teratoma removal which is critical for anti-NMDAR encephalitis recovery",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Critical care consult for ICU admission given autonomic instability, coma, or need for sedation/ventilation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Psychiatry consult for severe psychiatric symptoms, catatonia, or behavioral management in acute phase",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Epilepsy consult for refractory seizures and continuous EEG monitoring guidance",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for mobility assessment and fall prevention given fluctuating weakness and dyskinesias",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy for ADL assessment and cognitive rehabilitation to maximize functional recovery",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Speech therapy for swallow evaluation and communication strategies given dysarthria and aphasia",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neuropsychology for formal cognitive assessment to document deficits and guide rehabilitation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work for discharge planning and family support given prolonged recovery and potential disability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening confusion, seizures, or new symptoms develop (may indicate relapse requiring treatment escalation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Continue immunotherapy as prescribed even when feeling better; stopping early increases relapse risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Report fever or signs of infection promptly as immunosuppression increases infection risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Follow seizure precautions including no driving, swimming alone, or heights due to unpredictable seizure risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Attend all follow-up appointments as relapses can occur months to years after initial presentation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect that recovery may take months to years; improvement often continues for 2+ years",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Participate in cognitive rehabilitation as this is essential for optimizing recovery from memory and executive deficits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact Autoimmune Encephalitis Alliance (www.aealliance.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Use fall precautions including walker and supervision due to movement disorders and cognitive impairment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning if swallow impaired",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "DVT prophylaxis with SCDs and/or anticoagulation given prolonged immobility risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Avoid live vaccines while on immunosuppression; inactivated vaccines are safe and recommended",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Practice infection prevention including hand hygiene and avoiding sick contacts while on immunosuppression",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Continue regular cancer screening for paraneoplastic cases as tumor recurrence can trigger relapse",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use cognitive pacing with scheduled rest periods to manage post-encephalitis fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by neurology due to seizure risk and cognitive impairment",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "HSV encephalitis",
        "features": "Acute, temporal lobe predominant, hemorrhagic",
        "tests": "MRI temporal, HSV PCR"
      },
      {
        "diagnosis": "Other viral encephalitis",
        "features": "Fever, CSF pleocytosis, specific epidemiology",
        "tests": "Viral PCRs"
      },
      {
        "diagnosis": "Bacterial meningitis",
        "features": "Acute, toxic, PMN predominant CSF",
        "tests": "CSF Gram stain, culture"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute, basilar, low glucose",
        "tests": "CSF AFB, PCR, ADA"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Risk factors, varied presentations",
        "tests": "RPR, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "Primary CNS lymphoma",
        "features": "Immunocompromised, periventricular",
        "tests": "MRI pattern, CSF cytology"
      },
      {
        "diagnosis": "Glioblastoma",
        "features": "Focal deficits, ring-enhancing mass",
        "tests": "MRI, biopsy"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid dementia, myoclonus, DWI restriction",
        "tests": "MRI pattern, 14-3-3, RT-QuIC"
      },
      {
        "diagnosis": "Hashimoto's encephalopathy (SREAT)",
        "features": "Elevated TPO, responds to steroids",
        "tests": "TPO antibodies, exclusion"
      },
      {
        "diagnosis": "Psychiatric illness (primary)",
        "features": "No CSF/MRI changes, prior history",
        "tests": "Normal workup, psychiatric evaluation"
      },
      {
        "diagnosis": "Toxic/metabolic encephalopathy",
        "features": "Drug/toxin exposure, metabolic derangement",
        "tests": "Toxicology, metabolic panel"
      },
      {
        "diagnosis": "ADEM",
        "features": "Post-infectious, multifocal white matter",
        "tests": "MRI pattern (multifocal), monophasic"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Multifocal strokes, systemic symptoms",
        "tests": "Angiography, vessel wall MRI"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Alcoholism, classic triad, mammillary bodies",
        "tests": "Thiamine trial, MRI"
      },
      {
        "diagnosis": "Seizure-related (postictal)",
        "features": "Seizure witnessed, resolves with time",
        "tests": "EEG, observation"
      }
    ],
    "evidence": [
      {
        "recommendation": "First-line immunotherapy (steroids, IVIg, PLEX)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Early immunotherapy improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Second-line therapy (rituximab, cyclophosphamide)",
        "evidenceLevel": "Class III, Level C",
        "source": "[Dalmau et al. Lancet Neurol 2019](https://pubmed.ncbi.nlm.nih.gov/31326280/)"
      },
      {
        "recommendation": "Tumor removal essential for recovery",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "CSF more sensitive than serum for NMDAR",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gresa-Arribas et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24275432/)"
      },
      {
        "recommendation": "Extreme delta brush in anti-NMDAR",
        "evidenceLevel": "Class III, Level C",
        "source": "[Schmitt et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22966581/)"
      },
      {
        "recommendation": "LGI1 associated with hyponatremia and FBDS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Irani et al. Brain 2010](https://pubmed.ncbi.nlm.nih.gov/20833645/)"
      },
      {
        "recommendation": "Diagnostic criteria for autoimmune encephalitis",
        "evidenceLevel": "Consensus Guidelines",
        "source": "[Graus et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
      },
      {
        "recommendation": "Long-term outcomes and relapse risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam (GCS, MMSE)",
        "frequency": "q4-8h initially",
        "action": "Re-evaluate treatment, escalate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Seizure activity",
        "frequency": "Continuous if cEEG; q4h assessment",
        "action": "Escalate antiepileptic therapy",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Vital signs (autonomic function)",
        "frequency": "q1-4h",
        "action": "Supportive care, ICU if unstable",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h if on steroids",
        "action": "Insulin adjustment",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "q24-48h during IVIg",
        "action": "Hydration, adjust IVIg rate",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Serum sodium",
        "frequency": "q12-24h (especially LGI1)",
        "action": "Fluid restriction if hyponatremic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Antibody titers (serum/CSF)",
        "frequency": "q3-6 months",
        "action": "Consider treatment escalation",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Tumor surveillance",
        "frequency": "Per oncology",
        "action": "Oncology management",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "B-cell counts (if on rituximab)",
        "frequency": "Before each infusion",
        "action": "Adjust dosing interval",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "CBC (if on immunosuppression)",
        "frequency": "q1-4 weeks",
        "action": "Hold medication, infection workup",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "GCS <12; refractory seizures; autonomic instability; need for intubation; coma; severe psychiatric symptoms requiring restraint"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "GCS 12-14; controlled seizures; stable autonomic function; receiving immunotherapy"
      },
      {
        "disposition": "**General floor**",
        "criteria": "GCS 15; stable; no seizures; able to participate in therapies; can complete immunotherapy"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Significant cognitive or motor deficits; requires intensive therapy; medically stable"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Significant improvement; safe swallow; adequate support; outpatient immunotherapy arranged; neurology follow-up scheduled"
      },
      {
        "disposition": "**Long-term care**",
        "criteria": "Severe persistent deficits; unable to live independently"
      }
    ]
  },
  "Migraine": {
    "id": "migraine",
    "title": "Migraine",
    "version": "1.0",
    "icd10": [
      "** G43.909 (Migraine",
      "unspecified",
      "not intractable",
      "without status migrainosus)"
    ],
    "scope": "** Acute migraine treatment, preventive therapy initiation, and chronic migraine management. Excludes hemiplegic migraine, migraine with brainstem aura (separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Rule out anemia, infection as headache trigger",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities can trigger or mimic migraine",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction associated with headache disorders",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "rationale": "Rule out giant cell arteritis if age >50 with new headache",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D level",
            "rationale": "Deficiency associated with increased migraine frequency",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium (RBC)",
            "rationale": "Deficiency linked to migraine; RBC level more accurate",
            "target": ">4.2 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferritin",
            "rationale": "Iron deficiency associated with headache",
            "target": ">50 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Rule out CNS lupus in atypical presentations",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Antiphospholipid antibodies",
            "rationale": "Stroke mimic or migraine with aura risk",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (CACNA1A, ATP1A2, SCN1A)",
            "rationale": "Hemiplegic migraine suspected",
            "target": "Variant identified",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "First migraine presentation or change in pattern",
            "target": "Normal; rule out secondary causes",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "Acute severe headache (\"worst headache of life\") to rule out SAH",
            "target": "No hemorrhage",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Atypical features, focal deficits, papilledema",
            "target": "No enhancement",
            "contraindications": "Gadolinium allergy, severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head/Neck",
            "timing": "Suspected vascular etiology (thunderclap, positional)",
            "target": "Patent vessels; no dissection",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Urgent vascular imaging if MRI unavailable",
            "target": "No aneurysm, dissection",
            "contraindications": "Contrast allergy, CKD",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRV Brain",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET scan",
            "timing": "Refractory migraine, research protocols",
            "target": "Assess migraine generator activity",
            "contraindications": "Pregnancy, cost",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "First-line acute migraine in ED",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg IV",
                  "orderSentence": "Ketorolac 30 mg IV IV"
                },
                {
                  "text": "15 mg IV",
                  "orderSentence": "Ketorolac 15 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV x1 (15 mg if >65y, renal impairment, or <50 kg); max 5 days NSAIDs",
              "orderSentence": "Ketorolac 30 mg IV IV"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy; third trimester",
            "monitoring": "Renal function if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Antiemetic with anti-migraine properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Metoclopramide 10 mg IV IV"
                },
                {
                  "text": "20 mg IV",
                  "orderSentence": "Metoclopramide 20 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15 min; pretreat with diphenhydramine 25 mg to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia; bowel obstruction",
            "monitoring": "Akathisia, dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV",
            "indication": "Dopamine antagonist for acute migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Prochlorperazine 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV over 2 min; pretreat with diphenhydramine 25 mg",
              "orderSentence": "Prochlorperazine 10 mg IV IV"
            },
            "contraindications": "QT prolongation; Parkinson's; neuroleptic hypersensitivity",
            "monitoring": "Akathisia, dystonia, QTc",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "Prevent akathisia from dopamine antagonists",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg IV",
                  "orderSentence": "Diphenhydramine 25 mg IV IV"
                },
                {
                  "text": "50 mg IV",
                  "orderSentence": "Diphenhydramine 50 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV with dopamine antagonist",
              "orderSentence": "Diphenhydramine 25 mg IV IV"
            },
            "contraindications": "Glaucoma; urinary retention",
            "monitoring": "Sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate",
            "route": "IV",
            "indication": "Migraine with aura; refractory migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g IV",
                  "orderSentence": "Magnesium sulfate 2 g IV IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV over 20 min; may repeat x1",
              "orderSentence": "Magnesium sulfate 2 g IV IV"
            },
            "contraindications": "Heart block; hypermagnesemia; myasthenia gravis",
            "monitoring": "BP, HR during infusion",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "SC/PO",
            "indication": "Triptan-naive or triptan-responsive patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg SC",
                  "orderSentence": "Sumatriptan 6 mg SC SC/PO"
                },
                {
                  "text": "50 mg PO",
                  "orderSentence": "Sumatriptan 50 mg PO SC/PO"
                },
                {
                  "text": "100 mg PO",
                  "orderSentence": "Sumatriptan 100 mg PO SC/PO"
                }
              ],
              "route": "SC/PO",
              "instructions": "6 mg SC (may repeat after 1 hr, max 12 mg/24hr) OR 50-100 mg PO (max 200 mg/24hr)",
              "orderSentence": "Sumatriptan 6 mg SC SC/PO"
            },
            "contraindications": "Uncontrolled HTN; CAD; CVA history; MAOIs; hemiplegic migraine",
            "monitoring": "Chest tightness (triptan sensation vs cardiac)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate sodium",
            "route": "IV",
            "indication": "Status migrainosus; refractory to first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV",
                  "orderSentence": "Valproate sodium 500 mg IV IV"
                },
                {
                  "text": "1000 mg IV",
                  "orderSentence": "Valproate sodium 1000 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV over 5 min",
              "orderSentence": "Valproate sodium 500 mg IV IV"
            },
            "contraindications": "Hepatic disease; pregnancy; urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs, ammonia if altered mental status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "Refractory migraine; status migrainosus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV IV"
                },
                {
                  "text": "1 mg IV",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q8h for up to 3 days; pretreat with antiemetic",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV IV"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; use within 24h of triptan; severe hepatic/renal impairment",
            "monitoring": "BP, nausea; continuous cardiac monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "Prevent migraine recurrence after ED treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Dexamethasone 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV x1 at time of ED discharge",
              "orderSentence": "Dexamethasone 10 mg IV IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes",
            "monitoring": "Glucose if diabetic",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea/vomiting associated with migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg IV",
                  "orderSentence": "Ondansetron 4 mg IV IV/PO"
                },
                {
                  "text": "8 mg PO",
                  "orderSentence": "Ondansetron 8 mg PO IV/PO"
                },
                {
                  "text": "4 mg ODT",
                  "orderSentence": "Ondansetron 4 mg ODT IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4 mg IV or 8 mg PO/ODT; may repeat q8h",
              "orderSentence": "Ondansetron 4 mg IV IV/PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Mild-moderate migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg PO",
                  "orderSentence": "Ibuprofen 400 mg PO PO"
                },
                {
                  "text": "600 mg PO",
                  "orderSentence": "Ibuprofen 600 mg PO PO"
                },
                {
                  "text": "800 mg PO",
                  "orderSentence": "Ibuprofen 800 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO at onset; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg PO PO"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy",
            "monitoring": "GI symptoms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "Mild-moderate migraine; menstrual migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg PO",
                  "orderSentence": "Naproxen 500 mg PO PO"
                },
                {
                  "text": "550 mg PO",
                  "orderSentence": "Naproxen 550 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "500-550 mg PO at onset; may repeat 250 mg in 12 hr",
              "orderSentence": "Naproxen 500 mg PO PO"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy",
            "monitoring": "GI symptoms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen/Aspirin/Caffeine",
            "route": "PO",
            "indication": "Mild-moderate migraine (OTC option)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets PO",
                  "orderSentence": "Acetaminophen/Aspirin/Caffeine 2 tablets PO PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets (250/250/65 mg each) at onset; max 2 doses/24hr",
              "orderSentence": "Acetaminophen/Aspirin/Caffeine 2 tablets PO PO"
            },
            "contraindications": "Aspirin allergy; hepatic impairment; avoid if using other acetaminophen",
            "monitoring": "Limit total acetaminophen <3g/day",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rizatriptan",
            "route": "PO",
            "indication": "Acute migraine; faster onset than sumatriptan",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO",
                  "orderSentence": "Rizatriptan 5 mg PO PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Rizatriptan 10 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO (5 mg if on propranolol); may repeat after 2 hr; max 30 mg/24hr",
              "orderSentence": "Rizatriptan 5 mg PO PO"
            },
            "contraindications": "Same as sumatriptan; use 5 mg if on propranolol",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eletriptan",
            "route": "PO",
            "indication": "Acute migraine; good for return of headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg PO",
                  "orderSentence": "Eletriptan 40 mg PO PO"
                },
                {
                  "text": "80 mg PO",
                  "orderSentence": "Eletriptan 80 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "40 mg PO; may repeat 40 mg after 2 hr if partial response; max 80 mg/24hr",
              "orderSentence": "Eletriptan 40 mg PO PO"
            },
            "contraindications": "Same as sumatriptan; potent CYP3A4 inhibitors",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naratriptan",
            "route": "PO",
            "indication": "Slower onset but longer duration; menstrual migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg PO",
                  "orderSentence": "Naratriptan 2.5 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5 mg PO; may repeat after 4 hr; max 5 mg/24hr",
              "orderSentence": "Naratriptan 2.5 mg PO PO"
            },
            "contraindications": "Same as sumatriptan; moderate-severe renal/hepatic impairment",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ubrogepant",
            "route": "PO",
            "indication": "CGRP receptor antagonist; triptan contraindications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg PO",
                  "orderSentence": "Ubrogepant 50 mg PO PO"
                },
                {
                  "text": "100 mg PO",
                  "orderSentence": "Ubrogepant 100 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO; may repeat after 2 hr; max 200 mg/24hr",
              "orderSentence": "Ubrogepant 50 mg PO PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors; severe hepatic impairment",
            "monitoring": "None routine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rimegepant",
            "route": "PO/ODT",
            "indication": "CGRP antagonist; acute and preventive use",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg ODT",
                  "orderSentence": "Rimegepant 75 mg ODT PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg ODT at onset; max 75 mg/24hr for acute",
              "orderSentence": "Rimegepant 75 mg ODT PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors; severe hepatic impairment",
            "monitoring": "None routine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Nerve block (occipital)",
            "route": "SC",
            "indication": "Refractory migraine; occipital-predominant pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL of 2% lidocaine + 40 mg triamcinolone",
                  "orderSentence": "Nerve block (occipital) 2-3 mL of 2% lidocaine + 40 mg triamcinolone SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject at greater occipital nerve bilaterally; may add lesser occipital, supraorbital",
              "orderSentence": "Nerve block (occipital) 2-3 mL of 2% lidocaine + 40 mg triamcinolone SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Immediate pain relief; monitor for vasovagal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sphenopalatine ganglion block",
            "route": "Intranasal",
            "indication": "Refractory migraine; cluster-like features",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Lidocaine 4% via SphenoCath",
                  "orderSentence": "Sphenopalatine ganglion block Lidocaine 4% via SphenoCath Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "Apply via intranasal device; repeat up to 3x/week",
              "orderSentence": "Sphenopalatine ganglion block Lidocaine 4% via SphenoCath Intranasal"
            },
            "contraindications": "Nasal pathology; local anesthetic allergy",
            "monitoring": "Local numbness, epistaxis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ketamine",
            "route": "IV",
            "indication": "Status migrainosus refractory to DHE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.3 mg/kg/hr IV",
                  "orderSentence": "Ketamine 0.1-0.3 mg/kg/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1-0.3 mg/kg/hr infusion for 24-48 hr; subanesthetic dosing",
              "orderSentence": "Ketamine 0.1-0.3 mg/kg/hr IV IV"
            },
            "contraindications": "Uncontrolled HTN; psychosis; increased ICP",
            "monitoring": "Dissociation, BP, HR; requires cardiac monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "First-line prevention; comorbid HTN or anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                },
                {
                  "text": "80 mg daily LA",
                  "orderSentence": "Propranolol 80 mg daily LA PO"
                },
                {
                  "text": "160 mg daily LA",
                  "orderSentence": "Propranolol 160 mg daily LA PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID or 80 mg LA daily; titrate q2wk; target 80-240 mg/day",
              "orderSentence": "Propranolol 40 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Asthma; COPD; bradycardia <50; heart block; decompensated HF",
            "monitoring": "HR, BP; watch for fatigue, depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "First-line prevention; comorbid obesity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Topiramate 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Glaucoma; kidney stones; pregnancy",
            "monitoring": "Cognitive effects, paresthesias, weight, bicarbonate, kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Prevention; comorbid insomnia, depression, TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality; recent MI; glaucoma; urinary retention",
            "monitoring": "Sedation, weight gain, dry mouth; ECG if >100 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention; comorbid depression, anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled HTN; MAOIs; abrupt discontinuation",
            "monitoring": "BP at higher doses; serotonin syndrome signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Prevention; comorbid bipolar or epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "500 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 500 mg ER daily PO"
                },
                {
                  "text": "1000 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 1000 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1000 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "pretreatment": "LFTs, CBC",
            "contraindications": "Hepatic disease; pregnancy (teratogen); urea cycle disorders; pancreatitis",
            "monitoring": "LFTs q6mo; weight, hair loss, tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Erenumab (Aimovig)",
            "route": "SC",
            "indication": "CGRP mAb; failed 2+ oral preventives or intolerance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
                },
                {
                  "text": "140 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 140 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "70 mg SC monthly; may increase to 140 mg monthly after 3 months",
              "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to erenumab",
            "monitoring": "Constipation (can be severe), injection site reactions, HTN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fremanezumab (Ajovy)",
            "route": "SC",
            "indication": "CGRP mAb; alternative dosing options",
            "dosing": {
              "doseOptions": [
                {
                  "text": "225 mg SC monthly",
                  "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
                },
                {
                  "text": "675 mg SC quarterly",
                  "orderSentence": "Fremanezumab (Ajovy) 675 mg SC quarterly SC"
                }
              ],
              "route": "SC",
              "instructions": "225 mg SC monthly OR 675 mg SC quarterly",
              "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "CGRP mAb; also FDA-approved for cluster",
            "dosing": {
              "doseOptions": [
                {
                  "text": "240 mg SC load",
                  "orderSentence": "Galcanezumab (Emgality) 240 mg SC load SC"
                },
                {
                  "text": "120 mg SC monthly",
                  "orderSentence": "Galcanezumab (Emgality) 120 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "240 mg SC loading dose (2 x 120 mg), then 120 mg SC monthly",
              "orderSentence": "Galcanezumab (Emgality) 240 mg SC load SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eptinezumab (Vyepti)",
            "route": "IV",
            "indication": "CGRP mAb; IV option for rapid onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg IV quarterly",
                  "orderSentence": "Eptinezumab (Vyepti) 100 mg IV quarterly IV"
                },
                {
                  "text": "300 mg IV quarterly",
                  "orderSentence": "Eptinezumab (Vyepti) 300 mg IV quarterly IV"
                }
              ],
              "route": "IV",
              "instructions": "100 mg IV q3mo; may increase to 300 mg IV q3mo",
              "orderSentence": "Eptinezumab (Vyepti) 100 mg IV quarterly IV"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Infusion reactions (rare), nasopharyngitis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Onabotulinumtoxin A (Botox)",
            "route": "IM",
            "indication": "Chronic migraine (≥15 days/month); failed oral preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155-195 units IM",
                  "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units across 31-39 injection sites q12wk; PREEMPT protocol",
              "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM IM"
            },
            "pretreatment": "None",
            "contraindications": "Infection at injection sites; myasthenia gravis",
            "monitoring": "Neck weakness, ptosis (rare); effect takes 2-3 cycles",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Candesartan",
            "route": "PO",
            "indication": "Prevention; comorbid HTN; beta-blocker intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Candesartan 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Candesartan 16 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily; may increase to 16 mg daily",
              "orderSentence": "Candesartan 8 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Pregnancy; bilateral renal artery stenosis; hyperkalemia",
            "monitoring": "BP, K+, creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Prevention; comorbid HTN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 20 mg daily",
              "orderSentence": "Lisinopril 10 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Pregnancy; angioedema history; bilateral RAS",
            "monitoring": "BP, K+, creatinine, cough",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium oxide",
            "route": "PO",
            "indication": "Supplement for prevention; migraine with aura",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg daily",
                  "orderSentence": "Magnesium oxide 400 mg daily PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Magnesium oxide 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg daily in divided doses",
              "orderSentence": "Magnesium oxide 400 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Diarrhea; check Mg level if symptomatic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Riboflavin (B2)",
            "route": "PO",
            "indication": "Supplement for prevention; well-tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg daily",
                  "orderSentence": "Riboflavin (B2) 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg daily",
              "orderSentence": "Riboflavin (B2) 400 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "Fluorescent yellow urine (reassure patient)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Coenzyme Q10",
            "route": "PO",
            "indication": "Supplement; may benefit mitochondrial function",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Coenzyme Q10 100 mg TID PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Coenzyme Q10 300 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "100-300 mg daily",
              "orderSentence": "Coenzyme Q10 100 mg TID PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Headache specialist referral for chronic or refractory migraine management and preventive optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management referral for interventional procedures (nerve blocks, Botox) in chronic refractory cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Behavioral medicine/Psychology for cognitive behavioral therapy addressing pain catastrophizing and comorbid anxiety/depression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic component and postural contribution to headaches",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine evaluation if sleep disorder contributing to migraine frequency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology evaluation to rule out visual triggers and ensure appropriate vision correction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OB/GYN consultation for menstrual migraine management and hormonal contraception optimization",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for sudden severe headache different from typical migraine (\"worst headache of life\") which may indicate hemorrhage",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for headache with fever, stiff neck, or altered mental status which may indicate infection",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain headache diary tracking frequency, triggers, and medication use to guide treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute medication use to ≤10 days/month to prevent medication overuse headache",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take acute medications at first sign of migraine for best efficacy rather than waiting for severe pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and avoid personal triggers (stress, sleep changes, skipped meals, alcohol, specific foods)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime/wake time) as irregular sleep is a major trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meals to avoid fasting-triggered migraine; do not skip breakfast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Aerobic exercise (30 min moderate activity 5x/week) shown to reduce migraine frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques, mindfulness, or biofeedback",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine moderation (≤200 mg/day equivalent to 2 cups coffee) and consistent daily intake",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger migraine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol especially red wine which is a common trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Tension-type headache",
        "features": "Bilateral, pressing/tightening quality, mild-moderate intensity, no nausea/vomiting, no photo/phonophobia (may have one)",
        "tests": "Clinical criteria; no specific test"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Unilateral, periorbital, severe, autonomic features (lacrimation, rhinorrhea, ptosis), 15-180 min, occurs in clusters",
        "tests": "Clinical history; may see MRI normal"
      },
      {
        "diagnosis": "Medication overuse headache",
        "features": "Daily or near-daily headache; using acute medications ≥10-15 days/month",
        "tests": "Headache diary; improves with medication withdrawal"
      },
      {
        "diagnosis": "Secondary headache (intracranial pathology)",
        "features": "New onset, progressive, positional, neurological deficits, thunderclap",
        "tests": "MRI/MRA brain; consider LP"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50, scalp tenderness, jaw claudication, visual changes, elevated ESR/CRP",
        "tests": "ESR, CRP, temporal artery biopsy"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Positional headache, papilledema, pulsatile tinnitus, visual obscurations, obesity",
        "tests": "LP with opening pressure; MRI/MRV"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Unilateral, occipital-frontal radiation, neck movement triggers, reduced ROM",
        "tests": "Physical exam; C-spine imaging; diagnostic block"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Brief electric shock-like pain, unilateral V2/V3, triggered by touch/eating",
        "tests": "MRI for vascular loop; clinical criteria"
      }
    ],
    "evidence": [
      {
        "recommendation": "Triptans effective for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Marmura et al. Headache 2015](https://pubmed.ncbi.nlm.nih.gov/25600718/)"
      },
      {
        "recommendation": "CGRP monoclonal antibodies for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goadsby et al. NEJM 2017 (erenumab STRIVE)](https://pubmed.ncbi.nlm.nih.gov/29171821/)"
      },
      {
        "recommendation": "OnabotulinumtoxinA for chronic migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dodick et al. Headache 2010 (PREEMPT pooled)](https://pubmed.ncbi.nlm.nih.gov/20487038/)"
      },
      {
        "recommendation": "Topiramate for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silberstein et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15096395/)"
      },
      {
        "recommendation": "Metoclopramide effective for acute migraine",
        "evidenceLevel": "Class II, Level B",
        "source": "[Friedman et al. Ann Emerg Med 2008](https://pubmed.ncbi.nlm.nih.gov/17933425/)"
      },
      {
        "recommendation": "Dexamethasone reduces recurrence",
        "evidenceLevel": "Class I, Level B",
        "source": "[Singh et al. Acad Emerg Med 2008](https://pubmed.ncbi.nlm.nih.gov/18958636/)"
      },
      {
        "recommendation": "Propranolol for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Linde et al. Cochrane 2004](https://pubmed.ncbi.nlm.nih.gov/15106218/)"
      },
      {
        "recommendation": "Gepants (ubrogepant, rimegepant) for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dodick et al. JAMA 2019 (ubrogepant)](https://pubmed.ncbi.nlm.nih.gov/31742631/)"
      },
      {
        "recommendation": "Magnesium for migraine with aura prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Peikert et al. Cephalalgia 1996](https://pubmed.ncbi.nlm.nih.gov/8792038/)"
      },
      {
        "recommendation": "Exercise as effective as topiramate for prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Varkey et al. Cephalalgia 2011](https://pubmed.ncbi.nlm.nih.gov/21816772/)"
      }
    ],
    "monitoring": [
      {
        "item": "Headache diary (frequency, severity, duration)",
        "frequency": "Continuous at home",
        "action": "Adjust preventive therapy; consider Botox or CGRP mAb",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days",
        "frequency": "Monthly",
        "action": "Counsel on MOH; may need withdrawal protocol",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 or MIDAS score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "BP (if on beta-blocker or ARB)",
        "frequency": "Each visit",
        "action": "Adjust dose; switch agent if bradycardia",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on valproate)",
        "frequency": "Baseline, 3 months, then q6mo",
        "action": "Discontinue if >3x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or discontinuation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Adjust medications based on weight changes",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognitive function (if on topiramate)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Pain controlled; able to tolerate PO; no red flags; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Status migrainosus requiring IV therapy >24hr; inability to tolerate PO; need for DHE protocol"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare; only if hemodynamic instability from medications or concern for secondary cause requiring monitoring"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Within 2-4 weeks for new diagnosis; 4-12 weeks for established patients on preventives"
      }
    ]
  },
  "Transient Ischemic Attack (TIA)": {
    "id": "tia",
    "title": "Transient Ischemic Attack (TIA)",
    "version": "1.0",
    "icd10": [
      "** G45.9 (Transient cerebral ischemic attack",
      "unspecified)"
    ],
    "scope": "** Urgent evaluation, risk stratification (ABCD2), and secondary stroke prevention. Excludes completed stroke (see Acute Ischemic Stroke protocol).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Polycythemia, thrombocytosis as stroke risk; anemia evaluation",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolytes; glucose for hypoglycemia mimic; creatinine for contrast",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fingerstick)",
            "rationale": "Rule out hypoglycemia as TIA mimic",
            "target": "70-180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Baseline coagulation; evaluate if on anticoagulation",
            "target": "Normal or therapeutic",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel (fasting)",
            "rationale": "LDL target <70 for secondary prevention",
            "target": "LDL <70 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes assessment; target <7%",
            "target": "<7%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hyperthyroidism associated with atrial fibrillation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Troponin",
            "rationale": "Concurrent cardiac ischemia; AF with rapid rate",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels increase stroke risk",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Independent cardiovascular risk marker",
            "target": "<30 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "hsCRP",
            "rationale": "Inflammatory marker; guides statin intensity",
            "target": "<2 mg/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BNP/NT-proBNP",
            "rationale": "Heart failure; cardiac strain; AF risk",
            "target": "Age-adjusted normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Uric acid",
            "rationale": "Elevated associated with increased stroke risk",
            "target": "<6 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Hypercoagulability panel",
            "rationale": "Age <50, cryptogenic, recurrent events; includes Factor V Leiden, prothrombin mutation, protein C/S, antithrombin III",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Antiphospholipid antibodies",
            "rationale": "Lupus anticoagulant, anticardiolipin, anti-β2GP1; young stroke",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin electrophoresis",
            "rationale": "Sickle cell disease if not known",
            "target": "No sickling",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ESR, ANA",
            "rationale": "Suspected vasculitis",
            "target": "Normal/Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (α-galactosidase A)",
            "rationale": "Young cryptogenic stroke, family history, angiokeratomas",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT Head non-contrast",
            "timing": "Immediate",
            "target": "No hemorrhage; rule out stroke mimic",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRI Brain with DWI",
            "timing": "Within 24 hours",
            "target": "No restricted diffusion (DWI+/ADC-) confirming infarct vs true TIA",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "CTA Head and Neck",
            "timing": "Same visit",
            "target": "No significant stenosis (>50%) in carotid, vertebral, or intracranial vessels",
            "contraindications": "Contrast allergy, CKD (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRA Head and Neck",
            "timing": "Alternative to CTA",
            "target": "Patent vessels; no stenosis >50%",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "Within 24-48 hours",
            "target": "<50% stenosis bilaterally",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "Immediate",
            "target": "Sinus rhythm; no AF, LVH, or acute changes",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transthoracic echocardiogram",
            "timing": "Within 24-48 hours",
            "target": "No thrombus, PFO, or significant valvular disease",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Cardiac telemetry (continuous)",
            "timing": "24-72 hours minimum",
            "target": "No atrial fibrillation or flutter",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Holter monitor (24-48 hour)",
            "timing": "Outpatient",
            "target": "No paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Extended cardiac monitoring (14-30 day)",
            "timing": "Cryptogenic stroke/TIA",
            "target": "Detect paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram",
            "timing": "Cryptogenic, young, embolic",
            "target": "No PFO, LAA thrombus, aortic arch atheroma",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Bubble study (TTE or TEE)",
            "timing": "Suspected paradoxical embolism",
            "target": "No right-to-left shunt",
            "contraindications": "None specific",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT/MR perfusion",
            "timing": "Uncertain timing, large vessel occlusion symptoms",
            "target": "No mismatch suggesting salvageable tissue",
            "contraindications": "Contrast issues",
            "ED": "EXT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Vessel wall MRI",
            "timing": "Suspected intracranial vasculitis or dissection",
            "target": "No vessel wall enhancement",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DSA (cerebral angiogram)",
            "timing": "Vasculitis workup, moyamoya, uncertain vessel status",
            "target": "Define vascular anatomy",
            "contraindications": "Contrast allergy, bleeding risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Implantable loop recorder",
            "timing": "Recurrent cryptogenic events after negative workup",
            "target": "Detect occult AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "Immediate antiplatelet therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg PO x1 load",
                  "orderSentence": "Aspirin 325 mg PO x1 load PO"
                },
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg loading dose, then 81 mg daily ongoing",
              "orderSentence": "Aspirin 325 mg PO x1 load PO"
            },
            "contraindications": "Active GI bleed; aspirin allergy; planned thrombolysis",
            "monitoring": "GI symptoms, bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel (DAPT with aspirin)",
            "route": "PO",
            "indication": "ABCD2 ≥4 or minor stroke; first 21 days",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg PO x1 load",
                  "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
                },
                {
                  "text": "75 mg PO daily",
                  "orderSentence": "Clopidogrel (DAPT with aspirin) 75 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg load then 75 mg daily with aspirin x21 days (POINT/CHANCE protocol)",
              "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
            },
            "contraindications": "Active bleeding; planned surgery within 7 days",
            "monitoring": "Bleeding, bruising",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ticagrelor (alternative DAPT)",
            "route": "PO",
            "indication": "Aspirin + ticagrelor if clopidogrel contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg PO x1 load",
                  "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
                },
                {
                  "text": "90 mg PO BID",
                  "orderSentence": "Ticagrelor (alternative DAPT) 90 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "180 mg load then 90 mg BID with aspirin x30 days (THALES protocol)",
              "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
            },
            "contraindications": "Active bleeding; prior ICH; severe hepatic impairment",
            "monitoring": "Bleeding, dyspnea",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "High-intensity statin for LDL <70",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg PO daily",
                  "orderSentence": "Atorvastatin 80 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "80 mg daily (high-intensity); target LDL <70 mg/dL",
              "orderSentence": "Atorvastatin 80 mg PO daily PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline; myalgias",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood pressure management",
            "route": "-",
            "indication": "Permissive hypertension acutely; goal <140/90 long-term",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Target <180/110 first 24h",
                  "orderSentence": "Blood pressure management Target <180/110 first 24h -"
                },
                {
                  "text": "<140/90 after",
                  "orderSentence": "Blood pressure management <140/90 after -"
                }
              ],
              "route": "-",
              "instructions": "Do NOT lower BP aggressively in first 24h unless >220/120 or end-organ damage",
              "orderSentence": "Blood pressure management Target <180/110 first 24h -"
            },
            "contraindications": "Symptomatic hypotension",
            "monitoring": "BP q1h x24h, then q4h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "IV fluids (isotonic saline)",
            "route": "IV",
            "indication": "Maintain euvolemia; avoid hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75-125 mL/hr NS",
                  "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
                }
              ],
              "route": "IV",
              "instructions": "75-125 mL/hr; adjust to maintain euvolemia; avoid D5W",
              "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
            },
            "contraindications": "Fluid overload, CHF",
            "monitoring": "Fluid balance, I/Os",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Pantoprazole",
            "route": "IV/PO",
            "indication": "GI protection with DAPT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg IV daily",
                  "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
                },
                {
                  "text": "40 mg PO daily",
                  "orderSentence": "Pantoprazole 40 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "40 mg daily",
              "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Cilostazol (triple antiplatelet)",
            "route": "PO",
            "indication": "Asian populations; high-risk stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg PO BID",
                  "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; add to aspirin in select cases",
              "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
            },
            "contraindications": "Heart failure; bleeding",
            "monitoring": "Bleeding, headache, palpitations",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Prasugrel",
            "route": "PO",
            "indication": "Clopidogrel resistance or failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg PO x1 load",
                  "orderSentence": "Prasugrel 60 mg PO x1 load PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Prasugrel 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg load then 10 mg daily; avoid if >75y or <60 kg",
              "orderSentence": "Prasugrel 60 mg PO x1 load PO"
            },
            "contraindications": "Prior TIA/stroke (black box); bleeding risk",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Secondary Prevention)": [
          {
            "item": "Aspirin (long-term)",
            "route": "PO",
            "indication": "Lifelong secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily indefinitely",
              "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Active GI bleed",
            "monitoring": "GI symptoms; annual CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel (monotherapy)",
            "route": "PO",
            "indication": "Alternative to aspirin if aspirin-intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg PO daily",
                  "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg daily",
              "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Active bleeding",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin + extended-release dipyridamole (Aggrenox)",
            "route": "PO",
            "indication": "Alternative antiplatelet regimen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/200 mg PO BID",
                  "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "One capsule (25 mg ASA/200 mg ER dipyridamole) BID",
              "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Coronary stenosis (coronary steal); severe headache",
            "monitoring": "Headache (often limits use); GI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Atrial fibrillation-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO BID",
                  "orderSentence": "Apixaban 5 mg PO BID PO"
                },
                {
                  "text": "2.5 mg PO BID",
                  "orderSentence": "Apixaban 2.5 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)",
              "orderSentence": "Apixaban 5 mg PO BID PO"
            },
            "pretreatment": "Active major bleeding; mechanical valve",
            "contraindications": "CrCl, bleeding signs",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "AF-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg PO daily",
                  "orderSentence": "Rivaroxaban 20 mg PO daily PO"
                },
                {
                  "text": "15 mg PO daily",
                  "orderSentence": "Rivaroxaban 15 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with food (15 mg if CrCl 15-50)",
              "orderSentence": "Rivaroxaban 20 mg PO daily PO"
            },
            "pretreatment": "Active major bleeding; mechanical valve",
            "contraindications": "CrCl, bleeding",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Dabigatran",
            "route": "PO",
            "indication": "AF-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg PO BID",
                  "orderSentence": "Dabigatran 150 mg PO BID PO"
                },
                {
                  "text": "110 mg PO BID",
                  "orderSentence": "Dabigatran 110 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg BID (110 mg BID if CrCl 30-50 or age >80)",
              "orderSentence": "Dabigatran 150 mg PO BID PO"
            },
            "pretreatment": "Active bleeding; CrCl <30; mechanical valve",
            "contraindications": "CrCl, bleeding",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve; some hypercoagulable states",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-10 mg PO daily adjusted",
                  "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; adjust to INR 2-3 (2.5-3.5 for mechanical valve)",
              "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
            },
            "pretreatment": "Baseline INR",
            "contraindications": "Pregnancy; active bleeding; frequent falls",
            "monitoring": "INR weekly then monthly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Blood pressure control for secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO daily",
                  "orderSentence": "Lisinopril 5 mg PO daily PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Lisinopril 10 mg PO daily PO"
                },
                {
                  "text": "20 mg PO daily",
                  "orderSentence": "Lisinopril 20 mg PO daily PO"
                },
                {
                  "text": "40 mg PO daily",
                  "orderSentence": "Lisinopril 40 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate to goal BP <130/80; max 40 mg",
              "orderSentence": "Lisinopril 5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Angioedema; pregnancy; bilateral RAS; hyperkalemia",
            "monitoring": "K+, Cr, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "BP control; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO daily",
                  "orderSentence": "Amlodipine 5 mg PO daily PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Amlodipine 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Amlodipine 5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe aortic stenosis (relative)",
            "monitoring": "Peripheral edema, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "BP control; thiazide-like diuretic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg PO daily",
                  "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
                },
                {
                  "text": "25 mg PO daily",
                  "orderSentence": "Chlorthalidone 25 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; may increase to 25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe hypokalemia; severe hyponatremia",
            "monitoring": "K+, Na+, uric acid, glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ezetimibe",
            "route": "PO",
            "indication": "Add-on for LDL not at goal on statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Ezetimibe 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg daily",
              "orderSentence": "Ezetimibe 10 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCSK9 inhibitor (evolocumab, alirocumab)",
            "route": "SC",
            "indication": "LDL >70 despite maximal statin + ezetimibe",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140 mg SC q2wk",
                  "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
                },
                {
                  "text": "420 mg SC monthly",
                  "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 420 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "Evolocumab 140 mg q2wk or 420 mg monthly; alirocumab 75-150 mg q2wk",
              "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
            },
            "pretreatment": "LFTs, lipid panel",
            "contraindications": "None",
            "monitoring": "Injection site reactions; LDL",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Icosapent ethyl (Vascepa)",
            "route": "PO",
            "indication": "Triglycerides ≥150 despite statin; reduces CV events",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g PO BID",
                  "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "2 g BID with meals",
              "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Seafood/fish allergy (relative)",
            "monitoring": "AF monitoring (slightly increased risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid endarterectomy (CEA)",
            "route": "Surgical",
            "indication": "Symptomatic carotid stenosis 70-99%; 50-69% in select",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgery",
                  "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Perform within 2 weeks of TIA if stable; high-volume surgeon",
              "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
            },
            "pretreatment": "None",
            "contraindications": "Unstable plaque with delay; total occlusion",
            "monitoring": "Surgical complications; stroke",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Carotid artery stenting (CAS)",
            "route": "Endovascular",
            "indication": "CEA high-risk; radiation neck; recurrent stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Stenting",
                  "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
                }
              ],
              "route": "Endovascular",
              "instructions": "Alternative to CEA; requires DAPT",
              "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
            },
            "pretreatment": "None",
            "contraindications": "Tortuous anatomy; heavy calcification",
            "monitoring": "Hyperperfusion syndrome; stroke",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "PFO closure",
            "route": "Endovascular",
            "indication": "Age <60, PFO with shunt, cryptogenic stroke/TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Device closure",
                  "orderSentence": "PFO closure Device closure Endovascular"
                }
              ],
              "route": "Endovascular",
              "instructions": "Consider after comprehensive evaluation; DAPT post-procedure",
              "orderSentence": "PFO closure Device closure Endovascular"
            },
            "pretreatment": "None",
            "contraindications": "Small PFO without shunt",
            "monitoring": "AF (transient); device complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Stroke consult for urgent evaluation, risk stratification, and secondary prevention optimization",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology consultation for atrial fibrillation management, anticoagulation decisions, and PFO evaluation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy timing",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interventional neurology for carotid stenting evaluation if CEA high-risk or anatomically unsuitable",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac electrophysiology for recurrent AF management and potential ablation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Registered dietitian for Mediterranean diet counseling and sodium restriction education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Smoking cessation counseling and pharmacotherapy initiation if current smoker",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if symptoms return as this indicates high stroke risk (up to 10% in first 48 hours)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive for at least 2-4 weeks after TIA per state regulations and stroke risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed especially antiplatelet therapy which significantly reduces stroke risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Know stroke warning signs (FAST: Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep follow-up appointments as early intervention reduces stroke risk by up to 80%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg to significantly reduce stroke recurrence risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL target <70 mg/dL with high-intensity statin for secondary prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (reduces stroke risk by 50% within 1 year of quitting)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet emphasizing fruits, vegetables, whole grains, fish, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink/day for women, ≤2 drinks/day for men",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (150 min/week moderate or 75 min/week vigorous)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management with target BMI 18.5-24.9 kg/m²",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sodium restriction <2300 mg/day (ideally <1500 mg if hypertensive)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset (minutes), visual scintillations, headache follows; younger patient",
        "tests": "Clinical history; normal DWI"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "Preceding convulsion; confusion; gradual resolution over hours",
        "tests": "EEG; clinical history"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Altered mentation, diaphoresis, tremor; resolves with glucose",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Peripheral vertigo (BPPV, vestibular neuritis)",
        "features": "Isolated vertigo with nystagmus; positive Dix-Hallpike",
        "tests": "HINTS exam; no central signs"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia; repetitive questioning; resolves <24h",
        "tests": "Clinical criteria; DWI may show hippocampal lesions"
      },
      {
        "diagnosis": "Functional neurological disorder",
        "features": "Inconsistent exam; incongruent symptoms; often with psychiatric comorbidity",
        "tests": "Clinical exam; normal workup"
      },
      {
        "diagnosis": "Bell's palsy",
        "features": "Peripheral facial weakness (forehead involved); no other deficits",
        "tests": "Clinical exam"
      },
      {
        "diagnosis": "Hypertensive encephalopathy",
        "features": "Severe HTN; headache; confusion; visual changes",
        "tests": "BP, posterior MRI findings"
      },
      {
        "diagnosis": "Demyelinating disease (MS)",
        "features": "Younger patient; prior episodes; MRI with characteristic lesions",
        "tests": "MRI brain/spine; CSF"
      }
    ],
    "evidence": [
      {
        "recommendation": "Dual antiplatelet therapy (DAPT) for 21 days after minor stroke/TIA",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wang et al. NEJM 2021 (CHANCE-2)](https://pubmed.ncbi.nlm.nih.gov/34265411/); [Johnston et al. NEJM 2018 (POINT)](https://pubmed.ncbi.nlm.nih.gov/29766749/)"
      },
      {
        "recommendation": "High-intensity statin for LDL <70 mg/dL",
        "evidenceLevel": "Class I, Level A",
        "source": "[Amarenco et al. NEJM 2006 (SPARCL)](https://pubmed.ncbi.nlm.nih.gov/16899775/)"
      },
      {
        "recommendation": "CEA for symptomatic carotid stenosis 70-99%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET Collaborators. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1852179/)"
      },
      {
        "recommendation": "ABCD2 score for TIA risk stratification",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Johnston et al. Lancet 2007](https://pubmed.ncbi.nlm.nih.gov/17258668/)"
      },
      {
        "recommendation": "Extended cardiac monitoring for cryptogenic stroke",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Sanna et al. NEJM 2014 (CRYSTAL-AF)](https://pubmed.ncbi.nlm.nih.gov/24963567/)"
      },
      {
        "recommendation": "PFO closure in cryptogenic stroke <60 years",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Mas et al. NEJM 2017 (CLOSE)](https://pubmed.ncbi.nlm.nih.gov/28902593/)"
      },
      {
        "recommendation": "BP target <130/80 for secondary prevention",
        "evidenceLevel": "Class I, Level B",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Urgent TIA evaluation reduces stroke risk",
        "evidenceLevel": "Class I, Level B",
        "source": "[Rothwell et al. Lancet 2007 (EXPRESS)](https://pubmed.ncbi.nlm.nih.gov/17928046/)"
      },
      {
        "recommendation": "DOACs preferred over warfarin for NVAF",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ruff et al. Lancet 2014 (meta-analysis)](https://pubmed.ncbi.nlm.nih.gov/24315724/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam",
        "frequency": "q1h x 24h then q4h",
        "action": "Immediate imaging if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1h x 24h then q4h",
        "action": "Titrate antihypertensives",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cardiac rhythm (telemetry)",
        "frequency": "Continuous x 24-72h",
        "action": "Anticoagulation if AF detected",
        "ED": "URGENT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Extended cardiac monitoring",
        "frequency": "14-30 days outpatient",
        "action": "Anticoagulation if AF detected",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ABCD2 score",
        "frequency": "At presentation",
        "action": "High-risk patients need admission or rapid TIA clinic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "LDL cholesterol",
        "frequency": "Baseline, 6 weeks, then annually",
        "action": "Intensify statin or add ezetimibe/PCSK9i",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Baseline, then q3mo if diabetic",
        "action": "Optimize diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine/eGFR",
        "frequency": "With contrast; then annually",
        "action": "Dose-adjust medications",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Rapid TIA clinic (<24-48h)",
        "criteria": "ABCD2 <4; no acute findings on imaging; reliable patient with close follow-up"
      },
      {
        "disposition": "Admit to stroke unit",
        "criteria": "ABCD2 ≥4; DWI positive (minor stroke); symptomatic carotid stenosis; new AF; unable to complete workup as outpatient"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare for isolated TIA; only if concurrent acute coronary syndrome or hemodynamic instability"
      },
      {
        "disposition": "Discharge with urgent follow-up",
        "criteria": "Completed rapid workup; started on secondary prevention; ABCD2 <4; no high-risk features"
      }
    ]
  },
  "Dementia Evaluation": {
    "id": "dementia-evaluation",
    "title": "Dementia Evaluation",
    "version": "1.0",
    "icd10": [
      "** G31.9 (Degenerative disease of nervous system",
      "unspecified)",
      "R41.81 (Age-related cognitive decline)",
      "F03.90 (Unspecified dementia without behavioral disturbance)"
    ],
    "scope": "** Comprehensive evaluation for cognitive impairment, identification of reversible causes, dementia subtype diagnosis, and symptomatic management. Covers Alzheimer's disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection, anemia, malignancy contributing to cognitive changes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Hyponatremia, uremia, hypercalcemia as causes",
            "target": "Normal electrolytes, BUN, Cr",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes reversible dementia",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fasting)",
            "rationale": "Diabetes management affects cognition",
            "target": "70-100 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs, albumin)",
            "rationale": "Hepatic encephalopathy; nutritional status",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with cognitive decline",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Chronic glucose control affects cognition",
            "target": "<7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk factor for vascular dementia",
            "target": "LDL <100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels associated with AD and vascular dementia",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis (rare but treatable)",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory/autoimmune causes",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Heavy metal panel (lead, mercury, arsenic)",
            "rationale": "Toxic exposure history",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Autoimmune dementia; occult malignancy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GABA-B, AMPA-R)",
            "rationale": "Autoimmune encephalitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (APOE, PSEN1, PSEN2, APP)",
            "rationale": "Family history early-onset AD; prognostic",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Prion protein gene testing",
            "rationale": "Suspected CJD with family history",
            "target": "No mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42 (amyloid beta 1-42)",
            "rationale": "Low in Alzheimer's disease",
            "target": "<600 pg/mL suggests AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau",
            "rationale": "Elevated in neurodegeneration",
            "target": "<400 pg/mL normal; elevated in AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF p-tau (phosphorylated tau 181)",
            "rationale": "Specific for AD pathology",
            "target": "Elevated in AD; Aβ42/p-tau ratio most predictive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio",
            "rationale": "More accurate than Aβ42 alone",
            "target": "<0.05-0.08 suggests AD (assay-dependent)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "14-3-3 protein",
            "rationale": "Creutzfeldt-Jakob disease",
            "target": "Positive in CJD (not specific)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RT-QuIC",
            "rationale": "Prion disease confirmation",
            "target": "Positive indicates CJD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autoimmune encephalitis panel",
            "rationale": "Autoimmune dementia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Assess atrophy pattern; rule out structural causes (tumor, SDH, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain volumetrics",
            "timing": "Disease monitoring; clinical trials",
            "target": "Hippocampal and whole brain atrophy quantification",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate AD from FTD; atypical presentations",
            "target": "AD: temporoparietal hypometabolism; FTD: frontal/temporal hypometabolism",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amyloid PET (florbetapir, florbetaben, flutemetamol)",
            "timing": "Atypical age/presentation; clinical trial eligibility",
            "target": "Positive: amyloid deposition; negative rules out AD",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tau PET (flortaucipir)",
            "timing": "Research; staging AD pathology",
            "target": "Pattern correlates with clinical phenotype",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate DLB from AD",
            "target": "Reduced: DLB/PDD; Normal: AD",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Encephalopathy; CJD; seizures",
            "target": "AD: mild slowing; CJD: periodic sharp wave complexes",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep apnea contributing to cognition; RBD suggesting DLB",
            "target": "Assess AHI; REM without atonia",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "SPECT (perfusion)",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with SWI/GRE sequences",
            "timing": "Cerebral amyloid angiopathy; microbleeds",
            "target": "Lobar microbleeds pattern",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Whole body PET-CT",
            "timing": "Paraneoplastic workup",
            "target": "Identify occult malignancy",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic/infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat reversible causes Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hyponatremia, treat UTI, replace B12, treat hypothyroidism",
              "orderSentence": "Treat reversible causes Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment after treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine (if nutritional risk)",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine (if nutritional risk) 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine (if nutritional risk) 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily",
              "orderSentence": "Thiamine (if nutritional risk) 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg IM daily x 7 days",
                  "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
                },
                {
                  "text": "1000 mcg IM weekly x 4",
                  "orderSentence": "Vitamin B12 1000 mcg IM weekly x 4 IM/PO"
                },
                {
                  "text": "1000-2000 mcg PO daily",
                  "orderSentence": "Vitamin B12 1000-2000 mcg PO daily IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
            },
            "contraindications": "None",
            "monitoring": "B12 level, MMA; neuro improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Behavioral)": [
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; agitation in dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly (QT risk)",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "QTc (especially >20 mg)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety in dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "GI upset initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning; agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg; typical 50-150 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension, priapism (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly; keep dose as low as possible",
              "orderSentence": "Quetiapine 12.5 mg qHS PO"
            },
            "contraindications": "Black box: increased mortality in dementia",
            "monitoring": "Metabolic effects, sedation, QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone",
            "route": "PO",
            "indication": "Severe aggression/psychosis (short-term use only)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Risperidone 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Risperidone 0.5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; max 1 mg BID; short-term use only",
              "orderSentence": "Risperidone 0.25 mg BID PO"
            },
            "contraindications": "Black box: increased mortality in dementia",
            "monitoring": "EPS, metabolic, stroke risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV/PO",
            "indication": "Acute severe agitation in delirium (not chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Haloperidol 1 mg IM IM/IV/PO"
                },
                {
                  "text": "2 mg IM",
                  "orderSentence": "Haloperidol 2 mg IM IM/IV/PO"
                }
              ],
              "route": "IM/IV/PO",
              "instructions": "0.5-2 mg IM/IV q4-6h PRN; short-term only; avoid chronic use",
              "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
            },
            "contraindications": "QT prolongation; Parkinson's; DLB",
            "monitoring": "QTc, EPS",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS; may increase to 9 mg; give 30 min before bed",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Daytime sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cognitive Enhancers": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Mild-moderate AD; vascular dementia; DLB",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                },
                {
                  "text": "23 mg daily",
                  "orderSentence": "Donepezil 23 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; increase to 10 mg qHS; 23 mg for moderate-severe",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation",
            "monitoring": "Bradycardia, GI symptoms, vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral",
            "route": "PO",
            "indication": "Mild-moderate AD; Parkinson's dementia; DLB",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine oral 1.5 mg BID PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine oral 3 mg BID PO"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine oral 4.5 mg BID PO"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine oral 6 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID; increase by 1.5 mg BID q2wk; target 6 mg BID",
              "orderSentence": "Rivastigmine oral 1.5 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe hepatic impairment",
            "monitoring": "GI symptoms, weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Mild-moderate AD; better GI tolerability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch 9.5 mg/24hr TD"
                },
                {
                  "text": "13.3 mg/24hr",
                  "orderSentence": "Rivastigmine patch 13.3 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase q4wk; target 9.5-13.3 mg/24hr",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Same as oral",
            "monitoring": "Skin irritation, GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine",
            "route": "PO",
            "indication": "Mild-moderate AD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg BID",
                  "orderSentence": "Galantamine 4 mg BID PO"
                },
                {
                  "text": "8 mg BID",
                  "orderSentence": "Galantamine 8 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Galantamine 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID x 4wk; increase to 8 mg BID x 4wk; target 8-12 mg BID",
              "orderSentence": "Galantamine 4 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe renal/hepatic",
            "monitoring": "GI symptoms, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine ER",
            "route": "PO",
            "indication": "Once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Galantamine ER 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Galantamine ER 16 mg daily PO"
                },
                {
                  "text": "24 mg daily",
                  "orderSentence": "Galantamine ER 24 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily x 4wk; increase q4wk; target 16-24 mg daily",
              "orderSentence": "Galantamine ER 8 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe AD; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust CrCl <30)",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine XR",
            "route": "PO",
            "indication": "Once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg daily",
                  "orderSentence": "Memantine XR 7 mg daily PO"
                },
                {
                  "text": "14 mg daily",
                  "orderSentence": "Memantine XR 14 mg daily PO"
                },
                {
                  "text": "21 mg daily",
                  "orderSentence": "Memantine XR 21 mg daily PO"
                },
                {
                  "text": "28 mg daily",
                  "orderSentence": "Memantine XR 28 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7 mg daily; increase by 7 mg/wk; target 28 mg daily",
              "orderSentence": "Memantine XR 7 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine + Donepezil (Namzaric)",
            "route": "PO",
            "indication": "Moderate-severe AD on both medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "28/10 mg daily",
                  "orderSentence": "Memantine + Donepezil (Namzaric) 28/10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "28 mg memantine XR + 10 mg donepezil; take qHS",
              "orderSentence": "Memantine + Donepezil (Namzaric) 28/10 mg daily PO"
            },
            "contraindications": "Same as individual drugs",
            "monitoring": "Same as individual drugs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid pathology (MCI or mild dementia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg IV q2wk",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over 1 hour",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
            },
            "pretreatment": "Amyloid PET or CSF confirming amyloid; MRI baseline; APOE genotyping recommended",
            "contraindications": "ARIA risk with anticoagulation; >4 microbleeds on MRI; recent stroke/TIA",
            "monitoring": "MRI at baseline, weeks 14, 52, 78; monitor for ARIA-E/H",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid and tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg IV q4wk x 3",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
                },
                {
                  "text": "1400 mg IV q4wk",
                  "orderSentence": "Donanemab (Kisunla) 1400 mg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg q4wk x 3 doses, then 1400 mg q4wk until amyloid cleared",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
            },
            "pretreatment": "Amyloid PET positive; tau PET intermediate/high",
            "contraindications": "Similar to lecanemab; higher ARIA risk with APOE4 homozygotes",
            "monitoring": "MRI at baseline, weeks 16, 24, 52, 76; ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Aducanumab (Aduhelm)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid (limited use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Titration to 10 mg/kg IV q4wk",
                  "orderSentence": "Aducanumab (Aduhelm) Titration to 10 mg/kg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "Slow titration: 1→3→6→10 mg/kg monthly",
              "orderSentence": "Aducanumab (Aduhelm) Titration to 10 mg/kg IV q4wk IV"
            },
            "pretreatment": "Same as lecanemab",
            "contraindications": "Same as lecanemab; limited clinical adoption",
            "monitoring": "MRI for ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for diagnosis confirmation, subtype classification, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline and guide diagnosis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for behavioral symptoms, medication management, and capacity evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced dementia symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Legal/Elder law attorney for advance directives, healthcare proxy, and financial planning while patient has capacity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling if familial/early-onset AD for family members",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden confusion worsens which may indicate stroke, infection, or medication effect",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives while patient has capacity to document wishes for future care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Establish healthcare proxy/power of attorney for future decision-making",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if cognitive impairment affects judgment or reaction time (formal driving evaluation may be needed)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed and use pill organizers or reminders to ensure adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a consistent daily routine which helps with orientation and reduces confusion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in mentally stimulating activities (reading, puzzles, social interaction) to support cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular physical exercise (150 min/week moderate aerobic) may slow cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet emphasizing vegetables, berries, fish, nuts, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (7-8 hours) and treat sleep disorders (sleep apnea assessment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and cognitive stimulation through activities, hobbies, and relationships",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control (BP <130/80, diabetes control, cholesterol management) reduces vascular contribution",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing loss correction with hearing aids as untreated hearing loss is modifiable dementia risk factor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink daily as excess alcohol accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home modifications as dementia increases fall and injury risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Delirium",
        "features": "Acute onset; fluctuating attention; identifiable cause (infection, medication, metabolic)",
        "tests": "Resolve cause; reassess cognition when clear"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of deficits; improves with antidepressants",
        "tests": "GDS, PHQ-9; trial of antidepressant"
      },
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Insidious onset; short-term memory most affected; language and visuospatial later",
        "tests": "MRI hippocampal atrophy; amyloid/tau PET or CSF biomarkers"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal findings; executive dysfunction; vascular risk factors",
        "tests": "MRI with significant white matter disease, strategic infarcts"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan; clinical criteria"
      },
      {
        "diagnosis": "Frontotemporal dementia (behavioral)",
        "features": "Personality change; disinhibition; apathy; hyperorality; age <65 often",
        "tests": "FDG-PET frontal hypometabolism; genetics"
      },
      {
        "diagnosis": "Primary progressive aphasia",
        "features": "Language predominates; word-finding, grammar, or comprehension primarily affected",
        "tests": "Neuropsychological testing; FDG-PET language areas"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG",
        "tests": "EEG, MRI DWI cortical ribboning, CSF RT-QuIC"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait disturbance prominent; urinary incontinence; dementia triad",
        "tests": "MRI ventriculomegaly; LP with gait improvement test"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; seizures; psychiatric features; often younger",
        "tests": "Autoantibody panel (serum/CSF); MRI"
      }
    ],
    "evidence": [
      {
        "recommendation": "Cholinesterase inhibitors for mild-moderate AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Birks J. Cochrane 2006](https://pubmed.ncbi.nlm.nih.gov/16437532/)"
      },
      {
        "recommendation": "Memantine for moderate-severe AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Reisberg et al. NEJM 2003](https://pubmed.ncbi.nlm.nih.gov/12672860/)"
      },
      {
        "recommendation": "Combination therapy (ChEI + memantine)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Tariot et al. JAMA 2004](https://pubmed.ncbi.nlm.nih.gov/14970063/)"
      },
      {
        "recommendation": "Lecanemab slows cognitive decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows cognitive decline",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "CSF biomarkers accurate for AD diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Mediterranean diet associated with lower dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Scarmeas et al. Ann Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16832238/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Avoid antipsychotics long-term (mortality risk)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "B12 supplementation reverses deficiency-related cognitive impairment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Smith et al. PLoS One 2010](https://pubmed.ncbi.nlm.nih.gov/20838622/)"
      }
    ],
    "monitoring": [
      {
        "item": "MMSE or MoCA",
        "frequency": "Every 6-12 months",
        "action": "Adjust treatment; reassess diagnosis if unexpected decline",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ADL/IADL function (FAQ, DAD)",
        "frequency": "Every 6-12 months",
        "action": "Increase support services; OT referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Behavioral symptoms (NPI)",
        "frequency": "Each visit",
        "action": "Behavioral interventions; consider medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment; speech therapy for swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit scale)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI (ARIA monitoring if on anti-amyloid)",
        "frequency": "Per protocol",
        "action": "Hold infusion; follow protocol for resumption",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on donepezil or citalopram)",
        "frequency": "Baseline; if dose increased",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Metabolic panel",
        "frequency": "Annually",
        "action": "Adjust medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Reversible causes treated; safe environment; caregiver support; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; behavioral crisis unsafe for home; aspiration pneumonia"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology/geriatrics 1-3 months after diagnosis; then every 6-12 months"
      },
      {
        "disposition": "Long-term care",
        "criteria": "Progressive decline; caregiver unable to manage; safety concerns; 24-hour supervision needed"
      }
    ]
  },
  "Essential Tremor": {
    "id": "essential-tremor",
    "title": "Essential Tremor",
    "version": "1.0",
    "icd10": [
      "** G25.0 (Essential tremor)"
    ],
    "scope": "** Diagnosis confirmation, differentiation from Parkinson's disease and other tremors, and symptomatic treatment. Covers classic essential tremor and ET-plus syndrome.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "TSH",
            "rationale": "Hyperthyroidism causes action tremor",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free T4",
            "rationale": "If TSH abnormal",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities (hypomagnesemia) can cause tremor",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose",
            "rationale": "Hypoglycemia causes tremor",
            "target": "70-180 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel",
            "rationale": "Hepatic encephalopathy can cause asterixis/tremor; baseline before medications",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia causes tremor",
            "target": "1.8-2.4 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's confirmation",
            "target": "<100 μg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Drug/toxin screen",
            "rationale": "Caffeine, stimulants, alcohol withdrawal",
            "target": "Negative or explains tremor",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause tremor",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Heavy metal panel (mercury, lead, arsenic)",
            "rationale": "Occupational exposure; toxin-induced tremor",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Atypical tremor; occult malignancy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-GAD65 antibodies",
            "rationale": "Stiff-person spectrum; autoimmune etiology",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (LINGO1, SLC1A2)",
            "rationale": "Research; strong family history",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Clinical examination (spiral drawing, water pouring)",
            "timing": "At evaluation",
            "target": "Symmetric action tremor; improves with alcohol; family history",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain",
            "timing": "Atypical features; focal signs; concern for structural lesion",
            "target": "Normal",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate ET from Parkinson's disease",
            "target": "NORMAL in ET (abnormal in PD)",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG with accelerometry",
            "timing": "Characterize tremor frequency (8-12 Hz typical ET)",
            "target": "4-12 Hz, predominantly postural/kinetic",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI Brain with SWI",
            "timing": "Wilson's disease evaluation; iron deposition",
            "target": "No basal ganglia abnormalities",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET scan",
            "timing": "Research; rule out neurodegenerative parkinsonian syndromes",
            "target": "Normal nigrostriatal pathway",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Slit lamp examination",
            "timing": "Wilson's disease (Kayser-Fleischer rings)",
            "target": "No KF rings",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Propranolol (as needed)",
            "route": "PO",
            "indication": "Situational tremor (performance anxiety, important meeting)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg PO",
                  "orderSentence": "Propranolol (as needed) 20 mg PO PO"
                },
                {
                  "text": "40 mg PO",
                  "orderSentence": "Propranolol (as needed) 40 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg PO 30-60 min before anxiety-provoking situation; single dose PRN",
              "orderSentence": "Propranolol (as needed) 20 mg PO PO"
            },
            "contraindications": "Asthma; severe bradycardia; decompensated HF",
            "monitoring": "HR, BP if first dose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (First-line)": [
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "First-line chronic therapy; most evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Propranolol 20 mg BID PO"
                },
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "60 mg BID",
                  "orderSentence": "Propranolol 60 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                },
                {
                  "text": "120 mg daily LA",
                  "orderSentence": "Propranolol 120 mg daily LA PO"
                },
                {
                  "text": "160 mg daily LA",
                  "orderSentence": "Propranolol 160 mg daily LA PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg BID or 60 mg LA daily; titrate q2wk; target 60-240 mg/day",
              "orderSentence": "Propranolol 20 mg BID PO"
            },
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated HF",
            "monitoring": "HR (>50 bpm), BP, fatigue, depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol LA",
            "route": "PO",
            "indication": "Once daily option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Propranolol LA 60 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Propranolol LA 80 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Propranolol LA 120 mg daily PO"
                },
                {
                  "text": "160 mg daily",
                  "orderSentence": "Propranolol LA 160 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60-80 mg daily; titrate q2wk; max 320 mg/day",
              "orderSentence": "Propranolol LA 60 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primidone",
            "route": "PO",
            "indication": "First-line; equal efficacy to propranolol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Primidone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Primidone 50 mg qHS PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Primidone 50 mg TID PO"
                },
                {
                  "text": "125 mg TID",
                  "orderSentence": "Primidone 125 mg TID PO"
                },
                {
                  "text": "250 mg TID",
                  "orderSentence": "Primidone 250 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS (VERY LOW to avoid acute toxicity); increase by 25-50 mg q1wk; target 250-750 mg/day divided",
              "orderSentence": "Primidone 25 mg qHS PO"
            },
            "contraindications": "Porphyria; severe hepatic impairment",
            "monitoring": "Sedation (especially initial), ataxia, GI upset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol + Primidone",
            "route": "PO",
            "indication": "Combination for better efficacy than monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per individual drug",
                  "orderSentence": "Propranolol + Primidone Per individual drug PO"
                }
              ],
              "route": "PO",
              "instructions": "Add second agent if monotherapy insufficient; use lower doses of each",
              "orderSentence": "Propranolol + Primidone Per individual drug PO"
            },
            "contraindications": "Per individual drug",
            "monitoring": "Monitor both sets of side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Beta-blocker contraindicated; weight concern",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg q1wk; target 100-400 mg/day divided",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "contraindications": "Glaucoma; kidney stones; pregnancy",
            "monitoring": "Cognitive effects, paresthesias, weight loss, metabolic acidosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Mild benefit; good tolerability; neuropathic pain comorbidity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7d; target 1200-3600 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alprazolam",
            "route": "PO",
            "indication": "Anxiolytic benefit; use with caution",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Alprazolam 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Alprazolam 0.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg TID; titrate slowly; max 3 mg/day; avoid long-term if possible",
              "orderSentence": "Alprazolam 0.25 mg TID PO"
            },
            "contraindications": "Respiratory depression; history of substance use",
            "monitoring": "Dependence, sedation, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Orthostatic tremor; head tremor; refractory cases",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Clonazepam 1 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; titrate slowly; typical 0.5-2 mg/day",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Same as alprazolam",
            "monitoring": "Same as alprazolam",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atenolol",
            "route": "PO",
            "indication": "Beta-blocker alternative (more beta-1 selective)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Atenolol 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Atenolol 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Atenolol 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg daily; max 100 mg daily",
              "orderSentence": "Atenolol 25 mg daily PO"
            },
            "contraindications": "Heart block; severe bradycardia",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nadolol",
            "route": "PO",
            "indication": "Long-acting beta-blocker alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Nadolol 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Nadolol 80 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Nadolol 120 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg daily; titrate q1-2wk; max 240 mg daily",
              "orderSentence": "Nadolol 40 mg daily PO"
            },
            "contraindications": "Same as propranolol",
            "monitoring": "Same as propranolol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sotalol",
            "route": "PO",
            "indication": "Beta-blocker with additional antiarrhythmic properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg BID",
                  "orderSentence": "Sotalol 80 mg BID PO"
                },
                {
                  "text": "120 mg BID",
                  "orderSentence": "Sotalol 120 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 80 mg BID; max 240 mg/day; requires QTc monitoring",
              "orderSentence": "Sotalol 80 mg BID PO"
            },
            "contraindications": "QT prolongation; severe renal impairment",
            "monitoring": "QTc, electrolytes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nimodipine",
            "route": "PO",
            "indication": "Limited evidence; calcium channel blocker",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Nimodipine 30 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "30 mg TID",
              "orderSentence": "Nimodipine 30 mg TID PO"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Zonisamide",
            "route": "PO",
            "indication": "Limited evidence; weight neutral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily",
                  "orderSentence": "Zonisamide 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Zonisamide 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; may increase to 200 mg daily",
              "orderSentence": "Zonisamide 100 mg daily PO"
            },
            "contraindications": "Sulfonamide allergy; renal stones",
            "monitoring": "Kidney stones, rash",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Interventional/Advanced Therapies": [
          {
            "item": "Botulinum toxin (head tremor)",
            "route": "IM",
            "indication": "Head/neck tremor refractory to oral medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 units total",
                  "orderSentence": "Botulinum toxin (head tremor) 100-200 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject into sternocleidomastoid and splenius capitis bilaterally; repeat q3-4mo",
              "orderSentence": "Botulinum toxin (head tremor) 100-200 units total IM"
            },
            "pretreatment": "EMG guidance recommended",
            "contraindications": "Infection at site; myasthenia gravis",
            "monitoring": "Dysphagia, neck weakness",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Botulinum toxin (hand tremor)",
            "route": "IM",
            "indication": "Hand tremor refractory to oral medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 units per hand",
                  "orderSentence": "Botulinum toxin (hand tremor) 50-100 units per hand IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject into forearm flexors/extensors; EMG-guided; repeat q3mo",
              "orderSentence": "Botulinum toxin (hand tremor) 50-100 units per hand IM"
            },
            "pretreatment": "EMG guidance required",
            "contraindications": "Same as above",
            "monitoring": "Finger weakness (limits use)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Medication-refractory disabling tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "VIM thalamus stimulation",
                  "orderSentence": "Deep brain stimulation (DBS) VIM thalamus stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Unilateral or bilateral VIM thalamus; programming over weeks",
              "orderSentence": "Deep brain stimulation (DBS) VIM thalamus stimulation Surgical"
            },
            "pretreatment": "MRI; neuropsych testing; multidisciplinary evaluation",
            "contraindications": "Cognitive impairment; unstable psychiatric disease; coagulopathy",
            "monitoring": "Programming optimization; speech side effects (bilateral)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI-guided focused ultrasound (MRgFUS)",
            "route": "Non-invasive",
            "indication": "Unilateral tremor; DBS declined or contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "VIM thalamotomy",
                  "orderSentence": "MRI-guided focused ultrasound (MRgFUS) VIM thalamotomy Non-invasive"
                }
              ],
              "route": "Non-invasive",
              "instructions": "Unilateral lesion of VIM thalamus; immediate effect",
              "orderSentence": "MRI-guided focused ultrasound (MRgFUS) VIM thalamotomy Non-invasive"
            },
            "pretreatment": "Must tolerate prolonged MRI",
            "contraindications": "Bilateral procedure not recommended (speech risk); skull density ratio",
            "monitoring": "Numbness, ataxia, speech changes (usually transient)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gamma Knife radiosurgery",
            "route": "Non-invasive",
            "indication": "VIM thalamotomy; DBS contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "130-150 Gy to VIM",
                  "orderSentence": "Gamma Knife radiosurgery 130-150 Gy to VIM Non-invasive"
                }
              ],
              "route": "Non-invasive",
              "instructions": "Unilateral lesion; delayed effect (months)",
              "orderSentence": "Gamma Knife radiosurgery 130-150 Gy to VIM Non-invasive"
            },
            "pretreatment": "MRI compatible",
            "contraindications": "Same as MRgFUS",
            "monitoring": "Same as MRgFUS; delayed effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders neurology for diagnosis confirmation if uncertain and treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for DBS or MRgFUS evaluation if medication-refractory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for adaptive devices and hand-writing strategies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for postural training and coordination exercises",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/counseling for anxiety management and coping strategies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Avoid or minimize caffeine which can worsen tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol (may temporarily improve tremor but rebound worsening occurs and dependence risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Get adequate sleep as fatigue worsens tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress and anxiety which exacerbate tremor (relaxation techniques, regular exercise)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use weighted utensils and adaptive devices for eating and writing if tremor interferes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new symptoms such as slowness, stiffness, or balance problems which may indicate progression to ET-plus or Parkinson's",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider alerting employer/school if tremor affects work performance to discuss accommodations",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular physical exercise improves overall motor function and stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Relaxation techniques (yoga, meditation, deep breathing) reduce stress-related tremor exacerbation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen tremor (lithium, valproate, some antidepressants, stimulants) when alternatives exist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use larger-grip pens and utensils to improve function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Voice-to-text software if writing is significantly impaired",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol despite temporary improvement to avoid dependence and rebound tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Parkinson's disease",
        "features": "Rest tremor predominant; bradykinesia; rigidity; asymmetric onset",
        "tests": "DaTscan (abnormal in PD, normal in ET); clinical exam"
      },
      {
        "diagnosis": "Enhanced physiologic tremor",
        "features": "Typically bilateral, postural; related to caffeine, anxiety, medications, hyperthyroidism",
        "tests": "Remove triggers; check TSH, caffeine history"
      },
      {
        "diagnosis": "Drug-induced tremor",
        "features": "Temporal relationship with medication; bilateral",
        "tests": "Medication review; trial withdrawal"
      },
      {
        "diagnosis": "Dystonic tremor",
        "features": "Irregular, jerky; task-specific; associated dystonic posturing; null point",
        "tests": "Clinical exam; may see dystonia at rest"
      },
      {
        "diagnosis": "Cerebellar tremor",
        "features": "Intention tremor (worsens at target); associated ataxia, dysarthria",
        "tests": "MRI brain (cerebellar pathology); clinical exam"
      },
      {
        "diagnosis": "Psychogenic tremor",
        "features": "Variable frequency; distractible; entrainment with contralateral movement",
        "tests": "Clinical maneuvers; psychiatric evaluation"
      },
      {
        "diagnosis": "Wilson's disease",
        "features": "Age <50; liver disease; psychiatric symptoms; Kayser-Fleischer rings",
        "tests": "Ceruloplasmin, 24h urine copper, slit lamp"
      },
      {
        "diagnosis": "Orthostatic tremor",
        "features": "Tremor in legs/trunk when standing; relief with sitting/walking",
        "tests": "EMG (13-18 Hz characteristic)"
      },
      {
        "diagnosis": "Rubral tremor",
        "features": "Rest + postural + intention (\"Holmes tremor\"); midbrain lesion history",
        "tests": "MRI (midbrain pathology)"
      },
      {
        "diagnosis": "Neuropathic tremor",
        "features": "Associated with peripheral neuropathy (CIDP, IgM paraprotein)",
        "tests": "EMG/NCS; protein electrophoresis"
      }
    ],
    "evidence": [
      {
        "recommendation": "Propranolol first-line for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zesiewicz et al. Neurology 2011 (AAN Guideline)](https://pubmed.ncbi.nlm.nih.gov/22013182/)"
      },
      {
        "recommendation": "Primidone first-line for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zesiewicz et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/22013182/)"
      },
      {
        "recommendation": "Topiramate effective for ET",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ondo et al. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/16636234/)"
      },
      {
        "recommendation": "DBS effective for medication-refractory ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Flora et al. Cochrane 2010](https://pubmed.ncbi.nlm.nih.gov/20927732/)"
      },
      {
        "recommendation": "MRI-guided focused ultrasound for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Elias et al. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27557301/)"
      },
      {
        "recommendation": "DaTscan differentiates ET from PD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Benamer et al. Mov Disord 2000](https://pubmed.ncbi.nlm.nih.gov/10752577/)"
      },
      {
        "recommendation": "Botulinum toxin for head tremor",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pahwa et al. Neurology 1995](https://pubmed.ncbi.nlm.nih.gov/7617193/)"
      },
      {
        "recommendation": "Gabapentin modest benefit",
        "evidenceLevel": "Class II, Level U",
        "source": "[Ondo et al. Neurology 2000](https://pubmed.ncbi.nlm.nih.gov/10680798/)"
      },
      {
        "recommendation": "Combination therapy superior to monotherapy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Koller et al. Neurology 1989](https://pubmed.ncbi.nlm.nih.gov/2668781/)"
      }
    ],
    "monitoring": [
      {
        "item": "Tremor severity (clinical rating scales: Fahn-Tolosa-Marin, TETRAS)",
        "frequency": "Each visit",
        "action": "Adjust medication dose; consider second agent or intervention",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional impact (writing, eating, drinking)",
        "frequency": "Each visit",
        "action": "OT referral; adaptive devices; consider advanced therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Heart rate (if on beta-blocker)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (if on beta-blocker)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Sedation/cognition (if on primidone or benzodiazepines)",
        "frequency": "Each visit",
        "action": "Reduce dose; slow titration",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Signs of parkinsonism",
        "frequency": "Each visit",
        "action": "Re-evaluate diagnosis; DaTscan if uncertain",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight (if on topiramate)",
        "frequency": "Every 3 months",
        "action": "Adjust dose",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "QTc (if on sotalol)",
        "frequency": "Baseline, with dose changes",
        "action": "Reduce dose or discontinue",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "New diagnosis with treatment started; follow-up arranged; no red flags"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Rare; only if tremor is severe and workup needed urgently (e.g., Wilson's disease suspected)"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "4-8 weeks for medication titration; then every 6-12 months when stable"
      }
    ]
  },
  "Diabetic Neuropathy": {
    "id": "diabetic-neuropathy",
    "title": "Diabetic Neuropathy",
    "version": "1.0",
    "icd10": [
      "** G63.2 (Diabetic polyneuropathy)",
      "E11.42 (Type 2 DM with diabetic polyneuropathy)",
      "E10.42 (Type 1 DM with diabetic polyneuropathy)"
    ],
    "scope": "** Distal symmetric polyneuropathy (most common), painful diabetic neuropathy treatment, foot care, and screening for other diabetic neuropathy types. Excludes diabetic amyotrophy (separate protocol) and autonomic neuropathy (mentioned but not primary focus).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "HbA1c",
            "rationale": "Assess glycemic control; primary modifiable risk factor",
            "target": "<7% (individualized goals for elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Current glycemic status",
            "target": "70-130 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (including creatinine, eGFR)",
            "rationale": "Renal function for medication dosing; CKD common in diabetes",
            "target": "eGFR >60 preferred; adjust meds if lower",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Cardiovascular risk; dyslipidemia common comorbidity",
            "target": "LDL <100 mg/dL (or <70 if ASCVD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Metformin causes B12 deficiency; mimics diabetic neuropathy",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes neuropathy; common comorbidity",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC",
            "rationale": "Anemia evaluation; baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "More sensitive for B12 deficiency if B12 borderline",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to neuropathy",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D",
            "rationale": "Deficiency associated with neuropathic pain",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "SPEP/UPEP with immunofixation",
            "rationale": "Rule out paraproteinemia if atypical features",
            "target": "No monoclonal protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Autoimmune/vasculitic neuropathy if atypical",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers if vasculitis suspected",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B, C serologies",
            "rationale": "Hepatitis C associated with neuropathy; prevalence in diabetics",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV",
            "rationale": "HIV neuropathy if risk factors",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Cryoglobulins",
            "rationale": "Cryoglobulinemic neuropathy (esp. with Hep C)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-MAG antibodies",
            "rationale": "IgM paraprotein-associated neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic neuropathy panel (CMT genes)",
            "rationale": "Family history; atypical presentation",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Nerve biopsy",
            "rationale": "Vasculitic neuropathy suspected; atypical non-length-dependent",
            "target": "Diagnostic findings",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy for IENFD",
            "rationale": "Quantify small fiber neuropathy",
            "target": "Reduced intraepidermal nerve fiber density",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Monofilament testing (10g)",
            "timing": "At every diabetic visit; annually minimum",
            "target": "Intact sensation 8-10 sites",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tuning fork (128 Hz)",
            "timing": "Vibration sense at great toe",
            "target": "Intact vibration sense",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ankle reflexes",
            "timing": "Deep tendon reflex assessment",
            "target": "Present (may be diminished/absent in neuropathy)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Foot examination",
            "timing": "Inspect for ulcers, calluses, deformities, pulses",
            "target": "No ulcers or pre-ulcerative lesions",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "EMG/NCS (nerve conduction study)",
            "timing": "Atypical presentation; asymmetric; rapid progression",
            "target": "Length-dependent sensory > motor polyneuropathy",
            "contraindications": "Anticoagulation (relative for EMG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic testing (QSART, HR variability, tilt table)",
            "timing": "Symptoms of autonomic neuropathy; syncope; gastroparesis",
            "target": "Abnormal sudomotor, cardiovagal, or adrenergic function",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI lumbar spine",
            "timing": "Radiculopathy suspected; focal deficits",
            "target": "Rule out compressive lesion",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Skin biopsy (punch biopsy at ankle and thigh)",
            "timing": "Confirm small fiber neuropathy; normal NCS",
            "target": "Reduced IENFD (<threshold for age/sex)",
            "contraindications": "Bleeding diathesis; anticoagulation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Corneal confocal microscopy",
            "timing": "Research; non-invasive small fiber assessment",
            "target": "Reduced corneal nerve fiber length/density",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sudoscan",
            "timing": "Screening for sudomotor dysfunction; small fiber",
            "target": "Abnormal electrochemical skin conductance",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Wound care",
            "route": "Topical",
            "indication": "Diabetic foot ulcer",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Debridement",
                  "orderSentence": "Wound care Debridement Topical"
                },
                {
                  "text": "offloading",
                  "orderSentence": "Wound care offloading Topical"
                },
                {
                  "text": "appropriate dressing",
                  "orderSentence": "Wound care appropriate dressing Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Wound assessment; debridement if needed; offload pressure; moist wound healing",
              "orderSentence": "Wound care Debridement Topical"
            },
            "contraindications": "None",
            "monitoring": "Signs of infection; healing progress",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Antibiotics (diabetic foot infection)",
            "route": "PO/IV",
            "indication": "Infected diabetic foot ulcer",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per culture/severity",
                  "orderSentence": "Antibiotics (diabetic foot infection) Per culture/severity PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "Mild: oral (cephalexin, amox/clav); Moderate-severe: IV (piptazo, vanc); per wound culture",
              "orderSentence": "Antibiotics (diabetic foot infection) Per culture/severity PO/IV"
            },
            "contraindications": "Drug allergy",
            "monitoring": "Infection markers; wound healing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Pain crisis management",
            "route": "IV/PO",
            "indication": "Severe acute neuropathic pain flare",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Multimodal",
                  "orderSentence": "Pain crisis management Multimodal IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Consider IV lidocaine if refractory; short-term low-dose opioid for acute crisis",
              "orderSentence": "Pain crisis management Multimodal IV/PO"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Pain scores; sedation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Neuropathic Pain - First-line)": [
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "First-line for painful diabetic neuropathy; FDA-approved",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day (limited evidence for higher doses)",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled glaucoma; severe renal impairment (CrCl <30)",
            "monitoring": "Hepatic function; BP; suicidal ideation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "First-line; FDA-approved for DPN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg TID",
                  "orderSentence": "Pregabalin 50 mg TID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Pregabalin 100 mg TID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Pregabalin 200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg TID or 75 mg BID; titrate q3-7d based on response; max 300 mg/day (CrCl 30-60: reduce dose)",
              "orderSentence": "Pregabalin 50 mg TID PO"
            },
            "contraindications": "Angioedema to pregabalin/gabapentin",
            "monitoring": "Dizziness, somnolence, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "First-line alternative; less expensive; similar efficacy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7d; target 1800-3600 mg/day divided TID; reduce dose if CrCl <60",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Same as pregabalin; less edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "TCA option; also helps sleep; less expensive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Amitriptyline 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS; max 150 mg",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly (use with caution)",
            "monitoring": "ECG if >40y or cardiac history; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "TCA with less sedation and anticholinergic effects than amitriptyline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Same as amitriptyline",
            "monitoring": "Same as amitriptyline; ECG if >100 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "SNRI alternative to duloxetine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate by 37.5-75 mg q1wk; target 150-225 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled HTN",
            "monitoring": "BP at higher doses; withdrawal if abrupt discontinuation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Neuropathic Pain)": [
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "Topical",
            "indication": "Localized neuropathic pain; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply for 30 min",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) Apply for 30 min Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Applied by healthcare provider; local anesthetic pre-treatment; repeat q3mo",
              "orderSentence": "Capsaicin 8% patch (Qutenza) Apply for 30 min Topical"
            },
            "contraindications": "Application to face; broken skin",
            "monitoring": "Local pain during application; burning",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "Topical",
            "indication": "Localized pain; adjunctive therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches to painful area",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches to painful area Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Apply to most painful area; up to 3 patches for 12h on/12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches to painful area Topical"
            },
            "contraindications": "Allergy to local anesthetics",
            "monitoring": "Skin irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Refractory pain; opioid with norepinephrine reuptake inhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Tapentadol ER 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Tapentadol ER 100 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Tapentadol ER 150 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Tapentadol ER 200 mg BID PO"
                },
                {
                  "text": "250 mg BID",
                  "orderSentence": "Tapentadol ER 250 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; titrate by 50 mg BID q3d; max 500 mg/day; FDA-approved for DPN",
              "orderSentence": "Tapentadol ER 50 mg BID PO"
            },
            "contraindications": "Severe respiratory depression; MAOIs; paralytic ileus",
            "monitoring": "Constipation, sedation, respiratory status",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate pain; opioid-like with serotonergic properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg q6h PRN",
                  "orderSentence": "Tramadol 50 mg q6h PRN PO"
                },
                {
                  "text": "100 mg ER BID",
                  "orderSentence": "Tramadol 100 mg ER BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; max 400 mg/day; reduce if renal/hepatic impairment",
              "orderSentence": "Tramadol 50 mg q6h PRN PO"
            },
            "contraindications": "Seizure disorder; concurrent MAOIs/SSRIs (serotonin syndrome risk)",
            "monitoring": "Seizures, serotonin syndrome, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "TCA with minimal anticholinergic effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Desipramine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Desipramine 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Desipramine 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25 mg q1-2wk; target 50-100 mg",
              "orderSentence": "Desipramine 25 mg qHS PO"
            },
            "contraindications": "Same as other TCAs",
            "monitoring": "ECG; therapeutic drug monitoring available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Second-line anticonvulsant; less evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; titrate by 300 mg/wk; typical 600-1200 mg/day",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Hyponatremia risk",
            "monitoring": "Sodium level; rash (SJS rare)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Combination therapy",
            "route": "Various",
            "indication": "Inadequate response to single agent",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Combine agents from different classes",
                  "orderSentence": "Combination therapy Combine agents from different classes Various"
                }
              ],
              "route": "Various",
              "instructions": "Use lower doses of each; duloxetine + pregabalin; TCA + gabapentinoid",
              "orderSentence": "Combination therapy Combine agents from different classes Various"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Additive side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buprenorphine patch",
            "route": "TD",
            "indication": "Severe refractory pain; opioid option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mcg/hr",
                  "orderSentence": "Buprenorphine patch 5 mcg/hr TD"
                },
                {
                  "text": "10 mcg/hr",
                  "orderSentence": "Buprenorphine patch 10 mcg/hr TD"
                },
                {
                  "text": "20 mcg/hr",
                  "orderSentence": "Buprenorphine patch 20 mcg/hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 5 mcg/hr weekly patch; titrate slowly",
              "orderSentence": "Buprenorphine patch 5 mcg/hr TD"
            },
            "contraindications": "Severe respiratory depression; QT prolongation",
            "monitoring": "Respiratory status, QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Spinal cord stimulation",
            "route": "Implant",
            "indication": "Refractory painful DPN; failed multiple medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per implant protocol",
                  "orderSentence": "Spinal cord stimulation Per implant protocol Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Trial stimulation before permanent; high-frequency or burst stimulation",
              "orderSentence": "Spinal cord stimulation Per implant protocol Implant"
            },
            "contraindications": "Infection; coagulopathy; psychiatric instability",
            "monitoring": "Device function; pain relief",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying / Preventive Therapies": [
          {
            "item": "Glycemic control optimization",
            "route": "Various",
            "indication": "Primary prevention and slowing progression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "HbA1c target <7%",
                  "orderSentence": "Glycemic control optimization HbA1c target <7% Various"
                }
              ],
              "route": "Various",
              "instructions": "Individualized; tighter control (6-6.5%) in younger patients; less strict (7.5-8%) in elderly/comorbid",
              "orderSentence": "Glycemic control optimization HbA1c target <7% Various"
            },
            "pretreatment": "None",
            "contraindications": "Hypoglycemia risk",
            "monitoring": "HbA1c q3mo until at goal, then q6mo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alpha-lipoic acid",
            "route": "PO/IV",
            "indication": "Antioxidant; European data for DPN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg daily",
                  "orderSentence": "Alpha-lipoic acid 600 mg daily PO/IV"
                },
                {
                  "text": "600 mg IV daily",
                  "orderSentence": "Alpha-lipoic acid 600 mg IV daily PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "600 mg PO daily; IV form (600 mg daily x 3wk) for acute symptom relief; limited evidence",
              "orderSentence": "Alpha-lipoic acid 600 mg daily PO/IV"
            },
            "pretreatment": "None",
            "contraindications": "GI upset; may lower glucose",
            "monitoring": "Glucose (may enhance insulin sensitivity)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12 supplementation",
            "route": "PO/IM",
            "indication": "B12 deficiency or metformin use",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg PO daily",
                  "orderSentence": "Vitamin B12 supplementation 1000 mcg PO daily PO/IM"
                },
                {
                  "text": "1000 mcg IM monthly",
                  "orderSentence": "Vitamin B12 supplementation 1000 mcg IM monthly PO/IM"
                }
              ],
              "route": "PO/IM",
              "instructions": "1000-2000 mcg PO daily; or 1000 mcg IM monthly if poor absorption",
              "orderSentence": "Vitamin B12 supplementation 1000 mcg PO daily PO/IM"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "B12 level q6-12mo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benfotiamine",
            "route": "PO",
            "indication": "Thiamine derivative; AGE inhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Benfotiamine 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg BID; limited evidence",
              "orderSentence": "Benfotiamine 300 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "GI upset",
            "monitoring": "None specific",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE inhibitor or ARB",
            "route": "PO",
            "indication": "Nephroprotection; may slow neuropathy progression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "ACE inhibitor or ARB Per agent PO"
                }
              ],
              "route": "PO",
              "instructions": "Standard doses; benefit for kidney protection proven; neuropathy benefit theoretical",
              "orderSentence": "ACE inhibitor or ARB Per agent PO"
            },
            "pretreatment": "Angioedema; pregnancy; hyperkalemia; bilateral RAS",
            "contraindications": "K+, creatinine",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Statin therapy",
            "route": "PO",
            "indication": "Cardiovascular protection; anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Statin therapy Per agent PO"
                }
              ],
              "route": "PO",
              "instructions": "High-intensity statin for most diabetics",
              "orderSentence": "Statin therapy Per agent PO"
            },
            "pretreatment": "Active liver disease",
            "contraindications": "LFTs, myalgias",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Endocrinology for diabetes optimization if HbA1c not at goal or complex regimen needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Podiatry for foot exam, nail care, custom orthotics, and offloading devices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery if peripheral arterial disease suspected (ABI <0.9 or absent pulses)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management for refractory neuropathic pain and interventional options (SCS)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for balance training and gait assessment to reduce fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care specialist for diabetic foot ulcers not healing with standard care",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology for annual diabetic retinopathy screening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nephrology if eGFR <30 or rapidly declining renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Inspect feet daily using mirror for soles; look for cuts, blisters, redness, or swelling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Never walk barefoot, even indoors, to prevent foot injuries",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear properly fitted shoes with adequate support; have shoes fitted by professional",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Test bath water temperature with elbow (not feet) to prevent burns from impaired sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any foot wounds, color changes, or pain immediately as diabetic foot ulcers can progress rapidly",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all prescribed medications as directed; do not skip doses of pain medications abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor blood glucose as directed; excellent glycemic control is the most important factor to slow progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol which can worsen neuropathy and interact with pain medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Optimal glycemic control (HbA1c <7%) is the primary intervention to prevent and slow neuropathy progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation as smoking worsens peripheral vascular disease and neuropathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control (<130/80) reduces microvascular complications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL cholesterol control with statin therapy reduces cardiovascular risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical activity (150 min/week moderate) improves glycemic control and overall health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Healthy diet (Mediterranean or DASH) supports glycemic and cardiovascular goals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol which worsens neuropathy independently and affects glycemic control",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Annual comprehensive foot examination by healthcare provider",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home safety modifications given impaired proprioception",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "B12 deficiency neuropathy",
        "features": "Sensory > motor; may have subacute combined degeneration; metformin use",
        "tests": "B12, MMA levels"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Motor involvement; areflexia; elevated CSF protein; demyelinating NCS",
        "tests": "EMG/NCS (demyelinating pattern); CSF protein"
      },
      {
        "diagnosis": "Uremic neuropathy",
        "features": "Advanced CKD (eGFR <15); improves with dialysis",
        "tests": "BUN, creatinine, eGFR"
      },
      {
        "diagnosis": "Alcoholic neuropathy",
        "features": "Heavy alcohol use history; painful; coexisting thiamine deficiency",
        "tests": "History; thiamine level"
      },
      {
        "diagnosis": "Hypothyroid neuropathy",
        "features": "Other hypothyroid symptoms; CTS common",
        "tests": "TSH, free T4"
      },
      {
        "diagnosis": "Paraproteinemic neuropathy",
        "features": "IgM most common; anti-MAG antibodies; may have ataxia",
        "tests": "SPEP/UPEP; immunofixation; anti-MAG"
      },
      {
        "diagnosis": "Chemotherapy-induced neuropathy",
        "features": "Temporal relationship with chemotherapy (platinum, taxanes, vincristine)",
        "tests": "Medication history"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history; high arches (pes cavus); hammer toes; slowly progressive",
        "tests": "Genetic testing; NCS pattern"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Asymmetric; mononeuritis multiplex pattern; systemic symptoms",
        "tests": "Nerve biopsy; inflammatory markers; angiography"
      },
      {
        "diagnosis": "Amyloid neuropathy",
        "features": "Autonomic involvement; cardiomyopathy; carpal tunnel; paraprotein may be present",
        "tests": "Fat pad or nerve biopsy; genetic testing (TTR); SPEP"
      }
    ],
    "evidence": [
      {
        "recommendation": "Duloxetine for painful DPN (FDA-approved)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wernicke et al. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/17060567/)"
      },
      {
        "recommendation": "Pregabalin for painful DPN (FDA-approved)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Derry et al. Cochrane 2019](https://pubmed.ncbi.nlm.nih.gov/30673120/)"
      },
      {
        "recommendation": "Gabapentin effective for DPN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Wiffen et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/28597471/)"
      },
      {
        "recommendation": "Tricyclic antidepressants effective",
        "evidenceLevel": "Class II, Level B",
        "source": "[Moore et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25879104/)"
      },
      {
        "recommendation": "Glycemic control prevents neuropathy progression",
        "evidenceLevel": "Class I, Level A",
        "source": "[DCCT/EDIC Research Group. NEJM 1993](https://pubmed.ncbi.nlm.nih.gov/8366922/)"
      },
      {
        "recommendation": "Alpha-lipoic acid may improve symptoms",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ziegler et al. Diabetes Care 2011](https://pubmed.ncbi.nlm.nih.gov/21994426/)"
      },
      {
        "recommendation": "Comprehensive foot exam reduces amputations",
        "evidenceLevel": "Class II, Level B",
        "source": "[ADA Standards of Care 2024 (Section 12)](https://pubmed.ncbi.nlm.nih.gov/38078577/)"
      },
      {
        "recommendation": "Tapentadol effective for DPN (FDA-approved)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vinik et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24947790/)"
      },
      {
        "recommendation": "Spinal cord stimulation for refractory DPN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Slangen et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24947789/)"
      },
      {
        "recommendation": "Capsaicin 8% patch effective",
        "evidenceLevel": "Class I, Level A",
        "source": "[Simpson et al. Pain 2017](https://pubmed.ncbi.nlm.nih.gov/27479770/)"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "frequency": "Every 3-6 months",
        "action": "Intensify diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Comprehensive foot exam",
        "frequency": "Annually (more often if high risk)",
        "action": "Podiatry referral; offloading; wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Monofilament testing",
        "frequency": "At least annually",
        "action": "High-risk foot care; education",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Pain scores (VAS, NRS)",
        "frequency": "Each visit",
        "action": "Adjust therapy; consider combination or referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "B12 level",
        "frequency": "Annually if on metformin",
        "action": "Supplement B12",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Kidney function (eGFR)",
        "frequency": "At least annually",
        "action": "Adjust medication doses; nephrology referral if declining",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize antihypertensives",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Autonomic symptoms screen",
        "frequency": "Each visit",
        "action": "Autonomic testing; cardiology referral if cardiac autonomic neuropathy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screen (PHQ-9)",
        "frequency": "Annually or if symptoms",
        "action": "Treatment; referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Symptoms managed; no foot infection; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Diabetic foot infection requiring IV antibiotics; severe uncontrolled pain; associated acute kidney injury"
      },
      {
        "disposition": "Surgical admission",
        "criteria": "Foot infection requiring debridement or amputation"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for medication optimization; annually for comprehensive foot exam"
      }
    ]
  },
  "Parkinson's Disease": {
    "id": "parkinsons-disease",
    "title": "Parkinson's Disease",
    "version": "1.0",
    "icd10": [
      "** G20 (Parkinson's disease)"
    ],
    "scope": "** Diagnosis confirmation, dopaminergic therapy initiation and optimization, motor fluctuation management, and non-motor symptom treatment. Excludes Parkinson-plus syndromes (MSA, PSP, CBD, DLB - separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Baseline; rule out anemia contributing to fatigue",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Renal function for medication dosing; electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs)",
            "rationale": "Baseline before COMT inhibitors",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Rule out hypothyroidism mimicking bradykinesia",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause parkinsonism; common in elderly",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency common; associated with falls and disease severity",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's disease confirmation",
            "target": "<100 μg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ferritin, iron studies",
            "rationale": "Neurodegeneration with brain iron accumulation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Syphilis can cause parkinsonism",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated parkinsonism",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Genetic testing (LRRK2, GBA, SNCA, PARK2, PINK1, DJ-1)",
            "rationale": "Family history or early-onset (<50 years)",
            "target": "Identifies genetic form",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF biomarkers (alpha-synuclein, tau, amyloid)",
            "rationale": "Research/atypical; synuclein seed amplification assay",
            "target": "Abnormal synuclein aggregation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy for alpha-synuclein",
            "rationale": "Research; confirms synucleinopathy",
            "target": "Phosphorylated synuclein deposits",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At diagnosis",
            "target": "Normal (rules out structural causes, vascular parkinsonism, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "DaTscan (ioflupane I-123 SPECT)",
            "timing": "Diagnostic uncertainty; essential tremor vs PD",
            "target": "Reduced dopamine transporter uptake in striatum",
            "contraindications": "Hypersensitivity to iodine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain with SWI sequence",
            "timing": "Suspected atypical parkinsonism or iron deposition",
            "target": "No \"hot cross bun\" (MSA) or \"hummingbird\" (PSP) signs",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac MIBG scan",
            "timing": "Differentiate PD from MSA",
            "target": "Reduced uptake in PD (preserved in MSA)",
            "contraindications": "Recent MI; drugs affecting uptake",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "REM sleep behavior disorder evaluation",
            "target": "Confirms RBD (prodromal marker)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Dysautonomia assessment",
            "target": "Orthostatic hypotension, abnormal HR variability",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "FDG-PET",
            "timing": "Atypical parkinsonism differentiation",
            "target": "Pattern recognition for PD vs PSP vs MSA",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Transcranial ultrasound",
            "timing": "Screening tool",
            "target": "Hyperechogenicity of substantia nigra",
            "contraindications": "Inadequate bone window",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Carbidopa-Levodopa (continue home dose)",
            "route": "PO/NG",
            "indication": "Admitted PD patient; DO NOT HOLD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose, same timing",
                  "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
                }
              ],
              "route": "PO",
              "instructions": "Give at EXACT same times as home; crushing allowed; use NG if NPO",
              "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
            },
            "contraindications": "Active psychosis; MAOIs within 14 days",
            "monitoring": "Dyskinesias, confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Carbidopa-Levodopa (NPO protocol)",
            "route": "IV/NG",
            "indication": "Patient NPO >4 hours",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose equivalent",
                  "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
                }
              ],
              "route": "NG",
              "instructions": "Crush tablets; give via NG at home schedule; consult neurology for IV options if unavailable",
              "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
            },
            "contraindications": "Same as PO",
            "monitoring": "Same as PO",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Apomorphine SC",
            "route": "SC",
            "indication": "Off episode in clinic/ED; NPO patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg SC",
                  "orderSentence": "Apomorphine SC 2 mg SC SC"
                },
                {
                  "text": "3 mg SC",
                  "orderSentence": "Apomorphine SC 3 mg SC SC"
                },
                {
                  "text": "4 mg SC",
                  "orderSentence": "Apomorphine SC 4 mg SC SC"
                },
                {
                  "text": "5 mg SC",
                  "orderSentence": "Apomorphine SC 5 mg SC SC"
                },
                {
                  "text": "6 mg SC",
                  "orderSentence": "Apomorphine SC 6 mg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "Test dose 2 mg; titrate by 1 mg to effect; max 6 mg; pretreat with trimethobenzamide",
              "orderSentence": "Apomorphine SC 2 mg SC SC"
            },
            "contraindications": "Concurrent 5-HT3 antagonists (ondansetron); severe hypotension",
            "monitoring": "BP, nausea; may cause severe hypotension",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch",
            "route": "TD",
            "indication": "NPO patient; bridge therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg/24hr",
                  "orderSentence": "Rotigotine patch 2 mg/24hr TD"
                },
                {
                  "text": "4 mg/24hr",
                  "orderSentence": "Rotigotine patch 4 mg/24hr TD"
                },
                {
                  "text": "6 mg/24hr patch",
                  "orderSentence": "Rotigotine patch 6 mg/24hr patch TD"
                }
              ],
              "route": "TD",
              "instructions": "Apply patch equivalent to oral dopamine agonist dose; onset 2-3 hours",
              "orderSentence": "Rotigotine patch 2 mg/24hr TD"
            },
            "contraindications": "Sulfite allergy (adhesive)",
            "monitoring": "Application site reactions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Trimethobenzamide",
            "route": "IM/PO",
            "indication": "Pretreat before apomorphine to prevent nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg IM/PO",
                  "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "300 mg TID starting 3 days before apomorphine initiation",
              "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
            },
            "contraindications": "Hypersensitivity",
            "monitoring": "Drowsiness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Carbidopa-Levodopa IR (Sinemet)",
            "route": "PO",
            "indication": "Motor symptoms; first-line dopaminergic therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 TID",
                  "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
                },
                {
                  "text": "25/250 TID",
                  "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/250 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 TID; titrate by 1 tablet q1-2wk; typical target 25/100-25/250 TID",
              "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
            },
            "contraindications": "Active psychosis; MAOIs within 14 days",
            "monitoring": "Dyskinesias, nausea, orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa CR (Sinemet CR)",
            "route": "PO",
            "indication": "Nocturnal symptoms; wearing off",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 CR qHS",
                  "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
                },
                {
                  "text": "50/200 CR BID",
                  "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 50/200 CR BID PO"
                }
              ],
              "route": "PO",
              "instructions": "25/100 to 50/200 CR at bedtime or BID; 70% bioavailability vs IR",
              "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa ER (Rytary)",
            "route": "PO",
            "indication": "Motor fluctuations; extend levodopa effect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "23.75/95 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
                },
                {
                  "text": "36.25/145 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 36.25/145 TID PO"
                },
                {
                  "text": "48.75/195 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 48.75/195 TID PO"
                },
                {
                  "text": "61.25/245 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 61.25/245 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Convert from IR using manufacturer table; typically TID dosing",
              "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pramipexole",
            "route": "PO",
            "indication": "Adjunct to levodopa; monotherapy in early PD; tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg TID",
                  "orderSentence": "Pramipexole 0.125 mg TID PO"
                },
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Pramipexole 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Pramipexole 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Pramipexole 1 mg TID PO"
                },
                {
                  "text": "1.5 mg TID",
                  "orderSentence": "Pramipexole 1.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg TID; titrate by 0.125-0.25 mg TID q5-7 days; max 1.5 mg TID",
              "orderSentence": "Pramipexole 0.125 mg TID PO"
            },
            "contraindications": "Impulse control history",
            "monitoring": "Impulse control disorders, somnolence, leg edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole",
            "route": "PO",
            "indication": "Adjunct or monotherapy; similar to pramipexole",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Ropinirole 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Ropinirole 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Ropinirole 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Ropinirole 2 mg TID PO"
                },
                {
                  "text": "3 mg TID",
                  "orderSentence": "Ropinirole 3 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg TID; titrate weekly; max 8 mg TID",
              "orderSentence": "Ropinirole 0.25 mg TID PO"
            },
            "contraindications": "Same as pramipexole",
            "monitoring": "Same as pramipexole",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole XL",
            "route": "PO",
            "indication": "Extended-release option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg daily",
                  "orderSentence": "Ropinirole XL 2 mg daily PO"
                },
                {
                  "text": "4 mg daily",
                  "orderSentence": "Ropinirole XL 4 mg daily PO"
                },
                {
                  "text": "6 mg daily",
                  "orderSentence": "Ropinirole XL 6 mg daily PO"
                },
                {
                  "text": "8 mg daily",
                  "orderSentence": "Ropinirole XL 8 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg daily; titrate by 2 mg q1-2wk; max 24 mg daily",
              "orderSentence": "Ropinirole XL 2 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Selegiline",
            "route": "PO",
            "indication": "MAO-B inhibitor; adjunct; mild neuroprotection theory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Selegiline 5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg at breakfast and lunch (avoid evening due to insomnia); max 10 mg/day",
              "orderSentence": "Selegiline 5 mg BID PO"
            },
            "contraindications": "MAOIs; meperidine; TCAs (caution)",
            "monitoring": "Insomnia, hypertensive crisis with tyramine (rare at this dose)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rasagiline",
            "route": "PO",
            "indication": "MAO-B inhibitor; once daily; adjunct or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg daily",
                  "orderSentence": "Rasagiline 0.5 mg daily PO"
                },
                {
                  "text": "1 mg daily",
                  "orderSentence": "Rasagiline 1 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5-1 mg daily; max 1 mg daily",
              "orderSentence": "Rasagiline 0.5 mg daily PO"
            },
            "contraindications": "Same as selegiline",
            "monitoring": "Hypertensive crisis (rare); serotonin syndrome with other serotonergics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Safinamide",
            "route": "PO",
            "indication": "MAO-B inhibitor with additional mechanisms; adjunct in fluctuations",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Safinamide 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Safinamide 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; may increase to 100 mg daily after 2 weeks",
              "orderSentence": "Safinamide 50 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; MAOIs; opioids",
            "monitoring": "Same as rasagiline; may improve dyskinesia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Entacapone",
            "route": "PO",
            "indication": "COMT inhibitor; extends levodopa effect; wearing off",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg with each levodopa dose",
                  "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
                }
              ],
              "route": "PO",
              "instructions": "200 mg with each levodopa dose; max 8 doses (1600 mg)/day",
              "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs",
            "monitoring": "Diarrhea, orange urine, dyskinesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Opicapone",
            "route": "PO",
            "indication": "COMT inhibitor; once daily alternative to entacapone",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Opicapone 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg once daily at bedtime; take 1 hour before or after levodopa",
              "orderSentence": "Opicapone 50 mg qHS PO"
            },
            "contraindications": "Pheochromocytoma; paraganglioma",
            "monitoring": "Dyskinesias, constipation, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Dyskinesia reduction; mild motor benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Amantadine 100 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; titrate to 100 mg BID-TID; max 400 mg/day; dose-reduce in renal impairment",
              "orderSentence": "Amantadine 100 mg BID PO"
            },
            "contraindications": "End-stage renal disease; seizure history",
            "monitoring": "Livedo reticularis, ankle edema, confusion, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine ER (Gocovri)",
            "route": "PO",
            "indication": "Dyskinesia; extended-release taken at bedtime",
            "dosing": {
              "doseOptions": [
                {
                  "text": "137 mg qHS",
                  "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
                },
                {
                  "text": "274 mg qHS",
                  "orderSentence": "Amantadine ER (Gocovri) 274 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 137 mg qHS; increase to 274 mg qHS after 1 week",
              "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trihexyphenidyl",
            "route": "PO",
            "indication": "Tremor-dominant PD; younger patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Trihexyphenidyl 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Trihexyphenidyl 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg TID; titrate by 2 mg/day q3-5 days; max 15 mg/day",
              "orderSentence": "Trihexyphenidyl 1 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; dementia; age >70",
            "monitoring": "Cognitive impairment, dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benztropine",
            "route": "PO",
            "indication": "Alternative anticholinergic for tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Benztropine 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Benztropine 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Benztropine 2 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg BID; titrate slowly; max 6 mg/day",
              "orderSentence": "Benztropine 0.5 mg BID PO"
            },
            "contraindications": "Same as trihexyphenidyl",
            "monitoring": "Same as trihexyphenidyl",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Istradefylline",
            "route": "PO",
            "indication": "Adenosine A2A antagonist; adjunct for OFF time",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Istradefylline 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Istradefylline 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; may increase to 40 mg daily",
              "orderSentence": "Istradefylline 20 mg daily PO"
            },
            "contraindications": "Strong CYP3A4 inducers",
            "monitoring": "Dyskinesias, dizziness, constipation, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Non-Motor Symptom Treatments": [
          {
            "item": "Pimavanserin (Nuplazid)",
            "route": "PO",
            "indication": "Parkinson's disease psychosis (hallucinations, delusions)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg daily",
                  "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration needed",
              "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; QT prolongation",
            "monitoring": "QTc, efficacy assessment at 6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Psychosis; alternative if pimavanserin unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Quetiapine 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly by 12.5-25 mg q3-7d; typical max 150 mg/day",
              "orderSentence": "Quetiapine 12.5 mg qHS PO"
            },
            "contraindications": "Dementia with Lewy bodies (black box)",
            "monitoring": "Sedation, metabolic effects, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clozapine",
            "route": "PO",
            "indication": "Refractory psychosis; best evidence but monitoring required",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6.25 mg qHS",
                  "orderSentence": "Clozapine 6.25 mg qHS PO"
                },
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Clozapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Clozapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Clozapine 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6.25-12.5 mg qHS; titrate by 12.5 mg q1-2wk; max 50-100 mg/day in PD",
              "orderSentence": "Clozapine 6.25 mg qHS PO"
            },
            "contraindications": "REMS enrollment required",
            "monitoring": "ANC weekly x 6 mo, then q2wk x 6 mo, then monthly; agranulocytosis risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine (Exelon)",
            "route": "PO/Patch",
            "indication": "Parkinson's disease dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 3 mg BID PO/Patch"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 4.5 mg BID PO/Patch"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 6 mg BID PO/Patch"
                },
                {
                  "text": "9.5 mg/24hr patch",
                  "orderSentence": "Rivastigmine (Exelon) 9.5 mg/24hr patch PO/Patch"
                },
                {
                  "text": "13.3 mg/24hr patch",
                  "orderSentence": "Rivastigmine (Exelon) 13.3 mg/24hr patch PO/Patch"
                }
              ],
              "route": "PO/Patch",
              "instructions": "Start 1.5 mg BID or 4.6 mg/24hr patch; titrate monthly; max 6 mg BID or 13.3 mg/24hr",
              "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Nausea, weight loss, tremor worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Parkinson's disease dementia; once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; increase to 10 mg after 4-6 weeks",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "GI bleeding; sick sinus syndrome",
            "monitoring": "Nausea, bradycardia, vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Confusion, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (before arising, before lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
            "monitoring": "Supine BP (must avoid lying flat for 4 hours after dose)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
            },
            "contraindications": "Supine hypertension",
            "monitoring": "Supine BP, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily; max 0.3 mg",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; renal failure; severe hypertension",
            "monitoring": "K+, edema, supine BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression in PD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg daily",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs within 14 days",
            "monitoring": "Serotonin syndrome (caution with MAO-B inhibitors)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression; anxiety in PD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "Same as sertraline",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation (ubiquitous in PD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna + docusate",
            "route": "PO",
            "indication": "Constipation stimulant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets qHS",
                  "orderSentence": "Senna + docusate 2 tablets qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets qHS; may increase to 4 tablets",
              "orderSentence": "Senna + docusate 2 tablets qHS PO"
            },
            "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
            "monitoring": "Electrolytes with chronic use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "REM sleep behavior disorder",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Clonazepam 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Clonazepam 0.5 mg qHS PO"
                },
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Clonazepam 1 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg qHS; titrate to effect; typical 0.5-1 mg",
              "orderSentence": "Clonazepam 0.25 mg qHS PO"
            },
            "contraindications": "Severe sleep apnea; respiratory compromise",
            "monitoring": "Sedation, falls, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "REM sleep behavior disorder; sleep disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                },
                {
                  "text": "12 mg qHS",
                  "orderSentence": "Melatonin 12 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3-6 mg qHS; may increase to 12 mg",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (drooling)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Glycopyrrolate 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Glycopyrrolate 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg TID; titrate to effect; max 2 mg TID",
              "orderSentence": "Glycopyrrolate 1 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (salivary glands)",
            "route": "IM",
            "indication": "Sialorrhea refractory to oral therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 units total",
                  "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "30-50 units per parotid, 10-20 units per submandibular; repeat q3-4 months",
              "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
            },
            "contraindications": "Infection at site",
            "monitoring": "Dysphagia (rare), dry mouth",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Advanced Therapies": [
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Motor fluctuations or tremor refractory to optimal medication",
            "dosing": {
              "doseOptions": [
                {
                  "text": "STN or GPi stimulation",
                  "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Unilateral or bilateral; programming done over weeks post-op",
              "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
            },
            "pretreatment": "Neuropsych testing, MRI, off-medication evaluation",
            "contraindications": "Dementia; active psychiatric disease; medical comorbidities",
            "monitoring": "Programming optimization; battery checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levodopa-carbidopa intestinal gel (Duopa)",
            "route": "Enteral",
            "indication": "Severe motor fluctuations; 4+ hours OFF/day",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Continuous infusion",
                  "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
                }
              ],
              "route": "Enteral",
              "instructions": "Via PEG-J; 16-hour infusion; morning bolus + continuous rate + extra doses",
              "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
            },
            "pretreatment": "GI tract accessible",
            "contraindications": "GI disease preventing PEG-J; coagulopathy",
            "monitoring": "Tube site, infections, GI complications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apomorphine continuous infusion",
            "route": "SC",
            "indication": "Severe motor fluctuations; not DBS candidate",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-8 mg/hr continuous",
                  "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
                }
              ],
              "route": "SC",
              "instructions": "Via subcutaneous pump; typical 3-8 mg/hr during waking hours",
              "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
            },
            "pretreatment": "Caregiver training",
            "contraindications": "Same as SC apomorphine",
            "monitoring": "Same as SC apomorphine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders specialist for diagnosis confirmation and advanced therapy evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance exercises, and LSVT BIG program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation and fine motor strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy (LSVT LOUD) for hypophonia and swallowing evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for cognitive assessment and DBS candidacy evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression, anxiety, impulse control disorders, or psychosis management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced disease symptom management and goals of care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and disability planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology for urinary symptoms not responsive to first-line treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for severe constipation or Duopa tube placement",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Do not skip or delay levodopa doses as this can cause severe OFF episodes and immobility",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take levodopa 30-60 minutes before meals for better absorption (protein competes with levodopa transport)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform all healthcare providers about PD medications to avoid drug interactions (especially antipsychotics, antiemetics)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new impulsive behaviors (gambling, shopping, hypersexuality) which may indicate impulse control disorder from dopamine agonists",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report hallucinations early as these can be managed with medication adjustment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in regular exercise which may slow disease progression and improves mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (30-60 min, 3-5x/week) improves motor function and may be neuroprotective",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Tai chi or dance-based exercise programs improve balance and reduce falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "High-fiber diet and adequate hydration to prevent constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen parkinsonism (metoclopramide, prochlorperazine, haloperidol, risperidone)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet may have protective benefits based on observational studies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Coffee consumption associated with reduced PD risk; continued moderate use reasonable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Drug-induced parkinsonism",
        "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no levodopa response",
        "tests": "DaTscan normal; history of causative medication"
      },
      {
        "diagnosis": "Vascular parkinsonism",
        "features": "Stepwise progression; lower body predominant; vascular risk factors; pyramidal signs",
        "tests": "MRI with subcortical/basal ganglia infarcts"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Early falls; vertical gaze palsy; axial rigidity > limb; poor levodopa response",
        "tests": "MRI \"hummingbird sign\"; clinical criteria"
      },
      {
        "diagnosis": "Multiple system atrophy (MSA)",
        "features": "Severe dysautonomia; cerebellar signs; stridor; poor levodopa response",
        "tests": "MRI \"hot cross bun\" sign; MIBG preserved"
      },
      {
        "diagnosis": "Corticobasal degeneration (CBD)",
        "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
        "tests": "MRI asymmetric cortical atrophy"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (DLB)",
        "features": "Dementia before or within 1 year of motor symptoms; fluctuating cognition; visual hallucinations",
        "tests": "Clinical criteria; DaTscan may be abnormal"
      },
      {
        "diagnosis": "Essential tremor",
        "features": "Action tremor > rest tremor; improves with alcohol; family history; no bradykinesia",
        "tests": "DaTscan normal; clinical criteria"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait apraxia (\"magnetic gait\"); urinary incontinence; dementia",
        "tests": "MRI ventricular enlargement; LP with gait improvement"
      }
    ],
    "evidence": [
      {
        "recommendation": "Levodopa most effective symptomatic treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Fahn et al. NEJM 2004 (ELLDOPA)](https://pubmed.ncbi.nlm.nih.gov/15590952/)"
      },
      {
        "recommendation": "MAO-B inhibitors provide mild motor benefit",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rascol et al. NEJM 2005 (rasagiline)](https://pubmed.ncbi.nlm.nih.gov/15728780/)"
      },
      {
        "recommendation": "Pimavanserin for PD psychosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315521/)"
      },
      {
        "recommendation": "DBS improves motor fluctuations",
        "evidenceLevel": "Class I, Level A",
        "source": "[Weaver et al. JAMA 2009](https://pubmed.ncbi.nlm.nih.gov/19126699/)"
      },
      {
        "recommendation": "Rivastigmine for PD dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
      },
      {
        "recommendation": "Exercise improves motor function",
        "evidenceLevel": "Class II, Level B",
        "source": "[Schenkman et al. JAMA Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29228079/)"
      },
      {
        "recommendation": "LSVT LOUD improves speech",
        "evidenceLevel": "Class I, Level B",
        "source": "[Ramig et al. JSLHR 2001](https://pubmed.ncbi.nlm.nih.gov/11407973/)"
      },
      {
        "recommendation": "Clonazepam and melatonin for RBD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Aurora et al. AASM 2010](https://pubmed.ncbi.nlm.nih.gov/21135521/)"
      },
      {
        "recommendation": "Amantadine reduces dyskinesia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ory-Magne et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24726067/)"
      },
      {
        "recommendation": "Duopa for motor fluctuations",
        "evidenceLevel": "Class I, Level A",
        "source": "[Olanow et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24184024/)"
      }
    ],
    "monitoring": [
      {
        "item": "Motor function (UPDRS-III or MDS-UPDRS)",
        "frequency": "Every visit",
        "action": "Adjust medications if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ON/OFF time diary",
        "frequency": "Daily for 1 week before visits",
        "action": "Add adjunct therapy; consider advanced options",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dyskinesia severity",
        "frequency": "Each visit",
        "action": "Reduce levodopa; add amantadine; adjust timing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic blood pressure",
        "frequency": "Each visit",
        "action": "Add midodrine or droxidopa",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognition (MoCA)",
        "frequency": "Annually, more often if concerns",
        "action": "Add cholinesterase inhibitor; adjust anticholinergics",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood (GDS, PHQ-9)",
        "frequency": "Annually",
        "action": "Add antidepressant; psychiatry referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Impulse control screen (QUIP)",
        "frequency": "Each visit if on dopamine agonist",
        "action": "Reduce or discontinue dopamine agonist",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; medication review; home safety evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Annually or if symptoms",
        "action": "Speech therapy; modify diet",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ANC (if on clozapine)",
        "frequency": "Per REMS protocol",
        "action": "Hold clozapine if ANC <1000; discontinue if <500",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable motor status; able to take PO; adequate caregiver support; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Unable to take PO medications >24 hours; severe OFF episode; aspiration pneumonia; acute infection"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Neuroleptic malignant syndrome; severe rigidity with rhabdomyolysis; respiratory compromise"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for stable patients; more frequently during medication adjustments"
      }
    ]
  },
  "Cluster Headache": {
    "id": "cluster-headache",
    "title": "Cluster Headache",
    "version": "1.0",
    "icd10": [
      "** G44.009 (Cluster headache syndrome",
      "unspecified)"
    ],
    "scope": "** Acute cluster headache attack treatment, transitional therapy, and preventive therapy for episodic and chronic cluster headache. Excludes other trigeminal autonomic cephalalgias (paroxysmal hemicrania, SUNCT/SUNA - separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Baseline before starting preventive therapy; rule out infection",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Baseline renal function before lithium or other preventives",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can mimic or exacerbate headache; baseline for lithium",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Baseline hepatic function before verapamil, valproate",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Pituitary function panel (FSH, LH, prolactin, IGF-1, cortisol)",
            "rationale": "Atypical features or pituitary lesion on imaging",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lithium level",
            "rationale": "Monitoring when on lithium therapy",
            "target": "0.6-1.0 mEq/L therapeutic range",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Calcium, PTH",
            "rationale": "Lithium-induced hypercalcemia monitoring",
            "target": "Normal calcium; PTH not elevated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free T4",
            "rationale": "Lithium-induced thyroid dysfunction monitoring",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BUN, creatinine",
            "rationale": "Lithium nephrotoxicity monitoring",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ESR, CRP",
            "rationale": "Atypical features; rule out giant cell arteritis in older patients",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Growth hormone stimulation test",
            "rationale": "Suspected pituitary adenoma with GH deficiency",
            "target": "Normal response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "rationale": "Suspected obstructive sleep apnea as trigger",
            "target": "AHI <5 (normal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain with pituitary protocol",
            "timing": "New diagnosis of cluster headache",
            "target": "Normal; exclude pituitary lesion, hypothalamic lesion, cavernous sinus pathology",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head",
            "timing": "Suspected vascular etiology; atypical features",
            "target": "No aneurysm, dissection, vascular malformation",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI orbits with contrast",
            "timing": "Orbital pain, suspected retro-orbital pathology",
            "target": "No orbital mass, Tolosa-Hunt syndrome",
            "contraindications": "Gadolinium allergy, severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "MRI unavailable; acute presentation",
            "target": "No acute pathology",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Urgent vascular imaging if MRI unavailable",
            "target": "No aneurysm, dissection",
            "contraindications": "Contrast allergy, CKD",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRV Brain",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CT sinuses",
            "timing": "Suspected sinus pathology contributing",
            "target": "No sinusitis, mucocele",
            "contraindications": "Pregnancy (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Carotid Doppler ultrasound",
            "timing": "Suspected carotid dissection",
            "target": "No dissection",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Abortive Therapy for Active Attacks)": [
          {
            "item": "High-flow oxygen",
            "route": "INH",
            "indication": "First-line abortive; most effective acute treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100% at 12-15 L/min x 15-20 min",
                  "orderSentence": "High-flow oxygen 100% at 12-15 L/min x 15-20 min INH"
                }
              ],
              "route": "INH",
              "instructions": "100% O2 via non-rebreather mask at 12-15 L/min for 15-20 min; patient seated, leaning forward; may repeat",
              "orderSentence": "High-flow oxygen 100% at 12-15 L/min x 15-20 min INH"
            },
            "contraindications": "Severe COPD with CO2 retention (relative)",
            "monitoring": "SpO2; symptom resolution typically within 15 min",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "SC",
            "indication": "First-line abortive; rapid onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg SC",
                  "orderSentence": "Sumatriptan 6 mg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC at onset; may repeat after 1 hr if needed; max 12 mg/24hr",
              "orderSentence": "Sumatriptan 6 mg SC SC"
            },
            "contraindications": "Uncontrolled HTN; CAD; prior MI/stroke; hemiplegic migraine; MAOIs; within 24h of ergot",
            "monitoring": "Triptan sensation; monitor BP if cardiac risk factors",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "Intranasal",
            "indication": "Alternative to SC when injection not preferred",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg intranasal",
                  "orderSentence": "Sumatriptan 20 mg intranasal Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "20 mg intranasal at onset; may repeat after 2 hr; max 40 mg/24hr",
              "orderSentence": "Sumatriptan 20 mg intranasal Intranasal"
            },
            "contraindications": "Same as SC sumatriptan",
            "monitoring": "Nasal irritation; triptan sensation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan",
            "route": "Intranasal",
            "indication": "Alternative triptan; effective nasal delivery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg intranasal",
                  "orderSentence": "Zolmitriptan 5 mg intranasal Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "5 mg intranasal at onset; may repeat after 2 hr; max 10 mg/24hr",
              "orderSentence": "Zolmitriptan 5 mg intranasal Intranasal"
            },
            "contraindications": "Same as sumatriptan",
            "monitoring": "Triptan sensation; nasal discomfort",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan",
            "route": "PO",
            "indication": "Oral option when SC/nasal unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO",
                  "orderSentence": "Zolmitriptan 5 mg PO PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Zolmitriptan 10 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO at onset; may repeat after 2 hr; max 10 mg/24hr",
              "orderSentence": "Zolmitriptan 5 mg PO PO"
            },
            "contraindications": "Same as sumatriptan",
            "monitoring": "Triptan sensation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Octreotide",
            "route": "SC",
            "indication": "Second-line; triptan contraindications or failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mcg SC",
                  "orderSentence": "Octreotide 100 mcg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "100 mcg SC at onset; may repeat once after 1 hr",
              "orderSentence": "Octreotide 100 mcg SC SC"
            },
            "contraindications": "Gallbladder disease; diabetes (may alter glucose)",
            "monitoring": "Blood glucose; GI symptoms",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lidocaine",
            "route": "Intranasal",
            "indication": "Adjunctive therapy; sphenopalatine ganglion block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mL of 4-10% solution",
                  "orderSentence": "Lidocaine 1 mL of 4-10% solution Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "Instill 1 mL of 4-10% lidocaine into nostril ipsilateral to pain; head tilted back 45 degrees toward affected side; may repeat x1",
              "orderSentence": "Lidocaine 1 mL of 4-10% solution Intranasal"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "Numbness; bitter taste",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Transitional Therapy (Bridge Until Preventive Takes Effect)": [
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Rapid cluster suppression; bridge to verapamil",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily x 5 days",
                  "orderSentence": "Prednisone 60 mg daily x 5 days PO"
                },
                {
                  "text": "40 mg daily x 5 days",
                  "orderSentence": "Prednisone 40 mg daily x 5 days PO"
                },
                {
                  "text": "20 mg daily x 5 days",
                  "orderSentence": "Prednisone 20 mg daily x 5 days PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60-80 mg daily x 5 days, taper by 10-20 mg q5d over 2-3 weeks; limit to 2-3 courses/year",
              "orderSentence": "Prednisone 60 mg daily x 5 days PO"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI bleeding; psychosis history",
            "monitoring": "Glucose; BP; mood changes; sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV/PO",
            "indication": "Alternative steroid; hospitalized patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg IV/PO daily x 3-5 days",
                  "orderSentence": "Dexamethasone 8 mg IV/PO daily x 3-5 days IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV or PO daily x 3-5 days, then taper or switch to prednisone",
              "orderSentence": "Dexamethasone 8 mg IV/PO daily x 3-5 days IV/PO"
            },
            "contraindications": "Same as prednisone",
            "monitoring": "Glucose; BP",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Greater occipital nerve block",
            "route": "SC",
            "indication": "Transitional therapy; rapid reduction in attack frequency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL 2% lidocaine + 40 mg triamcinolone",
                  "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine + 40 mg triamcinolone SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject 2-3 mL of 2% lidocaine + 40 mg triamcinolone (or 6 mg betamethasone) at greater occipital nerve ipsilateral to pain; may do bilaterally",
              "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine + 40 mg triamcinolone SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site; anticoagulation (relative)",
            "monitoring": "Immediate relief; vasovagal reaction; alopecia at injection site",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "Status cluster; refractory attacks; inpatient protocol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV q8h x 5 days",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h x 5 days IV"
                },
                {
                  "text": "1 mg IV q8h x 5 days",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg IV q8h x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q8h (after test dose 0.25-0.5 mg) for 3-5 days; pretreat with antiemetic; requires telemetry",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h x 5 days IV"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; peripheral vascular disease; use within 24h of triptan; hepatic/renal impairment; sepsis",
            "monitoring": "BP; ECG monitoring; nausea; leg cramps; paresthesias",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "SC/IM",
            "indication": "Home transitional therapy; bridge after inpatient protocol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg SC/IM at onset",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg SC/IM at onset SC/IM"
                }
              ],
              "route": "SC/IM",
              "instructions": "1 mg SC or IM at onset of attack; max 3 mg/24hr; max 6 mg/week",
              "orderSentence": "Dihydroergotamine (DHE) 1 mg SC/IM at onset SC/IM"
            },
            "contraindications": "Same as IV DHE",
            "monitoring": "Same as IV DHE",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Acute Treatments)": [
          {
            "item": "Sphenopalatine ganglion block",
            "route": "Intranasal",
            "indication": "Refractory acute attacks; alternative to nerve block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mL 0.5% bupivacaine",
                  "orderSentence": "Sphenopalatine ganglion block 0.3 mL 0.5% bupivacaine Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "Apply 0.3 mL of 0.5% bupivacaine via intranasal catheter (Tx360, SphenoCath) to sphenopalatine ganglion",
              "orderSentence": "Sphenopalatine ganglion block 0.3 mL 0.5% bupivacaine Intranasal"
            },
            "contraindications": "Local anesthetic allergy; nasal pathology",
            "monitoring": "Local numbness; epistaxis; vasovagal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketamine",
            "route": "Intranasal",
            "indication": "Refractory attacks; investigational",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-75 mg intranasal",
                  "orderSentence": "Ketamine 50-75 mg intranasal Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "50-75 mg intranasal via atomizer; may repeat x1",
              "orderSentence": "Ketamine 50-75 mg intranasal Intranasal"
            },
            "contraindications": "Uncontrolled HTN; psychosis; increased ICP",
            "monitoring": "Dissociation; BP; HR",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ergotamine tartrate",
            "route": "SL/PO",
            "indication": "Alternative when DHE unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg SL at onset",
                  "orderSentence": "Ergotamine tartrate 2 mg SL at onset SL"
                }
              ],
              "route": "SL",
              "instructions": "2 mg sublingual at onset; may repeat 1-2 mg q30min; max 6 mg/attack, 10 mg/week",
              "orderSentence": "Ergotamine tartrate 2 mg SL at onset SL"
            },
            "contraindications": "Same as DHE",
            "monitoring": "Nausea; peripheral vasoconstriction",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Preventive Therapies": [
          {
            "item": "Verapamil",
            "route": "PO",
            "indication": "First-line preventive; episodic and chronic CH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg TID",
                  "orderSentence": "Verapamil 80 mg TID PO"
                },
                {
                  "text": "120 mg TID",
                  "orderSentence": "Verapamil 120 mg TID PO"
                },
                {
                  "text": "160 mg TID",
                  "orderSentence": "Verapamil 160 mg TID PO"
                },
                {
                  "text": "240 mg TID",
                  "orderSentence": "Verapamil 240 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 80 mg TID; increase by 80 mg q10-14d as tolerated; target 240-480 mg TID (720-960 mg/day total); some patients require up to 960 mg/day",
              "orderSentence": "Verapamil 80 mg TID PO"
            },
            "pretreatment": "Baseline ECG; repeat ECG with each dose increase",
            "contraindications": "Second/third-degree heart block; sick sinus syndrome; severe hypotension; decompensated HF; concurrent beta-blocker (relative)",
            "monitoring": "ECG before each dose increase (monitor PR interval >0.24s or 40% increase); HR; BP; constipation; edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lithium carbonate",
            "route": "PO",
            "indication": "Chronic cluster headache; verapamil failure/intolerance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lithium carbonate 300 mg BID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Lithium carbonate 300 mg TID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Lithium carbonate 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Lithium carbonate 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; titrate by 300 mg q3-7d to target level 0.6-1.0 mEq/L; typical dose 600-1200 mg/day",
              "orderSentence": "Lithium carbonate 300 mg BID PO"
            },
            "pretreatment": "Baseline TSH, BMP, calcium, ECG",
            "contraindications": "Renal impairment; sick sinus syndrome; pregnancy; Brugada syndrome; concurrent NSAIDs/ACE-I/thiazides",
            "monitoring": "Lithium level q1wk during titration, then q1-3mo; TSH, creatinine, calcium q3-6mo; tremor; polyuria",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Preventive; especially with comorbid migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Topiramate 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 100-200 mg/day divided BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Glaucoma; kidney stones; pregnancy; metabolic acidosis",
            "monitoring": "Cognitive effects; paresthesias; weight; serum bicarbonate; kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "FDA-approved for episodic cluster headache; CGRP mAb",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg SC monthly",
                  "orderSentence": "Galcanezumab (Emgality) 300 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "300 mg SC (3 consecutive 100 mg injections) at onset of cluster period; repeat monthly during cluster period",
              "orderSentence": "Galcanezumab (Emgality) 300 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to galcanezumab",
            "monitoring": "Injection site reactions; constipation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Adjunctive prevention; circadian dysregulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Melatonin 10 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Melatonin 15 mg qHS PO"
                },
                {
                  "text": "20 mg qHS",
                  "orderSentence": "Melatonin 20 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg PO 30 min before bedtime; may help regulate cluster periodicity",
              "orderSentence": "Melatonin 10 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "None significant",
            "monitoring": "Sedation; morning grogginess",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Alternative preventive; especially with comorbid epilepsy/mood disorder",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "500 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 500 mg ER daily PO"
                },
                {
                  "text": "1000 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 1000 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1500 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "pretreatment": "LFTs, CBC",
            "contraindications": "Hepatic disease; pregnancy (teratogen); urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs q6mo; CBC; ammonia if AMS; weight; hair loss; tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Alternative preventive; trigeminal autonomic pathway modulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; titrate by 5 mg/dose q3d; target 30-60 mg/day divided TID",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "pretreatment": "None",
            "contraindications": "Withdrawal if abrupt discontinuation; renal impairment (reduce dose)",
            "monitoring": "Sedation; weakness; withdrawal syndrome; do not stop abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Alternative preventive; neuropathic pain component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q1-3d; target 1800-3600 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Reduce dose in renal impairment",
            "monitoring": "Sedation; dizziness; edema; weight gain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Refractory/Interventional Therapies": [
          {
            "item": "Occipital nerve stimulation",
            "route": "Implant",
            "indication": "Chronic refractory cluster headache; failed multiple preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - surgical implant",
                  "orderSentence": "Occipital nerve stimulation N/A - surgical implant Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Percutaneous or surgical implantation of occipital nerve stimulator; specialist referral required",
              "orderSentence": "Occipital nerve stimulation N/A - surgical implant Implant"
            },
            "pretreatment": "Neurosurgical evaluation; psychological screening; failed at least 3 preventive medications",
            "contraindications": "Active infection; coagulopathy; psychiatric instability",
            "monitoring": "Post-implant follow-up; battery life; lead migration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation",
            "route": "Implant",
            "indication": "Severe refractory chronic CH; last resort",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - surgical implant",
                  "orderSentence": "Deep brain stimulation N/A - surgical implant Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Targeting posterior hypothalamus; investigational; specialist center only",
              "orderSentence": "Deep brain stimulation N/A - surgical implant Implant"
            },
            "pretreatment": "Extensive workup; ethics committee review; failed all other options",
            "contraindications": "Same as ONS; structural brain abnormality",
            "monitoring": "Long-term neurological monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sphenopalatine ganglion stimulation",
            "route": "Implant",
            "indication": "Refractory CH; acute and preventive effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - surgical implant",
                  "orderSentence": "Sphenopalatine ganglion stimulation N/A - surgical implant Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Pulsante SPG microstimulator; patient-controlled acute therapy",
              "orderSentence": "Sphenopalatine ganglion stimulation N/A - surgical implant Implant"
            },
            "pretreatment": "Neurosurgical evaluation; imaging confirmation",
            "contraindications": "Facial/jaw abnormalities; active infection",
            "monitoring": "Lead integrity; battery; efficacy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Radiofrequency ablation trigeminal ganglion",
            "route": "Procedure",
            "indication": "Refractory chronic CH; trigeminal nerve modulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - procedure",
                  "orderSentence": "Radiofrequency ablation trigeminal ganglion N/A - procedure Procedure"
                }
              ],
              "route": "Procedure",
              "instructions": "Percutaneous RF ablation; provides 6-18 months relief; may need repeat",
              "orderSentence": "Radiofrequency ablation trigeminal ganglion N/A - procedure Procedure"
            },
            "pretreatment": "Facial imaging; failed medical therapy",
            "contraindications": "Anticoagulation; infection; facial numbness intolerance",
            "monitoring": "Facial sensation; corneal reflex; recurrence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Headache specialist/Neurology referral for diagnosis confirmation and preventive therapy optimization",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management referral for interventional procedures (nerve blocks, neuromodulation evaluation) in refractory cases",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine evaluation for polysomnography if obstructive sleep apnea suspected as cluster trigger",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology referral if pituitary abnormality identified on imaging or atypical hormone levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for neuromodulation or ablative procedures in medically refractory cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cardiology clearance before initiating high-dose verapamil in patients with cardiac history",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry referral for suicidal ideation screening given high depression/suicide risk in cluster headache patients",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for sudden severe headache different from typical cluster attacks which may indicate new pathology",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep high-flow oxygen available at home during cluster period for acute attack treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use sumatriptan injection at first sign of attack for fastest relief; do not wait for pain to worsen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain detailed headache diary including attack timing, duration, severity, and treatment response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known triggers during cluster period especially alcohol (even small amounts), strong odors, and napping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not abruptly stop preventive medications especially lithium and baclofen which require gradual taper",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry injectable sumatriptan at all times during active cluster period for emergency use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alert healthcare providers to cluster headache diagnosis as this affects anesthesia and medication choices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict alcohol avoidance during entire cluster period as even small amounts trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule with consistent bedtime and wake time to regulate circadian rhythm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid daytime napping during cluster period as sleep transitions can trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk and potential cluster exacerbation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid high altitude exposure during cluster period if altitude is a known trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid vasodilators (nitroglycerin, sildenafil) during cluster period as these trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Screen for and treat obstructive sleep apnea as treatment may reduce cluster frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques as emotional stress may influence cluster cycle onset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid strong chemical odors (solvents, perfumes, gasoline) which can trigger attacks in some patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine",
        "features": "Longer duration (4-72 hrs); bilateral or alternating sides; nausea/vomiting prominent; photophobia/phonophobia; no autonomic features",
        "tests": "Clinical criteria (ICHD-3); MRI if new onset"
      },
      {
        "diagnosis": "Paroxysmal hemicrania",
        "features": "Shorter attacks (2-30 min); more frequent (>5/day); absolute response to indomethacin",
        "tests": "Indomethacin trial (150-225 mg/day); complete response diagnostic"
      },
      {
        "diagnosis": "SUNCT/SUNA",
        "features": "Very brief attacks (seconds to minutes); very frequent (up to 200/day); triggered by cutaneous stimuli",
        "tests": "Clinical criteria; may have refractory period; no response to indomethacin"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Electric shock-like pain; seconds duration; triggered by touch, chewing, talking; refractory period",
        "tests": "MRI for vascular compression; response to carbamazepine"
      },
      {
        "diagnosis": "Hemicrania continua",
        "features": "Continuous baseline pain with superimposed exacerbations; unilateral; autonomic features",
        "tests": "Absolute response to indomethacin diagnostic"
      },
      {
        "diagnosis": "Primary stabbing headache",
        "features": "Ultra-short jabs (seconds); unpredictable location; no autonomic features",
        "tests": "Clinical diagnosis; exclusion of secondary causes"
      },
      {
        "diagnosis": "Secondary cluster headache",
        "features": "Atypical features; pituitary or hypothalamic lesion; carotid dissection",
        "tests": "MRI with pituitary protocol; MRA head/neck"
      },
      {
        "diagnosis": "Tolosa-Hunt syndrome",
        "features": "Painful ophthalmoplegia; orbital pain; CN III, IV, VI involvement",
        "tests": "MRI orbits with contrast; CSF if needed; steroid response"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; scalp tenderness; jaw claudication; visual symptoms; elevated ESR/CRP",
        "tests": "ESR, CRP; temporal artery biopsy"
      },
      {
        "diagnosis": "Carotid dissection",
        "features": "Neck pain; Horner syndrome; stroke symptoms",
        "tests": "CTA or MRA neck; carotid ultrasound"
      }
    ],
    "evidence": [
      {
        "recommendation": "High-flow oxygen (100% at 12-15 L/min) first-line abortive",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cohen et al. JAMA 2009](https://pubmed.ncbi.nlm.nih.gov/20040554/)"
      },
      {
        "recommendation": "Subcutaneous sumatriptan 6 mg effective for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[The Sumatriptan Cluster Headache Study Group. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1652413/)"
      },
      {
        "recommendation": "Intranasal zolmitriptan 5-10 mg effective for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cittadini et al. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/17101886/)"
      },
      {
        "recommendation": "Verapamil first-line preventive for episodic and chronic CH",
        "evidenceLevel": "Class I, Level C (expert consensus)",
        "source": "[May et al. Cephalalgia 2006](https://pubmed.ncbi.nlm.nih.gov/16919064/)"
      },
      {
        "recommendation": "Galcanezumab FDA-approved for episodic cluster headache",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goadsby et al. NEJM 2019](https://pubmed.ncbi.nlm.nih.gov/30860986/)"
      },
      {
        "recommendation": "Greater occipital nerve block effective as transitional therapy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ambrosini et al. Pain 2005](https://pubmed.ncbi.nlm.nih.gov/15885916/)"
      },
      {
        "recommendation": "Lithium effective for chronic cluster headache prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Steiner et al. Headache 1997](https://pubmed.ncbi.nlm.nih.gov/9227503/)"
      },
      {
        "recommendation": "Prednisone taper effective transitional therapy",
        "evidenceLevel": "Class II, Level C",
        "source": "[Obermann et al. Curr Pain Headache Rep 2011](https://pubmed.ncbi.nlm.nih.gov/21069491/)"
      },
      {
        "recommendation": "Octreotide effective when triptans contraindicated",
        "evidenceLevel": "Class II, Level B",
        "source": "[Matharu et al. Ann Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15349875/)"
      },
      {
        "recommendation": "Melatonin 10 mg may reduce attack frequency",
        "evidenceLevel": "Class II, Level C",
        "source": "[Leone et al. Cephalalgia 1996](https://pubmed.ncbi.nlm.nih.gov/8980856/)"
      },
      {
        "recommendation": "Occipital nerve stimulation for refractory chronic CH",
        "evidenceLevel": "Class III, Level C",
        "source": "[Burns et al. Lancet 2007](https://pubmed.ncbi.nlm.nih.gov/17336639/)"
      },
      {
        "recommendation": "European Headache Federation cluster headache guidelines",
        "evidenceLevel": "Guideline",
        "source": "[Mitsikostas et al. J Headache Pain 2023](https://pubmed.ncbi.nlm.nih.gov/36577931/)"
      }
    ],
    "monitoring": [
      {
        "item": "Attack frequency diary",
        "frequency": "Daily during cluster",
        "action": "Escalate preventive therapy; consider transitional bridge",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on verapamil)",
        "frequency": "Baseline and with each dose increase",
        "action": "Hold dose increase; may need cardiology clearance",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Heart rate (if on verapamil)",
        "frequency": "Each visit",
        "action": "Reduce dose; consider alternative",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lithium level",
        "frequency": "Weekly during titration, then q1-3 months",
        "action": "Adjust dose; assess renal function if unexpected level",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH (if on lithium)",
        "frequency": "Baseline, 3 months, then q6 months",
        "action": "Endocrine referral; may need thyroid replacement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "BUN/Creatinine (if on lithium)",
        "frequency": "Baseline, q1-3 months",
        "action": "Dose reduction; nephrology referral if progressive",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Calcium (if on lithium)",
        "frequency": "Baseline, q6 months",
        "action": "Evaluate for hyperparathyroidism",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Serum bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Reduce dose or discontinue",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression/Suicidal ideation screening",
        "frequency": "Each visit",
        "action": "Urgent psychiatric referral; crisis intervention",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Oxygen saturation (during O2 therapy)",
        "frequency": "During treatment",
        "action": "Adjust flow rate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Acute attack aborted with oxygen/triptan; stable; access to home oxygen and rescue medications; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Status cluster (continuous attacks); requires IV DHE protocol; suicidal ideation requiring monitoring; oral intake compromised"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare; only if hemodynamic instability, cardiac arrhythmia from verapamil, or severe psychiatric crisis"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Within 1-2 weeks if in active cluster period; 2-4 weeks after initiating new preventive; q3 months during remission"
      },
      {
        "disposition": "Transfer to headache center",
        "criteria": "Refractory to multiple preventives; candidate for neuromodulation; requires specialized interventional procedures"
      }
    ]
  },
  "Mild Cognitive Impairment (MCI)": {
    "id": "mild-cognitive-impairment",
    "title": "Mild Cognitive Impairment (MCI)",
    "version": "1.0",
    "icd10": [
      "** G31.84"
    ],
    "scope": "** Outpatient-focused evaluation for MCI, identification of reversible causes, subtype classification (amnestic vs non-amnestic), risk factor modification, monitoring for progression, and symptomatic treatment. Includes guidance on disease-modifying therapy eligibility (anti-amyloid agents) and advance care planning.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Anemia, infection, or malignancy contributing to cognitive changes",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CMP (BMP + hepatic panel)",
            "rationale": "Hyponatremia, uremia, hypercalcemia, hepatic encephalopathy as reversible causes",
            "target": "Normal electrolytes, renal, hepatic function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes reversible cognitive impairment; common in elderly",
            "target": ">300 pg/mL (>400 pg/mL optimal for neurological function)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment; check with B12",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes management affects cognition; vascular risk factor",
            "target": "<7% (individualize in elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting lipid panel",
            "rationale": "Vascular risk factor assessment; hyperlipidemia accelerates cognitive decline",
            "target": "LDL <100 mg/dL; <70 if established CVD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fasting)",
            "rationale": "Diabetes screening; glycemic control affects cognition",
            "target": "70-100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis is rare but treatable cause of cognitive impairment",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder; if risk factors present",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with cognitive decline and dementia risk",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels associated with Alzheimer's disease and vascular cognitive impairment",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory or autoimmune causes; vasculitis screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI in elderly can present as cognitive changes; rule out reversible cause",
            "target": "Negative for infection",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "More sensitive than B12 level for functional B12 deficiency",
            "target": "<0.4 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Heavy metal panel (lead, mercury, arsenic)",
            "rationale": "Toxic exposure history; occupational risk",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson's disease if age <50; hepatic symptoms",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Autoimmune cognitive impairment; unexplained rapid progression",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GABA-B)",
            "rationale": "Autoimmune encephalitis presenting as MCI",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (APOE genotyping)",
            "rationale": "Risk stratification for AD progression; anti-amyloid therapy planning",
            "target": "Informational (APOE4 increases risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (PSEN1, PSEN2, APP)",
            "rationale": "Familial early-onset AD (<65); family history of early-onset dementia",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area; outdoor exposure; systemic symptoms",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42 (amyloid beta 1-42)",
            "rationale": "Low in Alzheimer's pathology; biomarker confirmation",
            "target": "Low Aβ42 (<600 pg/mL) suggests AD pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau (t-tau)",
            "rationale": "Elevated in neurodegeneration; nonspecific",
            "target": "Mildly elevated in MCI due to AD; marked elevation suggests rapid progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF p-tau (phosphorylated tau 181)",
            "rationale": "Specific for AD pathology; predictor of progression",
            "target": "Elevated p-tau with low Aβ42 = high risk of AD progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio",
            "rationale": "More accurate than Aβ42 alone for amyloid status",
            "target": "<0.05-0.08 suggests amyloid positivity (assay-dependent)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF neurofilament light chain (NfL)",
            "rationale": "Nonspecific neurodegeneration marker; prognostic",
            "target": "Elevated suggests active neurodegeneration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis if RPR positive or high suspicion",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Hippocampal volume, medial temporal atrophy (Scheltens scale), white matter disease burden, rule out structural causes (tumor, SDH, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychological testing (formal)",
            "timing": "At diagnosis; gold standard for MCI characterization",
            "target": "Objective impairment 1-1.5 SD below age/education norms; preserved ADLs; characterize domain(s) affected",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mini-Mental State Examination (MMSE)",
            "timing": "Screening; serial monitoring",
            "target": "24-30 (MCI often 24-27); <24 suggests dementia",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Montreal Cognitive Assessment (MoCA)",
            "timing": "More sensitive than MMSE for MCI",
            "target": "<26 abnormal; typically 18-25 in MCI",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI contraindicated or unavailable",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain volumetrics",
            "timing": "Quantitative assessment; research/clinical trials",
            "target": "Hippocampal volume percentile for age; whole brain atrophy rate",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate underlying pathology when diagnosis uncertain",
            "target": "AD pattern: temporoparietal hypometabolism; FTD: frontal/temporal hypometabolism",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amyloid PET (florbetapir, florbetaben, flutemetamol)",
            "timing": "Diagnostic uncertainty; early-onset; anti-amyloid therapy eligibility",
            "target": "Positive confirms amyloid pathology (at risk for AD); negative makes AD unlikely",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep apnea screening; sleep disturbance affecting cognition",
            "target": "AHI <5 normal; treat if elevated",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Atypical features; concern for seizures or encephalopathy",
            "target": "Normal or mild nonspecific slowing in MCI",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Tau PET (flortaucipir)",
            "timing": "Research; disease staging; clinical trial eligibility",
            "target": "Pattern correlates with clinical syndrome; elevated tau predicts faster progression",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "MCI with parkinsonism; differentiate DLB prodrome",
            "target": "Reduced uptake suggests Lewy body pathology",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SPECT (perfusion)",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with SWI/GRE sequences",
            "timing": "Cerebral amyloid angiopathy; microbleed assessment",
            "target": "Lobar microbleeds suggest CAA; affects anti-amyloid eligibility",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic, nutritional, or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat reversible causes Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hypothyroidism, replace B12/folate, treat infections, adjust medications",
              "orderSentence": "Treat reversible causes Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment 3-6 months after treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency (<300 pg/mL or elevated MMA)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg IM daily x 7 days",
                  "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
                },
                {
                  "text": "1000 mcg IM weekly x 4",
                  "orderSentence": "Vitamin B12 1000 mcg IM weekly x 4 IM/PO"
                },
                {
                  "text": "1000-2000 mcg PO daily",
                  "orderSentence": "Vitamin B12 1000-2000 mcg PO daily IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
            },
            "contraindications": "None",
            "monitoring": "B12 level, MMA at 3 months; neurological improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "route": "PO",
            "indication": "Folate deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg PO daily",
                  "orderSentence": "Folate 1 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg PO daily; ensure B12 adequate before treating to avoid masking deficiency",
              "orderSentence": "Folate 1 mg PO daily PO"
            },
            "contraindications": "None",
            "monitoring": "Folate level at 3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "MCI with high likelihood of AD pathology (amnestic MCI, positive biomarkers); modest symptomatic benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; may increase to 10 mg qHS; limited evidence in MCI but may offer modest benefit",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe COPD",
            "monitoring": "Bradycardia, GI symptoms, vivid dreams; limited efficacy data in MCI",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Alternative to donepezil; better GI tolerability; MCI with positive AD biomarkers",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch 9.5 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr; increase q4wk to 9.5 mg/24hr; limited evidence in MCI",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Same as donepezil; severe hepatic impairment",
            "monitoring": "Skin irritation, GI symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression contributing to cognitive symptoms (pseudodementia component)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT risk",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "QTc at baseline and if dose >20 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety contributing to cognitive complaints",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs; caution with bleeding risk",
            "monitoring": "GI upset initially; reassess cognition after mood improves",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety with cognitive symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Escitalopram 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase to 10 mg after 1 week; max 10 mg in elderly",
              "orderSentence": "Escitalopram 5 mg daily PO"
            },
            "contraindications": "QT prolongation; MAOIs",
            "monitoring": "QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite, insomnia, and weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain (may be beneficial), sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion",
            "route": "PO",
            "indication": "Depression with fatigue; avoid if seizure risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Bupropion 100 mg BID PO"
                },
                {
                  "text": "150 mg SR BID",
                  "orderSentence": "Bupropion 150 mg SR BID PO"
                },
                {
                  "text": "300 mg XL daily",
                  "orderSentence": "Bupropion 300 mg XL daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID or 150 mg SR daily; increase after 1 week; max 300 mg/day",
              "orderSentence": "Bupropion 100 mg BID PO"
            },
            "contraindications": "Seizure disorder; eating disorder; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; may improve alertness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia in MCI patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate to effect; typical 50-100 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension, morning sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm support",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Melatonin 1 mg qHS PO"
                },
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Melatonin 5 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1-3 mg qHS; may increase to 5 mg; take 30 min before bed",
              "orderSentence": "Melatonin 1 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Daytime sedation; limited long-term data",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cardiovascular Risk Factor Management": [
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "Hyperlipidemia; vascular risk reduction; may slow cognitive decline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Atorvastatin 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Atorvastatin 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Atorvastatin 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Atorvastatin 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg daily; titrate to LDL goal; target LDL <100 (or <70 if established CVD)",
              "orderSentence": "Atorvastatin 10 mg daily PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline; lipid panel q3-6mo initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "Hyperlipidemia; alternative statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Rosuvastatin 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Rosuvastatin 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rosuvastatin 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; adjust to LDL goal",
              "orderSentence": "Rosuvastatin 5 mg daily PO"
            },
            "contraindications": "Active liver disease; severe renal impairment (dose adjust)",
            "monitoring": "LFTs, lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Hypertension; target BP <130/80 for vascular protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Lisinopril 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Lisinopril 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate q2wk to BP goal",
              "orderSentence": "Lisinopril 5 mg daily PO"
            },
            "contraindications": "Angioedema history; pregnancy; bilateral renal artery stenosis",
            "monitoring": "K+, Cr, BP; cough",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "Hypertension; especially if ACE-I intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg daily",
                  "orderSentence": "Amlodipine 2.5 mg daily PO"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Amlodipine 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Amlodipine 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg daily; increase q2wk; max 10 mg",
              "orderSentence": "Amlodipine 2.5 mg daily PO"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "Peripheral edema, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Losartan",
            "route": "PO",
            "indication": "Hypertension; alternative if ACE-I intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Losartan 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Losartan 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Losartan 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg daily; titrate to BP goal; max 100 mg",
              "orderSentence": "Losartan 25 mg daily PO"
            },
            "contraindications": "Same as lisinopril",
            "monitoring": "K+, Cr, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metformin",
            "route": "PO",
            "indication": "Type 2 diabetes; potential neuroprotective effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg daily",
                  "orderSentence": "Metformin 500 mg daily PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Metformin 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Metformin 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg daily with meal; increase by 500 mg weekly; max 2000 mg/day",
              "orderSentence": "Metformin 500 mg daily PO"
            },
            "contraindications": "eGFR <30; risk of lactic acidosis",
            "monitoring": "HbA1c q3mo; B12 annually (metformin reduces absorption)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin (low-dose)",
            "route": "PO",
            "indication": "Secondary prevention if established CVD; not for primary prevention in MCI",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily; only if established CVD or high vascular risk",
              "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
            },
            "contraindications": "Active bleeding; aspirin allergy; high bleeding risk",
            "monitoring": "GI symptoms; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "MCI due to AD with confirmed amyloid pathology (positive amyloid PET or CSF biomarkers)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg IV q2wk",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over 1 hour; continue as long as benefit maintained",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
            },
            "pretreatment": "Amyloid PET or CSF confirming amyloid positivity; MRI baseline (within 1 year); APOE genotyping recommended; informed consent for ARIA risk",
            "contraindications": ">4 microbleeds on MRI; superficial siderosis; anticoagulation (increased ARIA risk); recent stroke/TIA",
            "monitoring": "MRI at baseline, weeks 14, 52, 78; monitor for ARIA-E/H symptoms (headache, confusion, vision changes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "MCI due to AD with confirmed amyloid and intermediate/high tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg IV q4wk x 3",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
                },
                {
                  "text": "1400 mg IV q4wk",
                  "orderSentence": "Donanemab (Kisunla) 1400 mg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg q4wk x 3 doses, then 1400 mg q4wk until amyloid cleared (PET-guided discontinuation)",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
            },
            "pretreatment": "Amyloid PET positive; tau PET intermediate/high; MRI baseline; APOE genotyping",
            "contraindications": "APOE4 homozygotes have higher ARIA risk; >4 microbleeds; anticoagulation",
            "monitoring": "MRI at baseline, weeks 16, 24, 52, 76; amyloid PET to guide discontinuation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for MCI subtype characterization, biomarker interpretation, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline, characterize affected domains, and distinguish MCI subtypes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatrics for comprehensive geriatric assessment, polypharmacy review, and functional optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for cognitive strategies, compensatory techniques, and home safety evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy driving evaluation to assess fitness to drive given cognitive impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for community resources, support services, and early care planning guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies if language domain affected (non-amnestic MCI)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for sleep apnea evaluation if symptoms present (snoring, daytime sleepiness, witnessed apneas)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression evaluation if significant mood symptoms confounding cognitive assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling if early-onset (<65), family history of early-onset dementia, or considering genetic testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical trial referral for eligible patients interested in research studies targeting MCI and early AD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, and financial planning while patient has full capacity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCP follow-up for cardiovascular risk factor management and coordination of vascular prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return if sudden confusion worsens or new neurological symptoms develop which may indicate stroke or other acute process",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives and establish healthcare proxy NOW while you have full capacity to make decisions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider long-term care preferences, financial planning, and legal arrangements with family while fully competent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Discuss driving safety with physician; formal driving evaluation recommended as MCI may affect reaction time and judgment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use memory aids (calendars, smartphone reminders, pill organizers, written lists) to compensate for memory difficulties",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a consistent daily routine which helps with memory and reduces confusion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; bring medication list to all appointments",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return for follow-up cognitive testing every 6-12 months to monitor for progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new memory concerns, personality changes, or functional difficulties to physician promptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid anticholinergic medications (diphenhydramine, PM sleep aids) as they can worsen cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Engage in regular aerobic exercise (150 minutes/week moderate intensity) which may slow cognitive decline and improve brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow Mediterranean or MIND diet emphasizing vegetables, berries, fish, nuts, whole grains, and olive oil to reduce dementia risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Participate in cognitively stimulating activities (reading, puzzles, learning new skills, social engagement) to build cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain active social connections and relationships as social isolation is a modifiable dementia risk factor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Achieve adequate sleep (7-8 hours nightly) and treat sleep disorders (CPAP for sleep apnea) as poor sleep accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control with target BP <130/80, HbA1c <7%, LDL <100 to reduce vascular contribution to cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Address hearing loss with hearing aids as untreated hearing loss is a modifiable risk factor for cognitive decline",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to maximum 1 drink daily as excess alcohol accelerates brain atrophy and cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk and improve overall brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress through relaxation techniques, mindfulness, or counseling as chronic stress impairs cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Review all medications with physician to identify and discontinue drugs that impair cognition (anticholinergics, benzodiazepines, opioids)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Normal aging",
        "features": "Subjective memory concerns without objective impairment; no functional decline; normal neuropsych testing",
        "tests": "Neuropsychological testing within 1 SD of norms"
      },
      {
        "diagnosis": "Subjective cognitive decline",
        "features": "Memory complaints but normal objective testing; may be earliest preclinical stage",
        "tests": "Neuropsychological testing normal; monitor annually"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of and distressed by deficits; improves with antidepressants",
        "tests": "GDS, PHQ-9; trial of antidepressant; reassess cognition"
      },
      {
        "diagnosis": "Medication-induced cognitive impairment",
        "features": "Temporal relationship to medication initiation; improvement with discontinuation",
        "tests": "Medication review; trial discontinuation of suspect agents"
      },
      {
        "diagnosis": "Sleep apnea-related cognitive impairment",
        "features": "Excessive daytime sleepiness; snoring; morning headaches; reversible with CPAP",
        "tests": "Polysomnography; cognitive reassessment after CPAP"
      },
      {
        "diagnosis": "Alzheimer's disease (dementia stage)",
        "features": "Functional impairment in ADLs (not just IADLs); more severe cognitive deficits",
        "tests": "Functional assessment; neuropsychological testing"
      },
      {
        "diagnosis": "Vascular cognitive impairment",
        "features": "Stepwise decline; focal findings; executive dysfunction prominent; significant white matter disease",
        "tests": "MRI with confluent white matter disease; vascular risk factors"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (prodromal)",
        "features": "Visual hallucinations; REM sleep behavior disorder; parkinsonism; fluctuating cognition",
        "tests": "DaTscan; clinical features; sleep study for RBD"
      },
      {
        "diagnosis": "Frontotemporal dementia (prodromal)",
        "features": "Behavioral/personality changes; disinhibition; apathy; language variants; typically <65",
        "tests": "FDG-PET frontal/temporal hypometabolism; neuropsychological profile"
      },
      {
        "diagnosis": "Thyroid dysfunction",
        "features": "Fatigue, weight changes, cold/heat intolerance; reversible with treatment",
        "tests": "TSH, free T4; reassess after treatment"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Peripheral neuropathy; macrocytic anemia; reversible with replacement",
        "tests": "B12, MMA; improvement with supplementation"
      }
    ],
    "evidence": [
      {
        "recommendation": "MCI diagnostic criteria and subtypes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Petersen et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15477521/); [Albert et al. Alzheimers Dement 2011](https://pubmed.ncbi.nlm.nih.gov/21514249/)"
      },
      {
        "recommendation": "Neuropsychological testing for MCI diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN Practice Parameter 2018](https://pubmed.ncbi.nlm.nih.gov/29282327/)"
      },
      {
        "recommendation": "CSF biomarkers for AD pathology",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Amyloid PET for AD diagnosis in MCI",
        "evidenceLevel": "Class I, Level A",
        "source": "[Johnson et al. Alzheimers Dement 2013](https://pubmed.ncbi.nlm.nih.gov/23360977/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors limited benefit in MCI",
        "evidenceLevel": "Class I, Level B",
        "source": "[Petersen et al. NEJM 2005](https://pubmed.ncbi.nlm.nih.gov/15800226/); [Russ & Morling, Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22972104/)"
      },
      {
        "recommendation": "Lecanemab slows decline in MCI due to AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission on Dementia)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Mediterranean/MIND diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Morris et al. Alzheimers Dement 2015](https://pubmed.ncbi.nlm.nih.gov/25681666/)"
      },
      {
        "recommendation": "Cardiovascular risk factor control protects cognition",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ngandu et al. Lancet 2015 (FINGER trial)](https://pubmed.ncbi.nlm.nih.gov/25771249/)"
      },
      {
        "recommendation": "Sleep apnea treatment improves cognition",
        "evidenceLevel": "Class II, Level B",
        "source": "[Osorio et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25878179/)"
      },
      {
        "recommendation": "MCI progression rate to dementia (~10-15%/year)",
        "evidenceLevel": "Epidemiological",
        "source": "[Mitchell & Shiri-Feshki, Acta Psychiatr Scand 2009](https://pubmed.ncbi.nlm.nih.gov/19327298/)"
      },
      {
        "recommendation": "Hearing loss as modifiable dementia risk factor",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lin et al. Arch Neurol 2011](https://pubmed.ncbi.nlm.nih.gov/21320988/)"
      },
      {
        "recommendation": "Modifiable risk factors for dementia prevention",
        "evidenceLevel": "Class II, Level A",
        "source": "[Livingston et al. Lancet 2024 (Lancet Commission Update)](https://pubmed.ncbi.nlm.nih.gov/39096926/)"
      }
    ],
    "monitoring": [
      {
        "item": "MoCA or MMSE",
        "frequency": "Every 6-12 months",
        "action": "Decline >3 points or reaching dementia threshold warrants reassessment; consider biomarker workup if not done",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Full neuropsychological testing",
        "frequency": "Every 1-2 years or if significant change",
        "action": "Decline suggests progression to dementia; adjust care plan",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "IADL/ADL function (FAQ, Lawton)",
        "frequency": "Every 6-12 months",
        "action": "Functional decline suggests progression to dementia; increase supports",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (GDS, PHQ-9)",
        "frequency": "Annually or if symptoms",
        "action": "Treat depression; reassess cognition after treatment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize antihypertensive therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (if diabetic)",
        "frequency": "Every 3-6 months",
        "action": "Optimize glycemic control",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lipid panel",
        "frequency": "Annually",
        "action": "Optimize statin therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin B12",
        "frequency": "Annually",
        "action": "Supplement if low",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH",
        "frequency": "Annually",
        "action": "Treat thyroid dysfunction",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI (ARIA monitoring if on anti-amyloid)",
        "frequency": "Per protocol (baseline, weeks 14, 52, 78 for lecanemab)",
        "action": "Hold infusion per protocol; resume after resolution",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving safety",
        "frequency": "Annually or with decline",
        "action": "Recommend driving cessation or OT driving evaluation",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment if declining",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver/family concerns",
        "frequency": "Each visit",
        "action": "Investigate reported changes; adjust care plan",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management (most MCI)",
        "criteria": "Stable MCI; reversible causes addressed; care plan established; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; safety concerns at home; caregiver crisis"
      },
      {
        "disposition": "Outpatient neurology follow-up",
        "criteria": "Every 6-12 months for cognitive monitoring; sooner if concerns"
      },
      {
        "disposition": "Outpatient neuropsychology",
        "criteria": "At diagnosis for baseline; repeat in 1-2 years or if significant change"
      },
      {
        "disposition": "Referral to memory care program",
        "criteria": "Progressive decline; need for specialized multidisciplinary management"
      },
      {
        "disposition": "Clinical trial referral",
        "criteria": "Eligible patient interested in research; positive biomarkers; early stage"
      }
    ]
  },
  "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)": {
    "id": "cidp",
    "title": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
    "version": "1.0",
    "icd10": [
      "** G61.81"
    ],
    "scope": "** Evaluation, diagnosis, treatment initiation, and long-term management of CIDP in adults. Covers typical CIDP, CIDP variants (MADSAM, DADS, sensory CIDP), first-line immunotherapy (IVIg, corticosteroids, plasmapheresis), second-line immunosuppressants, and subcutaneous immunoglobulin therapy. Primary focus is outpatient management with coverage for acute presentations and hospitalizations. Excludes Guillain-Barré syndrome (acute onset <8 weeks), hereditary neuropathies (CMT), and pediatric CIDP.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline, infection screen, pre-treatment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal/hepatic function for IVIg",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory marker; elevated in some CIDP",
            "target": "Document baseline",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Document baseline",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetic neuropathy in differential; diabetes worsens CIDP",
            "target": "<5.7% (normal); >6.5% diagnostic for diabetes",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease causing neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency neuropathy",
            "target": ">300 pg/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Methylmalonic acid",
            "rationale": "If B12 borderline (200-400 pg/mL)",
            "target": "Normal if B12 sufficient",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "rationale": "Paraproteinemic neuropathy screen",
            "target": "No monoclonal spike",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum immunofixation",
            "rationale": "Confirms monoclonal protein if SPEP abnormal",
            "target": "Characterize M-protein",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated neuropathy/CIDP",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening; HBV reactivation risk",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis B core antibody",
            "rationale": "Prior HBV exposure; reactivation risk with immunosuppression",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "HCV-associated cryoglobulinemic neuropathy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Extended Workup": [
          {
            "item": "Urine protein electrophoresis (UPEP)",
            "rationale": "Light chain deposition in neuropathy",
            "target": "No monoclonal protein",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum free light chains",
            "rationale": "AL amyloidosis, POEMS screening",
            "target": "Normal kappa:lambda ratio",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VEGF level",
            "rationale": "Elevated in POEMS syndrome",
            "target": "Normal (<200 pg/mL)",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-MAG antibody",
            "rationale": "DADS variant; IgM paraproteinemic neuropathy",
            "target": "Negative (if positive, suggests DADS-CIDP or anti-MAG neuropathy)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b)",
            "rationale": "MMN differentiation; axonal GBS variants",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-GQ1b antibody",
            "rationale": "Miller Fisher variant if ophthalmoplegia",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "rationale": "IgA deficiency (IVIg contraindication); IgM elevation",
            "target": "IgA >7 mg/dL; document IgM",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ANA",
            "rationale": "Connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rheumatoid factor",
            "rationale": "Vasculitic neuropathy screen",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-SSA/SSB",
            "rationale": "Sjogren syndrome neuropathy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoid neuropathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP, pre-PLEX",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-contactin-1 (CNTN1) antibody",
            "rationale": "Aggressive CIDP variant; poor IVIg response",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-neurofascin-155 (NF155) antibody",
            "rationale": "Young onset, tremor, poor IVIg response",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-caspr-1 antibody",
            "rationale": "Nodopathy; aggressive course",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-NF186/NF140 antibodies",
            "rationale": "Nodal/paranodal antibodies",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Genetic testing for CMT",
            "rationale": "If family history or atypical features",
            "target": "Negative (excludes CMT)",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area, outdoor exposure",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Heavy metals (lead, arsenic)",
            "rationale": "Toxic neuropathy differential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Urine porphyrins",
            "rationale": "Motor neuropathy with systemic symptoms",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Bone marrow biopsy",
            "rationale": "If POEMS or amyloidosis suspected",
            "target": "Normal or diagnostic",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Fat pad biopsy for amyloid",
            "rationale": "If amyloidosis suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Cryoglobulins",
            "rationale": "If HCV positive or vasculitic features",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Baseline; usually normal in CIDP",
            "target": "10-20 cmH2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Albuminocytologic dissociation",
            "target": "WBC <10/mm³ (usually <5)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in CIDP",
            "target": "Elevated (>45 mg/dL; often 50-200 mg/dL)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Glucose",
            "rationale": "Exclude infection",
            "target": "Normal (>60% serum glucose)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Exclude infection",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Cytology",
            "rationale": "Exclude carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis in differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "MS or CNS inflammation in differential",
            "target": "Usually negative; may be mildly positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS)",
            "timing": "At diagnosis; before treatment",
            "target": "Demyelinating features: prolonged distal latencies (>125% ULN), slow conduction velocities (<80% LLN), conduction block, temporal dispersion, prolonged F-waves",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Electromyography (EMG)",
            "timing": "At diagnosis; with NCS",
            "target": "Secondary axonal loss; fibrillations in severe cases",
            "contraindications": "Severe coagulopathy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Chest X-ray",
            "timing": "Pre-treatment baseline",
            "target": "Normal (rule out mass if paraneoplastic concern)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine with contrast (cervical/lumbar)",
            "timing": "Diagnostic workup",
            "target": "Nerve root enhancement, cauda equina hypertrophy",
            "contraindications": "Pacemaker, severe claustrophobia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRI brachial plexus with contrast",
            "timing": "If asymmetric or plexus involvement",
            "target": "Nerve hypertrophy, enhancement",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRI lumbosacral plexus with contrast",
            "timing": "If lower extremity predominant",
            "target": "Plexus enhancement, thickening",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Nerve ultrasound",
            "timing": "Complementary to MRI; assess nerve enlargement",
            "target": "Increased cross-sectional area of peripheral nerves",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "If POEMS or malignancy suspected",
            "target": "Sclerotic bone lesions (POEMS), organomegaly",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult malignancy, lymphoma, Castleman disease",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Nerve biopsy (sural)",
            "timing": "Diagnostic uncertainty, vasculitis suspected",
            "target": "Demyelination, inflammation, onion bulbs",
            "contraindications": "Active infection at site",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Skeletal survey",
            "timing": "POEMS evaluation",
            "target": "Sclerotic or lytic lesions",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Treatment": {
        "First-line Immunotherapy - Induction": [
          {
            "item": "IVIg (immune globulin IV) - Loading",
            "route": "IV",
            "indication": "First-line induction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg over 2-5 days",
                  "orderSentence": "IVIg (immune globulin IV) - Loading 2 g/kg over 2-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg total divided over 2-5 days (e.g., 0.4 g/kg/day x 5 days or 1 g/kg/day x 2 days); infuse slowly day 1 (start 0.5-1 mL/kg/hr, max 4 mL/kg/hr)",
              "orderSentence": "IVIg (immune globulin IV) - Loading 2 g/kg over 2-5 days IV"
            },
            "contraindications": "IgA deficiency with anti-IgA antibodies; uncontrolled heart failure; recent thrombosis; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; pre-medicate with acetaminophen and diphenhydramine",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone - Daily",
            "route": "PO",
            "indication": "First-line induction (if IVIg unavailable or contraindicated)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone - Daily 60 mg daily PO"
                },
                {
                  "text": "1 mg/kg daily",
                  "orderSentence": "Prednisone - Daily 1 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60 mg (or 1 mg/kg) daily for 4-8 weeks until clinical improvement, then begin slow taper",
              "orderSentence": "Prednisone - Daily 60 mg daily PO"
            },
            "contraindications": "Uncontrolled diabetes, active infection, psychosis, osteoporosis",
            "monitoring": "Glucose, BP, bone density, mood, infection signs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Prednisone - Pulse",
            "route": "PO",
            "indication": "Alternative oral pulse therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily x 5 days monthly",
                  "orderSentence": "Prednisone - Pulse 40 mg daily x 5 days monthly PO"
                }
              ],
              "route": "PO",
              "instructions": "40-60 mg daily for 5 consecutive days each month; may have fewer side effects than daily",
              "orderSentence": "Prednisone - Pulse 40 mg daily x 5 days monthly PO"
            },
            "contraindications": "Uncontrolled diabetes, active infection",
            "monitoring": "Glucose, BP during pulse",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Methylprednisolone - IV Pulse",
            "route": "IV",
            "indication": "Severe CIDP, rapid induction needed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 3-5 days",
                  "orderSentence": "Methylprednisolone - IV Pulse 1000 mg daily x 3-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily for 3-5 days; can repeat monthly as needed; transition to oral",
              "orderSentence": "Methylprednisolone - IV Pulse 1000 mg daily x 3-5 days IV"
            },
            "contraindications": "Active untreated infection, uncontrolled HTN/diabetes",
            "monitoring": "Glucose, BP, K+, psychiatric effects",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "—",
            "indication": "First-line if IVIg/steroids contraindicated or failed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 exchanges over 2-4 weeks",
                  "orderSentence": "Plasma exchange (PLEX) 5-10 exchanges over 2-4 weeks —"
                }
              ],
              "route": "—",
              "instructions": "5-10 exchanges (1-1.5 plasma volumes each) over 2-4 weeks; typically 2-3 sessions per week",
              "orderSentence": "Plasma exchange (PLEX) 5-10 exchanges over 2-4 weeks —"
            },
            "contraindications": "Hemodynamic instability, severe sepsis, poor vascular access",
            "monitoring": "BP, electrolytes, coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "First-line Immunotherapy - Maintenance": [
          {
            "item": "IVIg - Maintenance",
            "route": "IV",
            "indication": "Maintenance after loading response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg q3wk",
                  "orderSentence": "IVIg - Maintenance 0.4 g/kg q3wk IV"
                },
                {
                  "text": "0.5 g/kg q3wk",
                  "orderSentence": "IVIg - Maintenance 0.5 g/kg q3wk IV"
                },
                {
                  "text": "1 g/kg q3-4wk",
                  "orderSentence": "IVIg - Maintenance 1 g/kg q3-4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4-1 g/kg every 3-4 weeks; titrate to lowest effective dose and longest interval; some patients need 1 g/kg q2-3wk",
              "orderSentence": "IVIg - Maintenance 0.4 g/kg q3wk IV"
            },
            "contraindications": "IgA deficiency, renal impairment, recent thrombosis",
            "monitoring": "Renal function q3-6mo; trough IgG levels optional",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "SCIg (Hizentra) - Maintenance",
            "route": "SC",
            "indication": "Home maintenance after IVIg response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Weekly dose = IVIg monthly dose ÷ 4",
                  "orderSentence": "SCIg (Hizentra) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
                }
              ],
              "route": "SC",
              "instructions": "Convert from IVIg: weekly SC dose equals monthly IV dose divided by 4; typical range 0.2-0.4 g/kg/week; divide into 1-7 infusions/week",
              "orderSentence": "SCIg (Hizentra) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
            },
            "contraindications": "Severe thrombocytopenia, skin conditions at injection site",
            "monitoring": "Local site reactions; IgG trough levels q6mo",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "SCIg (Gamunex-C 10%) - Maintenance",
            "route": "SC",
            "indication": "Home maintenance alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Weekly dose = IVIg monthly dose ÷ 4",
                  "orderSentence": "SCIg (Gamunex-C 10%) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
                }
              ],
              "route": "SC",
              "instructions": "Same as Hizentra; 10% concentration; can give larger volume per site",
              "orderSentence": "SCIg (Gamunex-C 10%) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
            },
            "contraindications": "Severe thrombocytopenia",
            "monitoring": "Local reactions, IgG levels",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Prednisone - Maintenance taper",
            "route": "PO",
            "indication": "Continuation after steroid induction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Taper by 5-10 mg q2-4wk",
                  "orderSentence": "Prednisone - Maintenance taper Taper by 5-10 mg q2-4wk PO"
                }
              ],
              "route": "PO",
              "instructions": "After improvement, taper by 5-10 mg every 2-4 weeks; target lowest effective dose (often 5-20 mg daily or QOD); add steroid-sparing agent if unable to taper below 15-20 mg",
              "orderSentence": "Prednisone - Maintenance taper Taper by 5-10 mg q2-4wk PO"
            },
            "contraindications": "Ongoing infection",
            "monitoring": "Glucose, BP, bone density, cataracts",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Second-line/Steroid-Sparing Agents": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing; maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                },
                {
                  "text": "2-3 mg/kg daily",
                  "orderSentence": "Azathioprine 2-3 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg every 2-4 weeks to target 2-3 mg/kg/day; check TPMT before starting; onset 3-6 months",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "contraindications": "TPMT deficiency, pregnancy, myelosuppression",
            "monitoring": "CBC weekly x 4 weeks, then monthly x 3 months, then q3mo; LFTs monthly",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing; maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks; onset 2-4 months",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "contraindications": "Pregnancy (teratogenic), severe renal impairment",
            "monitoring": "CBC q2wk x 2 months, then monthly; LFTs",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Refractory CIDP, nodal antibody-positive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² weekly x 4 doses OR 1000 mg x 2 doses (2 weeks apart); repeat q6-12mo PRN; pre-medicate",
              "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
            },
            "contraindications": "Active infection, HBV (screen first; may reactivate)",
            "monitoring": "Infusion reactions, CD19/CD20 counts, immunoglobulins; HBV DNA if prior exposure",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "Severe refractory CIDP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g/m² monthly x 6 months",
                  "orderSentence": "Cyclophosphamide 1 g/m² monthly x 6 months IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g/m² IV monthly for 6 months; reserve for severe refractory cases",
              "orderSentence": "Cyclophosphamide 1 g/m² monthly x 6 months IV"
            },
            "contraindications": "Pregnancy, active infection, hemorrhagic cystitis",
            "monitoring": "CBC, urinalysis, fertility counseling; MESNA for bladder protection",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Cyclosporine",
            "route": "PO",
            "indication": "Steroid-sparing alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 mg/kg/day divided BID",
                  "orderSentence": "Cyclosporine 2.5-5 mg/kg/day divided BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg/kg/day divided BID; increase to 5 mg/kg/day based on levels and response; target trough 100-200 ng/mL",
              "orderSentence": "Cyclosporine 2.5-5 mg/kg/day divided BID PO"
            },
            "contraindications": "Uncontrolled HTN, renal impairment",
            "monitoring": "Cr, BP, drug levels, K+, Mg",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Disease-Modifying Therapy - Special Populations": [
          {
            "item": "IVIg - Anti-MAG positive",
            "route": "IV",
            "indication": "Anti-MAG neuropathy (may have partial response)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg loading then 0.4-1 g/kg q3-4wk",
                  "orderSentence": "IVIg - Anti-MAG positive 2 g/kg loading then 0.4-1 g/kg q3-4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "Anti-MAG neuropathy often less responsive to IVIg; may require rituximab if poor response",
              "orderSentence": "IVIg - Anti-MAG positive 2 g/kg loading then 0.4-1 g/kg q3-4wk IV"
            },
            "pretreatment": "SPEP/UPEP to assess for underlying plasma cell dyscrasia",
            "contraindications": "IgA deficiency",
            "monitoring": "Response may be slower; consider rituximab if no improvement",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab - Anti-MAG positive",
            "route": "IV",
            "indication": "Anti-MAG neuropathy preferred therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab - Anti-MAG positive 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab - Anti-MAG positive 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "First-line for anti-MAG neuropathy given superior efficacy; repeat q6-12mo",
              "orderSentence": "Rituximab - Anti-MAG positive 375 mg/m² weekly x 4 weeks IV"
            },
            "pretreatment": "HBV/HCV screening, quantitative immunoglobulins, CBC",
            "contraindications": "Active HBV, active infection",
            "monitoring": "Anti-MAG titers, CD19/20, immunoglobulins",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab - Nodal antibody positive (NF155, CNTN1)",
            "route": "IV",
            "indication": "CIDP with nodal/paranodal antibodies",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab - Nodal antibody positive (NF155, CNTN1) 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab - Nodal antibody positive (NF155, CNTN1) 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "Preferred for NF155/CNTN1/CASPR1 positive CIDP (poor IVIg response); repeat q6mo",
              "orderSentence": "Rituximab - Nodal antibody positive (NF155, CNTN1) 375 mg/m² weekly x 4 weeks IV"
            },
            "pretreatment": "HBV/HCV screening, immunoglobulins",
            "contraindications": "Active HBV",
            "monitoring": "Antibody titers, B-cell counts",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness, edema; reduce dose if CrCl <60",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 600 mg/day",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, edema, weight gain",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain, depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily; increase to 60 mg daily after 1-2 weeks; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Uncontrolled glaucoma, severe hepatic impairment, MAOIs",
            "monitoring": "BP, hepatic function, serotonin syndrome",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain, sleep",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac arrhythmias, recent MI, glaucoma, urinary retention",
            "monitoring": "ECG if >100 mg/day; anticholinergic effects",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h PRN",
                  "orderSentence": "Acetaminophen 650 mg q6h PRN PO"
                },
                {
                  "text": "1000 mg q6h PRN",
                  "orderSentence": "Acetaminophen 1000 mg q6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg q6h PRN; max 4 g/day (3 g if hepatic impairment)",
              "orderSentence": "Acetaminophen 650 mg q6h PRN PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged use",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Mexiletine",
            "route": "PO",
            "indication": "Muscle cramps, neuropathic pain (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg TID",
                  "orderSentence": "Mexiletine 150 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Mexiletine 200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg TID; may increase to 200-300 mg TID; max 1200 mg/day",
              "orderSentence": "Mexiletine 150 mg TID PO"
            },
            "contraindications": "Cardiac arrhythmia, heart block",
            "monitoring": "ECG, hepatic function",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Muscle cramps, spasms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose every 3 days; max 80 mg/day",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Severe renal impairment",
            "monitoring": "Sedation; do not stop abruptly",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Prophylaxis and Supportive Care": [
          {
            "item": "Calcium + Vitamin D",
            "route": "PO",
            "indication": "Bone protection on steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Calcium 1000-1200 mg daily",
                  "orderSentence": "Calcium + Vitamin D Calcium 1000-1200 mg daily PO"
                },
                {
                  "text": "Vitamin D 800-2000 IU daily",
                  "orderSentence": "Calcium + Vitamin D Vitamin D 800-2000 IU daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 500-600 mg BID (with food) + Vitamin D 800-2000 IU daily for all patients on chronic steroids",
              "orderSentence": "Calcium + Vitamin D Calcium 1000-1200 mg daily PO"
            },
            "contraindications": "Hypercalcemia, kidney stones",
            "monitoring": "Calcium levels, 25-OH vitamin D",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Bisphosphonate (alendronate)",
            "route": "PO",
            "indication": "Osteoporosis prevention on steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg weekly",
                  "orderSentence": "Bisphosphonate (alendronate) 70 mg weekly PO"
                }
              ],
              "route": "PO",
              "instructions": "70 mg PO weekly if prednisone >7.5 mg for >3 months; take with water, remain upright 30 min",
              "orderSentence": "Bisphosphonate (alendronate) 70 mg weekly PO"
            },
            "contraindications": "Esophageal disorders, CrCl <35, hypocalcemia",
            "monitoring": "DEXA scan at baseline and q1-2yr; dental exam",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI protection on steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Omeprazole 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily for patients on high-dose steroids or with GI symptoms",
              "orderSentence": "Omeprazole 20 mg daily PO"
            },
            "contraindications": "Long-term use concerns (Mg, B12, fractures)",
            "monitoring": "Mg levels if prolonged",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Aspirin (low-dose)",
            "route": "PO",
            "indication": "Thrombosis prevention with IVIg",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily during IVIg infusions for patients with thrombosis risk factors (age >60, obesity, immobility, prior VTE, hyperviscosity)",
              "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
            },
            "contraindications": "Active bleeding, allergy",
            "monitoring": "None routine",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (immobile patients)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily for immobile hospitalized patients; continue until ambulating",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, CrCl <30",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "PCP prophylaxis (TMP-SMX)",
            "route": "PO",
            "indication": "Pneumocystis prevention on high-dose steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 DS tablet 3x/week",
                  "orderSentence": "PCP prophylaxis (TMP-SMX) 1 DS tablet 3x/week PO"
                }
              ],
              "route": "PO",
              "instructions": "TMP-SMX DS (160/800 mg) 3x/week or daily if prednisone >20 mg for >4 weeks + another immunosuppressant",
              "orderSentence": "PCP prophylaxis (TMP-SMX) 1 DS tablet 3x/week PO"
            },
            "contraindications": "Sulfa allergy (use dapsone or atovaquone)",
            "monitoring": "CBC, renal function",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, treatment initiation, and long-term management planning",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neuromuscular specialist referral for diagnostic uncertainty, treatment-refractory cases, or consideration of advanced therapies",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Infusion center referral for ongoing IVIg administration and monitoring",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Home infusion service referral for SCIg training and home therapy setup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Physical therapy for gait training, fall prevention, strengthening exercises, and mobility optimization",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Occupational therapy for ADL assessment, adaptive equipment, and energy conservation strategies",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Pain management consult for refractory neuropathic pain not responding to gabapentin/pregabalin/duloxetine",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Endocrinology consult for steroid-induced diabetes management or osteoporosis prevention",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Hematology consult if monoclonal protein detected for POEMS or myeloma workup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Pulmonology consult if respiratory symptoms develop (rare in CIDP; consider GBS overlap)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Rheumatology consult if connective tissue disease suspected based on labs or clinical features",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work for disability resources, transportation assistance, and community support services",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "PCP follow-up for chronic disease management, steroid side effect monitoring, and preventive care",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if progressive weakness, difficulty walking, or breathing problems develop (may indicate disease progression or acute worsening)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Keep all IVIg/infusion appointments as scheduled to maintain disease control and prevent relapses",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop immunosuppressive medications suddenly as this may cause disease flare; taper only under physician guidance",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Report signs of infection (fever, cough, dysuria) promptly as immunosuppression increases infection risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Use fall precautions including handrails, non-slip surfaces, and assistive devices due to balance and weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Perform home exercises as prescribed by physical therapy to maintain strength and flexibility",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for IVIg side effects including headache, fever, chills, or rash during infusions; report severe symptoms",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a symptom diary tracking strength, numbness, and functional abilities to share at follow-up visits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry a medical ID card indicating CIDP diagnosis and current treatments in case of emergency",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact GBS-CIDP Foundation (www.gbs-cidp.org) for patient education, support groups, and resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Maintain glycemic control (HbA1c <7%) to prevent worsening of neuropathy if diabetic",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol consumption as alcohol worsens peripheral neuropathy and interacts with medications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ensure adequate vitamin B12 and folate intake through diet or supplementation to support nerve health",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid smoking as it impairs circulation and may worsen neuropathy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay up to date on vaccinations (flu, pneumonia, COVID-19, shingles) but avoid live vaccines while on immunosuppression",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear protective footwear to prevent injury to numb feet and avoid burns or trauma",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform daily foot inspections for wounds or ulcers given sensory loss",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in low-impact exercise (swimming, stationary cycling, walking) to maintain cardiovascular health and strength",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain bone health with calcium, vitamin D, and weight-bearing exercise, especially if on steroids",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress and get adequate sleep as fatigue worsens CIDP symptoms",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Guillain-Barré syndrome (GBS)",
        "features": "Acute onset (<4 weeks to nadir); monophasic; often post-infectious",
        "tests": "Time course (<8 weeks); NCS; CSF"
      },
      {
        "diagnosis": "Multifocal motor neuropathy (MMN)",
        "features": "Pure motor; asymmetric; conduction block; no sensory involvement",
        "tests": "Anti-GM1 antibodies; NCS (conduction block without sensory abnormality)"
      },
      {
        "diagnosis": "POEMS syndrome",
        "features": "Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes",
        "tests": "VEGF, bone survey, SPEP/UPEP (lambda light chain)"
      },
      {
        "diagnosis": "Anti-MAG neuropathy",
        "features": "Distal, sensory-predominant; IgM paraprotein; tremor",
        "tests": "Anti-MAG antibody; SPEP/UPEP"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history; pes cavus, hammer toes; slowly progressive since childhood",
        "tests": "Genetic testing; NCS pattern"
      },
      {
        "diagnosis": "Diabetic polyneuropathy",
        "features": "Length-dependent sensory > motor; diabetes history",
        "tests": "HbA1c; NCS (axonal predominantly)"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Painful; asymmetric; multifocal (mononeuritis multiplex); systemic symptoms",
        "tests": "ESR/CRP, ANA, ANCA, nerve biopsy"
      },
      {
        "diagnosis": "Amyloid neuropathy",
        "features": "Autonomic involvement; carpal tunnel; cardiac involvement",
        "tests": "Fat pad/nerve biopsy; genetic testing (TTR); serum free light chains"
      },
      {
        "diagnosis": "Lymphoma/paraneoplastic",
        "features": "Weight loss, lymphadenopathy; subacute course",
        "tests": "CT/PET; paraneoplastic panel"
      },
      {
        "diagnosis": "Sarcoid neuropathy",
        "features": "Multisystem involvement; skin, lungs, lymph nodes",
        "tests": "ACE level; chest imaging; biopsy"
      },
      {
        "diagnosis": "Paraproteinemic neuropathy (other)",
        "features": "IgG or IgA monoclonal; may mimic CIDP",
        "tests": "SPEP/UPEP; bone marrow biopsy"
      },
      {
        "diagnosis": "Drug-induced neuropathy",
        "features": "Temporal relationship to drug; axonal pattern",
        "tests": "Medication review; NCS"
      },
      {
        "diagnosis": "HIV-associated neuropathy",
        "features": "HIV risk factors; may have CSF pleocytosis",
        "tests": "HIV testing; CD4 count"
      },
      {
        "diagnosis": "Lyme neuroborreliosis",
        "features": "Endemic area; facial palsy; radicular pain; CSF pleocytosis",
        "tests": "Lyme serology; CSF Lyme antibodies"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Lancet Neurol 2008 (ICE Trial)](https://pubmed.ncbi.nlm.nih.gov/18178525/)"
      },
      {
        "recommendation": "IVIg dosing 2 g/kg loading, 1 g/kg maintenance",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Lancet Neurol 2008 (ICE Trial)](https://pubmed.ncbi.nlm.nih.gov/18178525/)"
      },
      {
        "recommendation": "Corticosteroids effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/29185258/)"
      },
      {
        "recommendation": "Plasma exchange effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26378276/)"
      },
      {
        "recommendation": "SCIg non-inferior to IVIg for maintenance",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Schaik et al. Lancet Neurol 2018 (PATH Trial)](https://pubmed.ncbi.nlm.nih.gov/29288189/)"
      },
      {
        "recommendation": "EFNS/PNS diagnostic criteria for CIDP",
        "evidenceLevel": "Expert Consensus",
        "source": "[Van den Bergh et al. J Peripher Nerv Syst 2021](https://pubmed.ncbi.nlm.nih.gov/34085743/)"
      },
      {
        "recommendation": "Rituximab for anti-MAG neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Dalakas et al. Ann Neurol 2009](https://pubmed.ncbi.nlm.nih.gov/19937997/)"
      },
      {
        "recommendation": "Rituximab for refractory CIDP",
        "evidenceLevel": "Class III, Level C",
        "source": "[Benedetti et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21411742/)"
      },
      {
        "recommendation": "Nodal/paranodal antibodies predict IVIg response",
        "evidenceLevel": "Class II, Level B",
        "source": "[Querol et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28566549/)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class III, Level C",
        "source": "[Hughes et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/29185258/)"
      },
      {
        "recommendation": "Mycophenolate for CIDP",
        "evidenceLevel": "Class III, Level C",
        "source": "[Gorson et al. Neurology 2004](https://pubmed.ncbi.nlm.nih.gov/15477545/)"
      },
      {
        "recommendation": "MRI nerve root enhancement supportive criterion",
        "evidenceLevel": "Class II, Level B",
        "source": "[Van den Bergh et al. J Peripher Nerv Syst 2021](https://pubmed.ncbi.nlm.nih.gov/34085743/)"
      },
      {
        "recommendation": "INCAT scale for disability measurement",
        "evidenceLevel": "Expert Consensus",
        "source": "[Merkies et al. Neurology 2002](https://pubmed.ncbi.nlm.nih.gov/11781402/)"
      },
      {
        "recommendation": "Treatment-related fluctuations in CIDP",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kuitwaard et al. J Peripher Nerv Syst 2009](https://pubmed.ncbi.nlm.nih.gov/20021564/)"
      }
    ],
    "monitoring": [
      {
        "item": "Clinical strength exam (MRC grading)",
        "frequency": "Each visit; q3-6mo stable",
        "action": "Adjust therapy if declining",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "INCAT disability score",
        "frequency": "Baseline and q6-12mo",
        "action": "Consider therapy change if worsening",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "ONLS (Overall Neuropathy Limitations Scale)",
        "frequency": "Baseline and q6-12mo",
        "action": "Consider therapy change if worsening",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Grip strength (dynamometer)",
        "frequency": "Each visit",
        "action": "Document trend; correlate with symptoms",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Timed 10-meter walk",
        "frequency": "Baseline and q6-12mo",
        "action": "Consider PT intensification if slowing",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Nerve conduction studies",
        "frequency": "Baseline, 6mo after treatment, then annually if stable",
        "action": "Guides treatment effectiveness",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Renal function (BUN/Cr)",
        "frequency": "Before each IVIg; q3-6mo on IVIg",
        "action": "Hold IVIg if rising; hydrate; may need dose adjustment",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "CBC",
        "frequency": "q3mo on immunosuppressants",
        "action": "Hold azathioprine/MMF if cytopenic",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "LFTs",
        "frequency": "q3mo on immunosuppressants",
        "action": "Hold azathioprine/MMF if significantly elevated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Blood glucose",
        "frequency": "Each visit on steroids; HbA1c q3mo",
        "action": "Intensify diabetes management",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit on steroids",
        "action": "Initiate antihypertensive if elevated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "DEXA bone density",
        "frequency": "Baseline if steroids >3mo; repeat q1-2yr",
        "action": "Bisphosphonate if osteopenia/osteoporosis",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "IgG trough level",
        "frequency": "q6mo on IVIg/SCIg (optional)",
        "action": "Adjust dose if low and clinically worsening",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Anti-MAG titer",
        "frequency": "q6-12mo if positive",
        "action": "Guides treatment response for anti-MAG",
        "ED": "—",
        "HOSP": "—",
        "OPD": "EXT",
        "ICU": "—"
      },
      {
        "item": "CD19/CD20 B-cell count",
        "frequency": "After rituximab q3-6mo",
        "action": "Guides retreatment timing",
        "ED": "—",
        "HOSP": "—",
        "OPD": "EXT",
        "ICU": "—"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable neurological exam; able to ambulate (with assistance if needed); oral medications tolerated; outpatient infusion arranged if needed; follow-up scheduled; adequate social support"
      },
      {
        "disposition": "**Admit to hospital**",
        "criteria": "Significant new weakness affecting ambulation; need for IV therapy initiation and monitoring; respiratory symptoms (rare but assess); unable to care for self at home"
      },
      {
        "disposition": "**ICU admission**",
        "criteria": "Respiratory compromise (FVC <30 mL/kg); rapidly progressive weakness raising concern for GBS overlap; severe autonomic dysfunction; hemodynamic instability"
      },
      {
        "disposition": "**Outpatient infusion center**",
        "criteria": "Stable CIDP on maintenance IVIg; appropriate for regular outpatient infusions every 3-4 weeks"
      },
      {
        "disposition": "**Home infusion (SCIg)**",
        "criteria": "Stable on IVIg who prefers home therapy; trained in self-injection; appropriate venous access not required"
      },
      {
        "disposition": "**Rehabilitation facility**",
        "criteria": "Significant residual weakness requiring intensive PT/OT; medically stable; goals for functional improvement"
      }
    ]
  }
}